1	Variants	NNS	O	variant	_	0	SENT_1	[p1l44t85r429b164],
2	in	IN	O	in	_	0	SENT_1	[p1l472t89r558b163],
3	the	DT	O	the	det	5	SENT_1	[p1l598t81r737b163],
4	VEGFA	NNP	O	VEGFA	nn	5	SENT_1	[p1l775t83r1144b183],
5	Gene	NNP	O	Gene	prep_in	1	SENT_1	[p1l1182t84r1417b163],
6	and	CC	O	and	_	0	SENT_1	[p1l1458t81r1618b163],
7	Treatment	NNP	O	Treatment	nn	8	SENT_1	[p1l44t202r523b280],
8	Outcome	NNP	O	Outcome	conj_and	5	SENT_1	[p1l562t201r972b280],
9	after	IN	O	after	_	0	SENT_1	[p1l1013t199r1220b280],
10	Anti	NNP	O	Anti	prep_after	1	SENT_1	[p1l1259t200r1797b281],
11	.	.	O	.	_	0	SENT_1	[p1l1259t200r1797b281],

1	—	NN	O	—	_	0	SENT_2	[p1l1259t200r1797b281],
2	.	.	O	.	_	0	SENT_2	[p1l1259t200r1797b281],

1	VEGF	NN	O	vegf	_	0	SENT_3	[p1l1259t200r1797b281],

1	Treatment	NN	O	treatment	_	0	SENT_4	[p1l44t318r523b396],
2	for	IN	O	for	_	0	SENT_4	[p1l562t315r691b396],
3	Neovascular	JJ	MISC	neovascular	amod	8	SENT_4	[p1l729t314r1292b397],
4	Age	NN	MISC	age	nn	8	SENT_4	[p1l1331t314r1852b417],
5	—	NN	O	—	nn	8	SENT_4	[p1l1331t314r1852b417],
6	related	JJ	O	related	amod	8	SENT_4	[p1l1331t314r1852b417],
7	Macular	NNP	ORGANIZATION	Macular	nn	8	SENT_4	[p1l43t430r414b512],
8	Degeneration	NNP	ORGANIZATION	Degeneration	prep_for	1	SENT_4	[p1l452t435r1057b533],

1	Farshad	NNP	PERSON	Farshad	nn	2	SENT_5	[p1l43t656r180b691],
2	Abedi	NNP	PERSON	Abedi	_	0	SENT_5	[p1l194t656r307b698],
3	,	,	O	,	_	0	SENT_5	[p1l194t656r307b698],
4	MD	NNP	O	MD	nn	7	SENT_5	[p1l327t650r428b698],
5	,1	CD	NUMBER	,1	num	7	SENT_5	[p1l327t650r428b698],
6	Sanjeewa	NNP	PERSON	Sanjeewa	nn	7	SENT_5	[p1l450t658r612b700],
7	Wickremasinghe	NNP	PERSON	Wickremasinghe	appos	2	SENT_5	[p1l628t656r921b700],
8	,	,	O	,	_	0	SENT_5	[p1l628t656r921b700],
9	FRCOphth	NN	O	frcophth	appos	2	SENT_5	[p1l941t656r1147b700],
10	,	,	O	,	_	0	SENT_5	[p1l941t656r1147b700],
11	FRANZCO	NNP	O	FRANZCO	nn	14	SENT_5	[p1l1168t650r1411b698],
12	,1	CD	NUMBER	,1	num	14	SENT_5	[p1l1168t650r1411b698],
13	Andrea	NNP	PERSON	Andrea	nn	14	SENT_5	[p1l1431t656r1602b697],
14	]	NNP	O	]	appos	2	SENT_5	[p1l1431t656r1602b697],
15	.	.	O	.	_	0	SENT_5	[p1l1431t656r1602b697],

1	Richardson	NNP	PERSON	Richardson	nn	3	SENT_6	[p1l1623t656r1824b698],
2	,	,	O	,	_	0	SENT_6	[p1l1623t656r1824b698],
3	BSC	NNP	O	BSC	dep	9	SENT_6	[p1l1845t658r1912b691],
4	(	CD	NUMBER	(	num	5	SENT_6	[p1l1931t650r2085b698],
5	Hons	NNS	O	hon	dep	3	SENT_6	[p1l1931t650r2085b698],
6	)	CD	NUMBER	)	dep	9	SENT_6	[p1l1931t650r2085b698],
7	,1	CD	NUMBER	,1	num	9	SENT_6	[p1l1931t650r2085b698],
8	Enes	NNP	PERSON	Enes	nn	9	SENT_6	[p1l43t708r124b741],
9	Makalic	NNP	PERSON	Makalic	dep	34	SENT_6	[p1l141t706r292b748],
10	,	,	O	,	_	0	SENT_6	[p1l141t706r292b748],
11	PhD	NNP	O	PhD	nn	15	SENT_6	[p1l313t700r422b748],
12	,2	CD	NUMBER	,2	num	15	SENT_6	[p1l313t700r422b748],
13	Daniel	NNP	PERSON	Daniel	nn	15	SENT_6	[p1l439t706r554b741],
14	F.	NNP	PERSON	F.	nn	15	SENT_6	[p1l570t708r605b741],
15	Schmidt	NNP	PERSON	Schmidt	appos	9	SENT_6	[p1l626t706r773b748],
16	,	,	O	,	_	0	SENT_6	[p1l626t706r773b748],
17	PhD	NNP	O	PhD	nn	21	SENT_6	[p1l794t700r903b748],
18	,2	CD	NUMBER	,2	num	21	SENT_6	[p1l794t700r903b748],
19	Sukhpal	NNP	PERSON	Sukhpal	nn	21	SENT_6	[p1l921t706r1058b750],
20	S.	NNP	PERSON	S.	nn	21	SENT_6	[p1l1074t708r1106b741],
21	Sandhu	NNP	PERSON	Sandhu	appos	9	SENT_6	[p1l1127t706r1267b748],
22	,	,	O	,	_	0	SENT_6	[p1l1127t706r1267b748],
23	MD	NNP	O	MD	appos	9	SENT_6	[p1l1286t708r1371b747],
24	,	,	O	,	_	0	SENT_6	[p1l1286t708r1371b747],
25	FRCOphth	NNP	O	FRCOphth	nn	29	SENT_6	[p1l1392t700r1614b750],
26	,1	CD	NUMBER	,1	num	29	SENT_6	[p1l1392t700r1614b750],
27	Paul	NNP	PERSON	Paul	nn	29	SENT_6	[p1l1636t706r1714b741],
28	N.	NNP	PERSON	N.	nn	29	SENT_6	[p1l1729t708r1775b741],
29	Baird	NNP	PERSON	Baird	appos	9	SENT_6	[p1l1797t706r1900b748],
30	,	,	O	,	_	0	SENT_6	[p1l1797t706r1900b748],
31	PhD	NNP	O	PhD	appos	9	SENT_6	[p1l1921t700r2064b748],
32	,1	CD	NUMBER	,1	num	31	SENT_6	[p1l1921t700r2064b748],
33	’	CD	NUMBER	’	num	34	SENT_6	[p1l1921t700r2064b748],
34	*	NN	O	*	dep	37	SENT_6	[p1l1921t700r2064b748],
35	Robyn	NNP	PERSON	Robyn	nn	37	SENT_6	[p1l43t756r154b800],
36	H.	NNP	PERSON	H.	nn	37	SENT_6	[p1l170t758r215b791],
37	Guymer	NNP	PERSON	Guymer	dep	43	SENT_6	[p1l237t758r391b800],
38	,	,	O	,	_	0	SENT_6	[p1l237t758r391b800],
39	PhD	NNP	O	PhD	appos	37	SENT_6	[p1l412t756r501b797],
40	,	,	O	,	_	0	SENT_6	[p1l412t756r501b797],
41	FRANZCO1	NN	O	franzco1	appos	37	SENT_6	[p1l521t750r787b791],
42	’	CD	NUMBER	’	num	43	SENT_6	[p1l521t750r787b791],
43	*	NN	O	*	_	0	SENT_6	[p1l521t750r787b791],

1	Purpose	NN	O	purpose	_	0	SENT_7	[p1l92t861r268b899],
2	:	:	O	:	_	0	SENT_7	[p1l92t861r268b899],
3	To	TO	O	to	aux	4	SENT_7	[p1l310t861r357b892],
4	determine	VB	O	determine	infmod	1	SENT_7	[p1l370t861r555b892],
5	the	DT	O	the	det	6	SENT_7	[p1l566t861r624b892],
6	association	NN	O	association	dobj	4	SENT_7	[p1l637t861r844b892],
7	of	IN	O	of	_	0	SENT_7	[p1l858t860r894b892],
8	genetic	JJ	O	genetic	amod	9	SENT_7	[p1l905t861r1039b900],
9	variants	NNS	O	variant	prep_of	6	SENT_7	[p1l1051t861r1195b892],
10	of	IN	O	of	_	0	SENT_7	[p1l1208t860r1243b892],
11	the	DT	O	the	det	13	SENT_7	[p1l1254t861r1312b892],
12	VEGFA	NN	O	vegfa	nn	13	SENT_7	[p1l1326t860r1454b892],
13	gene	NN	O	gene	prep_of	4	SENT_7	[p1l1469t868r1558b900],
14	with	IN	O	with	_	0	SENT_7	[p1l1570t861r1644b891],
15	outcome	NN	O	outcome	prep_with	4	SENT_7	[p1l1658t862r1821b892],
16	of	IN	O	of	_	0	SENT_7	[p1l1833t860r1868b892],
17	anti-vascular	JJ	O	anti-vascular	amod	20	SENT_7	[p1l1880t861r2118b892],
18	endothelial	JJ	O	endothelial	amod	20	SENT_7	[p1l44t906r243b938],
19	growth	NN	O	growth	nn	20	SENT_7	[p1l260t906r386b946],
20	factor	NN	O	factor	prep_of	15	SENT_7	[p1l403t906r511b938],
21	(	CD	NUMBER	(	num	24	SENT_7	[p1l526t906r651b945],
22	VEGF	NN	O	vegf	nn	24	SENT_7	[p1l526t906r651b945],
23	)	NN	O	)	nn	24	SENT_7	[p1l526t906r651b945],
24	treatment	NN	O	treatment	dep	31	SENT_7	[p1l666t908r844b938],
25	in	IN	O	in	_	0	SENT_7	[p1l862t906r889b937],
26	neovascular	JJ	O	neovascular	amod	27	SENT_7	[p1l908t906r1130b938],
27	age	NN	O	age	prep_in	24	SENT_7	[p1l1145t906r1354b946],
28	—	NN	O	—	dep	31	SENT_7	[p1l1145t906r1354b946],
29	related	JJ	O	related	amod	31	SENT_7	[p1l1145t906r1354b946],
30	macular	JJ	O	macular	amod	31	SENT_7	[p1l1373t906r1520b938],
31	degeneration	NN	O	degeneration	dep	4	SENT_7	[p1l1535t906r1776b946],
32	(	CD	NUMBER	(	num	33	SENT_7	[p1l1794t906r1915b945],
33	AMD	NNP	O	AMD	dep	31	SENT_7	[p1l1794t906r1915b945],
34	)	CD	NUMBER	)	num	33	SENT_7	[p1l1794t906r1915b945],
35	.	.	O	.	_	0	SENT_7	[p1l1794t906r1915b945],

1	Design	NN	O	design	_	0	SENT_8	[p1l92t952r241b991],
2	:	:	O	:	_	0	SENT_8	[p1l92t952r241b991],
3	A	DT	O	a	det	6	SENT_8	[p1l283t952r311b982],
4	prospective	JJ	O	prospective	amod	6	SENT_8	[p1l327t952r542b991],
5	cohort	NN	O	cohort	nn	6	SENT_8	[p1l558t952r676b983],
6	study	NN	O	study	dep	1	SENT_8	[p1l692t952r802b991],
7	.	.	O	.	_	0	SENT_8	[p1l692t952r802b991],

1	Participants	NNS	O	participant	_	0	SENT_9	[p1l92t998r343b1036],
2	:	:	O	:	_	0	SENT_9	[p1l92t998r343b1036],
3	We	PRP	O	we	nsubj	4	SENT_9	[p1l386t998r446b1029],
4	included	VBD	O	include	dep	1	SENT_9	[p1l463t998r617b1029],
5	201	CD	NUMBER	201	num	7	SENT_9	[p1l634t998r694b1029],
6	consecutive	JJ	O	consecutive	amod	7	SENT_9	[p1l718t998r939b1029],
7	patients	NNS	O	patient	dobj	4	SENT_9	[p1l957t998r1102b1037],
8	receiving	VBG	O	receive	xcomp	4	SENT_9	[p1l1119t998r1282b1037],
9	anti-VEGF	JJ	O	anti-vegf	amod	10	SENT_9	[p1l1300t997r1488b1029],
10	injections	NNS	O	injection	dobj	8	SENT_9	[p1l1505t998r1678b1037],
11	for	IN	O	for	_	0	SENT_9	[p1l1694t997r1744b1029],
12	neovascular	JJ	O	neovascular	amod	13	SENT_9	[p1l1760t998r1982b1029],
13	AMD	NNP	ORGANIZATION	AMD	prep_for	8	SENT_9	[p1l1995t998r2097b1028],
14	.	.	O	.	_	0	SENT_9	[p1l1995t998r2097b1028],

1	Methods	NNS	O	method	_	0	SENT_10	[p1l92t1043r277b1074],
2	:	:	O	:	_	0	SENT_10	[p1l92t1043r277b1074],
3	Patients	NNS	O	patient	nsubjpass	5	SENT_10	[p1l323t1043r470b1074],
4	were	VBD	O	be	auxpass	5	SENT_10	[p1l486t1051r574b1074],
5	followed	VBN	O	follow	dep	1	SENT_10	[p1l590t1043r744b1074],
6	over	IN	O	over	_	0	SENT_10	[p1l762t1051r842b1074],
7	12	CD	DURATION	12	num	8	SENT_10	[p1l859t1044r900b1074],
8	months	NNS	NUMBER	month	prep_over	5	SENT_10	[p1l919t1043r1064b1074],
9	.	.	O	.	_	0	SENT_10	[p1l919t1043r1064b1074],

1	They	PRP	O	they	nsubjpass	3	SENT_11	[p1l1081t1043r1172b1082],
2	were	VBD	O	be	auxpass	3	SENT_11	[p1l1187t1051r1275b1074],
3	treated	VBN	O	treat	_	0	SENT_11	[p1l1290t1043r1420b1074],
4	with	IN	O	with	_	0	SENT_11	[p1l1437t1043r1511b1074],
5	3	CD	NUMBER	3	num	8	SENT_11	[p1l1528t1044r1549b1074],
6	initial	JJ	O	initial	amod	8	SENT_11	[p1l1567t1043r1658b1074],
7	monthly	JJ	SET	monthly	amod	8	SENT_11	[p1l1677t1043r1823b1082],
8	ranibizumab	NN	O	ranibizumab	prep_with	3	SENT_11	[p1l1839t1043r2064b1074],
9	or	CC	O	or	_	0	SENT_11	[p1l2081t1051r2118b1074],
10	bevacizumab	NN	O	bevacizumab	nn	11	SENT_11	[p1l45t1088r289b1119],
11	injections	NNS	O	injection	prep_with	3	SENT_11	[p1l304t1088r487b1127],
12	.	.	O	.	_	0	SENT_11	[p1l304t1088r487b1127],

1	Thereafter	RB	O	thereafter	advmod	8	SENT_12	[p1l502t1088r700b1125],
2	,	,	O	,	_	0	SENT_12	[p1l502t1088r700b1125],
3	the	DT	O	the	det	4	SENT_12	[p1l715t1088r773b1119],
4	decision	NN	O	decision	nsubjpass	8	SENT_12	[p1l787t1088r939b1119],
5	to	TO	O	to	_	0	SENT_12	[p1l953t1090r989b1119],
6	retreat	NN	O	retreat	prep_to	4	SENT_12	[p1l1004t1090r1122b1119],
7	was	VBD	O	be	auxpass	8	SENT_12	[p1l1136t1096r1209b1119],
8	made	VBN	O	make	_	0	SENT_12	[p1l1224t1088r1326b1119],
9	by	IN	O	by	_	0	SENT_12	[p1l1341t1088r1384b1127],
10	clinicians	NNS	O	clinician	agent	8	SENT_12	[p1l1397t1088r1566b1119],
11	at	IN	O	at	_	0	SENT_12	[p1l1580t1090r1614b1119],
12	each	DT	O	each	det	14	SENT_12	[p1l1628t1088r1714b1119],
13	follow-up	JJ	O	follow-up	amod	14	SENT_12	[p1l1729t1088r1902b1127],
14	visit	NN	O	visit	prep_at	10	SENT_12	[p1l1915t1088r1987b1119],
15	on	IN	O	on	_	0	SENT_12	[p1l2001t1096r2044b1119],
16	the	DT	O	the	det	17	SENT_12	[p1l2059t1088r2117b1119],
17	basis	NN	O	basis	prep_on	8	SENT_12	[p1l45t1134r139b1165],
18	of	IN	O	of	_	0	SENT_12	[p1l156t1133r191b1165],
19	retreatment	NN	O	retreatment	nn	20	SENT_12	[p1l208t1135r420b1165],
20	criteria	NNS	O	criterion	prep_of	17	SENT_12	[p1l437t1134r571b1165],
21	.	.	O	.	_	0	SENT_12	[p1l437t1134r571b1165],

1	Seven	CD	NUMBER	seven	nsubj	2	SENT_13	[p1l590t1133r702b1165],
2	tagged	VBD	O	tag	_	0	SENT_13	[p1l719t1134r847b1173],
3	single	JJ	O	single	amod	5	SENT_13	[p1l865t1134r972b1173],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_13	[p1l990t1134r1181b1165],
5	polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_13	[p1l1199t1134r1481b1173],
6	(	VBP	O	(	ccomp	2	SENT_13	[p1l1499t1133r1635b1173],
7	tSNPs	NNS	O	tsnp	nsubjpass	14	SENT_13	[p1l1499t1133r1635b1173],
8	)	CD	NUMBER	)	num	7	SENT_13	[p1l1499t1133r1635b1173],
9	in	IN	O	in	_	0	SENT_13	[p1l1654t1134r1682b1164],
10	the	DT	O	the	det	12	SENT_13	[p1l1699t1134r1757b1165],
11	VEGFA	NN	O	vegfa	nn	12	SENT_13	[p1l1775t1133r1904b1165],
12	gene	NN	O	gene	prep_in	7	SENT_13	[p1l1922t1141r2012b1173],
13	were	VBD	O	be	auxpass	14	SENT_13	[p1l2028t1141r2117b1165],
14	seltected	VBN	O	seltect	ccomp	6	SENT_13	[p1l43t1179r197b1247],
15	and	CC	O	and	_	0	SENT_13	[p1l217t1179r283b1210],
16	examined	VBN	O	examine	conj_and	14	SENT_13	[p1l303t1179r491b1210],
17	.	.	O	.	_	0	SENT_13	[p1l303t1179r491b1210],

1	Multivariate	JJ	O	multivariate	amod	3	SENT_14	[p1l514t1179r725b1210],
2	data	NN	O	datum	nn	3	SENT_14	[p1l743t1179r824b1210],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_14	[p1l842t1179r988b1218],
4	was	VBD	O	be	auxpass	5	SENT_14	[p1l1006t1187r1079b1210],
5	used	VBN	O	use	_	0	SENT_14	[p1l1098t1179r1184b1210],
6	to	TO	O	to	aux	7	SENT_14	[p1l1203t1181r1238b1210],
7	determine	VB	O	determine	xcomp	5	SENT_14	[p1l1257t1179r1442b1210],
8	the	DT	O	the	det	9	SENT_14	[p1l1459t1179r1516b1210],
9	role	NN	O	role	dobj	7	SENT_14	[p1l1535t1179r1602b1210],
10	of	IN	O	of	_	0	SENT_14	[p1l1620t1179r1655b1210],
11	each	DT	O	each	det	12	SENT_14	[p1l1672t1179r1758b1210],
12	tSNP	NN	O	tsnp	prep_of	9	SENT_14	[p1l1777t1179r1873b1210],
13	in	IN	O	in	_	0	SENT_14	[p1l1893t1179r1920b1210],
14	treatment	NN	O	treatment	nn	15	SENT_14	[p1l1938t1181r2116b1210],
15	ou	NN	O	ou	prep_in	7	SENT_14	[p1l43t1224r87b1247],
16	come	VBN	O	come	partmod	15	SENT_14	[p1l104t1224r215b1247],
17	.	.	O	.	_	0	SENT_14	[p1l104t1224r215b1247],

1	Main	NNP	O	Main	nn	3	SENT_15	[p1l92t1262r188b1293],
2	Outcome	NNP	O	Outcome	nn	3	SENT_15	[p1l210t1261r390b1293],
3	Measures	NNS	O	measure	_	0	SENT_15	[p1l409t1262r614b1293],
4	:	:	O	:	_	0	SENT_15	[p1l409t1262r614b1293],
5	The	DT	O	the	det	6	SENT_15	[p1l657t1262r726b1293],
6	influence	NN	O	influence	dep	3	SENT_15	[p1l747t1261r911b1293],
7	of	IN	O	of	_	0	SENT_15	[p1l931t1261r966b1293],
8	selected	VBN	O	select	amod	10	SENT_15	[p1l985t1262r1139b1293],
9	VEGFA	NNP	O	VEGFA	nn	10	SENT_15	[p1l1163t1261r1292b1293],
10	tSNPs	NNS	O	tsnp	prep_of	6	SENT_15	[p1l1312t1261r1429b1293],
11	on	IN	O	on	_	0	SENT_15	[p1l1449t1269r1493b1293],
12	visual	JJ	O	visual	amod	13	SENT_15	[p1l1514t1262r1616b1293],
13	acuity	NN	O	acuity	prep_on	6	SENT_15	[p1l1638t1262r1748b1301],
14	(	CD	NUMBER	(	num	13	SENT_15	[p1l1768t1261r1838b1301],
15	VA	NNP	ORGANIZATION	VA	nn	17	SENT_15	[p1l1768t1261r1838b1301],
16	)	CD	NUMBER	)	num	17	SENT_15	[p1l1768t1261r1838b1301],
17	outcome	NN	O	outcome	dep	13	SENT_15	[p1l1860t1263r2022b1293],
18	at	IN	O	at	_	0	SENT_15	[p1l2042t1263r2075b1293],
19	6	CD	DURATION	6	num	20	SENT_15	[p1l2096t1262r2116b1293],
20	months	NNS	NUMBER	month	prep_at	17	SENT_15	[p1l45t1308r190b1339],
21	.	.	O	.	_	0	SENT_15	[p1l45t1308r190b1339],

1	Results	NNS	O	result	_	0	SENT_16	[p1l92t1354r252b1385],
2	:	:	O	:	_	0	SENT_16	[p1l92t1354r252b1385],
3	Mean	NN	O	mean	nn	5	SENT_16	[p1l297t1354r396b1385],
4	baseline	NN	O	baseline	nn	5	SENT_16	[p1l414t1354r565b1385],
5	VA	NN	O	va	nsubj	8	SENT_16	[p1l579t1354r632b1384],
6	was	VBD	O	be	cop	8	SENT_16	[p1l645t1362r718b1385],
7	51	CD	NUMBER	51	number	8	SENT_16	[p1l734t1354r771b1385],
8	:17	CD	NUMBER	:17	dep	1	SENT_16	[p1l783t1354r858b1384],
9	Early	JJ	O	early	amod	18	SENT_16	[p1l876t1354r964b1393],
10	Treatment	NN	O	treatment	nn	18	SENT_16	[p1l977t1354r1166b1385],
11	Diabetic	NNP	O	Diabetic	nn	18	SENT_16	[p1l1183t1354r1332b1385],
12	Retinopathy	NNP	O	Retinopathy	nn	18	SENT_16	[p1l1349t1354r1571b1393],
13	Study	NNP	O	Study	nn	18	SENT_16	[p1l1585t1353r1692b1393],
14	(	CD	NUMBER	(	num	18	SENT_16	[p1l1708t1353r1860b1393],
15	ETDRS	NNP	O	ETDRS	nn	18	SENT_16	[p1l1708t1353r1860b1393],
16	)	CD	NUMBER	)	num	18	SENT_16	[p1l1708t1353r1860b1393],
17	letter	NN	O	letter	nn	18	SENT_16	[p1l1877t1354r1969b1385],
18	scores	NNS	O	score	dep	8	SENT_16	[p1l1983t1362r2114b1385],
19	.	.	O	.	_	0	SENT_16	[p1l1983t1362r2114b1385],

1	Overall	RB	O	overall	advmod	11	SENT_17	[p1l44t1399r180b1436],
2	,	,	O	,	_	0	SENT_17	[p1l44t1399r180b1436],
3	the	DT	O	the	det	5	SENT_17	[p1l195t1400r253b1431],
4	mean	JJ	O	mean	amod	5	SENT_17	[p1l268t1407r367b1431],
5	change	NN	O	change	nsubj	11	SENT_17	[p1l383t1400r518b1439],
6	in	IN	O	in	_	0	SENT_17	[p1l533t1400r561b1430],
7	VA	NNP	O	VA	prep_in	5	SENT_17	[p1l575t1400r628b1430],
8	from	IN	O	from	_	0	SENT_17	[p1l640t1399r723b1431],
9	baseline	NN	O	baseline	prep_from	7	SENT_17	[p1l739t1400r890b1431],
10	was	VBD	O	be	cop	11	SENT_17	[p1l904t1407r977b1431],
11	+6.5:12	CD	TIME	+6.5:12	_	0	SENT_17	[p1l995t1400r1172b1436],
12	,	,	O	,	_	0	SENT_17	[p1l995t1400r1172b1436],
13	+4.4:13.4	CD	TIME	+4.4:13.4	conj_and	11	SENT_17	[p1l1192t1400r1404b1436],
14	,	,	O	,	_	0	SENT_17	[p1l1192t1400r1404b1436],
15	and	CC	O	and	_	0	SENT_17	[p1l1420t1400r1487b1431],
16	+2.3:14.6	CD	TIME	+2.3:14.6	num	17	SENT_17	[p1l1506t1400r1708b1431],
17	letters	NNS	O	letter	conj_and	11	SENT_17	[p1l1724t1400r1835b1431],
18	at	IN	O	at	_	0	SENT_17	[p1l1850t1401r1883b1431],
19	3	CD	NUMBER	3	prep_at	17	SENT_17	[p1l1897t1400r1927b1436],
20	,	,	O	,	_	0	SENT_17	[p1l1897t1400r1927b1436],
21	6	CD	NUMBER	6	conj_and	19	SENT_17	[p1l1944t1400r1974b1436],
22	,	,	O	,	_	0	SENT_17	[p1l1944t1400r1974b1436],
23	and	CC	DURATION	and	_	0	SENT_17	[p1l1991t1400r2057b1431],
24	12	CD	DURATION	12	num	25	SENT_17	[p1l2075t1400r2115b1430],
25	months	NNS	NUMBER	month	conj_and	19	SENT_17	[p1l45t1446r190b1482],
26	,	,	O	,	_	0	SENT_17	[p1l45t1446r190b1482],
27	respectively	RB	O	respectively	advmod	11	SENT_17	[p1l209t1446r437b1485],
28	.	.	O	.	_	0	SENT_17	[p1l209t1446r437b1485],

1	The	DT	O	the	det	3	SENT_18	[p1l453t1446r522b1477],
2	tSNP	NN	O	tsnp	nn	3	SENT_18	[p1l536t1445r632b1477],
3	rs3025000	NN	O	rs3025000	nsubj	7	SENT_18	[p1l649t1446r842b1477],
4	was	VBD	O	be	cop	7	SENT_18	[p1l857t1454r930b1477],
5	the	DT	O	the	det	7	SENT_18	[p1l945t1446r1002b1477],
6	only	JJ	O	only	amod	7	SENT_18	[p1l1018t1446r1093b1485],
7	SNP	NN	ORGANIZATION	snp	dep	9	SENT_18	[p1l1108t1445r1189b1477],
8	significantly	RB	O	significantly	advmod	9	SENT_18	[p1l1205t1446r1423b1485],
9	associated	VBD	O	associate	_	0	SENT_18	[p1l1437t1446r1636b1477],
10	(	CD	NUMBER	(	num	11	SENT_18	[p1l1653t1445r1739b1484],
11	P	NN	O	p	nsubj	12	SENT_18	[p1l1653t1445r1739b1484],
12	<	JJR	O	<	xcomp	9	SENT_18	[p1l1653t1445r1739b1484],
13	1	CD	NUMBER	1	num	16	SENT_18	[p1l1653t1445r1739b1484],
14	X	NN	O	x	nn	16	SENT_18	[p1l1765t1450r1790b1475],
15	1074	CD	DATE	1074	num	16	SENT_18	[p1l1811t1439r1907b1484],
16	)	NN	O	)	nsubj	9	SENT_18	[p1l1811t1439r1907b1484],
17	with	IN	O	with	_	0	SENT_18	[p1l1922t1446r1996b1476],
18	visual	JJ	O	visual	amod	19	SENT_18	[p1l2013t1446r2115b1477],
19	outcome	NN	O	outcome	prep_with	9	SENT_18	[p1l43t1493r206b1522],
20	at	IN	O	at	_	0	SENT_18	[p1l223t1493r256b1522],
21	6	CD	DURATION	6	num	22	SENT_18	[p1l273t1491r293b1522],
22	months	NNS	NUMBER	month	prep_at	19	SENT_18	[p1l312t1491r448b1522],
23	with	IN	O	with	_	0	SENT_18	[p1l464t1491r538b1522],
24	multiple	JJ	O	multiple	amod	25	SENT_18	[p1l558t1491r701b1530],
25	correction	NN	O	correction	prep_with	22	SENT_18	[p1l718t1491r913b1522],
26	.	.	O	.	_	0	SENT_18	[p1l718t1491r913b1522],

1	The	DT	O	the	det	2	SENT_19	[p1l931t1491r1000b1522],
2	presence	NN	O	presence	nsubj	17	SENT_19	[p1l1018t1499r1186b1530],
3	of	IN	O	of	_	0	SENT_19	[p1l1203t1491r1238b1522],
4	the	DT	O	the	det	8	SENT_19	[p1l1253t1491r1311b1522],
5	T	NN	O	t	nn	8	SENT_19	[p1l1326t1491r1350b1522],
6	allele	NN	O	allele	nn	8	SENT_19	[p1l1366t1491r1459b1522],
7	(	CD	NUMBER	(	num	8	SENT_19	[p1l1476t1490r1537b1530],
8	TC	NN	O	tc	prep_of	2	SENT_19	[p1l1476t1490r1537b1530],
9	or	CC	O	or	_	0	SENT_19	[p1l1555t1499r1592b1522],
10	Tl	NN	O	tl	nn	11	SENT_19	[p1l1606t1491r1654b1521],
11	’	NN	O	’	prep_of	2	SENT_19	[p1l1606t1491r1654b1521],
12	genotypes	NNS	O	genotype	nsubj	13	SENT_19	[p1l1670t1490r1873b1530],
13	)	VBP	O	)	rcmod	8	SENT_19	[p1l1670t1490r1873b1530],
14	at	IN	O	at	_	0	SENT_19	[p1l1890t1493r1924b1522],
15	this	DT	O	this	det	16	SENT_19	[p1l1939t1491r2004b1522],
16	tSNP	NN	O	tsnp	prep_at	13	SENT_19	[p1l2020t1490r2116b1522],
17	predicted	VBD	O	predict	_	0	SENT_19	[p1l45t1537r217b1576],
18	a	DT	O	a	det	20	SENT_19	[p1l234t1544r254b1568],
19	better	JJR	O	better	amod	20	SENT_19	[p1l270t1537r377b1568],
20	outcome	NN	O	outcome	dobj	17	SENT_19	[p1l391t1538r553b1568],
21	of	IN	O	of	_	0	SENT_19	[p1l568t1536r603b1568],
22	+7	CD	NUMBER	+7	num	23	SENT_19	[p1l620t1537r672b1567],
23	letters	NNS	O	letter	prep_of	20	SENT_19	[p1l689t1537r800b1568],
24	at	IN	O	at	_	0	SENT_19	[p1l815t1538r848b1568],
25	6	CD	DURATION	6	num	26	SENT_19	[p1l863t1537r884b1568],
26	months	NNS	NUMBER	month	prep_at	23	SENT_19	[p1l900t1537r1036b1568],
27	compared	VBN	O	compare	_	0	SENT_19	[p1l1051t1537r1237b1576],
28	with	IN	O	with	prepc_compared_with	17	SENT_19	[p1l1253t1537r1327b1567],
29	the	DT	O	the	det	31	SENT_19	[p1l1342t1537r1400b1568],
30	CC	NN	O	cc	nn	31	SENT_19	[p1l1415t1536r1472b1568],
31	genotype	NN	O	genotype	pobj	17	SENT_19	[p1l1487t1538r1669b1576],
32	.	.	O	.	_	0	SENT_19	[p1l1487t1538r1669b1576],

1	In	IN	O	in	_	0	SENT_20	[p1l1688t1537r1716b1567],
2	a	DT	O	a	det	4	SENT_20	[p1l1733t1544r1753b1568],
3	subgroup	NN	O	subgroup	nn	4	SENT_20	[p1l1768t1537r1943b1576],
4	analysis	NN	O	analysis	prep_in	11	SENT_20	[p1l1959t1537r2115b1576],
5	,	,	O	,	_	0	SENT_20	[p1l1959t1537r2115b1576],
6	presence	NN	O	presence	nsubj	11	SENT_20	[p1l45t1590r213b1621],
7	of	IN	O	of	_	0	SENT_20	[p1l227t1582r262b1614],
8	the	DT	O	the	det	10	SENT_20	[p1l274t1582r331b1614],
9	T	NN	O	t	nn	10	SENT_20	[p1l344t1582r368b1613],
10	allele	NN	O	allele	prep_of	6	SENT_20	[p1l381t1582r473b1614],
11	predicted	VBD	O	predict	_	0	SENT_20	[p1l488t1582r661b1621],
12	a	DT	O	a	det	15	SENT_20	[p1l676t1590r697b1614],
13	significantly	RB	O	significantly	advmod	14	SENT_20	[p1l710t1582r928b1622],
14	higher	JJR	O	higher	amod	15	SENT_20	[p1l942t1582r1055b1622],
15	chance	NN	O	chance	dobj	11	SENT_20	[p1l1068t1582r1202b1614],
16	of	IN	O	of	_	0	SENT_20	[p1l1215t1582r1251b1614],
17	the	DT	O	the	det	18	SENT_20	[p1l1262t1582r1320b1614],
18	patients	NNS	O	patient	prep_of	15	SENT_20	[p1l1335t1582r1480b1621],
19	belonging	VBG	O	belong	partmod	18	SENT_20	[p1l1495t1582r1674b1622],
20	to	TO	O	to	_	0	SENT_20	[p1l1688t1584r1723b1614],
21	the	DT	O	the	det	23	SENT_20	[p1l1736t1582r1794b1614],
22	responder	NN	O	responder	nn	23	SENT_20	[p1l1809t1582r1997b1621],
23	group	NN	O	group	prep_to	19	SENT_20	[p1l2009t1590r2116b1622],
24	(	CD	NUMBER	(	num	25	SENT_20	[p1l44t1627r129b1667],
25	gain	NN	O	gain	dep	42	SENT_20	[p1l44t1627r129b1667],
26	of	IN	O	of	_	0	SENT_20	[p1l153t1628r188b1659],
27	25	CD	NUMBER	25	num	28	SENT_20	[p1l210t1629r263b1659],
28	letters	NNS	O	letter	prep_of	25	SENT_20	[p1l287t1628r398b1659],
29	from	IN	O	from	_	0	SENT_20	[p1l419t1628r502b1659],
30	baseline	NN	O	baseline	nn	31	SENT_20	[p1l527t1627r688b1667],
31	)	NN	O	)	prep_from	28	SENT_20	[p1l527t1627r688b1667],
32	after	IN	O	after	_	0	SENT_20	[p1l710t1628r793b1659],
33	3	CD	NUMBER	3	prep_after	31	SENT_20	[p1l814t1628r844b1665],
34	,	,	O	,	_	0	SENT_20	[p1l814t1628r844b1665],
35	6	CD	NUMBER	6	conj_and	33	SENT_20	[p1l868t1628r898b1664],
36	,	,	O	,	_	0	SENT_20	[p1l868t1628r898b1664],
37	and	CC	DURATION	and	_	0	SENT_20	[p1l922t1628r989b1659],
38	12	CD	DURATION	12	num	39	SENT_20	[p1l1014t1628r1055b1659],
39	months	NNS	NUMBER	month	conj_and	33	SENT_20	[p1l1079t1628r1215b1659],
40	treatment	NN	O	treatment	dep	42	SENT_20	[p1l1236t1630r1414b1659],
41	(	CD	NUMBER	(	num	40	SENT_20	[p1l1436t1627r1539b1667],
42	odds	NNS	O	odds	dep	19	SENT_20	[p1l1436t1627r1539b1667],
43	ratio	NN	O	ratio	dep	42	SENT_20	[p1l1561t1628r1650b1664],
44	,	,	O	,	_	0	SENT_20	[p1l1561t1628r1650b1664],
45	2.7	CD	NUMBER	2.7	appos	43	SENT_20	[p1l1674t1628r1739b1664],
46	,	,	O	,	_	0	SENT_20	[p1l1674t1628r1739b1664],
47	3.5	CD	NUMBER	3.5	num	45	SENT_20	[p1l1763t1628r1828b1664],
48	,	,	O	,	_	0	SENT_20	[p1l1763t1628r1828b1664],
49	and	CC	O	and	_	0	SENT_20	[p1l1852t1628r1919b1659],
50	2.4	CD	NUMBER	2.4	appos	43	SENT_20	[p1l1942t1628r2007b1664],
51	;	:	O	;	_	0	SENT_20	[p1l1942t1628r2007b1664],
52	95	CD	PERCENT	95	number	53	SENT_20	[p1l2031t1627r2114b1659],
53	%	NN	PERCENT	%	amod	55	SENT_20	[p1l2031t1627r2114b1659],
54	confidence	NN	O	confidence	nn	55	SENT_20	[p1l44t1673r247b1705],
55	interval	NN	O	interval	dep	43	SENT_20	[p1l265t1674r405b1710],
56	,	,	O	,	_	0	SENT_20	[p1l265t1674r405b1710],
57	1.46-5	CD	NUMBER	1.46-5	num	58	SENT_20	[p1l425t1674r618b1710],
58	.07	CD	NUMBER	.07	conj_and	55	SENT_20	[p1l425t1674r618b1710],
59	,	,	O	,	_	0	SENT_20	[p1l425t1674r618b1710],
60	1.82-6	CD	NUMBER	1.82-6	num	61	SENT_20	[p1l639t1674r832b1710],
61	.71	CD	NUMBER	.71	appos	58	SENT_20	[p1l639t1674r832b1710],
62	,	,	O	,	_	0	SENT_20	[p1l639t1674r832b1710],
63	and	CC	O	and	_	0	SENT_20	[p1l850t1674r916b1705],
64	1.27-4	CD	NUMBER	1.27-4	num	65	SENT_20	[p1l936t1674r1129b1710],
65	.57	CD	NUMBER	.57	conj_and	55	SENT_20	[p1l936t1674r1129b1710],
66	,	,	O	,	_	0	SENT_20	[p1l936t1674r1129b1710],
67	respectively	RB	O	respectively	advmod	65	SENT_20	[p1l1149t1673r1378b1713],
68	)	RB	O	)	advmod	19	SENT_20	[p1l1149t1673r1378b1713],
69	than	IN	O	than	_	0	SENT_20	[p1l1393t1674r1473b1705],
70	any	DT	O	any	det	73	SENT_20	[p1l1490t1681r1555b1713],
71	other	JJ	O	other	amod	73	SENT_20	[p1l1571t1674r1666b1705],
72	outcome	NN	O	outcome	nn	73	SENT_20	[p1l1681t1675r1843b1705],
73	group	NN	O	group	prep_than	19	SENT_20	[p1l1859t1681r1976b1713],
74	.	.	O	.	_	0	SENT_20	[p1l1859t1681r1976b1713],

1	Conclusions	NNS	O	conclusion	_	0	SENT_21	[p1l94t1719r347b1751],
2	:	:	O	:	_	0	SENT_21	[p1l94t1719r347b1751],
3	Pharmacogenetic	JJ	O	pharmacogenetic	amod	4	SENT_21	[p1l393t1719r716b1759],
4	association	NN	O	association	nsubj	9	SENT_21	[p1l728t1719r936b1751],
5	with	IN	O	with	_	0	SENT_21	[p1l948t1719r1022b1750],
6	anti-VEGF	JJ	O	anti-vegf	amod	7	SENT_21	[p1l1035t1719r1223b1751],
7	treatments	NNS	O	treatment	prep_with	4	SENT_21	[p1l1234t1721r1432b1751],
8	may	MD	O	may	aux	9	SENT_21	[p1l1445t1727r1521b1759],
9	influence	VB	O	influence	dep	1	SENT_21	[p1l1534t1719r1698b1751],
10	the	DT	O	the	det	12	SENT_21	[p1l1708t1719r1765b1751],
11	visual	JJ	O	visual	amod	12	SENT_21	[p1l1776t1719r1879b1751],
12	outcomes	NNS	O	outcome	dobj	9	SENT_21	[p1l1892t1721r2075b1751],
13	in	IN	O	in	_	0	SENT_21	[p1l2088t1719r2115b1750],
14	neovascular	JJ	O	neovascular	amod	15	SENT_21	[p1l45t1765r267b1796],
15	AMD	NNP	O	AMD	prep_in	12	SENT_21	[p1l277t1765r378b1796],
16	.	.	O	.	_	0	SENT_21	[p1l277t1765r378b1796],

1	In	IN	O	in	_	0	SENT_22	[p1l395t1765r424b1796],
2	patients	NNS	O	patient	prep_in	12	SENT_22	[p1l439t1765r585b1804],
3	with	IN	O	with	_	0	SENT_22	[p1l597t1765r671b1796],
4	the	DT	O	the	det	6	SENT_22	[p1l684t1765r742b1796],
5	T	NN	O	t	nn	6	SENT_22	[p1l753t1765r778b1795],
6	allele	NN	O	allele	prep_with	2	SENT_22	[p1l789t1765r882b1796],
7	in	IN	O	in	_	0	SENT_22	[p1l896t1765r923b1795],
8	tSNP	NN	O	tsnp	prep_in	6	SENT_22	[p1l937t1764r1032b1796],
9	rs3025000	CD	NUMBER	rs3025000	num	8	SENT_22	[p1l1047t1765r1250b1801],
10	,	,	O	,	_	0	SENT_22	[p1l1047t1765r1250b1801],
11	there	EX	O	there	expl	12	SENT_22	[p1l1264t1765r1358b1796],
12	was	VBD	O	be	_	0	SENT_22	[p1l1370t1773r1443b1796],
13	a	DT	O	a	det	17	SENT_22	[p1l1456t1773r1476b1796],
14	significantly	RB	O	significantly	advmod	15	SENT_22	[p1l1489t1765r1706b1804],
15	better	JJR	O	better	amod	17	SENT_22	[p1l1720t1765r1827b1796],
16	visual	JJ	O	visual	amod	17	SENT_22	[p1l1838t1765r1940b1796],
17	outcome	NN	O	outcome	nsubj	12	SENT_22	[p1l1955t1767r2117b1796],
18	at	IN	O	at	_	0	SENT_22	[p1l44t1812r77b1842],
19	6	CD	DURATION	6	num	20	SENT_22	[p1l91t1811r111b1842],
20	months	NNS	NUMBER	month	prep_at	17	SENT_22	[p1l127t1811r263b1842],
21	and	CC	O	and	_	0	SENT_22	[p1l277t1811r344b1842],
22	a	DT	O	a	det	24	SENT_22	[p1l359t1818r380b1842],
23	greater	JJR	O	greater	amod	24	SENT_22	[p1l393t1812r524b1850],
24	chance	NN	O	chance	conj_and	20	SENT_22	[p1l537t1811r671b1842],
25	of	IN	O	of	_	0	SENT_22	[p1l685t1810r720b1842],
26	the	DT	O	the	det	27	SENT_22	[p1l731t1811r789b1842],
27	patients	NNS	O	patient	prep_of	17	SENT_22	[p1l804t1811r950b1850],
28	belonging	VBG	O	belong	partmod	27	SENT_22	[p1l965t1811r1144b1850],
29	to	TO	O	to	_	0	SENT_22	[p1l1158t1812r1194b1842],
30	the	DT	O	the	det	32	SENT_22	[p1l1207t1811r1264b1842],
31	responder	NN	O	responder	nn	32	SENT_22	[p1l1279t1811r1467b1850],
32	group	NN	O	group	prep_to	28	SENT_22	[p1l1480t1818r1587b1850],
33	with	IN	O	with	_	0	SENT_22	[p1l1601t1811r1675b1841],
34	anti-VEGF	JJ	O	anti-vegf	amod	35	SENT_22	[p1l1690t1810r1879b1842],
35	treatment	NN	O	treatment	prep_with	32	SENT_22	[p1l1891t1812r2069b1842],
36	at	IN	O	at	_	0	SENT_22	[p1l2083t1812r2116b1842],
37	3	CD	NUMBER	3	prep_at	28	SENT_22	[p1l43t1857r74b1893],
38	,	,	O	,	_	0	SENT_22	[p1l43t1857r74b1893],
39	6	CD	NUMBER	6	prep_at	28	SENT_22	[p1l88t1857r118b1893],
40	,	,	O	,	_	0	SENT_22	[p1l88t1857r118b1893],
41	and	CC	DURATION	and	_	0	SENT_22	[p1l132t1856r199b1888],
42	12	CD	DURATION	12	num	43	SENT_22	[p1l214t1857r255b1887],
43	months	NNS	NUMBER	month	prep_at	28	SENT_22	[p1l270t1856r415b1888],
44	.	.	O	.	_	0	SENT_22	[p1l270t1856r415b1888],

1	The	DT	O	the	det	3	SENT_23	[p1l428t1856r497b1888],
2	VA	NNP	O	VA	nn	3	SENT_23	[p1l507t1856r560b1887],
3	outcomes	NNS	O	outcome	nsubj	14	SENT_23	[p1l571t1858r754b1888],
4	of	IN	O	of	_	0	SENT_23	[p1l766t1856r801b1888],
5	patients	NNS	O	patient	prep_of	3	SENT_23	[p1l813t1856r958b1895],
6	harboring	VBG	O	harbor	partmod	5	SENT_23	[p1l972t1856r1145b1896],
7	the	DT	O	the	det	9	SENT_23	[p1l1157t1856r1215b1888],
8	T	NN	O	t	nn	9	SENT_23	[p1l1225t1856r1250b1887],
9	allele	NN	O	allele	dobj	6	SENT_23	[p1l1260t1856r1353b1888],
10	at	IN	O	at	_	0	SENT_23	[p1l1365t1858r1398b1888],
11	SNP	NN	ORGANIZATION	snp	prep_at	6	SENT_23	[p1l1410t1856r1492b1888],
12	rs3025000	CD	NUMBER	rs3025000	num	11	SENT_23	[p1l1505t1857r1698b1888],
13	were	VBD	O	be	cop	14	SENT_23	[p1l1710t1864r1799b1888],
14	comparable	JJ	O	comparable	_	0	SENT_23	[p1l1810t1856r2030b1895],
15	with	IN	O	with	_	0	SENT_23	[p1l2041t1856r2115b1887],
16	those	DT	O	those	prep_with	14	SENT_23	[p1l42t1902r145b1933],
17	of	IN	O	of	_	0	SENT_23	[p1l160t1902r195b1933],
18	the	DT	O	the	det	21	SENT_23	[p1l208t1902r265b1933],
19	pivotal	JJ	O	pivotal	amod	21	SENT_23	[p1l281t1902r400b1941],
20	clinical	JJ	O	clinical	amod	21	SENT_23	[p1l416t1902r540b1933],
21	trials	NNS	O	trial	prep_of	16	SENT_23	[p1l555t1902r643b1933],
22	but	CC	O	but	_	0	SENT_23	[p1l659t1902r717b1933],
23	with	IN	O	with	_	0	SENT_23	[p1l731t1902r805b1933],
24	fewer	JJR	O	fewer	amod	25	SENT_23	[p1l821t1902r923b1933],
25	injections	NNS	O	injection	conj_but	16	SENT_23	[p1l938t1902r1121b1941],
26	,	,	O	,	_	0	SENT_23	[p1l938t1902r1121b1941],
27	making	VBG	O	make	xcomp	14	SENT_23	[p1l1139t1902r1270b1941],
28	the	DT	O	the	det	29	SENT_23	[p1l1286t1902r1343b1933],
29	treatment	NN	O	treatment	nsubj	32	SENT_23	[p1l1357t1904r1535b1933],
30	perhaps	RB	O	perhaps	advmod	31	SENT_23	[p1l1551t1902r1700b1941],
31	more	RBR	O	more	dep	32	SENT_23	[p1l1716t1910r1809b1933],
32	cost	VB	O	cost	xcomp	27	SENT_23	[p1l1824t1904r1901b1933],
33	effective	JJ	O	effective	acomp	32	SENT_23	[p1l1917t1902r2072b1933],
34	in	IN	O	in	_	0	SENT_23	[p1l2088t1902r2115b1933],
35	certain	JJ	O	certain	amod	36	SENT_23	[p1l43t1948r166b1979],
36	subgroups	NNS	O	subgroup	prep_in	33	SENT_23	[p1l184t1948r381b1987],
37	of	IN	O	of	_	0	SENT_23	[p1l397t1948r432b1979],
38	patients	NNS	O	patient	prep_of	36	SENT_23	[p1l448t1948r603b1987],
39	.	.	O	.	_	0	SENT_23	[p1l448t1948r603b1987],

1	Financial	NNP	O	Financial	nn	2	SENT_24	[p1l92t1993r272b2024],
2	DiscIosure	NNP	O	DiscIosure	nsubj	9	SENT_24	[p1l293t1993r559b2031],
3	(	CD	NUMBER	(	num	4	SENT_24	[p1l293t1993r559b2031],
4	s	NNS	O	s	dep	2	SENT_24	[p1l293t1993r559b2031],
5	)	CD	NUMBER	)	dep	2	SENT_24	[p1l293t1993r559b2031],
6	:	:	O	:	_	0	SENT_24	[p1l293t1993r559b2031],
7	The	DT	O	the	det	8	SENT_24	[p1l602t1993r669b2024],
8	authors	NNS	O	author	dep	5	SENT_24	[p1l692t1993r826b2024],
9	have	VBP	O	have	_	0	SENT_24	[p1l850t1993r933b2024],
10	no	DT	O	no	det	14	SENT_24	[p1l958t2001r1000b2024],
11	proprietary	NN	O	proprietary	nn	14	SENT_24	[p1l1025t1993r1217b2032],
12	or	CC	O	or	_	0	SENT_24	[p1l1240t2001r1276b2024],
13	commercial	JJ	O	commercial	conj_or	11	SENT_24	[p1l1298t1993r1504b2024],
14	interest	NN	O	interest	dobj	9	SENT_24	[p1l1530t1993r1659b2024],
15	in	IN	O	in	_	0	SENT_24	[p1l1684t1993r1711b2024],
16	any	DT	O	any	prep_in	14	SENT_24	[p1l1736t2001r1799b2032],
17	of	IN	O	of	_	0	SENT_24	[p1l1821t1993r1856b2024],
18	the	DT	O	the	det	19	SENT_24	[p1l1877t1993r1933b2024],
19	materials	NNS	O	material	prep_of	16	SENT_24	[p1l1957t1993r2117b2024],
20	discussed	VBN	O	discuss	partmod	19	SENT_24	[p1l43t2039r222b2070],
21	in	IN	O	in	_	0	SENT_24	[p1l240t2039r266b2069],
22	this	DT	O	this	det	23	SENT_24	[p1l281t2039r344b2070],
23	article	NN	O	article	prep_in	20	SENT_24	[p1l358t2039r472b2070],
24	.	.	O	.	_	0	SENT_24	[p1l358t2039r472b2070],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_25	[p1l497t2038r770b2078],
2	2013	CD	DATE	2013	num	1	SENT_25	[p1l781t2039r977b2076],
3	;	:	O	;	_	0	SENT_25	[p1l781t2039r977b2076],
4	120:1	CD	NUMBER	120:1	num	5	SENT_25	[p1l781t2039r977b2076],
5	15-121	CD	NUMBER	15-121	dep	1	SENT_25	[p1l987t2039r1109b2070],
6	©	CD	NUMBER	©	num	7	SENT_25	[p1l1127t2038r1159b2070],
7	2013	CD	DATE	2013	dep	5	SENT_25	[p1l1171t2039r1261b2070],
8	by	IN	O	by	_	0	SENT_25	[p1l1274t2039r1319b2078],
9	the	DT	O	the	det	11	SENT_25	[p1l1332t2039r1386b2070],
10	American	NNP	ORGANIZATION	American	nn	11	SENT_25	[p1l1398t2039r1568b2070],
11	Academy	NNP	ORGANIZATION	Academy	prep_by	7	SENT_25	[p1l1580t2039r1753b2078],
12	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1765t2039r1803b2070],
13	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	11	SENT_25	[p1l1813t2038r2090b2078],
14	.	.	O	.	_	0	SENT_25	[p1l1813t2038r2090b2078],

1	Vascular	JJ	O	vascular	amod	4	SENT_26	[p1l6t2369r323b2431],
2	endothelial	JJ	O	endothelial	amod	4	SENT_26	[p1l353t2369r747b2431],
3	growth	NN	O	growth	nn	4	SENT_26	[p1l779t2369r1029b2450],
4	factor	NN	O	factor	_	0	SENT_26	[p1l1059t2369r1266b2431],
5	(	CD	NUMBER	(	num	8	SENT_26	[p1l1298t2370r1583b2446],
6	VEGF	NN	O	vegf	nn	8	SENT_26	[p1l1298t2370r1583b2446],
7	)	NN	O	)	nn	8	SENT_26	[p1l1298t2370r1583b2446],
8	inhibition	NN	O	inhibition	dep	4	SENT_26	[p1l1616t2369r1961b2431],
9	with	IN	O	with	_	0	SENT_26	[p1l1992t2369r2149b2431],
10	the	DT	O	the	det	14	SENT_26	[p1l7t2468r113b2530],
11	intravitreal	JJ	O	intravitreal	amod	12	SENT_26	[p1l154t2468r544b2530],
12	anti-VEGF	JJ	O	anti-vegf	amod	14	SENT_26	[p1l587t2468r980b2530],
13	monoclonal	JJ	O	monoclonal	amod	14	SENT_26	[p1l1021t2468r1440b2530],
14	antibodies	NNS	O	antibody	prep_with	8	SENT_26	[p1l1483t2468r1844b2530],
15	bevacizumab	IN	O	bevacizumab	amod	14	SENT_26	[p1l1886t2468r2145b2530, p1l7t2567r241b2629],

1	and	CC	O	and	cc	4	SENT_27	[p1l272t2567r397b2629],
2	ranibizumab	NN	O	ranibizumab	nsubj	4	SENT_27	[p1l423t2567r866b2629],
3	has	VBZ	O	have	aux	4	SENT_27	[p1l894t2567r1009b2629],
4	revolutionized	VBN	O	revolutionize	_	0	SENT_27	[p1l1038t2567r1553b2629],
5	the	DT	O	the	det	6	SENT_27	[p1l1580t2567r1686b2629],
6	treatment	NN	O	treatment	dep	15	SENT_27	[p1l1714t2576r2050b2629],
7	of	IN	O	of	_	0	SENT_27	[p1l2078t2567r2154b2629],
8	neovascular	JJ	O	neovascular	amod	10	SENT_27	[p1l7t2665r432b2728],
9	age	NN	O	age	nn	10	SENT_27	[p1l480t2665r873b2746],
10	—	NN	O	—	prep_of	6	SENT_27	[p1l480t2665r873b2746],
11	related	JJ	O	related	amod	12	SENT_27	[p1l480t2665r873b2746],
12	macular	JJ	O	macular	amod	10	SENT_27	[p1l920t2665r1207b2727],
13	degeneration	NN	O	degeneration	dep	15	SENT_27	[p1l1254t2665r1712b2746],
14	(	CD	NUMBER	(	num	13	SENT_27	[p1l1763t2654r2145b2742],
15	AMD	NNP	O	AMD	dep	19	SENT_27	[p1l1763t2654r2145b2742],
16	)	CD	NUMBER	)	num	15	SENT_27	[p1l1763t2654r2145b2742],
17	.1	CD	NUMBER	.1	num	18	SENT_27	[p1l1763t2654r2145b2742],
18	‘	NN	O	‘	dep	15	SENT_27	[p1l1763t2654r2145b2742],
19	3	CD	NUMBER	3	dep	4	SENT_27	[p1l1763t2654r2145b2742],
20	The	DT	O	the	det	24	SENT_27	[p1l7t2766r142b2828],
21	international	JJ	O	international	amod	24	SENT_27	[p1l203t2766r652b2828],
22	randomized	JJ	O	randomized	amod	24	SENT_27	[p1l712t2766r1133b2828],
23	clinical	JJ	O	clinical	amod	24	SENT_27	[p1l1193t2766r1453b2828],
24	trials	NNS	O	trial	nsubj	25	SENT_27	[p1l1514t2766r1688b2828],
25	(	VBP	O	(	rcmod	19	SENT_27	[p1l1753t2767r2013b2843],
26	RCTs	NNS	O	rct	dobj	25	SENT_27	[p1l1753t2767r2013b2843],
27	)	CD	NUMBER	)	num	26	SENT_27	[p1l1753t2767r2013b2843],
28	of	IN	O	of	_	0	SENT_27	[p1l2077t2766r2154b2828],
29	ranibizumab	NN	O	ranibizumab	prep_of	26	SENT_27	[p1l6t2865r918b2927],
30	.	.	O	.	_	0	SENT_27	[p1l6t2865r918b2927],

1	—	NN	O	—	_	0	SENT_28	[p1l6t2865r918b2927],
2	.	.	O	.	_	0	SENT_28	[p1l6t2865r918b2927],

1	ANCHOR	NN	O	anchor	nn	4	SENT_29	[p1l6t2865r918b2927],
2	(	CD	NUMBER	(	num	4	SENT_29	[p1l984t2865r1436b2942],
3	ANti-VEGF	NN	O	anti-vegf	nn	4	SENT_29	[p1l984t2865r1436b2942],
4	antibody	NN	O	antibody	nsubj	16	SENT_29	[p1l1502t2865r1810b2945],
5	for	IN	O	for	_	0	SENT_29	[p1l1875t2865r1978b2927],
6	the	DT	O	the	det	7	SENT_29	[p1l2041t2865r2148b2927],
7	treatment	NN	O	treatment	prep_for	4	SENT_29	[p1l6t2973r343b3026],
8	of	IN	O	of	_	0	SENT_29	[p1l383t2964r460b3026],
9	predominantly	RB	O	predominantly	advmod	7	SENT_29	[p1l493t2964r1012b3044],
10	classic	JJ	O	classic	amod	12	SENT_29	[p1l1054t2964r1287b3026],
11	CHORoidal	NN	O	choroidal	nn	12	SENT_29	[p1l1333t2964r1748b3026],
12	neovascularization	NN	O	neovascularization	prep_of	7	SENT_29	[p1l1788t2983r2146b3026, p1l7t3062r342b3124],
13	in	IN	O	in	_	0	SENT_29	[p1l430t3062r498b3124],
14	age	NN	O	age	prep_in	12	SENT_29	[p1l588t3062r981b3143],
15	—	CD	NUMBER	—	num	14	SENT_29	[p1l588t3062r981b3143],
16	related	JJ	O	related	_	0	SENT_29	[p1l588t3062r981b3143],
17	macular	JJ	O	macular	amod	19	SENT_29	[p1l1069t3062r1357b3124],
18	degeneration	NN	O	degeneration	nn	19	SENT_29	[p1l1444t3062r1930b3143],
19	)	NN	O	)	dobj	16	SENT_29	[p1l1444t3062r1930b3143],
20	and	CC	O	and	_	0	SENT_29	[p1l2023t3062r2149b3124],
21	MARINA	NN	O	marina	conj_and	19	SENT_29	[p1l6t3163r366b3224],
22	(	CD	NUMBER	(	num	21	SENT_29	[p1l398t3162r794b3243],
23	Minimally	RB	O	minimally	advmod	25	SENT_29	[p1l398t3162r794b3243],
24	classic/occult	JJ	O	classic/occult	amod	25	SENT_29	[p1l825t3162r1304b3225],
25	trial	NN	O	trial	rcmod	21	SENT_29	[p1l1332t3162r1473b3224],
26	of	IN	O	of	_	0	SENT_29	[p1l1503t3162r1580b3224],
27	the	DT	O	the	det	28	SENT_29	[p1l1603t3162r1709b3224],
28	Anti	NNP	O	Anti	prep_of	25	SENT_29	[p1l1733t3162r2149b3225],
29	.	.	O	.	_	0	SENT_29	[p1l1733t3162r2149b3225],

1	—	NN	O	—	_	0	SENT_30	[p1l1733t3162r2149b3225],
2	.	.	O	.	_	0	SENT_30	[p1l1733t3162r2149b3225],

1	VEGF	NN	O	vegf	nn	2	SENT_31	[p1l1733t3162r2149b3225],
2	antibody	NN	O	antibody	_	0	SENT_31	[p1l8t3261r316b3341],
3	Ranibizumab	NNP	O	Ranibizumab	nsubj	14	SENT_31	[p1l338t3261r809b3323],
4	In	IN	O	in	_	0	SENT_31	[p1l832t3263r907b3322],
5	the	DT	O	the	det	6	SENT_31	[p1l931t3261r1037b3323],
6	treatment	NN	O	treatment	prep_in	14	SENT_31	[p1l1062t3270r1399b3323],
7	of	IN	O	of	_	0	SENT_31	[p1l1423t3261r1500b3323],
8	Neovascular	JJ	MISC	neovascular	amod	12	SENT_31	[p1l1515t3261r1959b3323],
9	Agerelated	JJ	MISC	agerelated	amod	12	SENT_31	[p1l1976t3262r2145b3341, p1l6t3360r248b3422],
10	macular	JJ	O	macular	amod	12	SENT_31	[p1l298t3360r585b3422],
11	degeneration	NN	O	degeneration	nn	12	SENT_31	[p1l634t3360r1213b3440],
12	)	NN	O	)	prep_of	6	SENT_31	[p1l634t3360r1213b3440],
13	have	VBP	O	have	aux	14	SENT_31	[p1l1224t3360r1390b3422],
14	reported	VBN	O	report	rcmod	2	SENT_31	[p1l1441t3360r1737b3440],
15	that	IN	O	that	advmod	14	SENT_31	[p1l1787t3360r1938b3433],
16	,	,	O	,	_	0	SENT_31	[p1l1787t3360r1938b3433],
17	with	IN	O	with	prep	14	SENT_31	[p1l1992t3360r2149b3422],

1	©	RB	O	©	dep	2	SENT_32	[p1l7t3600r51b3644],
2	2013	CD	DATE	2013	_	0	SENT_32	[p1l75t3600r195b3644],
3	by	IN	O	by	_	0	SENT_32	[p1l219t3600r281b3657],
4	the	DT	O	the	det	6	SENT_32	[p1l304t3600r378b3644],
5	American	NNP	ORGANIZATION	American	nn	6	SENT_32	[p1l401t3600r646b3644],
6	Academy	NNP	ORGANIZATION	Academy	prep_by	2	SENT_32	[p1l668t3600r906b3657],
7	of	IN	ORGANIZATION	of	_	0	SENT_32	[p1l930t3600r983b3644],
8	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	6	SENT_32	[p1l1003t3600r1392b3657],
9	Published	VBN	ORGANIZATION	publish	partmod	2	SENT_32	[p1l6t3679r252b3723],
10	by	IN	ORGANIZATION	by	_	0	SENT_32	[p1l273t3679r334b3735],
11	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_32	[p1l356t3679r561b3723],
12	Inc.	NNP	ORGANIZATION	Inc.	agent	9	SENT_32	[p1l582t3680r673b3723],
13	.	.	O	.	_	0	SENT_32	[p1l582t3680r673b3723],

1	monthly	JJ	SET	monthly	amod	3	SENT_33	[p2l7t118r302b200],
2	ranibizumab	NN	O	ranibizumab	nn	3	SENT_33	[p2l344t118r789b181],
3	injections	NNS	O	injection	nsubj	12	SENT_33	[p2l832t118r1197b200],
4	,	,	O	,	_	0	SENT_33	[p2l832t118r1197b200],
5	30	CD	PERCENT	30	number	9	SENT_33	[p2l1245t119r1401b181],
6	%	NN	PERCENT	%	dep	9	SENT_33	[p2l1245t119r1401b181],
7	to	TO	O	to	dep	9	SENT_33	[p2l1447t128r1513b181],
8	40	CD	PERCENT	40	number	9	SENT_33	[p2l1556t119r1714b181],
9	%	NN	PERCENT	%	appos	3	SENT_33	[p2l1556t119r1714b181],
10	of	IN	O	of	_	0	SENT_33	[p2l1762t118r1839b181],
11	patients	NNS	O	patient	prep_of	9	SENT_33	[p2l1875t118r2149b200],
12	gained	VBD	O	gain	_	0	SENT_33	[p2l8t219r243b300],
13	>	JJR	O	>	acomp	12	SENT_33	[p2l290t219r442b282],
14	15	CD	NUMBER	15	num	23	SENT_33	[p2l290t219r442b282],
15	Early	JJ	O	early	amod	23	SENT_33	[p2l487t219r677b300],
16	Treatment	NN	O	treatment	nn	23	SENT_33	[p2l720t221r1086b282],
17	Diabetic	NNP	O	Diabetic	nn	23	SENT_33	[p2l1126t219r1425b282],
18	Retinopathy	NNP	O	Retinopathy	nn	23	SENT_33	[p2l1469t219r1903b300],
19	Study	NNP	O	Study	nn	23	SENT_33	[p2l1947t219r2150b300],
20	(	CD	NUMBER	(	num	23	SENT_33	[p2l9t318r344b395],
21	ETDRS	NNP	O	ETDRS	nn	23	SENT_33	[p2l9t318r344b395],
22	)	CD	NUMBER	)	num	23	SENT_33	[p2l9t318r344b395],
23	letters	NNS	O	letter	tmod	12	SENT_33	[p2l378t318r613b392],
24	,	,	O	,	_	0	SENT_33	[p2l378t318r613b392],
25	5	CD	PERCENT	5	number	29	SENT_33	[p2l649t318r760b381],
26	%	NN	PERCENT	%	dep	29	SENT_33	[p2l649t318r760b381],
27	to	TO	O	to	dep	29	SENT_33	[p2l795t327r861b381],
28	10	CD	PERCENT	10	number	29	SENT_33	[p2l901t318r1051b381],
29	%	NN	PERCENT	%	appos	23	SENT_33	[p2l901t318r1051b381],
30	lost	VBD	O	lose	rcmod	29	SENT_33	[p2l1086t318r1214b381],
31	>	JJR	O	>	amod	33	SENT_33	[p2l1249t318r1401b381],
32	15	CD	NUMBER	15	num	33	SENT_33	[p2l1249t318r1401b381],
33	letters	NNS	O	letter	dobj	30	SENT_33	[p2l1436t318r1650b381],
34	despite	IN	O	despite	_	0	SENT_33	[p2l1684t318r1933b399],
35	treatment	NN	O	treatment	prep_despite	33	SENT_33	[p2l1965t327r2149b381, p2l6t428r202b492],
36	,	,	O	,	_	0	SENT_33	[p2l1965t327r2149b381, p2l6t428r202b492],
37	and	CC	O	and	_	0	SENT_33	[p2l232t418r357b481],
38	the	DT	O	the	det	39	SENT_33	[p2l381t418r487b481],
39	rest	NN	O	rest	nsubj	40	SENT_33	[p2l511t428r641b481],
40	maintained	VBD	O	maintain	conj_and	12	SENT_33	[p2l663t418r1059b481],
41	V1S1OI1	NN	O	v1s1oi1	nn	42	SENT_33	[p2l1083t406r1402b481],
42	.2	NN	NUMBER	.2	dobj	40	SENT_33	[p2l1083t406r1402b481],
43	’	CD	NUMBER	’	number	44	SENT_33	[p2l1083t406r1402b481],
44	3	CD	DURATION	3	dep	45	SENT_33	[p2l1083t406r1402b481],
45	Year	NN	DURATION	year	dep	42	SENT_33	[p2l1430t420r1603b481],
46	1	CD	NUMBER	1	num	47	SENT_33	[p2l1634t419r1660b480],
47	results	NNS	O	result	tmod	40	SENT_33	[p2l1691t418r1921b481],
48	of	IN	O	of	_	0	SENT_33	[p2l1949t418r2026b481],
49	the	DT	O	the	det	52	SENT_33	[p2l2045t418r2151b481],
50	CATT	NNP	O	CATT	nn	52	SENT_33	[p2l8t520r238b582],
51	(	CD	NUMBER	(	num	52	SENT_33	[p2l271t519r733b601],
52	Comparison	NN	O	comparison	prep_of	47	SENT_33	[p2l271t519r733b601],
53	of	IN	O	of	_	0	SENT_33	[p2l764t519r841b582],
54	Age	NNP	O	Age	prep_of	52	SENT_33	[p2l866t519r1316b601],
55	.	.	O	.	_	0	SENT_33	[p2l866t519r1316b601],

1	—	NN	O	—	_	0	SENT_34	[p2l866t519r1316b601],
2	.	.	O	.	_	0	SENT_34	[p2l866t519r1316b601],

1	Related	JJ	O	related	amod	7	SENT_35	[p2l866t519r1316b601],
2	Macular	NNP	ORGANIZATION	Macular	nn	7	SENT_35	[p2l1345t519r1643b582],
3	Degeneration	NNP	ORGANIZATION	Degeneration	nn	7	SENT_35	[p2l1671t519r2151b601],
4	Treatments	NNP	ORGANIZATION	Treatments	nn	7	SENT_35	[p2l7t622r404b683],
5	Trials	NNPS	ORGANIZATION	Trials	nn	7	SENT_35	[p2l460t620r693b697],
6	)	NN	O	)	nn	7	SENT_35	[p2l460t620r693b697],
7	study	NN	O	study	_	0	SENT_35	[p2l752t620r939b701],
8	showed	VBD	O	show	rcmod	7	SENT_35	[p2l997t620r1265b683],
9	that	IN	O	that	complm	13	SENT_35	[p2l1317t620r1450b683],
10	bevacizumab	NN	O	bevacizumab	nsubj	13	SENT_35	[p2l1501t620r1970b683],
11	and	CC	O	and	_	0	SENT_35	[p2l2026t620r2152b683],
12	ranibizumab	NN	O	ranibizumab	conj_and	10	SENT_35	[p2l6t719r450b781],
13	had	VBD	O	have	ccomp	8	SENT_35	[p2l499t719r627b781],
14	similar	JJ	O	similar	amod	15	SENT_35	[p2l677t719r922b781],
15	effects	NNS	O	effect	dobj	13	SENT_35	[p2l969t719r1202b781],
16	on	IN	O	on	_	0	SENT_35	[p2l1253t738r1339b781],
17	best-corrected	JJ	O	best-corrected	amod	21	SENT_35	[p2l1386t719r1892b781],
18	Visual	JJ	O	visual	amod	21	SENT_35	[p2l1940t719r2151b781],
19	acuity	NN	O	acuity	nn	21	SENT_35	[p2l8t817r222b899],
20	(	CD	NUMBER	(	num	21	SENT_35	[p2l268t818r568b895],
21	BCVA	NN	O	bcva	prep_on	15	SENT_35	[p2l268t818r568b895],
22	)	CD	NUMBER	)	dep	7	SENT_35	[p2l268t818r568b895],
23	when	WRB	O	when	advmod	24	SENT_35	[p2l613t817r804b880],
24	administered	VBN	O	administer	dep	22	SENT_35	[p2l848t817r1307b880],
25	under	IN	O	under	_	0	SENT_35	[p2l1348t817r1551b880],
26	the	DT	O	the	det	29	SENT_35	[p2l1592t817r1698b880],
27	same	JJ	O	same	amod	29	SENT_35	[p2l1744t837r1922b880],
28	treatment	NN	O	treatment	nn	29	SENT_35	[p2l1965t827r2148b880, p2l7t927r184b980],
29	protocol	NN	O	protocol	prep_under	24	SENT_35	[p2l214t906r566b998],
30	.4	CD	NUMBER	.4	dep	29	SENT_35	[p2l214t906r566b998],

1	The	DT	O	the	det	3	SENT_36	[p2l114t1019r250b1082],
2	SUSTAIN	NNP	O	SUSTAIN	nn	3	SENT_36	[p2l307t1019r680b1082],
3	study	NN	O	study	_	0	SENT_36	[p2l736t1019r944b1100],
4	,	,	O	,	_	0	SENT_36	[p2l736t1019r944b1100],
5	which	WDT	O	which	nsubj	6	SENT_36	[p2l1001t1019r1218b1082],
6	investigated	VBD	O	investigate	rcmod	3	SENT_36	[p2l1271t1019r1702b1100],
7	a	DT	O	a	det	11	SENT_36	[p2l1757t1039r1793b1082],
8	different	JJ	O	different	amod	11	SENT_36	[p2l1847t1019r2153b1082],
9	ranibizumab	NN	O	ranibizumab	nn	11	SENT_36	[p2l6t1120r450b1183],
10	treatment	NN	O	treatment	nn	11	SENT_36	[p2l475t1129r812b1183],
11	protocol	NN	O	protocol	dobj	6	SENT_36	[p2l833t1120r1130b1201],
12	with	IN	O	with	_	0	SENT_36	[p2l1154t1120r1311b1183],
13	a	DT	O	a	det	16	SENT_36	[p2l1336t1139r1373b1183],
14	ﬁxed	JJ	O	ﬁxed	amod	16	SENT_36	[p2l1397t1120r1573b1183],
15	monthly	JJ	SET	monthly	amod	16	SENT_36	[p2l1596t1120r1891b1201],
16	dosing	NN	O	dosing	prep_with	6	SENT_36	[p2l1917t1120r2151b1201],

1	ISSN	NN	O	issn	_	0	SENT_37	[p2l840t1361r974b1405],
2	0161-6420/13	CD	DURATION	0161-6420/13	dep	1	SENT_37	[p2l997t1358r1506b1409],
3	/	:	O	/	punct	1	SENT_37	[p2l997t1358r1506b1409],
4	$	$	MONEY	$	dep	1	SENT_37	[p2l997t1358r1506b1409],
5	.	.	MONEY	.	_	0	SENT_37	[p2l997t1358r1506b1409],

1	—	NN	O	—	_	0	SENT_38	[p2l997t1358r1506b1409],
2	.	.	O	.	_	0	SENT_38	[p2l997t1358r1506b1409],

1	see	VB	O	see	_	0	SENT_39	[p2l997t1358r1506b1409],
2	front	JJ	O	front	amod	3	SENT_39	[p2l1529t1361r1650b1405],
3	matter	NN	O	matter	dobj	1	SENT_39	[p2l1671t1367r1831b1405],
4	1	CD	NUMBER	1	num	5	SENT_39	[p2l2015t1334r2038b1404],
5	*	NN	O	*	nsubj	1	SENT_39	[p2l2064t1330r2147b1405],

1	http://dx.doi.org/10.1016/j.ophtha.2012.10.006	NN	O	http://dx.doi.org/10.1016/j.ophtha.2012.10.006	_	0	SENT_40	[p2l653t1425r1829b1482],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_41	[p2l559t1557r851b1601],
2	Volume	NN	O	volume	nn	3	SENT_41	[p2l897t1557r1030b1592],
3	l20	NN	O	l20	dep	1	SENT_41	[p2l1052t1559r1126b1598],
4	,	,	O	,	_	0	SENT_41	[p2l1052t1559r1126b1598],
5	Number	NN	O	number	appos	3	SENT_41	[p2l1146t1557r1291b1592],
6	1	CD	NUMBER	1	num	5	SENT_41	[p2l1311t1559r1340b1598],
7	,	,	O	,	_	0	SENT_41	[p2l1311t1559r1340b1598],
8	January	NNP	DATE	January	tmod	3	SENT_41	[p2l1357t1559r1495b1601],
9	2013	CD	DATE	2013	num	8	SENT_41	[p2l1514t1559r1601b1592],

1	.	.	O	.	_	0	SENT_42	[p2l20t1746r266b1787],

1	—	NN	O	—	_	0	SENT_43	[p2l20t1746r266b1787],
2	.	.	O	.	_	0	SENT_43	[p2l20t1746r266b1787],

1	O	NN	O	o	_	0	SENT_44	[p2l20t1746r266b1787],
2	.	.	O	.	_	0	SENT_44	[p2l20t1746r266b1787],

1	—	NN	O	—	_	0	SENT_45	[p2l20t1746r266b1787],
2	.	.	O	.	_	0	SENT_45	[p2l20t1746r266b1787],

1	TT	NN	O	tt	_	0	SENT_46	[p2l20t1746r266b1787],
2	or	CC	O	or	_	0	SENT_46	[p2l283t1759r331b1788],
3	TC	NN	O	tc	conj_or	1	SENT_46	[p2l347t1746r420b1788],
4	genotypes	NNS	O	genotype	dep	1	SENT_46	[p2l438t1751r678b1800],
5	.	.	O	.	_	0	SENT_46	[p2l711t1746r963b1788],

1	—	NN	O	—	_	0	SENT_47	[p2l711t1746r963b1788],
2	.	.	O	.	_	0	SENT_47	[p2l711t1746r963b1788],

1	I	PRP	O	I	_	0	SENT_48	[p2l711t1746r963b1788],
2	.	.	O	.	_	0	SENT_48	[p2l711t1746r963b1788],

1	—	NN	O	—	_	0	SENT_49	[p2l711t1746r963b1788],
2	.	.	O	.	_	0	SENT_49	[p2l711t1746r963b1788],

1	CC	NN	O	cc	nn	3	SENT_50	[p2l711t1746r963b1788],
2	genotype	NN	O	genotype	nn	3	SENT_50	[p2l981t1751r1197b1800],
3	L	NN	O	l	_	0	SENT_50	[p2l1231t1764r1236b1772],
4	;	:	O	;	_	0	SENT_50	[p2l1303t1764r1321b1786],
5	29	CD	PERCENT	29	num	6	SENT_50	[p2l1405t1745r2135b1789],
6	%	NN	PERCENT	%	amod	9	SENT_50	[p2l1405t1745r2135b1789],
7	ANCHOIU7l	CD	PERCENT	anchoiu7l	num	8	SENT_50	[p2l1405t1745r2135b1789],
8	%	NN	PERCENT	%	dep	6	SENT_50	[p2l1405t1745r2135b1789],
9	MARINA	NN	O	marina	dep	3	SENT_50	[p2l1405t1745r2135b1789],

1	I.	NN	O	i.	_	0	SENT_51	[p2l788t1843r816b1871],
2	.	.	O	.	_	0	SENT_51	[p2l833t1843r840b1850],

1	_	NN	O	_	_	0	SENT_52	[p2l857t1843r882b1850],
2	.	.	O	.	_	0	SENT_52	[p2l899t1843r906b1850],

1	_	NN	O	_	_	0	SENT_53	[p2l923t1843r947b1850],
2	.	.	O	.	_	0	SENT_53	[p2l964t1843r971b1850],

1	_	NN	O	_	_	0	SENT_54	[p2l988t1843r1013b1850],
2	.	.	O	.	_	0	SENT_54	[p2l1030t1843r1037b1850],

1	_	NN	O	_	_	0	SENT_55	[p2l1054t1843r1079b1850],
2	.	.	O	.	_	0	SENT_55	[p2l1096t1843r1126b1871],

1	I	PRP	O	I	_	0	SENT_56	[p2l1096t1843r1126b1871],
2	I	PRP	O	I	dep	1	SENT_56	[p2l789t1912r796b1937],

1	10	CD	NUMBER	10	dep	4	SENT_57	[p2l114t1942r165b1984],
2	;	:	O	;	_	0	SENT_57	[p2l790t1954r797b2002],
3	I	PRP	O	I	nsubj	4	SENT_57	[p2l2006t1915r2026b2053],
4	*	VBP	O	*	_	0	SENT_57	[p2l658t2131r716b2152],
5	iii	LS	O	iii	acomp	4	SENT_57	[p2l760t2085r811b2148],
6	.	.	O	.	_	0	SENT_57	[p2l760t2085r811b2148],
7	)	SYM	O	)	dep	4	SENT_57	[p2l760t2085r811b2148],

1	J	NN	O	j	nn	3	SENT_58	[p2l852t2128r903b2140],
2	V	NN	O	v	nn	3	SENT_58	[p2l949t2117r989b2133],
3	*	NN	O	*	_	0	SENT_58	[p2l1039t2110r1115b2135],
4	777	CD	NUMBER	777	num	5	SENT_58	[p2l1331t2098r1366b2107],
5	‘	NN	O	‘	dep	3	SENT_58	[p2l1331t2098r1366b2107],
6	377	CD	NUMBER	377	dep	5	SENT_58	[p2l1406t2089r1458b2099],
7	‘	NN	O	‘	dep	3	SENT_58	[p2l1406t2089r1458b2099],
8	'	''	O	'	_	0	SENT_58	[p2l1501t2085r1548b2096],
9	7	CD	NUMBER	7	number	10	SENT_58	[p2l1501t2085r1548b2096],
10	’	CD	NUMBER	’	num	11	SENT_58	[p2l1501t2085r1548b2096],
11	:7	CD	NUMBER	:7	dep	7	SENT_58	[p2l1592t2082r1644b2093],
12	!	.	O	!	_	0	SENT_58	[p2l1592t2082r1644b2093],

1	[	NN	O	[	_	0	SENT_59	[p2l1684t2075r1736b2089],
2	:77	CD	NUMBER	:77	number	3	SENT_59	[p2l1684t2075r1736b2089],
3	77	CD	NUMBER	77	num	4	SENT_59	[p2l1794t2070r1820b2072],
4	V77	NN	O	v77	dep	1	SENT_59	[p2l1870t2068r1921b2079],
5	;	:	O	;	_	0	SENT_59	[p2l1870t2068r1921b2079],
6	:7	CD	NUMBER	:7	dep	1	SENT_59	[p2l1963t2061r2001b2075],
7	?	.	O	?	_	0	SENT_59	[p2l1963t2061r2001b2075],

1	i	FW	O	i	nn	5	SENT_60	[p2l2038t2086r2039b2089],
2	ol	FW	O	ol	nn	5	SENT_60	[p2l617t2153r704b2195],
3	*	FW	O	*	nn	5	SENT_60	[p2l617t2153r704b2195],
4	ol	NN	O	ol	nn	5	SENT_60	[p2l793t2151r800b2199],
5	*	NN	O	*	_	0	SENT_60	[p2l793t2151r800b2199],
6	s	VBZ	O	s	cop	10	SENT_60	[p2l1123t2151r1130b2199],
7	*	CD	NUMBER	*	number	8	SENT_60	[p2l1123t2151r1130b2199],
8	6	CD	NUMBER	6	num	10	SENT_60	[p2l139t2201r165b2243],
9	ol	NN	O	ol	nn	10	SENT_60	[p2l559t2245r576b2268],
10	*	NN	O	*	rcmod	5	SENT_60	[p2l559t2245r576b2268],
11	“	CD	NUMBER	“	num	13	SENT_60	[p2l601t2204r624b2213],
12	;	:	O	;	_	0	SENT_60	[p2l794t2216r801b2265],
13	*	CD	NUMBER	*	dep	10	SENT_60	[p2l1105t2133r1132b2265],

1	/	:	O	/	punct	2	SENT_61	[p2l487t2322r508b2327],
2	1	CD	NUMBER	1	_	0	SENT_61	[p2l487t2322r508b2327],
3	i	FW	O	i	dep	2	SENT_61	[p2l794t2282r802b2331],

1	Mean	NN	O	mean	nn	2	SENT_62	[p2l32t2867r73b3002],
2	change	NN	O	change	_	0	SENT_62	[p2l30t2685r85b2851],
3	in	IN	O	in	_	0	SENT_62	[p2l30t2622r72b2667],
4	visual	JJ	O	visual	amod	7	SENT_62	[p2l30t2466r73b2607],
5	acuity	NN	O	acuity	nn	7	SENT_62	[p2l30t2304r85b2448],
6	(	NN	O	(	nn	7	SENT_62	[p2l30t2087r84b2287],
7	number	NN	O	number	prep_in	2	SENT_62	[p2l30t2087r84b2287],
8	of	IN	O	of	_	0	SENT_62	[p2l30t2017r73b2071],
9	letters	NNS	O	letter	prep_of	2	SENT_62	[p2l30t1864r73b2006],

1	4	CD	NUMBER	4	_	0	SENT_63	[p2l138t2331r165b2372],
2	,	,	O	,	_	0	SENT_63	[p2l419t2381r446b2397],
3	“	CD	NUMBER	“	appos	1	SENT_63	[p2l471t2343r479b2352],
4	i	LS	O	i	dep	3	SENT_63	[p2l795t2348r803b2396],
5	.	.	O	.	_	0	SENT_63	[p2l1126t2371r1133b2396],

1	2	CD	NUMBER	2	dep	4	SENT_64	[p2l138t2460r164b2501],
2	i	FW	O	i	dep	1	SENT_64	[p2l1128t2479r1135b2527],
3	o	NN	O	o	dep	4	SENT_64	[p2l139t2590r165b2631],
4	I	PRP	O	I	dep	6	SENT_64	[p2l799t2634r806b2658],
5	I	PRP	O	I	dep	4	SENT_64	[p2l1130t2606r1175b2658],
6	‘	VBP	O	‘	_	0	SENT_64	[p2l1721t2613r2016b2642],
7	ll	NN	O	ll	nn	9	SENT_64	[p2l211t2665r225b2700],
8	2	CD	NUMBER	2	num	9	SENT_64	[p2l504t2661r530b2702],
9	i4	NN	O	i4	dobj	6	SENT_64	[p2l799t2661r831b2724],
10	Predictive	JJ	O	predictive	amod	9	SENT_64	[p2l863t2661r1078b2699],
11	it	PRP	O	it	dep	10	SENT_64	[p2l1112t2673r1137b2725],
12	8	CD	NUMBER	8	number	13	SENT_64	[p2l1407t2661r1430b2703],
13	10	CD	NUMBER	10	dep	14	SENT_64	[p2l1696t2661r1746b2703],
14	V	NN	O	v	dep	9	SENT_64	[p2l2022t2673r2038b2699],

1	-2	CD	NUMBER	-2	_	0	SENT_65	[p2l119t2720r164b2761],
2	i	FW	O	i	dep	1	SENT_65	[p2l800t2742r808b2790],
3	window	NN	O	window	dep	1	SENT_65	[p2l874t2724r1067b2768],
4	;	:	O	;	_	0	SENT_65	[p2l1131t2742r1138b2790],
5	-4	CD	NUMBER	-4	num	6	SENT_65	[p2l119t2849r165b2890],
6	_	NN	O	_	dep	1	SENT_65	[p2l804t2824r829b2831],
7	.	.	O	.	_	0	SENT_65	[p2l846t2824r853b2831],

1	_	NN	O	_	_	0	SENT_66	[p2l870t2824r895b2831],
2	.	.	O	.	_	0	SENT_66	[p2l912t2824r919b2831],

1	_	NN	O	_	_	0	SENT_67	[p2l936t2824r960b2831],
2	.	.	O	.	_	0	SENT_67	[p2l977t2824r984b2831],

1	_	NN	O	_	_	0	SENT_68	[p2l1001t2824r1026b2831],
2	.	.	O	.	_	0	SENT_68	[p2l1043t2824r1050b2831],

1	_	NN	O	_	_	0	SENT_69	[p2l1067t2824r1091b2831],
2	.	.	O	.	_	0	SENT_69	[p2l1109t2824r1136b2831],

1	.	.	O	.	_	0	SENT_70	[p2l1109t2824r1136b2831],

1	6	CD	NUMBER	6	num	4	SENT_71	[p2l139t2979r165b3020],
2	Time	NNP	O	Time	nn	4	SENT_71	[p2l942t2938r1065b2981],
3	(	CD	NUMBER	(	num	4	SENT_71	[p2l1084t2938r1295b2993],
4	months	NNS	NUMBER	month	_	0	SENT_71	[p2l1084t2938r1295b2993],
5	)	IN	O	)	amod	4	SENT_71	[p2l1084t2938r1295b2993],

1	Figure	NNP	O	Figure	_	0	SENT_72	[p2l6t3117r195b3182],
2	1	CD	NUMBER	1	dep	1	SENT_72	[p2l244t3119r292b3168],
3	.	.	O	.	_	0	SENT_72	[p2l244t3119r292b3168],

1	Comparison	NN	O	comparison	_	0	SENT_73	[p2l333t3116r685b3183],
2	of	IN	O	of	_	0	SENT_73	[p2l726t3115r785b3168],
3	the	DT	O	the	det	5	SENT_73	[p2l822t3114r912b3169],
4	mean	JJ	O	mean	amod	5	SENT_73	[p2l955t3136r1112b3168],
5	change	NN	O	change	prep_of	1	SENT_73	[p2l1153t3114r1356b3182],
6	in	IN	O	in	_	0	SENT_73	[p2l1401t3122r1456b3168],
7	visual	JJ	O	visual	amod	8	SENT_73	[p2l1497t3114r1662b3168],
8	acuity	NN	O	acuity	prep_in	5	SENT_73	[p2l1705t3122r1876b3182],
9	over	IN	O	over	_	0	SENT_73	[p2l1918t3136r2043b3168],
10	12	CD	DURATION	12	num	11	SENT_73	[p2l2089t3117r2150b3168],
11	months	NNS	NUMBER	month	prep_over	1	SENT_73	[p2l8t3203r223b3258],
12	in	IN	O	in	_	0	SENT_73	[p2l246t3211r302b3257],
13	patients	NNS	O	patient	prep_in	11	SENT_73	[p2l320t3211r549b3272],
14	with	IN	O	with	_	0	SENT_73	[p2l569t3203r700b3258],
15	and	CC	O	and	_	0	SENT_73	[p2l720t3203r824b3258],
16	without	IN	O	without	_	0	SENT_73	[p2l843t3203r1069b3258],
17	the	DT	O	the	det	19	SENT_73	[p2l1089t3203r1180b3258],
18	T	NN	O	t	nn	19	SENT_73	[p2l1201t3206r1247b3257],
19	allele	NN	O	allele	prep_without	13	SENT_73	[p2l1268t3203r1419b3258],
20	at	IN	O	at	_	0	SENT_73	[p2l1441t3220r1493b3258],
21	SNP	NN	ORGANIZATION	snp	prep_at	19	SENT_73	[p2l1514t3205r1646b3258],
22	rs3025000	CD	NUMBER	rs3025000	num	21	SENT_73	[p2l1666t3204r1961b3258],
23	in	IN	O	in	_	0	SENT_73	[p2l1984t3211r2040b3257],
24	the	DT	O	the	det	28	SENT_73	[p2l2060t3203r2151b3258],
25	Vascular	JJ	O	vascular	amod	28	SENT_73	[p2l8t3290r241b3345],
26	endothelial	JJ	O	endothelial	amod	28	SENT_73	[p2l260t3290r587b3345],
27	growth	NN	O	growth	nn	28	SENT_73	[p2l606t3290r807b3359],
28	factor	NN	O	factor	prep_in	21	SENT_73	[p2l826t3291r992b3345],
29	A	DT	O	a	det	33	SENT_73	[p2l1009t3292r1064b3345],
30	(	JJ	O	(	amod	33	SENT_73	[p2l1087t3290r1370b3355],
31	VEGFA	NN	O	vegfa	nn	33	SENT_73	[p2l1087t3290r1370b3355],
32	)	NN	O	)	nn	33	SENT_73	[p2l1087t3290r1370b3355],
33	gene	NN	O	gene	prep_with	13	SENT_73	[p2l1395t3312r1542b3359],
34	.	.	O	.	_	0	SENT_73	[p2l1395t3312r1542b3359],

1	ANCHOR	NN	O	anchor	nsubj	2	SENT_74	[p2l1563t3292r1885b3345],
2	=	JJ	O	=	_	0	SENT_74	[p2l1910t3312r1953b3329],
3	AN	DT	O	a	det	7	SENT_74	[p2l1978t3293r2086b3345],
4	ti	NN	O	ti	nn	7	SENT_74	[p2l2088t3298r2150b3345],
5	»	CD	NUMBER	»	num	7	SENT_74	[p2l2088t3298r2150b3345],
6	VEGF	NN	O	vegf	nn	7	SENT_74	[p2l7t3381r189b3434],
7	antibody	NN	O	antibody	dobj	2	SENT_74	[p2l221t3379r472b3447],
8	for	IN	O	for	_	0	SENT_74	[p2l503t3380r582b3433],
9	the	DT	O	the	det	10	SENT_74	[p2l614t3379r705b3433],
10	treatment	NN	O	treatment	prep_for	7	SENT_74	[p2l739t3396r1022b3434],
11	of	IN	O	of	_	0	SENT_74	[p2l1054t3380r1113b3434],
12	predominantly	RB	O	predominantly	advmod	15	SENT_74	[p2l1137t3379r1562b3448],
13	classic	JJ	O	classic	amod	15	SENT_74	[p2l1593t3379r1773b3434],
14	Cl-lORoidal	JJ	O	cl-loroidal	amod	15	SENT_74	[p2l1805t3379r2153b3434],
15	neovascularization	NN	O	neovascularization	prep_of	10	SENT_74	[p2l7t3467r543b3522],
16	in	IN	O	in	_	0	SENT_74	[p2l587t3475r643b3521],
17	age	NN	O	age	npadvmod	19	SENT_74	[p2l687t3467r1001b3536],
18	—	CD	NUMBER	—	num	17	SENT_74	[p2l687t3467r1001b3536],
19	related	JJ	O	related	amod	21	SENT_74	[p2l687t3467r1001b3536],
20	macular	JJ	O	macular	amod	21	SENT_74	[p2l1045t3467r1274b3522],
21	degeneration	NN	O	degeneration	prep_in	15	SENT_74	[p2l1316t3467r1706b3535],
22	;	:	O	;	_	0	SENT_74	[p2l1316t3467r1706b3535],
23	MARINA	NN	O	marina	dep	15	SENT_74	[p2l1752t3469r2052b3521],
24	=	JJ	O	=	amod	23	SENT_74	[p2l2102t3489r2145b3506],
25	Minimally	RB	O	minimally	advmod	23	SENT_74	[p2l6t3554r308b3623],
26	classic/occult	JJ	O	classic/occult	amod	27	SENT_74	[p2l330t3554r709b3619],
27	trial	NN	O	trial	dep	23	SENT_74	[p2l732t3554r849b3609],
28	of	IN	O	of	_	0	SENT_74	[p2l871t3555r930b3609],
29	the	DT	O	the	det	46	SENT_74	[p2l947t3554r1038b3609],
30	Anti	NNP	O	Anti	npadvmod	44	SENT_74	[p2l1060t3557r1402b3610],
31	»	CD	NUMBER	»	number	32	SENT_74	[p2l1060t3557r1402b3610],
32	\	CD	NUMBER	\	amod	30	SENT_74	[p2l1060t3557r1402b3610],
33	/	:	O	/	punct	35	SENT_74	[p2l1060t3557r1402b3610],
34	ECIF	NN	O	ecif	nn	35	SENT_74	[p2l1060t3557r1402b3610],
35	antibody	NN	O	antibody	dep	32	SENT_74	[p2l1425t3554r1676b3623],
36	Ranibizumab	NNP	O	Ranibizumab	dep	35	SENT_74	[p2l1698t3554r2068b3609],
37	In	IN	O	in	dep	35	SENT_74	[p2l2092t3557r2153b3609],
38	the	DT	O	the	det	39	SENT_74	[p2l9t3644r100b3699],
39	treatment	NN	O	treatment	pobj	37	SENT_74	[p2l128t3661r411b3699],
40	of	IN	O	of	_	0	SENT_74	[p2l438t3645r497b3698],
41	Neovascular	JJ	MISC	neovascular	amod	43	SENT_74	[p2l516t3644r874b3699],
42	Age	NN	MISC	age	nn	43	SENT_74	[p2l898t3644r1235b3712],
43	—	NN	O	—	prep_of	39	SENT_74	[p2l898t3644r1235b3712],
44	related	JJ	O	related	amod	46	SENT_74	[p2l898t3644r1235b3712],
45	macular	JJ	O	macular	amod	46	SENT_74	[p2l1262t3644r1491b3699],
46	degeneration	NN	O	degeneration	prep_of	27	SENT_74	[p2l1516t3644r1906b3712],
47	;	:	O	;	_	0	SENT_74	[p2l1516t3644r1906b3712],
48	SNP	NN	O	snp	dep	15	SENT_74	[p2l1937t3646r2069b3699],
49	=	JJ	O	=	amod	52	SENT_74	[p2l2102t3666r2146b3683],
50	single	JJ	O	single	amod	52	SENT_74	[p2l8t3732r171b3801],
51	nucleotide	NN	O	nucleotide	nn	52	SENT_74	[p2l198t3732r501b3787],
52	polymorphism	NN	O	polymorphism	dep	48	SENT_74	[p2l527t3732r954b3801],
53	.	.	O	.	_	0	SENT_74	[p2l527t3732r954b3801],

1	regimen	NNS	O	regimen	nsubj	20	SENT_75	[p3l7t151r298b232],
2	for	IN	O	for	_	0	SENT_75	[p3l327t151r430b214],
3	3	CD	DURATION	3	num	4	SENT_75	[p3l459t151r494b214],
4	months	NNS	NUMBER	month	prep_for	1	SENT_75	[p3l526t151r806b225],
5	,	,	O	,	_	0	SENT_75	[p3l526t151r806b225],
6	followed	VBN	O	follow	partmod	1	SENT_75	[p3l838t151r1154b214],
7	by	IN	O	by	_	0	SENT_75	[p3l1180t151r1267b232],
8	a	DT	O	a	det	9	SENT_75	[p3l1298t171r1335b214],
9	ﬂexible	JJ	O	ﬂexible	agent	6	SENT_75	[p3l1363t151r1646b225],
10	,	,	O	,	_	0	SENT_75	[p3l1363t151r1646b225],
11	“	RB	O	“	advmod	6	SENT_75	[p3l1680t152r1787b214],
12	as	IN	O	as	_	0	SENT_75	[p3l1680t152r1787b214],
13	required	VBN	O	require	amod	15	SENT_75	[p3l1816t151r2150b232],
14	”	NN	O	”	nn	15	SENT_75	[p3l1816t151r2150b232],
15	treatment	NN	O	treatment	prep_as	6	SENT_75	[p3l7t257r344b310],
16	for	IN	O	for	_	0	SENT_75	[p3l369t247r472b310],
17	9	CD	DURATION	9	num	18	SENT_75	[p3l498t248r537b311],
18	months	NNS	NUMBER	month	prep_for	15	SENT_75	[p3l565t247r845b322],
19	,	,	O	,	_	0	SENT_75	[p3l565t247r845b322],
20	showed	VBD	O	show	_	0	SENT_75	[p3l878t247r1146b310],
21	that	IN	O	that	complm	26	SENT_75	[p3l1171t247r1304b310],
22	53	CD	PERCENT	53	num	23	SENT_75	[p3l1330t247r1486b311],
23	%	NN	PERCENT	%	nsubj	26	SENT_75	[p3l1330t247r1486b311],
24	of	IN	O	of	_	0	SENT_75	[p3l1517t247r1595b310],
25	patients	NNS	O	patient	prep_of	23	SENT_75	[p3l1614t247r1888b329],
26	gained	VBD	O	gain	ccomp	20	SENT_75	[p3l1917t247r2153b329],
27	and	CC	O	and	_	0	SENT_75	[p3l9t347r135b410],
28	maintained	VBD	O	maintain	ccomp	20	SENT_75	[p3l174t347r570b410],
29	vision	NN	O	vision	dobj	28	SENT_75	[p3l609t347r844b421],
30	,	,	O	,	_	0	SENT_75	[p3l609t347r844b421],
31	21	CD	PERCENT	21	num	32	SENT_75	[p3l888t347r1045b410],
32	%	NN	PERCENT	%	nsubj	33	SENT_75	[p3l888t347r1045b410],
33	gained	VBD	O	gain	ccomp	20	SENT_75	[p3l1090t347r1325b428],
34	but	CC	O	but	_	0	SENT_75	[p3l1363t347r1478b410],
35	did	VBD	O	do	aux	37	SENT_75	[p3l1517t347r1628b410],
36	not	RB	O	not	neg	37	SENT_75	[p3l1668t356r1781b410],
37	maintain	VB	O	maintain	conj_but	33	SENT_75	[p3l1819t347r2149b421],
38	,	,	O	,	_	0	SENT_75	[p3l1819t347r2149b421],
39	and	CC	O	and	_	0	SENT_75	[p3l9t444r135b506],
40	26	CD	PERCENT	26	num	41	SENT_75	[p3l166t444r323b506],
41	%	NN	PERCENT	%	nsubj	53	SENT_75	[p3l166t444r323b506],
42	did	VBD	O	do	aux	44	SENT_75	[p3l358t444r470b506],
43	not	RB	O	not	neg	44	SENT_75	[p3l500t453r613b506],
44	have	VB	O	have	rcmod	41	SENT_75	[p3l642t444r808b506],
45	any	DT	O	any	det	46	SENT_75	[p3l841t463r966b524],
46	gain	NN	O	gain	dobj	44	SENT_75	[p3l998t444r1149b524],
47	in	IN	O	in	_	0	SENT_75	[p3l1179t444r1247b505],
48	BCVA	NNP	O	BCVA	prep_in	46	SENT_75	[p3l1277t431r1576b506],
49	.5	CD	NUMBER	.5	num	48	SENT_75	[p3l1277t431r1576b506],
50	The	DT	O	the	det	51	SENT_75	[p3l1610t444r1746b506],
51	SUSTAIN	NN	O	sustain	nsubj	52	SENT_75	[p3l1779t444r2153b506],
52	results	VBZ	O	result	rcmod	41	SENT_75	[p3l7t540r237b602],
53	showed	VBD	O	show	conj_and	20	SENT_75	[p3l269t540r537b603],
54	that	IN	O	that	_	0	SENT_75	[p3l564t540r697b602],
55	the	DT	O	the	det	56	SENT_75	[p3l723t540r830b602],
56	outcome	NN	O	outcome	prep_that	53	SENT_75	[p3l858t550r1163b602],
57	of	IN	O	of	_	0	SENT_75	[p3l1191t540r1269b602],
58	the	DT	O	the	det	59	SENT_75	[p3l1290t540r1396b602],
59	treatment	NN	O	treatment	prep_of	56	SENT_75	[p3l1424t550r1760b602],
60	in	IN	O	in	_	0	SENT_75	[p3l1787t540r1854b602],
61	the	DT	O	the	det	62	SENT_75	[p3l1881t540r1988b602],
62	ﬁrst	NN	O	ﬁrst	prep_in	53	SENT_75	[p3l2017t540r2153b602],

1	3	LS	NUMBER	3	dep	7	SENT_76	[p3l10t640r77b702],
2	-	:	O	-	_	0	SENT_76	[p3l10t640r77b702],
3	to	TO	O	to	_	0	SENT_76	[p3l103t649r169b702],
4	5-month	JJ	DURATION	5-month	amod	5	SENT_76	[p3l195t639r494b702],
5	period	NN	O	period	prep_to	7	SENT_76	[p3l516t639r744b720],
6	could	MD	O	could	aux	7	SENT_76	[p3l768t639r964b702],
7	predict	VB	O	predict	_	0	SENT_76	[p3l985t639r1234b720],
8	the	DT	O	the	det	9	SENT_76	[p3l1255t639r1362b702],
9	outcomes	NNS	O	outcome	dobj	7	SENT_76	[p3l1387t649r1724b702],
10	at	IN	O	at	_	0	SENT_76	[p3l1751t648r1813b702],
11	year	NN	DURATION	year	prep_at	7	SENT_76	[p3l1835t659r1988b720],
12	1	CD	NUMBER	1	num	11	SENT_76	[p3l2018t640r2044b701],
13	so	RB	O	so	advmod	19	SENT_76	[p3l2079t659r2151b702],
14	that	IN	O	that	dep	19	SENT_76	[p3l7t736r140b798],
15	responder	NN	O	responder	nn	16	SENT_76	[p3l170t736r524b816],
16	types	NNS	O	type	nsubjpass	19	SENT_76	[p3l554t745r738b816],
17	could	MD	O	could	aux	19	SENT_76	[p3l773t736r969b798],
18	be	VB	O	be	auxpass	19	SENT_76	[p3l1000t736r1082b798],
19	recognized	VBN	O	recognize	advcl	7	SENT_76	[p3l1114t723r1558b816],
20	.5	CD	NUMBER	.5	dobj	19	SENT_76	[p3l1114t723r1558b816],
21	In	IN	O	in	_	0	SENT_76	[p3l1593t737r1666b797],
22	the	DT	O	the	det	24	SENT_76	[p3l1698t736r1804b798],
23	EXCITE	NNP	ORGANIZATION	EXCITE	nn	24	SENT_76	[p3l1836t736r2152b798],
24	study	NN	O	study	prep_in	70	SENT_76	[p3l11t832r218b914],
25	,	,	O	,	_	0	SENT_76	[p3l11t832r218b914],
26	which	WDT	O	which	nsubj	27	SENT_76	[p3l246t832r462b895],
27	compared	VBD	O	compare	rcmod	24	SENT_76	[p3l487t832r838b914],
28	the	DT	O	the	det	29	SENT_76	[p3l861t832r968b895],
29	outcome	NN	O	outcome	nsubj	35	SENT_76	[p3l994t842r1298b895],
30	of	IN	O	of	_	0	SENT_76	[p3l1324t832r1401b895],
31	3	CD	NUMBER	3	num	34	SENT_76	[p3l1422t833r1457b896],
32	different	JJ	O	different	amod	34	SENT_76	[p3l1487t832r1793b895],
33	treatment	NN	O	treatment	nn	34	SENT_76	[p3l1817t842r2153b895],
34	regimens	NNS	O	regimen	prep_of	29	SENT_76	[p3l7t932r424b1013],
35	—	VBD	O	—	ccomp	27	SENT_76	[p3l7t932r424b1013],
36	quarterly	JJ	SET	quarterly	amod	50	SENT_76	[p3l436t932r755b1013],
37	0.5	CD	NUMBER	0.5	amod	50	SENT_76	[p3l784t932r889b995],
38	mg	NN	O	mg	nn	50	SENT_76	[p3l921t952r1032b1013],
39	ranibizumab	NN	O	ranibizumab	nn	50	SENT_76	[p3l1059t932r1524b1006],
40	,	,	O	,	_	0	SENT_76	[p3l1059t932r1524b1006],
41	quarterly	JJ	SET	quarterly	amod	50	SENT_76	[p3l1556t932r1875b1013],
42	0.3	CD	NUMBER	0.3	num	44	SENT_76	[p3l1904t932r2008b995],
43	mg	NN	O	mg	nn	44	SENT_76	[p3l2040t952r2151b1013],
44	ranibizumab	NN	O	ranibizumab	tmod	41	SENT_76	[p3l7t1030r471b1104],
45	,	,	O	,	_	0	SENT_76	[p3l7t1030r471b1104],
46	and	CC	O	and	_	0	SENT_76	[p3l499t1030r625b1093],
47	monthly	JJ	SET	monthly	amod	48	SENT_76	[p3l646t1030r941b1111],
48	0.3	CD	NUMBER	0.3	tmod	41	SENT_76	[p3l965t1030r1069b1093],
49	mg	NN	O	mg	nn	50	SENT_76	[p3l1096t1049r1207b1111],
50	ranibizumab	NN	O	ranibizumab	nsubj	56	SENT_76	[p3l1230t1030r1674b1093],
51	after	IN	O	after	_	0	SENT_76	[p3l1700t1030r1861b1093],
52	3	CD	NUMBER	3	num	55	SENT_76	[p3l1884t1030r1919b1093],
53	initial	JJ	O	initial	amod	55	SENT_76	[p3l1946t1030r2152b1093],
54	loading	VBG	O	load	amod	55	SENT_76	[p3l8t1126r272b1208],
55	doses	NNS	O	dose	prep_after	50	SENT_76	[p3l303t1126r629b1189],
56	—	VBP	O	—	ccomp	35	SENT_76	[p3l303t1126r629b1189],
57	a	DT	O	a	det	59	SENT_76	[p3l303t1126r629b1189],
58	similar	JJ	O	similar	amod	59	SENT_76	[p3l660t1126r905b1189],
59	divergence	NN	O	divergence	nsubjpass	63	SENT_76	[p3l932t1126r1321b1208],
60	of	IN	O	of	_	0	SENT_76	[p3l1351t1126r1429b1189],
61	response	NN	O	response	prep_of	59	SENT_76	[p3l1450t1146r1761b1208],
62	was	VBD	O	be	auxpass	63	SENT_76	[p3l1791t1146r1925b1189],
63	noted	VBN	O	note	ccomp	56	SENT_76	[p3l1956t1126r2153b1189],
64	at	IN	O	at	_	0	SENT_76	[p3l9t1235r71b1288],
65	month	NN	DURATION	month	prep_at	63	SENT_76	[p3l102t1226r329b1288],
66	4.6	CD	NUMBER	4.6	num	65	SENT_76	[p3l361t1214r459b1288],
67	Thus	RB	O	thus	advmod	63	SENT_76	[p3l492t1226r688b1300],
68	,	,	O	,	_	0	SENT_76	[p3l492t1226r688b1300],
69	it	PRP	O	it	nsubj	70	SENT_76	[p3l724t1226r773b1288],
70	seems	VBZ	O	seem	rcmod	20	SENT_76	[p3l808t1246r1018b1288],
71	that	IN	O	that	complm	86	SENT_76	[p3l1054t1226r1187b1288],
72	the	DT	O	the	det	74	SENT_76	[p3l1218t1226r1325b1288],
73	visual	JJ	O	visual	amod	74	SENT_76	[p3l1358t1226r1569b1289],
74	outcome	NN	O	outcome	nsubj	86	SENT_76	[p3l1603t1235r1907b1288],
75	of	IN	O	of	_	0	SENT_76	[p3l1941t1226r2019b1288],
76	the	DT	O	the	det	77	SENT_76	[p3l2045t1226r2152b1288],
77	treatment	NN	O	treatment	prep_of	74	SENT_76	[p3l7t1333r344b1387],
78	in	IN	O	in	_	0	SENT_76	[p3l371t1324r438b1386],
79	the	DT	O	the	det	80	SENT_76	[p3l465t1324r572b1387],
80	ﬁrst	NN	O	ﬁrst	prep_in	77	SENT_76	[p3l602t1324r739b1387],
81	4	CD	DURATION	4	number	83	SENT_76	[p3l765t1324r806b1386],
82	to	TO	DURATION	to	dep	83	SENT_76	[p3l835t1333r901b1387],
83	6	CD	DURATION	6	num	84	SENT_76	[p3l931t1324r971b1387],
84	months	NNS	NUMBER	month	tmod	80	SENT_76	[p3l1000t1324r1259b1387],
85	can	MD	O	can	aux	86	SENT_76	[p3l1290t1343r1410b1387],
86	predict	VB	O	predict	ccomp	70	SENT_76	[p3l1437t1324r1685b1405],
87	the	DT	O	the	det	88	SENT_76	[p3l1712t1324r1818b1387],
88	outcome	NN	O	outcome	dobj	86	SENT_76	[p3l1848t1333r2152b1387],
89	at	IN	O	at	_	0	SENT_76	[p3l9t1430r71b1483],
90	year	NN	DURATION	year	prep_at	86	SENT_76	[p3l106t1440r260b1502],
91	1	CD	NUMBER	1	num	90	SENT_76	[p3l303t1421r354b1483],
92	.	.	O	.	_	0	SENT_76	[p3l303t1421r354b1483],

1	This	DT	O	this	nsubj	2	SENT_77	[p3l396t1420r550b1483],
2	4	LS	NUMBER	4	dep	10	SENT_77	[p3l588t1421r658b1482],
3	-	:	O	-	_	0	SENT_77	[p3l588t1421r658b1482],
4	to	TO	O	to	_	0	SENT_77	[p3l697t1430r763b1483],
5	6-month	JJ	DURATION	6-month	amod	7	SENT_77	[p3l802t1420r1102b1484],
6	treatment	NN	O	treatment	nn	7	SENT_77	[p3l1138t1430r1475b1483],
7	window	NN	O	window	prep_to	2	SENT_77	[p3l1511t1420r1795b1484],
8	has	VBZ	O	have	aux	10	SENT_77	[p3l1832t1420r1947b1483],
9	been	VBN	O	be	auxpass	10	SENT_77	[p3l1985t1420r2152b1483],
10	coined	VBN	O	coin	_	0	SENT_77	[p3l8t1520r244b1583],
11	a	DT	O	a	det	13	SENT_77	[p3l278t1540r314b1583],
12	predictive	JJ	O	predictive	amod	13	SENT_77	[p3l344t1520r700b1601],
13	window	NN	O	window	dobj	10	SENT_77	[p3l734t1520r1018b1583],
14	(	CD	NUMBER	(	num	17	SENT_77	[p3l1054t1520r1311b1601],
15	Figure	NN	O	figure	nn	17	SENT_77	[p3l1054t1520r1311b1601],
16	1	CD	NUMBER	1	num	17	SENT_77	[p3l1353t1521r1434b1598],
17	)	NN	O	)	nsubjpass	10	SENT_77	[p3l1353t1521r1434b1598],
18	.	.	O	.	_	0	SENT_77	[p3l1353t1521r1434b1598],

1	The	DT	O	the	det	2	SENT_78	[p3l115t1618r251b1681],
2	outcome	NN	O	outcome	nsubj	13	SENT_78	[p3l277t1627r581b1681],
3	after	IN	O	after	_	0	SENT_78	[p3l608t1618r769b1681],
4	the	DT	O	the	det	5	SENT_78	[p3l792t1618r898b1681],
5	ﬁrst	NN	O	ﬁrst	prep_after	2	SENT_78	[p3l925t1618r1062b1681],
6	6	CD	DURATION	6	num	7	SENT_78	[p3l1087t1618r1126b1681],
7	months	NNS	NUMBER	month	tmod	5	SENT_78	[p3l1152t1618r1411b1681],
8	of	IN	O	of	_	0	SENT_78	[p3l1439t1618r1515b1681],
9	treatment	NN	O	treatment	prep_of	5	SENT_78	[p3l1534t1627r1871b1681],
10	may	MD	O	may	aux	13	SENT_78	[p3l1894t1637r2045b1699],
11	be	VB	O	be	cop	13	SENT_78	[p3l2069t1618r2152b1681],
12	more	RBR	O	more	advmod	13	SENT_78	[p3l8t1734r189b1777],
13	informative	JJ	O	informative	_	0	SENT_78	[p3l219t1714r633b1778],
14	than	IN	O	than	_	0	SENT_78	[p3l664t1714r815b1777],
15	longer-term	JJ	O	longer-term	amod	16	SENT_78	[p3l845t1714r1266b1796],
16	outcomes	NNS	O	outcome	prep_than	13	SENT_78	[p3l1296t1724r1633b1777],
17	when	WRB	O	when	advmod	18	SENT_78	[p3l1666t1714r1857b1777],
18	investigating	VBG	O	investigate	advcl	13	SENT_78	[p3l1887t1714r2150b1778, p3l9t1814r228b1895],
19	the	DT	O	the	det	20	SENT_78	[p3l257t1814r364b1877],
20	effect	NN	O	effect	dobj	18	SENT_78	[p3l394t1814r596b1877],
21	of	IN	O	of	_	0	SENT_78	[p3l624t1814r701b1877],
22	genotype	NN	O	genotype	prep_of	20	SENT_78	[p3l725t1824r1049b1895],
23	on	IN	O	on	_	0	SENT_78	[p3l1079t1834r1165b1877],
24	response	NN	O	response	prep_on	18	SENT_78	[p3l1193t1834r1504b1895],
25	to	TO	O	to	_	0	SENT_78	[p3l1533t1824r1599b1877],
26	treatment	NN	O	treatment	prep_to	18	SENT_78	[p3l1629t1823r1982b1877],
27	.	.	O	.	_	0	SENT_78	[p3l1629t1823r1982b1877],

1	The	DT	O	the	det	4	SENT_79	[p3l2015t1814r2152b1877],
2	shorter	JJR	O	shorter	amod	4	SENT_79	[p3l11t1912r255b1975],
3	time	NN	O	time	nn	4	SENT_79	[p3l288t1912r444b1975],
4	period	NN	O	period	nsubj	5	SENT_79	[p3l477t1912r706b1993],
5	avoids	VBZ	O	avoid	_	0	SENT_79	[p3l741t1912r968b1975],
6	issues	NNS	O	issue	dobj	5	SENT_79	[p3l1004t1912r1214b1975],
7	of	IN	O	of	_	0	SENT_79	[p3l1251t1912r1328b1975],
8	the	DT	O	the	det	11	SENT_79	[p3l1356t1912r1462b1975],
9	variable	JJ	O	variable	amod	11	SENT_79	[p3l1497t1912r1782b1975],
10	treatment	NN	O	treatment	nn	11	SENT_79	[p3l1817t1921r2154b1975],
11	intervals	NNS	O	interval	prep_of	6	SENT_79	[p3l8t2008r311b2072],
12	that	WDT	O	that	nsubj	14	SENT_79	[p3l348t2008r482b2071],
13	are	VBP	O	be	cop	14	SENT_79	[p3l517t2028r622b2071],
14	likely	JJ	O	likely	rcmod	11	SENT_79	[p3l658t2008r858b2090],
15	to	TO	O	to	aux	16	SENT_79	[p3l894t2018r960b2071],
16	occur	VB	O	occur	xcomp	14	SENT_79	[p3l998t2028r1195b2071],
17	at	IN	O	at	_	0	SENT_79	[p3l1230t2018r1291b2071],
18	later	JJR	O	later	amod	20	SENT_79	[p3l1326t2008r1484b2071],
19	time	NN	O	time	nn	20	SENT_79	[p3l1517t2008r1673b2071],
20	points	NNS	O	point	prep_at	16	SENT_79	[p3l1708t2008r1923b2090],
21	when	WRB	O	when	advmod	26	SENT_79	[p3l1961t2008r2152b2072],
22	anti-VEGF	JJ	O	anti-vegf	amod	24	SENT_79	[p3l9t2108r403b2171],
23	treatment	NN	O	treatment	nn	24	SENT_79	[p3l444t2117r780b2171],
24	decisions	NNS	O	decision	nsubjpass	26	SENT_79	[p3l821t2108r1148b2171],
25	are	VBP	O	be	auxpass	26	SENT_79	[p3l1193t2128r1298b2171],
26	left	VBN	O	leave	advcl	16	SENT_79	[p3l1340t2108r1458b2171],
27	up	RP	O	up	prt	26	SENT_79	[p3l1497t2128r1583b2189],
28	to	TO	O	to	_	0	SENT_79	[p3l1625t2118r1691b2171],
29	the	DT	O	the	det	31	SENT_79	[p3l1733t2108r1840b2171],
30	treating	VBG	O	treat	amod	31	SENT_79	[p3l1881t2108r2151b2189],
31	clinicians	NNS	O	clinician	prep_to	26	SENT_79	[p3l8t2206r366b2269],
32	.	.	O	.	_	0	SENT_79	[p3l8t2206r366b2269],

1	Using	VBG	O	use	partmod	24	SENT_80	[p3l421t2206r631b2287],
2	a	DT	O	a	det	5	SENT_80	[p3l685t2226r722b2269],
3	6-month	JJ	DURATION	6-month	amod	5	SENT_80	[p3l772t2206r1072b2269],
4	time	NN	O	time	nn	5	SENT_80	[p3l1122t2206r1278b2269],
5	point	NN	O	point	dobj	1	SENT_80	[p3l1328t2206r1512b2287],
6	for	IN	O	for	_	0	SENT_80	[p3l1562t2206r1665b2269],
7	the	DT	O	the	det	9	SENT_80	[p3l1714t2206r1821b2269],
8	primary	JJ	O	primary	amod	9	SENT_80	[p3l1871t2206r2152b2287],
9	endpoint	NN	O	endpoint	prep_for	1	SENT_80	[p3l8t2302r320b2384],
10	of	IN	O	of	_	0	SENT_80	[p3l353t2302r430b2365],
11	the	DT	O	the	det	13	SENT_80	[p3l457t2303r563b2365],
12	visual	JJ	O	visual	amod	13	SENT_80	[p3l597t2302r808b2365],
13	acuity	NN	O	acuity	prep_of	9	SENT_80	[p3l844t2302r1058b2384],
14	(	CD	NUMBER	(	num	17	SENT_80	[p3l1094t2303r1275b2380],
15	VA	NNP	ORGANIZATION	VA	nn	17	SENT_80	[p3l1094t2303r1275b2380],
16	)	CD	NUMBER	)	num	17	SENT_80	[p3l1094t2303r1275b2380],
17	outcome	NN	O	outcome	nsubj	18	SENT_80	[p3l1312t2312r1616b2365],
18	gives	VBZ	O	give	rcmod	13	SENT_80	[p3l1651t2302r1834b2384],
19	the	DT	O	the	det	21	SENT_80	[p3l1870t2302r1977b2365],
20	best	JJS	O	best	amod	21	SENT_80	[p3l2009t2302r2153b2365],
21	opportunity	NN	O	opportunity	dobj	18	SENT_80	[p3l9t2402r442b2483],
22	,	,	O	,	_	0	SENT_80	[p3l9t2402r442b2483],
23	we	PRP	O	we	nsubj	24	SENT_80	[p3l477t2422r578b2465],
24	believe	VBP	O	believe	_	0	SENT_80	[p3l609t2402r885b2476],
25	,	,	O	,	_	0	SENT_80	[p3l609t2402r885b2476],
26	to	TO	O	to	aux	27	SENT_80	[p3l920t2412r986b2465],
27	examine	VB	O	examine	xcomp	24	SENT_80	[p3l1019t2402r1319b2465],
28	possible	JJ	O	possible	amod	30	SENT_80	[p3l1350t2402r1641b2483],
29	genetic	JJ	O	genetic	amod	30	SENT_80	[p3l1674t2402r1928b2483],
30	inﬂuences	NNS	O	inﬂuences	dobj	27	SENT_80	[p3l1961t2402r2150b2465, p3l8t2518r202b2561],
31	on	IN	O	on	_	0	SENT_80	[p3l240t2518r326b2561],
32	the	DT	O	the	det	33	SENT_80	[p3l361t2499r468b2561],
33	outcome	NN	O	outcome	prep_on	27	SENT_80	[p3l505t2508r809b2561],
34	because	IN	O	because	mark	36	SENT_80	[p3l843t2499r1125b2561],
35	it	PRP	O	it	nsubj	36	SENT_80	[p3l1161t2499r1209b2561],
36	avoids	VBZ	O	avoid	advcl	27	SENT_80	[p3l1245t2499r1472b2561],
37	the	DT	O	the	det	38	SENT_80	[p3l1509t2499r1616b2561],
38	effect	NN	O	effect	dobj	36	SENT_80	[p3l1652t2499r1854b2561],
39	of	IN	O	of	_	0	SENT_80	[p3l1889t2499r1966b2561],
40	confounding	VBG	O	confound	prep_of	38	SENT_80	[p3l1996t2518r2149b2561, p3l8t2595r327b2677],

1	variables	NNS	O	variable	_	0	SENT_81	[p3l376t2595r694b2658],
2	that	WDT	O	that	nsubj	3	SENT_81	[p3l744t2595r878b2658],
3	impact	VBP	O	impact	rcmod	1	SENT_81	[p3l924t2595r1167b2677],
4	the	DT	O	the	det	5	SENT_81	[p3l1213t2595r1319b2658],
5	outcome	NN	O	outcome	dobj	3	SENT_81	[p3l1369t2605r1673b2658],
6	with	IN	O	with	_	0	SENT_81	[p3l1722t2595r1878b2659],
7	longer	JJR	O	longer	amod	8	SENT_81	[p3l1926t2595r2154b2677],
8	durations	NNS	O	duration	prep_with	5	SENT_81	[p3l9t2694r356b2756],
9	.	.	O	.	_	0	SENT_81	[p3l9t2694r356b2756],

1	Recent	JJ	O	recent	amod	2	SENT_82	[p3l115t2792r362b2853],
2	research	NN	O	research	nsubj	7	SENT_82	[p3l384t2791r680b2853],
3	on	IN	O	on	_	0	SENT_82	[p3l704t2810r791b2853],
4	outcome	NN	O	outcome	nn	5	SENT_82	[p3l815t2800r1119b2853],
5	determinants	NNS	O	determinant	prep_on	2	SENT_82	[p3l1144t2791r1600b2853],
6	has	VBZ	O	have	aux	7	SENT_82	[p3l1625t2791r1740b2853],
7	focused	VBN	O	focus	_	0	SENT_82	[p3l1766t2791r2042b2853],
8	on	IN	O	on	_	0	SENT_82	[p3l2066t2810r2152b2853],
9	the	DT	O	the	det	10	SENT_82	[p3l7t2887r114b2950],
10	role	NN	O	role	prep_on	7	SENT_82	[p3l149t2887r286b2950],
11	of	IN	O	of	_	0	SENT_82	[p3l322t2887r399b2950],
12	known	JJ	O	known	amod	15	SENT_82	[p3l428t2887r670b2951],
13	AMD	NNP	ORGANIZATION	AMD	nn	15	SENT_82	[p3l705t2888r909b2949],
14	risk-associated	JJ	O	risk-associated	amod	15	SENT_82	[p3l945t2887r1476b2950],
15	genes	NNS	O	gene	prep_of	10	SENT_82	[p3l1511t2907r1710b2969],
16	on	IN	O	on	_	0	SENT_82	[p3l1748t2907r1834b2950],
17	the	DT	O	the	det	18	SENT_82	[p3l1869t2887r1975b2950],
18	outcome	NN	O	outcome	prep_on	7	SENT_82	[p3l2012t2897r2150b2950, p3l8t3006r198b3048],
19	of	IN	O	of	_	0	SENT_82	[p3l228t2986r305b3048],
20	anti	JJ	O	anti	amod	22	SENT_82	[p3l330t2986r459b3048],
21	VEGF	NN	O	vegf	nn	22	SENT_82	[p3l488t2986r719b3048],
22	treatment	NN	O	treatment	prep_of	18	SENT_82	[p3l747t2995r1084b3048],
23	for	IN	O	for	_	0	SENT_82	[p3l1111t2986r1215b3048],
24	neovascular	JJ	O	neovascular	amod	25	SENT_82	[p3l1241t2986r1668b3048],
25	AMD	NNP	ORGANIZATION	AMD	prep_for	22	SENT_82	[p3l1694t2987r1918b3048],
26	.	.	O	.	_	0	SENT_82	[p3l1694t2987r1918b3048],

1	Complement	NN	O	complement	_	0	SENT_83	[p3l1952t2986r2150b3048, p3l7t3084r295b3165],

1	factor	NN	O	factor	nsubjpass	30	SENT_84	[p3l323t3084r531b3147],
2	H	NN	O	h	nn	4	SENT_84	[p3l559t3085r620b3146],
3	(	CD	NUMBER	(	num	4	SENT_84	[p3l653t3084r905b3161],
4	CFPD	NNP	O	CFPD	dep	1	SENT_84	[p3l653t3084r905b3161],
5	,	,	O	,	_	0	SENT_84	[p3l653t3084r905b3161],
6	age-related	JJ	O	age-related	amod	8	SENT_84	[p3l940t3084r1334b3165],
7	macular	JJ	O	macular	amod	8	SENT_84	[p3l1363t3084r1650b3147],
8	susceptibility	NN	O	susceptibility	appos	1	SENT_84	[p3l1681t3084r2151b3165],
9	2	CD	NUMBER	2	number	10	SENT_84	[p3l9t3181r49b3242],
10	(	CD	NUMBER	(	num	12	SENT_84	[p3l111t3181r453b3258],
11	ARMS2	NN	O	arms2	nn	12	SENT_84	[p3l111t3181r453b3258],
12	)	NN	O	)	dep	8	SENT_84	[p3l111t3181r453b3258],
13	,	,	O	,	_	0	SENT_84	[p3l111t3181r453b3258],
14	in	IN	O	in	_	0	SENT_84	[p3l520t3180r587b3242],
15	particular	JJ	O	particular	amod	27	SENT_84	[p3l644t3180r987b3262],
16	the	DT	O	the	det	18	SENT_84	[p3l1044t3180r1150b3243],
17	A69S	NN	O	a69	nn	18	SENT_84	[p3l1203t3180r1398b3244],
18	variant	NN	O	variant	tmod	15	SENT_84	[p3l1454t3180r1719b3255],
19	,	,	O	,	_	0	SENT_84	[p3l1454t3180r1719b3255],
20	and	CC	O	and	_	0	SENT_84	[p3l1782t3180r1908b3243],
21	hightemperature	NN	O	hightemperature	nn	26	SENT_84	[p3l1965t3180r2150b3262, p3l8t3289r432b3361],
22	requirement	NN	O	requirement	nn	26	SENT_84	[p3l480t3280r913b3361],
23	A-l	NN	O	a-l	nn	26	SENT_84	[p3l960t3281r1089b3342],
24	(	CD	NUMBER	(	num	26	SENT_84	[p3l1148t3281r1469b3358],
25	HTRA1	NN	O	htra1	nn	26	SENT_84	[p3l1148t3281r1469b3358],
26	)	NN	O	)	conj_and	18	SENT_84	[p3l1148t3281r1469b3358],
27	genes	NNS	O	gene	prep_in	1	SENT_84	[p3l1521t3300r1719b3361],
28	have	VBP	O	have	aux	30	SENT_84	[p3l1770t3280r1936b3343],
29	been	VBN	O	be	auxpass	30	SENT_84	[p3l1985t3280r2153b3343],
30	reported	VBN	O	report	_	0	SENT_84	[p3l7t3378r304b3459],
31	to	TO	O	to	aux	32	SENT_84	[p3l336t3387r402b3441],
32	show	VB	O	show	xcomp	30	SENT_84	[p3l439t3378r622b3441],
33	some	DT	O	some	det	34	SENT_84	[p3l659t3397r842b3441],
34	association	NN	O	association	dobj	32	SENT_84	[p3l877t3378r1270b3441],
35	with	IN	O	with	_	0	SENT_84	[p3l1304t3378r1460b3441],
36	VA	NN	ORGANIZATION	va	nn	37	SENT_84	[p3l1493t3378r1620b3441],
37	outcome	NN	O	outcome	prep_with	34	SENT_84	[p3l1654t3387r1958b3441],
38	after	IN	O	after	_	0	SENT_84	[p3l1993t3378r2154b3441],
39	treatment	NN	O	treatment	prep_after	32	SENT_84	[p3l8t3483r344b3536],
40	with	IN	O	with	_	0	SENT_84	[p3l385t3474r541b3537],
41	bevacizumab	NN	O	bevacizumab	prep_with	39	SENT_84	[p3l580t3474r1050b3537],
42	or	CC	O	or	_	0	SENT_84	[p3l1093t3494r1166b3536],
43	ranibizumab	NN	O	ranibizumab	conj_or	41	SENT_84	[p3l1204t3462r1772b3536],
44	.7	CD	NUMBER	.7	number	45	SENT_84	[p3l1204t3462r1772b3536],
45	‘	CD	NUMBER	‘	dep	69	SENT_84	[p3l1204t3462r1772b3536],
46	9	CD	NUMBER	9	dobj	69	SENT_84	[p3l1204t3462r1772b3536],
47	In	IN	O	in	_	0	SENT_84	[p3l1814t3476r1887b3536],
48	a	DT	O	a	det	50	SENT_84	[p3l1929t3494r1966b3536],
49	prospective	JJ	O	prospective	amod	50	SENT_84	[p3l2005t3494r2150b3555, p3l11t3572r298b3652],
50	study	NN	O	study	prep_in	46	SENT_84	[p3l329t3572r517b3652],
51	by	IN	O	by	_	0	SENT_84	[p3l544t3572r632b3652],
52	Teper	NNP	PERSON	Teper	prep_by	50	SENT_84	[p3l660t3574r868b3652],
53	et	FW	O	et	nn	54	SENT_84	[p3l895t3581r957b3634],
54	al	FW	O	al	nsubj	69	SENT_84	[p3l986t3560r1100b3645],
55	,8	CD	NUMBER	,8	num	56	SENT_84	[p3l986t3560r1100b3645],
56	patients	NNS	O	patient	npadvmod	57	SENT_84	[p3l1129t3572r1403b3652],
57	homozygous	JJ	O	homozygous	amod	54	SENT_84	[p3l1432t3572r1886b3652],
58	for	IN	O	for	_	0	SENT_84	[p3l1916t3572r2019b3634],
59	the	DT	O	the	det	62	SENT_84	[p3l2045t3572r2152b3634],
60	T	NN	O	t	nn	62	SENT_84	[p3l8t3670r60b3731],
61	risk	NN	O	risk	nn	62	SENT_84	[p3l98t3669r233b3732],
62	allele	NN	O	allele	prep_for	54	SENT_84	[p3l272t3669r461b3732],
63	at	IN	O	at	_	0	SENT_84	[p3l503t3679r565b3732],
64	A69S	NN	O	a69	prep_at	62	SENT_84	[p3l597t3669r792b3732],
65	of	IN	O	of	_	0	SENT_84	[p3l830t3669r907b3732],
66	the	DT	O	the	det	68	SENT_84	[p3l941t3669r1047b3732],
67	ARMS2	NN	O	arms2	nn	68	SENT_84	[p3l1081t3669r1355b3732],
68	gene	NN	O	gene	prep_of	64	SENT_84	[p3l1398t3689r1563b3750],
69	showed	VBD	O	show	dep	32	SENT_84	[p3l1606t3669r1875b3732],
70	a	DT	O	a	det	72	SENT_84	[p3l1916t3689r1952b3732],
71	poor	JJ	O	poor	amod	72	SENT_84	[p3l1990t3689r2154b3750],
72	ll6	NN	O	ll6	dobj	69	SENT_84	[p4l17t117r150b188],

1	BCVA	NN	ORGANIZATION	bcva	nn	2	SENT_85	[p4l9t226r254b288],
2	response	NN	O	response	_	0	SENT_85	[p4l275t245r586b306],
3	to	TO	O	to	_	0	SENT_85	[p4l608t235r674b287],
4	a	DT	O	a	det	8	SENT_85	[p4l699t245r736b287],
5	variable	JJ	O	variable	amod	8	SENT_85	[p4l757t225r1041b287],
6	dosing	NN	O	dosing	nn	8	SENT_85	[p4l1065t225r1298b306],
7	treatment	NN	O	treatment	nn	8	SENT_85	[p4l1322t234r1657b287],
8	regimen	NN	O	regimen	prep_to	2	SENT_85	[p4l1677t225r1968b306],
9	with	IN	O	with	_	0	SENT_85	[p4l1990t225r2147b288],
10	ranibizumab	NN	O	ranibizumab	prep_with	2	SENT_85	[p4l8t327r469b389],
11	.	.	O	.	_	0	SENT_85	[p4l8t327r469b389],

1	However	RB	O	however	advmod	19	SENT_86	[p4l510t329r852b401],
2	,	,	O	,	_	0	SENT_86	[p4l510t329r852b401],
3	at	IN	O	at	_	0	SENT_86	[p4l893t336r954b389],
4	the	DT	O	the	det	5	SENT_86	[p4l988t327r1094b389],
5	Association	NNP	ORGANIZATION	Association	prep_at	19	SENT_86	[p4l1129t327r1549b389],
6	for	IN	ORGANIZATION	for	_	0	SENT_86	[p4l1584t327r1686b389],
7	Research	NNP	ORGANIZATION	Research	prep_for	5	SENT_86	[p4l1720t327r2044b389],
8	in	IN	O	in	_	0	SENT_86	[p4l2079t327r2147b388],
9	Vision	NNP	O	Vision	prep_in	7	SENT_86	[p4l8t427r244b489],
10	and	CC	O	and	_	0	SENT_86	[p4l275t427r401b489],
11	Ophthalmology	NNP	O	Ophthalmology	nn	13	SENT_86	[p4l431t427r986b507],
12	2012	CD	DATE	2012	num	13	SENT_86	[p4l1018t427r1192b489],
13	meeting	NN	O	meeting	prep_in	7	SENT_86	[p4l1222t427r1526b507],
14	,	,	O	,	_	0	SENT_86	[p4l1222t427r1526b507],
15	the	DT	O	the	det	18	SENT_86	[p4l1559t427r1665b489],
16	CATT	NNP	ORGANIZATION	CATT	nn	18	SENT_86	[p4l1696t427r1926b489],
17	study	NN	O	study	nn	18	SENT_86	[p4l1958t427r2145b507],
18	group	NN	O	group	nsubj	19	SENT_86	[p4l10t547r213b608],
19	reported	VBD	O	report	_	0	SENT_86	[p4l243t527r540b607],
20	that	IN	O	that	complm	22	SENT_86	[p4l570t527r702b589],
21	they	PRP	O	they	nsubj	22	SENT_86	[p4l731t527r881b608],
22	found	VBD	O	find	ccomp	19	SENT_86	[p4l913t527r1119b589],
23	no	DT	O	no	det	24	SENT_86	[p4l1148t547r1234b589],
24	association	NN	O	association	nsubj	29	SENT_86	[p4l1267t527r1660b589],
25	between	IN	O	between	_	0	SENT_86	[p4l1689t527r1984b589],
26	single	JJ	O	single	amod	28	SENT_86	[p4l2018t527r2143b589, p4l10t627r115b707],
27	nucleotide	NN	O	nucleotide	nn	28	SENT_86	[p4l160t627r528b689],
28	polymorphisms	NNS	O	polymorphism	prep_between	24	SENT_86	[p4l573t627r1124b707],
29	(	VBP	O	(	ccomp	22	SENT_86	[p4l1173t627r1423b703],
30	SNPS	NN	O	snp	nn	32	SENT_86	[p4l1173t627r1423b703],
31	)	CD	NUMBER	)	num	32	SENT_86	[p4l1173t627r1423b703],
32	rs1061170	NN	O	rs1061170	dobj	29	SENT_86	[p4l1469t627r1843b689],
33	(	CD	NUMBER	(	num	34	SENT_86	[p4l1892t628r2143b703],
34	CFH	NNP	O	CFH	dep	32	SENT_86	[p4l1892t628r2143b703],
35	)	CD	NUMBER	)	num	34	SENT_86	[p4l1892t628r2143b703],
36	,	,	O	,	_	0	SENT_86	[p4l1892t628r2143b703],
37	rslO490924	NN	O	rslo490924	nn	40	SENT_86	[p4l8t728r426b790],
38	(	CD	NUMBER	(	num	40	SENT_86	[p4l549t728r894b804],
39	ARMS2	NN	O	arms2	nn	40	SENT_86	[p4l549t728r894b804],
40	)	NN	O	)	dobj	29	SENT_86	[p4l549t728r894b804],
41	,	,	O	,	_	0	SENT_86	[p4l549t728r894b804],
42	rs11200638	NN	O	rs11200638	nn	45	SENT_86	[p4l1016t727r1432b790],
43	(	CD	NUMBER	(	num	45	SENT_86	[p4l1557t728r1897b804],
44	HTRAI	NN	O	htraus	nn	45	SENT_86	[p4l1557t728r1897b804],
45	)	NN	O	)	appos	40	SENT_86	[p4l1557t728r1897b804],
46	,	,	O	,	_	0	SENT_86	[p4l1557t728r1897b804],
47	and	CC	O	and	_	0	SENT_86	[p4l2021t727r2147b789],
48	rs2230l99	NN	O	rs2230l99	nn	51	SENT_86	[p4l8t829r381b892],
49	(	CD	NUMBER	(	num	51	SENT_86	[p4l412t829r568b906],
50	C3	NN	O	c3	nn	51	SENT_86	[p4l412t829r568b906],
51	)	NN	O	)	dobj	29	SENT_86	[p4l412t829r568b906],
52	and	CC	O	and	_	0	SENT_86	[p4l600t829r725b891],
53	the	DT	O	the	det	54	SENT_86	[p4l752t829r858b891],
54	outcome	NN	O	outcome	dobj	29	SENT_86	[p4l886t838r1189b891],
55	of	IN	O	of	_	0	SENT_86	[p4l1218t829r1295b891],
56	ranibizumab	NN	O	ranibizumab	nn	59	SENT_86	[p4l1315t829r1758b891],
57	or	CC	O	or	_	0	SENT_86	[p4l1788t849r1860b891],
58	bevacizumab	NN	O	bevacizumab	nn	59	SENT_86	[p4l1884t829r2143b891, p4l9t929r243b991],
59	treatment	NN	O	treatment	prep_of	54	SENT_86	[p4l268t938r603b991],
60	in	IN	O	in	_	0	SENT_86	[p4l626t929r694b990],
61	neovascular	JJ	O	neovascular	amod	65	SENT_86	[p4l717t929r1142b991],
62	AMD	NNP	O	AMD	nn	65	SENT_86	[p4l1165t929r1369b990],
63	(	NNP	O	(	nn	65	SENT_86	[p4l1398t929r1774b1009],
64	Hagstrom	NNP	ORGANIZATION	Hagstrom	nn	65	SENT_86	[p4l1398t929r1774b1009],
65	SA	NNP	ORGANIZATION	SA	prep_in	29	SENT_86	[p4l1800t929r1926b991],
66	.	.	O	.	_	0	SENT_86	[p4l1800t929r1926b991],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_87	[p4l1955t929r2144b991, p4l8t1029r490b1109],
2	of	IN	O	of	_	0	SENT_87	[p4l520t1029r597b1091],
3	Anti-VEGF	NN	O	anti-vegf	nn	4	SENT_87	[p4l618t1029r1037b1091],
4	Therapy	NN	O	therapy	prep_of	1	SENT_87	[p4l1064t1029r1358b1109],
5	in	IN	O	in	_	0	SENT_87	[p4l1386t1029r1453b1090],
6	the	DT	O	the	det	7	SENT_87	[p4l1480t1029r1586b1091],
7	Comparison	NN	O	comparison	prep_in	1	SENT_87	[p4l1615t1029r2047b1109],
8	of	IN	O	of	_	0	SENT_87	[p4l2076t1029r2152b1091],
9	AMD	NNP	ORGANIZATION	AMD	nn	13	SENT_87	[p4l8t1129r213b1190],
10	Treatments	NNP	ORGANIZATION	Treatments	nn	13	SENT_87	[p4l252t1130r648b1191],
11	Trials	NNPS	ORGANIZATION	Trials	nn	13	SENT_87	[p4l688t1129r891b1191],
12	(	NNP	O	(	nn	13	SENT_87	[p4l934t1129r1239b1205],
13	CATT	NNP	O	CATT	prep_of	7	SENT_87	[p4l934t1129r1239b1205],
14	)	NN	O	)	dep	13	SENT_87	[p4l934t1129r1239b1205],
15	.	.	O	.	_	0	SENT_87	[p4l934t1129r1239b1205],

1	Paper	NNP	O	Paper	nsubj	2	SENT_88	[p4l1280t1130r1483b1209],
2	presented	VBD	O	present	_	0	SENT_88	[p4l1518t1129r1859b1209],
3	at	IN	O	at	prep	2	SENT_88	[p4l1897t1138r1976b1191],
4	:	:	O	:	_	0	SENT_88	[p4l1897t1138r1976b1191],
5	Association	NNP	ORGANIZATION	Association	nsubj	13	SENT_88	[p4l2020t1129r2144b1191, p4l12t1229r328b1291],
6	for	IN	ORGANIZATION	for	_	0	SENT_88	[p4l367t1229r470b1291],
7	Research	NNP	ORGANIZATION	Research	prep_for	5	SENT_88	[p4l507t1229r832b1291],
8	in	IN	O	in	_	0	SENT_88	[p4l869t1229r937b1290],
9	Vision	NNP	O	Vision	prep_in	7	SENT_88	[p4l975t1229r1211b1291],
10	and	CC	O	and	_	0	SENT_88	[p4l1251t1229r1376b1291],
11	Ophthalmology	NNP	O	Ophthalmology	conj_and	9	SENT_88	[p4l1416t1229r1970b1310],
12	Annual	JJ	SET	annual	amod	9	SENT_88	[p4l2010t1230r2143b1290, p4l9t1329r159b1391],
13	Meeting	VBG	O	meet	dep	3	SENT_88	[p4l192t1329r506b1409],
14	,	,	O	,	_	0	SENT_88	[p4l192t1329r506b1409],
15	May	NNP	DATE	May	dep	2	SENT_88	[p4l541t1330r701b1409],
16	08	CD	DATE	08	num	15	SENT_88	[p4l735t1329r840b1402],
17	,	,	DATE	,	_	0	SENT_88	[p4l735t1329r840b1402],
18	2012	CD	DATE	2012	num	15	SENT_88	[p4l877t1329r1072b1402],
19	;	:	O	;	_	0	SENT_88	[p4l877t1329r1072b1402],
20	Florida	NNP	LOCATION	Florida	nn	21	SENT_88	[p4l1108t1329r1411b1405],
21	)	NN	O	)	dep	15	SENT_88	[p4l1108t1329r1411b1405],
22	.	.	O	.	_	0	SENT_88	[p4l1108t1329r1411b1405],

1	We	PRP	O	we	nsubj	4	SENT_89	[p4l115t1430r237b1490],
2	have	VBP	O	have	aux	4	SENT_89	[p4l268t1428r434b1491],
3	previously	RB	DATE	previously	advmod	4	SENT_89	[p4l464t1428r838b1509],
4	reported	VBN	O	report	_	0	SENT_89	[p4l869t1428r1166b1509],
5	that	IN	O	that	complm	16	SENT_89	[p4l1196t1428r1329b1490],
6	patients	NNS	O	patient	nsubj	16	SENT_89	[p4l1358t1428r1632b1509],
7	with	IN	O	with	_	0	SENT_89	[p4l1665t1428r1822b1491],
8	the	DT	O	the	det	13	SENT_89	[p4l1852t1428r1959b1490],
9	apolipoprotein	NN	O	apolipoprotein	nn	13	SENT_89	[p4l1992t1448r2144b1509, p4l9t1529r398b1609],
10	E	NN	O	e	nn	13	SENT_89	[p4l454t1531r507b1590],
11	(	CD	NUMBER	(	num	13	SENT_89	[p4l566t1530r816b1608],
12	ApoE	NN	O	apoe	nn	13	SENT_89	[p4l566t1530r816b1608],
13	)	NN	O	)	prep_with	6	SENT_89	[p4l566t1530r816b1608],
14	34	CD	NUMBER	34	num	15	SENT_89	[p4l878t1529r961b1591],
15	allele	NN	O	allele	dep	13	SENT_89	[p4l1021t1529r1210b1591],
16	had	VBD	O	have	ccomp	4	SENT_89	[p4l1266t1529r1394b1591],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_89	[p4l1453t1529r1888b1609],
18	better	JJR	O	better	amod	20	SENT_89	[p4l1944t1529r2148b1591],
19	BCVA	NN	O	bcva	nn	20	SENT_89	[p4l9t1629r254b1691],
20	outcomes	NNS	O	outcome	dobj	16	SENT_89	[p4l310t1638r646b1691],
21	after	IN	O	after	_	0	SENT_89	[p4l704t1629r865b1691],
22	anti-VEGF	JJ	O	anti-vegf	amod	23	SENT_89	[p4l919t1629r1312b1691],
23	treatment	NN	O	treatment	prep_after	16	SENT_89	[p4l1366t1638r1701b1691],
24	than	IN	O	than	_	0	SENT_89	[p4l1755t1629r1906b1691],
25	those	DT	O	those	prep_than	23	SENT_89	[p4l1960t1629r2146b1691],
26	without	IN	O	without	_	0	SENT_89	[p4l9t1730r280b1792],
27	this	DT	O	this	det	28	SENT_89	[p4l311t1730r435b1792],
28	allele	NN	O	allele	prep_without	16	SENT_89	[p4l471t1718r749b1792],
29	.	.	O	.	_	0	SENT_89	[p4l471t1718r749b1792],

1	”	NN	O	”	_	0	SENT_90	[p4l471t1718r749b1792],

1	An	DT	O	a	det	4	SENT_91	[p4l115t1831r222b1891],
2	endothelial	JJ	O	endothelial	amod	4	SENT_91	[p4l262t1830r654b1892],
3	cell-speciﬁc	NN	O	cell-speciﬁc	nn	4	SENT_91	[p4l695t1830r1121b1910],
4	mitogen	NN	O	mitogen	_	0	SENT_91	[p4l1161t1830r1470b1910],
5	,	,	O	,	_	0	SENT_91	[p4l1161t1830r1470b1910],
6	VEGF	NN	O	vegf	appos	4	SENT_91	[p4l1512t1830r1837b1892],
7	.	.	O	.	_	0	SENT_91	[p4l1512t1830r1837b1892],

1	—	NN	O	—	_	0	SENT_92	[p4l1512t1830r1837b1892],
2	.	.	O	.	_	0	SENT_92	[p4l1512t1830r1837b1892],

1	A	DT	O	a	_	0	SENT_93	[p4l1512t1830r1837b1892],
2	triggers	VBZ	O	trigger	csubj	7	SENT_93	[p4l1876t1830r2144b1910],
3	angiogenesis	NN	O	angiogenesis	dobj	2	SENT_93	[p4l10t1930r465b2011],
4	and	CC	O	and	advmod	2	SENT_93	[p4l492t1930r617b1993],
5	is	VBZ	O	be	cop	7	SENT_93	[p4l640t1930r695b1993],
6	a	DT	O	a	det	7	SENT_93	[p4l723t1950r759b1993],
7	mediator	NN	O	mediator	dep	1	SENT_93	[p4l781t1930r1098b1993],
8	of	IN	O	of	_	0	SENT_93	[p4l1121t1930r1197b1993],
9	vascular	JJ	O	vascular	amod	10	SENT_93	[p4l1215t1930r1511b1993],
10	permeability	NN	O	permeability	prep_of	7	SENT_93	[p4l1532t1919r2064b2011],
11	.	.	O	.	_	0	SENT_93	[p4l1532t1919r2064b2011],

1	“	RB	O	“	advmod	3	SENT_94	[p4l1532t1919r2064b2011],
2	It	PRP	O	it	nsubj	3	SENT_94	[p4l2094t1932r2147b1993],
3	initiates	VBZ	O	initiate	_	0	SENT_94	[p4l9t2031r286b2093],
4	and	CC	O	and	_	0	SENT_94	[p4l318t2031r443b2093],
5	promotes	VBZ	O	promote	conj_and	3	SENT_94	[p4l468t2041r797b2111],
6	pathologic	JJ	O	pathologic	amod	10	SENT_94	[p4l825t2031r1199b2112],
7	choroidal	JJ	O	choroidal	amod	10	SENT_94	[p4l1228t2031r1562b2093],
8	neovasculariza	NN	O	neovasculariza	nn	10	SENT_94	[p4l1589t2031r2143b2093],
9	—	NN	O	—	nn	10	SENT_94	[p4l1589t2031r2143b2093],
10	tion	NN	O	tion	dobj	5	SENT_94	[p4l8t2132r145b2194],
11	(	CD	NUMBER	(	num	14	SENT_94	[p4l172t2132r412b2208],
12	CNV	NN	ORGANIZATION	cnv	nn	14	SENT_94	[p4l172t2132r412b2208],
13	)	CD	NUMBER	)	num	14	SENT_94	[p4l172t2132r412b2208],
14	processes	NNS	O	process	dobj	3	SENT_94	[p4l438t2151r776b2212],
15	in	IN	O	in	_	0	SENT_94	[p4l803t2132r870b2193],
16	AMD	NNP	ORGANIZATION	AMD	prep_in	14	SENT_94	[p4l894t2120r1188b2194],
17	.	.	O	.	_	0	SENT_94	[p4l894t2120r1188b2194],

1	”	NN	O	”	_	0	SENT_95	[p4l894t2120r1188b2194],
2	The	DT	O	the	det	4	SENT_95	[p4l1214t2132r1349b2194],
3	VEGFA	NN	O	vegfa	nn	4	SENT_95	[p4l1379t2133r1651b2194],
4	gene	NN	O	gene	dep	1	SENT_95	[p4l1679t2151r1863b2212],
5	,	,	O	,	_	0	SENT_95	[p4l1679t2151r1863b2212],
6	located	JJ	O	located	amod	9	SENT_95	[p4l1891t2132r2147b2194],
7	on	IN	O	on	_	0	SENT_95	[p4l10t2251r96b2293],
8	chromosome	NN	O	chromosome	prep_on	6	SENT_95	[p4l137t2231r595b2293],
9	6p	NN	O	6p	appos	4	SENT_95	[p4l638t2231r722b2312],
10	21.1	CD	NUMBER	21.1	num	12	SENT_95	[p4l766t2232r910b2293],
11	(	CD	NUMBER	(	num	12	SENT_95	[p4l963t2231r1470b2308],
12	NM_003376	NN	O	nm_003376	dep	1	SENT_95	[p4l963t2231r1470b2308],
13	)	CD	NUMBER	)	number	14	SENT_95	[p4l963t2231r1470b2308],
14	(	CD	NUMBER	(	num	15	SENT_95	[p4l1517t2231r2141b2312],
15	http://www.ncbi	NNS	O	http://www.ncbi	dep	12	SENT_95	[p4l1517t2231r2141b2312],
16	.	.	O	.	_	0	SENT_95	[p4l1517t2231r2141b2312],

1	nlm	NN	O	nlm	_	0	SENT_96	[p4l9t2332r765b2412],
2	.	.	O	.	_	0	SENT_96	[p4l9t2332r765b2412],

1	nih	NN	O	nih	_	0	SENT_97	[p4l9t2332r765b2412],
2	.	.	O	.	_	0	SENT_97	[p4l9t2332r765b2412],

1	gov/nuccore	NN	O	gov/nuccore	nsubj	10	SENT_98	[p4l9t2332r765b2412],
2	;	:	O	;	_	0	SENT_98	[p4l9t2332r765b2412],
3	accessed	VBN	O	access	parataxis	10	SENT_98	[p4l794t2332r1114b2394],
4	April	NNP	DATE	April	tmod	3	SENT_98	[p4l1139t2332r1331b2412],
5	20	CD	DATE	20	num	4	SENT_98	[p4l1357t2332r1465b2405],
6	,	,	DATE	,	_	0	SENT_98	[p4l1357t2332r1465b2405],
7	2011	CD	DATE	2011	num	4	SENT_98	[p4l1495t2332r1727b2409],
8	)	NN	O	)	dep	4	SENT_98	[p4l1495t2332r1727b2409],
9	,	,	O	,	_	0	SENT_98	[p4l1495t2332r1727b2409],
10	consists	VBZ	O	consist	_	0	SENT_98	[p4l1756t2332r2045b2394],
11	of	IN	O	of	_	0	SENT_98	[p4l2074t2332r2152b2394],
12	8	CD	NUMBER	8	num	13	SENT_98	[p4l12t2432r48b2494],
13	exons	NNS	O	exon	prep_of	10	SENT_98	[p4l76t2451r286b2494],
14	and	CC	O	and	cc	10	SENT_98	[p4l315t2432r464b2505],
15	,	,	O	,	_	0	SENT_98	[p4l315t2432r464b2505],
16	as	IN	O	as	_	0	SENT_98	[p4l494t2451r564b2494],
17	a	DT	O	a	det	18	SENT_98	[p4l593t2451r630b2494],
18	result	NN	O	result	prep_as	24	SENT_98	[p4l652t2432r859b2494],
19	of	IN	O	of	_	0	SENT_98	[p4l884t2432r963b2494],
20	alternative	JJ	O	alternative	amod	21	SENT_98	[p4l984t2432r1373b2494],
21	splicing	NN	O	splicing	prep_of	18	SENT_98	[p4l1401t2432r1711b2512],
22	,	,	O	,	_	0	SENT_98	[p4l1401t2432r1711b2512],
23	it	PRP	O	it	nsubj	24	SENT_98	[p4l1740t2432r1790b2494],
24	produces	VBZ	O	produce	ccomp	10	SENT_98	[p4l1813t2432r2144b2512],
25	4	CD	NUMBER	4	num	27	SENT_98	[p4l8t2533r50b2593],
26	major	JJ	O	major	amod	27	SENT_98	[p4l112t2532r326b2613],
27	VEGF	NN	O	vegf	dobj	24	SENT_98	[p4l386t2533r720b2595],
28	.	.	O	.	_	0	SENT_98	[p4l386t2533r720b2595],

1	—	NN	O	—	_	0	SENT_99	[p4l386t2533r720b2595],
2	.	.	O	.	_	0	SENT_99	[p4l386t2533r720b2595],

1	A	DT	O	a	det	2	SENT_100	[p4l386t2533r720b2595],
2	isoforms	NNS	O	isoform	_	0	SENT_100	[p4l780t2532r1531b2595],
3	.	.	O	.	_	0	SENT_100	[p4l780t2532r1531b2595],

1	—	NN	O	—	_	0	SENT_101	[p4l780t2532r1531b2595],
2	.	.	O	.	_	0	SENT_101	[p4l780t2532r1531b2595],

1	VEGF	NN	O	vegf	_	0	SENT_102	[p4l780t2532r1531b2595],
2	.	.	O	.	_	0	SENT_102	[p4l780t2532r1531b2595],

1	—	NN	O	—	_	0	SENT_103	[p4l780t2532r1531b2595],
2	.	.	O	.	_	0	SENT_103	[p4l780t2532r1531b2595],

1	A	DT	O	a	det	2	SENT_104	[p4l780t2532r1531b2595],
2	121	CD	NUMBER	121	_	0	SENT_104	[p4l1601t2533r1748b2606],
3	,	,	O	,	_	0	SENT_104	[p4l1601t2533r1748b2606],
4	VEGF	NN	O	vegf	appos	2	SENT_104	[p4l1813t2533r2146b2595],
5	.	.	O	.	_	0	SENT_104	[p4l1813t2533r2146b2595],

1	—	NN	O	—	_	0	SENT_105	[p4l1813t2533r2146b2595],
2	.	.	O	.	_	0	SENT_105	[p4l1813t2533r2146b2595],

1	A	DT	O	a	det	2	SENT_106	[p4l1813t2533r2146b2595],
2	165	CD	NUMBER	165	_	0	SENT_106	[p4l17t2632r164b2706],
3	,	,	O	,	_	0	SENT_106	[p4l17t2632r164b2706],
4	VEGF	NN	O	vegf	appos	2	SENT_106	[p4l202t2633r526b2695],
5	.	.	O	.	_	0	SENT_106	[p4l202t2633r526b2695],

1	—	NN	O	—	_	0	SENT_107	[p4l202t2633r526b2695],
2	.	.	O	.	_	0	SENT_107	[p4l202t2633r526b2695],

1	A	DT	O	a	det	2	SENT_108	[p4l202t2633r526b2695],
2	189	CD	NUMBER	189	_	0	SENT_108	[p4l567t2633r709b2707],
3	,	,	O	,	_	0	SENT_108	[p4l567t2633r709b2707],
4	and	CC	O	and	_	0	SENT_108	[p4l747t2633r872b2695],
5	VEGF	NN	O	vegf	conj_and	2	SENT_108	[p4l903t2633r1229b2695],
6	.	.	O	.	_	0	SENT_108	[p4l903t2633r1229b2695],

1	—	NN	O	—	_	0	SENT_109	[p4l903t2633r1229b2695],
2	.	.	O	.	_	0	SENT_109	[p4l903t2633r1229b2695],

1	A	DT	O	a	det	3	SENT_110	[p4l903t2633r1229b2695],
2	206.13	CD	NUMBER	206.13	num	3	SENT_110	[p4l1262t2621r1478b2695],
3	Ranibizumab	NN	O	ranibizumab	nsubj	6	SENT_110	[p4l1514t2633r1986b2695],
4	and	CC	O	and	_	0	SENT_110	[p4l2021t2633r2147b2695],
5	bevacizumab	NN	O	bevacizumab	conj_and	3	SENT_110	[p4l7t2732r475b2795],
6	induce	VBP	O	induce	_	0	SENT_110	[p4l515t2732r750b2794],
7	their	PRP$	O	they	poss	9	SENT_110	[p4l788t2732r951b2794],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_110	[p4l987t2732r1379b2813],
9	effects	NNS	O	effect	dobj	6	SENT_110	[p4l1419t2732r1652b2794],
10	via	IN	O	via	_	0	SENT_110	[p4l1692t2732r1799b2794],
11	blocking	VBG	O	block	prepc_via	9	SENT_110	[p4l1835t2732r2145b2813],
12	all	DT	O	all	det	13	SENT_110	[p4l10t2834r95b2896],
13	VEGF	NN	O	vegf	dobj	11	SENT_110	[p4l118t2834r443b2896],
14	.	.	O	.	_	0	SENT_110	[p4l118t2834r443b2896],

1	—	NN	O	—	_	0	SENT_111	[p4l118t2834r443b2896],
2	.	.	O	.	_	0	SENT_111	[p4l118t2834r443b2896],

1	A	DT	O	a	det	2	SENT_112	[p4l118t2834r443b2896],
2	isoforms	NNS	O	isoform	_	0	SENT_112	[p4l466t2822r914b2896],
3	.1	CD	NUMBER	.1	number	4	SENT_112	[p4l466t2822r914b2896],
4	’14	CD	NUMBER	’14	dep	2	SENT_112	[p4l466t2822r914b2896],
5	We	PRP	O	we	nsubj	6	SENT_112	[p4l937t2836r1059b2896],
6	investigated	VBD	O	investigate	rcmod	2	SENT_112	[p4l1082t2834r1511b2914],
7	whether	IN	O	whether	complm	16	SENT_112	[p4l1534t2834r1820b2896],
8	different	JJ	O	different	amod	10	SENT_112	[p4l1843t2834r2147b2896],
9	SNP	NN	O	snp	nn	10	SENT_112	[p4l11t2934r170b2996],
10	variations	NNS	O	variation	nsubj	16	SENT_112	[p4l197t2934r544b2996],
11	in	IN	O	in	_	0	SENT_112	[p4l573t2934r640b2995],
12	the	DT	O	the	det	14	SENT_112	[p4l667t2934r773b2996],
13	VEGFA	NN	O	vegfa	nn	14	SENT_112	[p4l807t2935r1079b2996],
14	gene	NN	O	gene	prep_in	10	SENT_112	[p4l1110t2953r1274b3014],
15	could	MD	O	could	aux	16	SENT_112	[p4l1302t2934r1498b2996],
16	result	VB	O	result	ccomp	6	SENT_112	[p4l1524t2934r1721b2996],
17	in	IN	O	in	_	0	SENT_112	[p4l1747t2934r1814b2995],
18	different	JJ	O	different	amod	19	SENT_112	[p4l1843t2934r2147b2996],
19	outcomes	NNS	O	outcome	prep_in	16	SENT_112	[p4l10t3044r346b3096],
20	of	IN	O	of	_	0	SENT_112	[p4l381t3034r458b3096],
21	anti-VEGF	JJ	O	anti-vegf	amod	22	SENT_112	[p4l486t3034r878b3097],
22	treatment	NN	O	treatment	prep_of	19	SENT_112	[p4l910t3043r1262b3096],
23	.	.	O	.	_	0	SENT_112	[p4l910t3043r1262b3096],

1	Several	JJ	O	several	amod	2	SENT_113	[p4l118t3134r380b3196],
2	SNPs	NNS	O	snp	nsubjpass	9	SENT_113	[p4l407t3134r598b3196],
3	in	IN	O	in	_	0	SENT_113	[p4l624t3134r691b3195],
4	the	DT	O	the	det	6	SENT_113	[p4l714t3134r820b3196],
5	VEGFA	NN	O	vegfa	nn	6	SENT_113	[p4l850t3135r1122b3197],
6	gene	NN	O	gene	prep_in	2	SENT_113	[p4l1150t3153r1314b3214],
7	have	VBP	O	have	aux	9	SENT_113	[p4l1338t3134r1504b3196],
8	been	VBN	O	be	auxpass	9	SENT_113	[p4l1527t3134r1694b3196],
9	investigated	VBN	O	investigate	_	0	SENT_113	[p4l1718t3134r2147b3214],
10	for	IN	O	for	_	0	SENT_113	[p4l9t3234r112b3297],
11	their	PRP$	O	they	poss	12	SENT_113	[p4l142t3234r304b3297],
12	inﬂuence	NN	O	inﬂuence	prep_for	9	SENT_113	[p4l333t3234r658b3297],
13	on	IN	O	on	_	0	SENT_113	[p4l690t3254r776b3297],
14	anti-VEGF	JJ	O	anti-vegf	amod	16	SENT_113	[p4l809t3234r1201b3297],
15	treatment	NN	O	treatment	nn	16	SENT_113	[p4l1232t3244r1567b3297],
16	outcomes	NNS	O	outcome	prep_on	9	SENT_113	[p4l1599t3244r1955b3308],
17	,	,	O	,	_	0	SENT_113	[p4l1599t3244r1955b3308],
18	with	IN	O	with	_	0	SENT_113	[p4l1990t3234r2147b3297],
19	inconclusive	JJ	O	inconclusive	amod	20	SENT_113	[p4l9t3335r457b3397],
20	results	NNS	O	result	prep_with	9	SENT_113	[p4l484t3335r733b3397],
21	.	.	O	.	_	0	SENT_113	[p4l484t3335r733b3397],

1	One	CD	NUMBER	one	num	2	SENT_114	[p4l768t3336r912b3397],
2	study	NN	O	study	nsubj	4	SENT_114	[p4l943t3335r1130b3415],
3	has	VBZ	O	have	aux	4	SENT_114	[p4l1159t3335r1274b3397],
4	reported	VBN	O	report	_	0	SENT_114	[p4l1302t3335r1599b3415],
5	a	DT	O	a	det	6	SENT_114	[p4l1629t3355r1665b3397],
6	trend	NN	O	trend	dobj	4	SENT_114	[p4l1692t3335r1874b3397],
7	toward	IN	O	toward	_	0	SENT_114	[p4l1901t3335r2147b3397],
8	a	DT	O	a	det	10	SENT_114	[p4l11t3454r48b3497],
9	better	JJR	O	better	amod	10	SENT_114	[p4l92t3435r295b3497],
10	outcome	NN	O	outcome	prep_toward	6	SENT_114	[p4l342t3444r645b3497],
11	after	IN	O	after	_	0	SENT_114	[p4l694t3435r855b3497],
12	6	CD	DURATION	6	num	13	SENT_114	[p4l902t3434r941b3497],
13	months	NNS	NUMBER	month	tmod	14	SENT_114	[p4l990t3435r1271b3497],
14	’	JJ	O	’	amod	15	SENT_114	[p4l990t3435r1271b3497],
15	treatment	NN	O	treatment	prep_after	4	SENT_114	[p4l1326t3444r1662b3497],
16	with	IN	O	with	_	0	SENT_114	[p4l1708t3435r1864b3497],
17	ranibizumab	NN	O	ranibizumab	prep_with	4	SENT_114	[p4l1910t3435r2144b3497, p5l10t26r243b88],

1	in	IN	O	in	_	0	SENT_115	[p5l281t26r348b87],
2	those	DT	O	those	prep_in	31	SENT_115	[p5l386t26r571b88],
3	harboring	VBG	O	harbor	partmod	2	SENT_115	[p5l608t26r952b107],
4	the	DT	O	the	det	8	SENT_115	[p5l990t26r1096b88],
5	TC	NN	O	tc	nn	8	SENT_115	[p5l1134t27r1244b89],
6	or	CC	O	or	_	0	SENT_115	[p5l1284t46r1356b88],
7	CC	NN	O	cc	nn	8	SENT_115	[p5l1393t27r1507b89],
8	genotypes	NNS	O	genotype	dobj	3	SENT_115	[p5l1547t36r1924b107],
9	,	,	O	,	_	0	SENT_115	[p5l1547t36r1924b107],
10	compared	VBN	O	compare	_	0	SENT_115	[p5l1966t46r2143b88, p5l8t126r205b206],
11	with	IN	O	with	prepc_compared_with	3	SENT_115	[p5l230t126r386b188],
12	those	DT	O	those	nsubj	13	SENT_115	[p5l410t126r596b188],
13	having	VBG	O	have	pcomp	3	SENT_115	[p5l621t126r860b206],
14	the	DT	O	the	det	16	SENT_115	[p5l886t126r992b188],
15	TT	NN	O	tt	nn	16	SENT_115	[p5l1018t127r1124b187],
16	genotype	NN	O	genotype	dobj	13	SENT_115	[p5l1150t135r1473b206],
17	at	IN	O	at	_	0	SENT_115	[p5l1500t135r1562b188],
18	SNP	NN	O	snp	nn	19	SENT_115	[p5l1588t126r1747b188],
19	rs14137l1	NN	O	rs14137l1	prep_at	16	SENT_115	[p5l1771t126r2138b188],
20	in	IN	O	in	_	0	SENT_115	[p5l9t226r76b288],
21	the	DT	O	the	det	23	SENT_115	[p5l101t226r207b288],
22	VEGFA	NN	O	vegfa	nn	23	SENT_115	[p5l238t227r511b289],
23	gene	NN	O	gene	prep_in	19	SENT_115	[p5l540t215r758b307],
24	.7	CD	NUMBER	.7	dep	23	SENT_115	[p5l540t215r758b307],
25	However	RB	O	however	advmod	13	SENT_115	[p5l786t228r1129b300],
26	,	,	O	,	_	0	SENT_115	[p5l786t228r1129b300],
27	other	JJ	O	other	amod	28	SENT_115	[p5l1159t227r1340b289],
28	investigators	NNS	O	investigator	nsubj	31	SENT_115	[p5l1364t226r1815b307],
29	have	VBP	O	have	aux	31	SENT_115	[p5l1842t226r2008b289],
30	not	RB	O	not	neg	31	SENT_115	[p5l2034t235r2147b289],
31	found	VBN	O	find	_	0	SENT_115	[p5l9t327r215b389],
32	any	DT	O	any	det	33	SENT_115	[p5l254t347r377b407],
33	association	NN	O	association	dobj	31	SENT_115	[p5l418t327r811b389],
34	between	IN	O	between	_	0	SENT_115	[p5l847t327r1143b389],
35	different	JJ	O	different	amod	36	SENT_115	[p5l1181t327r1486b389],
36	genotypes	NNS	O	genotype	prep_between	33	SENT_115	[p5l1524t336r1880b407],
37	at	IN	O	at	_	0	SENT_115	[p5l1922t336r1983b389],
38	this	DT	O	this	det	42	SENT_115	[p5l2019t327r2144b389],
39	SNP	NN	O	snp	nn	42	SENT_115	[p5l11t428r170b490],
40	(	CD	NUMBER	(	num	42	SENT_115	[p5l221t428r649b504],
41	rs14137l1	NN	O	rs14137l1	nn	42	SENT_115	[p5l221t428r649b504],
42	)	NN	O	)	prep_at	31	SENT_115	[p5l221t428r649b504],
43	and	CC	O	and	_	0	SENT_115	[p5l702t427r827b490],
44	VA	NN	O	va	nn	45	SENT_115	[p5l875t428r1001b490],
45	outcome	NN	O	outcome	prep_at	31	SENT_115	[p5l1051t437r1354b490],
46	after	IN	O	after	_	0	SENT_115	[p5l1405t427r1566b490],
47	treatment	NN	O	treatment	prep_after	31	SENT_115	[p5l1612t415r2033b490],
48	.	.	O	.	_	0	SENT_115	[p5l1612t415r2033b490],

1	”	NN	O	”	nn	2	SENT_116	[p5l1612t415r2033b490],
2	A	NN	O	a	nsubj	6	SENT_116	[p5l2084t428r2146b489],
3	Japanese	JJ	MISC	japanese	amod	4	SENT_116	[p5l8t530r323b608],
4	study	NN	O	study	dep	2	SENT_116	[p5l382t528r570b609],
5	has	VBZ	O	have	aux	6	SENT_116	[p5l626t528r741b590],
6	reported	VBN	O	report	_	0	SENT_116	[p5l799t528r1095b608],
7	that	IN	O	that	complm	19	SENT_116	[p5l1151t528r1283b590],
8	the	DT	O	the	det	10	SENT_116	[p5l1338t528r1445b590],
9	G	NN	O	g	nn	10	SENT_116	[p5l1503t529r1564b591],
10	allele	NN	O	allele	nsubjpass	19	SENT_116	[p5l1621t528r1810b590],
11	at	IN	O	at	_	0	SENT_116	[p5l1869t537r1930b590],
12	SNP	NN	O	snp	nn	13	SENT_116	[p5l1987t529r2147b591],
13	rs699946	NN	O	rs699946	prep_at	10	SENT_116	[p5l8t628r337b691],
14	in	IN	O	in	_	0	SENT_116	[p5l379t628r447b689],
15	the	DT	O	the	det	17	SENT_116	[p5l488t628r594b690],
16	VEGFA	NN	O	vegfa	nn	17	SENT_116	[p5l641t629r913b690],
17	gene	NN	O	gene	prep_in	13	SENT_116	[p5l959t647r1123b708],
18	is	VBZ	O	be	auxpass	19	SENT_116	[p5l1165t628r1220b690],
19	associated	VBN	O	associate	ccomp	6	SENT_116	[p5l1265t628r1628b690],
20	with	IN	O	with	_	0	SENT_116	[p5l1670t628r1826b690],
21	a	DT	O	a	det	23	SENT_116	[p5l1869t647r1905b690],
22	better	JJR	O	better	amod	23	SENT_116	[p5l1944t628r2148b690],
23	response	NN	O	response	prep_with	19	SENT_116	[p5l8t747r318b808],
24	to	TO	O	to	_	0	SENT_116	[p5l345t737r411b789],
25	bevacizumab	NN	O	bevacizumab	nn	26	SENT_116	[p5l437t727r905b790],
26	treatment	NN	O	treatment	prep_to	23	SENT_116	[p5l933t736r1268b789],
27	in	IN	O	in	_	0	SENT_116	[p5l1294t727r1361b789],
28	patients	NNS	O	patient	prep_in	19	SENT_116	[p5l1386t727r1660b808],
29	with	IN	O	with	_	0	SENT_116	[p5l1689t727r1845b790],
30	neovascular	JJ	O	neovascular	amod	31	SENT_116	[p5l1872t747r2144b789, p5l9t829r186b891],
31	AMD	NNP	O	AMD	prep_with	28	SENT_116	[p5l216t817r510b891],
32	.16	CD	NUMBER	.16	num	31	SENT_116	[p5l216t817r510b891],

1	In	IN	O	in	_	0	SENT_117	[p5l116t930r188b990],
2	this	DT	O	this	det	3	SENT_117	[p5l225t929r349b991],
3	study	NN	O	study	prep_in	6	SENT_117	[p5l392t929r599b1009],
4	,	,	O	,	_	0	SENT_117	[p5l392t929r599b1009],
5	we	PRP	O	we	nsubj	6	SENT_117	[p5l640t948r741b991],
6	investigated	VBD	O	investigate	_	0	SENT_117	[p5l779t928r1208b1009],
7	whether	IN	O	whether	complm	15	SENT_117	[p5l1246t929r1532b991],
8	certain	JJ	O	certain	amod	9	SENT_117	[p5l1569t929r1808b991],
9	SNPs	NNS	O	snp	nsubjpass	15	SENT_117	[p5l1848t929r2040b991],
10	in	IN	O	in	_	0	SENT_117	[p5l2079t929r2147b990],
11	the	DT	O	the	det	13	SENT_117	[p5l9t1029r115b1091],
12	VEGFA	NN	O	vegfa	nn	13	SENT_117	[p5l155t1030r427b1092],
13	gene	NN	O	gene	prep_in	9	SENT_117	[p5l466t1049r630b1110],
14	are	VBP	O	be	auxpass	15	SENT_117	[p5l668t1049r772b1091],
15	associated	VBN	O	associate	ccomp	6	SENT_117	[p5l809t1029r1172b1091],
16	with	IN	O	with	_	0	SENT_117	[p5l1206t1029r1363b1091],
17	the	DT	O	the	det	18	SENT_117	[p5l1397t1029r1503b1091],
18	outcome	NN	O	outcome	prep_with	15	SENT_117	[p5l1540t1039r1843b1091],
19	of	IN	O	of	_	0	SENT_117	[p5l1879t1029r1956b1091],
20	antiVEGF	NN	O	antivegf	nn	21	SENT_117	[p5l1987t1029r2143b1091, p5l8t1129r239b1191],
21	treatment	NN	O	treatment	prep_of	18	SENT_117	[p5l283t1138r619b1191],
22	in	IN	O	in	_	0	SENT_117	[p5l662t1129r729b1190],
23	patients	NNS	O	patient	prep_in	15	SENT_117	[p5l772t1129r1046b1209],
24	with	IN	O	with	_	0	SENT_117	[p5l1093t1129r1248b1191],
25	neovascular	JJ	O	neovascular	amod	26	SENT_117	[p5l1293t1129r1718b1191],
26	AMD	NNP	ORGANIZATION	AMD	prep_with	23	SENT_117	[p5l1760t1129r1964b1190],
27	collected	VBN	O	collect	partmod	23	SENT_117	[p5l2011t1129r2143b1191, p5l9t1228r220b1290],
28	through	IN	O	through	_	0	SENT_117	[p5l251t1228r527b1309],
29	a	DT	O	a	det	31	SENT_117	[p5l560t1248r597b1290],
30	single	JJ	O	single	amod	31	SENT_117	[p5l631t1228r838b1309],
31	center	NN	O	center	prep_through	27	SENT_117	[p5l871t1238r1103b1290],
32	.	.	O	.	_	0	SENT_117	[p5l871t1238r1103b1290],

1	Methods	NNS	O	method	_	0	SENT_118	[p5l8t1470r420b1552],

1	Study	NNP	O	Study	nn	2	SENT_119	[p5l12t1664r246b1757],
2	Design	NNP	O	Design	_	0	SENT_119	[p5l280t1668r561b1757],
3	and	CC	O	and	_	0	SENT_119	[p5l597t1664r742b1739],
4	Eligibility	NNP	O	Eligibility	conj_and	2	SENT_119	[p5l775t1664r1172b1757],

1	Our	PRP$	O	we	poss	3	SENT_120	[p5l10t1851r132b1907],
2	study	NN	O	study	nn	3	SENT_120	[p5l154t1850r323b1923],
3	population	NN	O	population	nsubjpass	6	SENT_120	[p5l343t1850r685b1923],
4	was	VBD	O	be	auxpass	6	SENT_120	[p5l706t1868r827b1907],
5	prospectively	RB	O	prospectively	advmod	6	SENT_120	[p5l848t1850r1278b1923],
6	recruited	VBN	O	recruit	_	0	SENT_120	[p5l1299t1850r1583b1907],
7	from	IN	O	from	_	0	SENT_120	[p5l1604t1850r1758b1907],
8	the	DT	O	the	det	11	SENT_120	[p5l1778t1850r1873b1906],
9	medical	JJ	O	medical	amod	11	SENT_120	[p5l1894t1850r2146b1907],
10	retina	NN	O	retina	nn	11	SENT_120	[p5l8t1941r190b1998],
11	clinics	NNS	O	clinic	prep_from	6	SENT_120	[p5l210t1941r415b1998],
12	of	IN	O	of	_	0	SENT_120	[p5l438t1941r506b1998],
13	The	DT	O	the	det	14	SENT_120	[p5l519t1941r638b1998],
14	Royal	NNP	O	Royal	prep_of	11	SENT_120	[p5l657t1941r841b2014],
15	Victorian	JJ	O	victorian	amod	16	SENT_120	[p5l860t1941r1148b1998],
16	Eye	NNP	O	Eye	dep	22	SENT_120	[p5l1167t1943r1286b2014],
17	and	CC	O	and	_	0	SENT_120	[p5l1307t1942r1416b1998],
18	Ear	NN	ORGANIZATION	ear	nn	19	SENT_120	[p5l1434t1943r1542b1998],
19	Hospital	NN	ORGANIZATION	hospital	conj_and	16	SENT_120	[p5l1560t1941r1818b2014],
20	(	CD	NUMBER	(	num	21	SENT_120	[p5l1840t1942r2144b2011],
21	RVEEH	NN	O	rveeh	dep	22	SENT_120	[p5l1840t1942r2144b2011],
22	)	CD	NUMBER	)	dep	11	SENT_120	[p5l1840t1942r2144b2011],
23	from	IN	O	from	_	0	SENT_120	[p5l9t2033r159b2089],
24	2006	CD	DATE	2006	num	26	SENT_120	[p5l178t2032r330b2089],
25	to	TO	DATE	to	dep	26	SENT_120	[p5l351t2041r409b2089],
26	2010	CD	DATE	2010	prep_from	22	SENT_120	[p5l431t2033r598b2089],
27	.	.	O	.	_	0	SENT_120	[p5l431t2033r598b2089],

1	This	DT	O	this	det	2	SENT_121	[p5l622t2033r756b2089],
2	study	NN	O	study	nsubjpass	4	SENT_121	[p5l780t2033r942b2106],
3	was	VBD	O	be	auxpass	4	SENT_121	[p5l964t2050r1081b2089],
4	approved	VBN	O	approve	_	0	SENT_121	[p5l1104t2033r1388b2106],
5	by	IN	O	by	_	0	SENT_121	[p5l1407t2033r1484b2105],
6	the	DT	O	the	det	8	SENT_121	[p5l1505t2033r1597b2089],
7	Human	NNP	ORGANIZATION	Human	nn	8	SENT_121	[p5l1617t2034r1845b2089],
8	Research	NNP	ORGANIZATION	Research	agent	4	SENT_121	[p5l1865t2033r2147b2089],
9	and	CC	ORGANIZATION	and	_	0	SENT_121	[p5l10t2123r120b2179],
10	Ethics	NNP	ORGANIZATION	Ethics	nn	11	SENT_121	[p5l140t2123r329b2179],
11	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_121	[p5l352t2123r693b2180],
12	of	IN	O	of	_	0	SENT_121	[p5l715t2123r783b2179],
13	the	DT	O	the	det	14	SENT_121	[p5l798t2123r891b2179],
14	RVEEH	NNP	O	RVEEH	prep_of	8	SENT_121	[p5l912t2125r1185b2179],
15	.	.	O	.	_	0	SENT_121	[p5l912t2125r1185b2179],

1	Research	NNP	O	Research	nsubj	2	SENT_122	[p5l1210t2123r1492b2179],
2	adhered	VBD	O	adhere	_	0	SENT_122	[p5l1514t2123r1755b2179],
3	to	TO	O	to	_	0	SENT_122	[p5l1776t2131r1833b2179],
4	the	DT	O	the	det	5	SENT_122	[p5l1855t2123r1948b2179],
5	tenets	NNS	O	tenet	prep_to	2	SENT_122	[p5l1969t2131r2145b2179],
6	of	IN	O	of	_	0	SENT_122	[p5l9t2214r77b2270],
7	the	DT	O	the	det	8	SENT_122	[p5l98t2214r190b2271],
8	Declaration	NN	O	declaration	prep_of	5	SENT_122	[p5l218t2214r574b2271],
9	of	IN	O	of	_	0	SENT_122	[p5l602t2214r669b2271],
10	Helsinki	NNP	LOCATION	Helsinki	prep_of	8	SENT_122	[p5l690t2214r964b2281],
11	,	,	O	,	_	0	SENT_122	[p5l690t2214r964b2281],
12	and	CC	O	and	_	0	SENT_122	[p5l996t2214r1105b2271],
13	the	DT	O	the	det	14	SENT_122	[p5l1131t2214r1224b2270],
14	participants	NNS	O	participant	nsubj	15	SENT_122	[p5l1250t2214r1603b2287],
15	provided	VBD	O	provide	conj_and	2	SENT_122	[p5l1631t2214r1905b2287],
16	written	VBN	O	write	amod	18	SENT_122	[p5l1931t2214r2146b2271],
17	infonned	JJ	O	infonned	amod	18	SENT_122	[p5l9t2305r290b2362],
18	consent	NN	O	consent	dobj	15	SENT_122	[p5l316t2314r550b2361],
19	before	IN	O	before	_	0	SENT_122	[p5l573t2305r769b2361],
20	participation	NN	O	participation	prep_before	18	SENT_122	[p5l794t2305r1194b2378],
21	.	.	O	.	_	0	SENT_122	[p5l794t2305r1194b2378],

1	Abedi	NNP	PERSON	Abedi	nn	3	SENT_123	[p5l433t2453r535b2488],
2	et	NNP	O	et	nn	3	SENT_123	[p5l551t2464r581b2488],
3	al	NNP	O	al	_	0	SENT_123	[p5l597t2453r627b2488],
4	-	:	O	-	_	0	SENT_123	[p5l654t2468r661b2475],
5	VEGFA	NNP	O	VEGFA	nn	7	SENT_123	[p5l687t2454r840b2488],
6	Gene	NNP	O	Gene	nn	7	SENT_123	[p5l856t2454r956b2488],
7	Variants	NNS	O	variant	dep	3	SENT_123	[p5l973t2455r1129b2488],
8	and	CC	O	and	_	0	SENT_123	[p5l1147t2453r1214b2488],
9	Anti-VEGF	NN	O	anti-vegf	dep	3	SENT_123	[p5l1230t2454r1451b2488],
10	in	IN	O	in	_	0	SENT_123	[p5l1469t2458r1505b2488],
11	Wet	NNP	O	Wet	nn	12	SENT_123	[p5l1520t2455r1601b2488],
12	AMD	NNP	O	AMD	prep_in	7	SENT_123	[p5l1617t2454r1726b2488],

1	Patient	NN	O	patient	nn	2	SENT_124	[p5l6t2635r299b2706],
2	Selection	NN	O	selection	_	0	SENT_124	[p5l337t2631r708b2706],

1	Inclusion	NN	O	inclusion	nn	2	SENT_125	[p5l7t2791r304b2847],
2	criteria	NNS	O	criterion	nsubj	6	SENT_125	[p5l336t2791r562b2847],
3	were	VBD	O	be	cop	6	SENT_125	[p5l594t2808r747b2847],
4	patients	NNS	O	patient	npadvmod	6	SENT_125	[p5l778t2791r1025b2864],
5	aged	JJ	O	aged	amod	4	SENT_125	[p5l1061t2791r1210b2864],
6	>	JJR	O	>	_	0	SENT_125	[p5l1246t2791r1386b2847],
7	50	CD	DURATION	50	num	8	SENT_125	[p5l1246t2791r1386b2847],
8	years	NNS	NUMBER	year	tmod	6	SENT_125	[p5l1418t2808r1584b2864],
9	with	IN	O	with	_	0	SENT_125	[p5l1618t2791r1759b2847],
10	active	JJ	O	active	amod	12	SENT_125	[p5l1792t2791r1980b2847],
11	subfoveal	JJ	O	subfoveal	amod	12	SENT_125	[p5l2015t2791r2146b2847, p5l7t2878r205b2934],
12	CNV	NN	ORGANIZATION	cnv	prep_with	6	SENT_125	[p5l235t2879r402b2935],
13	due	JJ	O	due	_	0	SENT_125	[p5l433t2878r545b2934],
14	to	TO	O	to	_	0	SENT_125	[p5l575t2886r635b2934],
15	AMD	NNP	ORGANIZATION	AMD	prep_due_to	6	SENT_125	[p5l665t2879r850b2934],
16	who	WP	O	who	nsubj	17	SENT_125	[p5l881t2878r1016b2935],
17	received	VBD	O	receive	rcmod	15	SENT_125	[p5l1046t2878r1317b2934],
18	intravitreal	JJ	O	intravitreal	amod	19	SENT_125	[p5l1347t2878r1697b2935],
19	bevacizumab	NN	O	bevacizumab	dobj	17	SENT_125	[p5l1725t2878r2147b2934],
20	or	CC	O	or	_	0	SENT_125	[p5l7t2984r73b3023],
21	ranibizumab	NN	O	ranibizumab	conj_or	19	SENT_125	[p5l99t2966r498b3023],
22	in	IN	O	in	_	0	SENT_125	[p5l529t2966r589b3022],
23	RVEEH	NN	O	rveeh	nn	26	SENT_125	[p5l618t2968r884b3023],
24	medical	JJ	O	medical	amod	26	SENT_125	[p5l913t2966r1165b3023],
25	retina	NN	O	retina	nn	26	SENT_125	[p5l1193t2966r1376b3023],
26	clinics	NNS	O	clinic	prep_in	17	SENT_125	[p5l1405t2966r1610b3023],
27	since	IN	O	since	_	0	SENT_125	[p5l1643t2966r1803b3023],
28	2006	CD	DATE	2006	prep_since	17	SENT_125	[p5l1833t2966r2007b3023],
29	.	.	O	.	_	0	SENT_125	[p5l1833t2966r2007b3023],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_126	[p5l113t3055r364b3111],
2	were	VBD	O	be	auxpass	3	SENT_126	[p5l401t3072r554b3111],
3	identiﬁed	VBN	O	identiﬁed	_	0	SENT_126	[p5l589t3055r891b3111],
4	by	IN	O	by	_	0	SENT_126	[p5l924t3055r1003b3128],
5	medical	JJ	O	medical	amod	7	SENT_126	[p5l1038t3055r1290b3111],
6	retina	NN	O	retina	nn	7	SENT_126	[p5l1323t3055r1507b3111],
7	specialists	NNS	O	specialist	agent	3	SENT_126	[p5l1543t3055r1885b3128],
8	,	,	O	,	_	0	SENT_126	[p5l1543t3055r1885b3128],
9	experienced	VBN	O	experience	partmod	7	SENT_126	[p5l1923t3055r2146b3127, p5l7t3142r192b3198],
10	in	IN	O	in	_	0	SENT_126	[p5l228t3142r289b3198],
11	the	DT	O	the	det	12	SENT_126	[p5l325t3142r421b3198],
12	management	NN	O	management	prep_in	9	SENT_126	[p5l457t3150r867b3215],
13	of	IN	O	of	_	0	SENT_126	[p5l903t3142r973b3198],
14	AMD	NNP	ORGANIZATION	AMD	prep_of	12	SENT_126	[p5l1004t3143r1206b3209],
15	,	,	O	,	_	0	SENT_126	[p5l1004t3143r1206b3209],
16	on	IN	O	on	_	0	SENT_126	[p5l1246t3160r1324b3198],
17	the	DT	O	the	det	18	SENT_126	[p5l1360t3142r1456b3198],
18	basis	NN	O	basis	prep_on	7	SENT_126	[p5l1492t3142r1649b3198],
19	of	IN	O	of	_	0	SENT_126	[p5l1689t3142r1758b3198],
20	ophthalmic	JJ	O	ophthalmic	amod	21	SENT_126	[p5l1790t3142r2147b3215],
21	examination	NN	O	examination	prep_of	18	SENT_126	[p5l7t3230r419b3297],
22	,	,	O	,	_	0	SENT_126	[p5l7t3230r419b3297],
23	fundus	NN	O	fundus	nn	25	SENT_126	[p5l465t3230r679b3287],
24	ﬂuorescein	NN	O	ﬂuorescein	nn	25	SENT_126	[p5l725t3230r1074b3287],
25	angiography	NN	O	angiography	prep_of	18	SENT_126	[p5l1118t3230r1533b3303],
26	,	,	O	,	_	0	SENT_126	[p5l1118t3230r1533b3303],
27	fundus	NN	O	fundus	nn	28	SENT_126	[p5l1579t3230r1794b3287],
28	photography	NN	O	photography	prep_of	18	SENT_126	[p5l1837t3230r2146b3303, p5l6t3319r142b3392],
29	,	,	O	,	_	0	SENT_126	[p5l1837t3230r2146b3303, p5l6t3319r142b3392],
30	and	CC	O	and	_	0	SENT_126	[p5l177t3319r290b3375],
31	time-domain	JJ	O	time-domain	amod	33	SENT_126	[p5l321t3319r730b3375],
32	optical	JJ	O	optical	amod	33	SENT_126	[p5l762t3319r977b3392],
33	coherence	NN	O	coherence	prep_of	18	SENT_126	[p5l1009t3319r1332b3375],
34	tomography	NN	O	tomography	nn	37	SENT_126	[p5l1363t3319r1749b3392],
35	(	CD	NUMBER	(	num	37	SENT_126	[p5l1783t3319r2008b3388],
36	OCT	NN	DATE	oct	nn	37	SENT_126	[p5l1783t3319r2008b3388],
37	)	NN	O	)	dep	7	SENT_126	[p5l1783t3319r2008b3388],
38	.	.	O	.	_	0	SENT_126	[p5l1783t3319r2008b3388],

1	Establishing	VBG	O	establish	_	0	SENT_127	[p5l2043t3320r2146b3375, p5l6t3406r320b3479],
2	the	DT	O	the	det	3	SENT_127	[p5l355t3406r450b3462],
3	diagnosis	NN	O	diagnosis	dobj	1	SENT_127	[p5l485t3406r784b3479],
4	of	IN	O	of	_	0	SENT_127	[p5l820t3406r890b3462],
5	active	JJ	O	active	amod	6	SENT_127	[p5l919t3406r1107b3462],
6	CNV	NN	ORGANIZATION	cnv	prep_of	3	SENT_127	[p5l1142t3406r1308b3463],
7	required	VBD	O	require	dep	1	SENT_127	[p5l1341t3406r1609b3479],
8	the	DT	O	the	det	9	SENT_127	[p5l1641t3406r1737b3462],
9	presence	NN	O	presence	nsubj	1	SENT_127	[p5l1770t3424r2050b3479],
10	of	IN	O	of	_	0	SENT_127	[p5l2085t3406r2154b3462],
11	subfoveal	JJ	O	subfoveal	amod	12	SENT_127	[p5l9t3494r316b3551],
12	leakage	NN	O	leakage	prep_of	9	SENT_127	[p5l341t3494r602b3567],
13	,	,	O	,	_	0	SENT_127	[p5l341t3494r602b3567],
14	as	IN	O	as	mark	27	SENT_127	[p5l631t3512r692b3550],
15	seen	VBN	O	see	csubjpass	27	SENT_127	[p5l722t3512r859b3550],
16	on	IN	O	on	_	0	SENT_127	[p5l885t3512r962b3550],
17	fundus	NN	O	fundus	nn	19	SENT_127	[p5l987t3494r1202b3551],
18	ﬂuorescein	NN	O	ﬂuorescein	nn	19	SENT_127	[p5l1229t3494r1579b3551],
19	angiography	NN	O	angiography	prep_on	15	SENT_127	[p5l1605t3494r2019b3567],
20	,	,	O	,	_	0	SENT_127	[p5l1605t3494r2019b3567],
21	All	DT	O	all	det	22	SENT_127	[p5l2048t3494r2148b3550],
22	patients	NNS	O	patient	appos	19	SENT_127	[p5l6t3583r253b3656],
23	with	IN	O	with	_	0	SENT_127	[p5l286t3583r426b3639],
24	subfoveal	JJ	O	subfoveal	amod	25	SENT_127	[p5l460t3583r767b3639],
25	CNV	NN	ORGANIZATION	cnv	prep_with	22	SENT_127	[p5l799t3583r965b3639],
26	were	VBD	O	be	auxpass	27	SENT_127	[p5l998t3600r1151b3639],
27	included	VBN	O	include	dep	9	SENT_127	[p5l1182t3583r1457b3639],
28	and	CC	O	and	_	0	SENT_127	[p5l1489t3583r1602b3639],
29	followed	VBN	O	follow	dep	9	SENT_127	[p5l1633t3583r1917b3639],
30	for	IN	O	for	_	0	SENT_127	[p5l1948t3583r2041b3639],
31	12	CD	DURATION	12	num	32	SENT_127	[p5l2078t3583r2148b3638],
32	months	NNS	NUMBER	month	prep_for	27	SENT_127	[p5l6t3671r257b3727],
33	.	.	O	.	_	0	SENT_127	[p5l6t3671r257b3727],

1	One	CD	NUMBER	one	num	2	SENT_128	[p5l283t3671r413b3727],
2	eye	NN	O	eye	nsubjpass	5	SENT_128	[p5l435t3689r543b3744],
3	was	VBD	O	be	auxpass	5	SENT_128	[p5l565t3689r685b3727],
4	randomly	RB	O	randomly	advmod	5	SENT_128	[p5l707t3671r1013b3744],
5	determined	VBN	O	determine	_	0	SENT_128	[p5l1035t3671r1394b3727],
6	as	IN	O	as	_	0	SENT_128	[p5l1416t3689r1478b3727],
7	the	DT	O	the	det	9	SENT_128	[p5l1500t3671r1596b3727],
8	study	NN	O	study	nn	9	SENT_128	[p5l1619t3671r1788b3744],
9	eye	NN	O	eye	prep_as	5	SENT_128	[p5l1810t3689r1918b3744],
10	if	IN	O	if	mark	15	SENT_128	[p5l1939t3671r1992b3726],
11	both	DT	O	both	det	12	SENT_128	[p5l2006t3671r2148b3727],
12	eyes	NNS	O	eye	nsubj	15	SENT_128	[p5l7t3776r145b3831],
13	were	VBD	O	be	cop	15	SENT_128	[p5l174t3776r327b3815],
14	eligible	JJ	O	eligible	amod	15	SENT_128	[p5l354t3758r592b3831],
15	(	NN	O	(	advcl	5	SENT_128	[p5l621t3759r723b3828],
16	30	CD	NUMBER	30	num	17	SENT_128	[p5l621t3759r723b3828],
17	participants	NNS	O	participant	nsubj	18	SENT_128	[p5l749t3758r1121b3831],
18	underwent	VBD	O	undergo	rcmod	15	SENT_128	[p5l1149t3758r1488b3815],
19	bilateral	JJ	O	bilateral	amod	21	SENT_128	[p5l1512t3758r1774b3815],
20	treatment	NN	O	treatment	nn	21	SENT_128	[p5l1800t3759r2145b3828],
21	)	NN	O	)	dobj	18	SENT_128	[p5l1800t3759r2145b3828],
22	.	.	O	.	_	0	SENT_128	[p5l1800t3759r2145b3828],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_129	[p6l113t21r421b77],
2	criteria	NNS	O	criterion	nsubj	5	SENT_129	[p6l449t21r664b77],
3	were	VBD	O	be	cop	5	SENT_129	[p6l691t38r839b77],
4	(	CD	NUMBER	(	num	5	SENT_129	[p6l870t21r954b90],
5	1	CD	NUMBER	1	_	0	SENT_129	[p6l870t21r954b90],
6	)	CD	NUMBER	)	num	7	SENT_129	[p6l870t21r954b90],
7	CNV	NN	ORGANIZATION	cnv	attr	5	SENT_129	[p6l985t21r1148b77],
8	secondary	JJ	O	secondary	amod	7	SENT_129	[p6l1179t21r1486b94],
9	to	TO	O	to	_	0	SENT_129	[p6l1515t29r1573b77],
10	non-AMD	JJ	O	non-amd	amod	11	SENT_129	[p6l1602t21r1924b77],
11	conditions	NNS	O	condition	prep_to	8	SENT_129	[p6l1953t21r2146b77, p6l6t109r152b165],
12	such	JJ	O	such	_	0	SENT_129	[p6l193t109r331b165],
13	as	IN	O	as	_	0	SENT_129	[p6l368t127r428b165],
14	angioid	JJ	O	angioid	amod	15	SENT_129	[p6l467t109r696b182],
15	streaks	NNS	O	streak	prep_such_as	11	SENT_129	[p6l734t109r958b175],
16	,	,	O	,	_	0	SENT_129	[p6l734t109r958b175],
17	degenerative	JJ	O	degenerative	amod	18	SENT_129	[p6l998t109r1388b182],
18	myopia	NN	O	myopia	prep_such_as	11	SENT_129	[p6l1424t109r1671b182],
19	,	,	O	,	_	0	SENT_129	[p6l1424t109r1671b182],
20	central	JJ	O	central	amod	22	SENT_129	[p6l1710t109r1917b165],
21	serous	JJ	O	serous	amod	22	SENT_129	[p6l1955t127r2146b165],
22	retinopathy	NN	O	retinopathy	prep_such_as	11	SENT_129	[p6l6t196r370b269],
23	,	,	O	,	_	0	SENT_129	[p6l6t196r370b269],
24	or	CC	O	or	_	0	SENT_129	[p6l395t214r458b252],
25	hereditary	JJ	O	hereditary	amod	27	SENT_129	[p6l477t196r786b269],
26	retinal	JJ	O	retinal	amod	27	SENT_129	[p6l807t196r1001b253],
27	disorders	NNS	O	disorder	conj_or	15	SENT_129	[p6l1023t196r1319b263],
28	;	:	O	;	_	0	SENT_129	[p6l1023t196r1319b263],
29	(	NN	O	(	conj_and	11	SENT_129	[p6l1346t197r1429b266],
30	2	CD	NUMBER	2	number	31	SENT_129	[p6l1346t197r1429b266],
31	)	CD	NUMBER	)	num	33	SENT_129	[p6l1346t197r1429b266],
32	laser	NN	O	laser	nn	33	SENT_129	[p6l1452t196r1597b253],
33	photocoagulation	NN	O	photocoagulation	dep	29	SENT_129	[p6l1615t196r2148b269],
34	or	CC	O	or	_	0	SENT_129	[p6l7t302r71b341],
35	photodynamic	JJ	O	photodynamic	amod	36	SENT_129	[p6l99t285r539b358],
36	therapy	NN	O	therapy	conj_or	33	SENT_129	[p6l570t285r799b358],
37	before	IN	O	before	_	0	SENT_129	[p6l828t285r1024b341],
38	anti-VEGF	JJ	O	anti-vegf	amod	39	SENT_129	[p6l1056t285r1398b341],
39	administration	NN	O	administration	prep_before	33	SENT_129	[p6l1429t285r1886b351],
40	;	:	O	;	_	0	SENT_129	[p6l1429t285r1886b351],
41	(	CD	NUMBER	(	conj_and	11	SENT_129	[p6l1922t285r2005b354],
42	3	CD	NUMBER	3	number	43	SENT_129	[p6l1922t285r2005b354],
43	)	CD	NUMBER	)	num	47	SENT_129	[p6l1922t285r2005b354],
44	any	DT	O	any	det	47	SENT_129	[p6l2039t302r2148b357],
45	serious	JJ	O	serious	amod	47	SENT_129	[p6l9t373r221b429],
46	adverse	JJ	O	adverse	amod	47	SENT_129	[p6l255t373r487b429],
47	events	NNS	O	event	dep	41	SENT_129	[p6l519t381r711b429],
48	over	IN	O	over	_	0	SENT_129	[p6l745t391r882b429],
49	the	DT	O	the	det	51	SENT_129	[p6l911t373r1004b429],
50	treatment	NN	O	treatment	nn	51	SENT_129	[p6l1035t381r1325b429],
51	course	NN	O	course	prep_over	47	SENT_129	[p6l1355t391r1572b440],
52	;	:	O	;	_	0	SENT_129	[p6l1355t391r1572b440],
53	and	CC	O	and	_	0	SENT_129	[p6l1607t373r1717b429],
54	(	NN	O	(	nn	56	SENT_129	[p6l1750t373r1834b442],
55	4	CD	NUMBER	4	num	56	SENT_129	[p6l1750t373r1834b442],
56	)	NN	O	)	conj_and	11	SENT_129	[p6l1750t373r1834b442],
57	and	CC	O	and	_	0	SENT_129	[p6l1868t373r1978b429],
58	nonCaucasian	JJ	O	noncaucasian	amod	59	SENT_129	[p6l2008t391r2146b429, p6l7t460r322b517],
59	ancestry	NN	O	ancestry	conj_and	56	SENT_129	[p6l349t469r617b533],
60	.	.	O	.	_	0	SENT_129	[p6l349t469r617b533],

1	Data	NNS	O	datum	_	0	SENT_130	[p6l6t668r201b739],
2	Collection	NNP	O	Collection	dep	1	SENT_130	[p6l237t664r659b739],
3	and	CC	O	and	_	0	SENT_130	[p6l695t664r839b739],
4	Follow-up	JJ	MISC	follow-up	dep	1	SENT_130	[p6l873t664r1285b758],

1	Data	NNS	O	datum	nsubjpass	16	SENT_131	[p6l6t826r157b880],
2	pertaining	VBG	O	pertain	partmod	1	SENT_131	[p6l178t824r501b897],
3	to	TO	O	to	_	0	SENT_131	[p6l525t833r585b880],
4	patient	NN	O	patient	nn	5	SENT_131	[p6l607t824r826b897],
5	demographics	NNS	O	demographic	prep_to	2	SENT_131	[p6l848t824r1313b897],
6	,	,	O	,	_	0	SENT_131	[p6l848t824r1313b897],
7	medical	JJ	O	medical	amod	8	SENT_131	[p6l1339t824r1591b880],
8	history	NN	O	history	prep_to	2	SENT_131	[p6l1614t824r1852b897],
9	,	,	O	,	_	0	SENT_131	[p6l1614t824r1852b897],
10	VA	NNP	ORGANIZATION	VA	prep_to	2	SENT_131	[p6l1878t825r2009b891],
11	,	,	O	,	_	0	SENT_131	[p6l1878t825r2009b891],
12	and	CC	O	and	_	0	SENT_131	[p6l2036t824r2149b880],
13	treatment	NN	O	treatment	nn	14	SENT_131	[p6l6t921r309b969],
14	scheduling	NN	O	scheduling	conj_and	5	SENT_131	[p6l346t912r688b985],
15	were	VBD	O	be	auxpass	16	SENT_131	[p6l725t930r878b969],
16	collected	VBN	O	collect	_	0	SENT_131	[p6l914t912r1202b969],
17	after	IN	O	after	mark	20	SENT_131	[p6l1238t912r1384b968],
18	consent	NN	O	consent	nsubjpass	20	SENT_131	[p6l1418t921r1662b968],
19	was	VBD	O	be	auxpass	20	SENT_131	[p6l1696t930r1817b969],
20	obtained	VBN	O	obtain	advcl	16	SENT_131	[p6l1855t912r2145b969],
21	.	.	O	.	_	0	SENT_131	[p6l1855t912r2145b969],

1	Experienced	VBN	O	experience	amod	2	SENT_132	[p6l6t1001r407b1074],
2	examiners	NNS	O	examiner	nsubj	3	SENT_132	[p6l431t1001r757b1057],
3	measured	VBD	O	measure	_	0	SENT_132	[p6l783t1001r1090b1057],
4	VA	NNP	O	VA	dobj	3	SENT_132	[p6l1114t1001r1228b1057],
5	using	VBG	O	use	partmod	4	SENT_132	[p6l1252t1001r1423b1074],
6	ETDRS	NNP	O	ETDRS	nn	7	SENT_132	[p6l1449t1001r1698b1057],
7	charts	NNS	O	chart	dobj	5	SENT_132	[p6l1727t1001r1914b1057],
8	at	IN	O	at	_	0	SENT_132	[p6l1942t1009r1998b1057],
9	4	CD	NUMBER	4	num	12	SENT_132	[p6l2021t1001r2150b1056],
10	—	NN	O	—	nn	12	SENT_132	[p6l2021t1001r2150b1056],
11	m	NN	O	m	nn	12	SENT_132	[p6l2021t1001r2150b1056],
12	distance	NN	O	distance	prep_at	5	SENT_132	[p6l7t1088r267b1144],
13	at	IN	O	at	_	0	SENT_132	[p6l306t1096r361b1144],
14	each	DT	O	each	det	15	SENT_132	[p6l397t1088r541b1144],
15	visit	NN	O	visit	prep_at	12	SENT_132	[p6l578t1088r730b1144],
16	.	.	O	.	_	0	SENT_132	[p6l578t1088r730b1144],

1	A	DT	O	a	det	4	SENT_133	[p6l770t1089r826b1144],
2	peripheral	JJ	O	peripheral	amod	4	SENT_133	[p6l861t1088r1185b1161],
3	blood	NN	O	blood	nn	4	SENT_133	[p6l1221t1088r1404b1144],
4	sample	NN	O	sample	nsubjpass	6	SENT_133	[p6l1442t1088r1664b1161],
5	was	VBD	O	be	auxpass	6	SENT_133	[p6l1702t1106r1822b1144],
6	collected	VBN	O	collect	_	0	SENT_133	[p6l1861t1088r2149b1144],
7	from	IN	O	from	_	0	SENT_133	[p6l7t1176r162b1233],
8	each	DT	O	each	det	9	SENT_133	[p6l191t1176r335b1233],
9	patient	NN	O	patient	prep_from	6	SENT_133	[p6l364t1176r583b1249],
10	for	IN	O	for	_	0	SENT_133	[p6l611t1176r704b1232],
11	DNA	NN	O	dna	nn	12	SENT_133	[p6l732t1177r904b1233],
12	extraction	NN	O	extraction	prep_for	9	SENT_133	[p6l934t1176r1269b1233],
13	.	.	O	.	_	0	SENT_133	[p6l934t1176r1269b1233],

1	At	IN	O	at	_	0	SENT_134	[p6l1303t1177r1382b1232],
2	each	DT	O	each	det	3	SENT_134	[p6l1411t1176r1556b1233],
3	appointment	NN	O	appointment	prep_at	7	SENT_134	[p6l1587t1176r2002b1249],
4	,	,	O	,	_	0	SENT_134	[p6l1587t1176r2002b1249],
5	VA	NNP	ORGANIZATION	VA	nsubjpass	7	SENT_134	[p6l2035t1177r2149b1233],
6	was	VBD	O	be	auxpass	7	SENT_134	[p6l7t1282r127b1321],
7	reassessed	VBN	O	reassess	_	0	SENT_134	[p6l156t1265r491b1321],
8	and	CC	O	and	_	0	SENT_134	[p6l519t1265r632b1321],
9	patients	NNS	O	patient	nsubj	10	SENT_134	[p6l659t1265r906b1338],
10	underwent	VBD	O	undergo	conj_and	7	SENT_134	[p6l935t1265r1274b1321],
11	a	DT	O	a	det	14	SENT_134	[p6l1303t1282r1335b1321],
12	dilated	JJ	O	dilated	amod	14	SENT_134	[p6l1363t1265r1580b1321],
13	fundus	NN	O	fundus	nn	14	SENT_134	[p6l1607t1265r1822b1321],
14	examination	NN	O	examination	nsubj	25	SENT_134	[p6l1852t1265r2146b1321, p6l6t1353r129b1409],
15	and	CC	O	and	_	0	SENT_134	[p6l163t1353r276b1409],
16	a	DT	O	a	det	19	SENT_134	[p6l309t1371r342b1409],
17	time-domain	JJ	O	time-domain	amod	19	SENT_134	[p6l373t1353r782b1409],
18	OCT	NN	DATE	oct	nn	19	SENT_134	[p6l815t1353r972b1409],
19	imaging	NN	O	imaging	conj_and	14	SENT_134	[p6l1004t1353r1264b1426],
20	with	IN	O	with	_	0	SENT_134	[p6l1298t1353r1438b1409],
21	Stratus	NNP	O	Stratus	nn	23	SENT_134	[p6l1472t1353r1689b1409],
22	OCT	NN	DATE	oct	nn	23	SENT_134	[p6l1725t1353r1882b1409],
23	version	NN	O	version	prep_with	19	SENT_134	[p6l1914t1353r2149b1409],
24	5.0.1	CD	NUMBER	5.0.1	number	25	SENT_134	[p6l8t1440r158b1497],
25	(	CD	NUMBER	(	xcomp	10	SENT_134	[p6l189t1440r350b1510],
26	Carl	NNP	PERSON	Carl	nn	28	SENT_134	[p6l189t1440r350b1510],
27	Zeiss	NNP	PERSON	Zeiss	nn	28	SENT_134	[p6l372t1440r538b1497],
28	Meditec	NNP	PERSON	Meditec	dep	25	SENT_134	[p6l561t1440r840b1507],
29	,	,	O	,	_	0	SENT_134	[p6l561t1440r840b1507],
30	Dublin	NNP	LOCATION	Dublin	conj_or	25	SENT_134	[p6l865t1440r1104b1507],
31	,	,	O	,	_	0	SENT_134	[p6l865t1440r1104b1507],
32	CA	NNP	LOCATION	CA	appos	30	SENT_134	[p6l1129t1441r1257b1507],
33	;	:	O	;	_	0	SENT_134	[p6l1129t1441r1257b1507],
34	or	CC	O	or	_	0	SENT_134	[p6l1284t1458r1349b1497],
35	Cirrus	NNP	O	Cirrus	nn	37	SENT_134	[p6l1370t1440r1567b1497],
36	HD-OCT	NNP	O	HD-OCT	nn	37	SENT_134	[p6l1590t1441r1892b1497],
37	version	NN	O	version	conj_or	25	SENT_134	[p6l1914t1440r2149b1497],
38	6.0.0.599	CD	NUMBER	6.0.0.599	num	37	SENT_134	[p6l8t1529r323b1595],
39	,	,	O	,	_	0	SENT_134	[p6l8t1529r323b1595],
40	Carl	NNP	PERSON	Carl	nn	43	SENT_134	[p6l355t1529r491b1585],
41	Zeiss	NNP	PERSON	Zeiss	nn	43	SENT_134	[p6l519t1529r686b1585],
42	Meditec	NNP	PERSON	Meditec	nn	43	SENT_134	[p6l716t1529r1020b1598],
43	)	NN	O	)	appos	37	SENT_134	[p6l716t1529r1020b1598],
44	.	.	O	.	_	0	SENT_134	[p6l716t1529r1020b1598],

1	All	DT	O	all	det	2	SENT_135	[p6l113t1617r217b1672],
2	angiograms	NNS	O	angiogram	nsubjpass	4	SENT_135	[p6l246t1617r630b1690],
3	were	VBD	O	be	auxpass	4	SENT_135	[p6l659t1635r817b1673],
4	examined	VBN	O	examine	_	0	SENT_135	[p6l845t1617r1166b1673],
5	by	IN	O	by	_	0	SENT_135	[p6l1192t1617r1272b1690],
6	medical	JJ	O	medical	amod	8	SENT_135	[p6l1300t1617r1561b1673],
7	retina	NN	O	retina	nn	8	SENT_135	[p6l1587t1617r1779b1673],
8	specialists	NNS	O	specialist	agent	4	SENT_135	[p6l1807t1617r2147b1690],
9	to	TO	O	to	aux	10	SENT_135	[p6l6t1713r67b1761],
10	determine	VB	O	determine	xcomp	4	SENT_135	[p6l97t1704r428b1761],
11	the	DT	O	the	det	13	SENT_135	[p6l457t1704r556b1760],
12	lesion	NN	O	lesion	nn	13	SENT_135	[p6l585t1704r782b1761],
13	type	NN	O	type	dobj	10	SENT_135	[p6l811t1713r951b1777],
14	and	CC	O	and	_	0	SENT_135	[p6l981t1704r1097b1761],
15	measure	VB	O	measure	xcomp	4	SENT_135	[p6l1125t1722r1400b1760],
16	CNV	NNP	O	CNV	nn	17	SENT_135	[p6l1429t1705r1599b1761],
17	size	NN	O	size	dobj	15	SENT_135	[p6l1630t1704r1755b1761],
18	in	IN	O	in	_	0	SENT_135	[p6l1783t1704r1845b1760],
19	comparison	NN	O	comparison	prep_in	15	SENT_135	[p6l1874t1722r2147b1777, p6l6t1793r143b1849],
20	with	IN	O	with	_	0	SENT_135	[p6l177t1793r323b1849],
21	optic	JJ	O	optic	amod	23	SENT_135	[p6l358t1793r521b1865],
22	disc	NN	O	disc	nn	23	SENT_135	[p6l557t1793r687b1849],
23	area	NN	O	area	prep_with	15	SENT_135	[p6l724t1810r860b1849],
24	using	VBG	O	use	partmod	23	SENT_135	[p6l892t1793r1070b1866],
25	the	DT	O	the	det	28	SENT_135	[p6l1105t1793r1204b1849],
26	middle	JJ	O	middle	amod	28	SENT_135	[p6l1238t1793r1467b1849],
27	phase	NN	O	phase	nn	28	SENT_135	[p6l1501t1793r1689b1866],
28	frame	NN	O	frame	dobj	24	SENT_135	[p6l1723t1793r1914b1849],
29	of	IN	O	of	_	0	SENT_135	[p6l1950t1793r2020b1849],
30	the	DT	O	the	det	31	SENT_135	[p6l2049t1793r2148b1849],
31	angiogram	NN	O	angiogram	prep_of	28	SENT_135	[p6l8t1881r378b1954],
32	.	.	O	.	_	0	SENT_135	[p6l8t1881r378b1954],

1	Treatment	NN	O	treatment	_	0	SENT_136	[p6l7t2090r441b2161],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_137	[p6l6t2246r257b2302],
2	were	VBD	O	be	auxpass	3	SENT_137	[p6l296t2263r450b2302],
3	treated	VBN	O	treat	_	0	SENT_137	[p6l487t2246r705b2302],
4	with	IN	O	with	_	0	SENT_137	[p6l742t2246r883b2302],
5	a	DT	O	a	det	6	SENT_137	[p6l921t2263r954b2302],
6	dose	NN	O	dose	prep_with	3	SENT_137	[p6l991t2246r1135b2302],
7	of	IN	O	of	_	0	SENT_137	[p6l1173t2246r1243b2302],
8	0.5	CD	NUMBER	0.5	num	10	SENT_137	[p6l1275t2245r1370b2302],
9	mg	NN	O	mg	nn	10	SENT_137	[p6l1410t2263r1510b2319],
10	intravitreal	NN	O	intravitreal	prep_of	6	SENT_137	[p6l1548t2246r1899b2302],
11	ranibizumab	NN	O	ranibizumab	nn	13	SENT_137	[p6l1935t2246r2146b2302, p6l7t2334r217b2390],
12	(	CD	NUMBER	(	num	13	SENT_137	[p6l262t2334r580b2403],
13	Lucentis	NNP	O	Lucentis	dep	3	SENT_137	[p6l262t2334r580b2403],
14	;	:	O	;	_	0	SENT_137	[p6l262t2334r580b2403],
15	Novartis	NNP	ORGANIZATION	Novartis	nn	17	SENT_137	[p6l623t2334r896b2390],
16	Pharma	NNP	ORGANIZATION	Pharma	nn	17	SENT_137	[p6l939t2334r1184b2390],
17	AG	NNP	ORGANIZATION	AG	dep	13	SENT_137	[p6l1223t2334r1354b2401],
18	,	,	O	,	_	0	SENT_137	[p6l1223t2334r1354b2401],
19	Basel	NNP	LOCATION	Basel	nn	21	SENT_137	[p6l1397t2334r1591b2401],
20	,	,	O	,	_	0	SENT_137	[p6l1397t2334r1591b2401],
21	Switzerland	NNP	LOCATION	Switzerland	appos	17	SENT_137	[p6l1637t2334r2041b2403],
22	)	CD	NUMBER	)	num	28	SENT_137	[p6l1637t2334r2041b2403],
23	or	CC	O	or	_	0	SENT_137	[p6l2085t2352r2150b2390],
24	1.25	CD	NUMBER	1.25	conj_or	22	SENT_137	[p6l14t2421r141b2478],
25	mg	NN	O	mg	nn	28	SENT_137	[p6l175t2439r275b2494],
26	bevacizumab	NN	O	bevacizumab	nn	28	SENT_137	[p6l305t2421r727b2478],
27	(	CD	NUMBER	(	num	28	SENT_137	[p6l761t2421r1052b2491],
28	Avastin	NN	MISC	avastin	dep	21	SENT_137	[p6l761t2421r1052b2491],
29	;	:	O	;	_	0	SENT_137	[p6l761t2421r1052b2491],
30	Roche	NNP	PERSON	Roche	nn	34	SENT_137	[p6l1086t2421r1306b2488],
31	,	,	O	,	_	0	SENT_137	[p6l1086t2421r1306b2488],
32	Basel	NNP	LOCATION	Basel	appos	34	SENT_137	[p6l1340t2421r1533b2488],
33	,	,	O	,	_	0	SENT_137	[p6l1340t2421r1533b2488],
34	Switzerland	NNP	LOCATION	Switzerland	dep	13	SENT_137	[p6l1569t2421r1991b2491],
35	)	CD	NUMBER	)	num	34	SENT_137	[p6l1569t2421r1991b2491],
36	.	.	O	.	_	0	SENT_137	[p6l1569t2421r1991b2491],

1	The	DT	O	the	det	2	SENT_138	[p6l2026t2421r2148b2477],
2	majority	NN	O	majority	nsubjpass	6	SENT_138	[p6l6t2510r276b2583],
3	of	IN	O	of	_	0	SENT_138	[p6l300t2510r370b2566],
4	patients	NNS	O	patient	prep_of	2	SENT_138	[p6l385t2510r633b2583],
5	were	VBD	O	be	auxpass	6	SENT_138	[p6l658t2527r811b2566],
6	treated	VBN	O	treat	_	0	SENT_138	[p6l834t2510r1051b2566],
7	with	IN	O	with	_	0	SENT_138	[p6l1073t2510r1214b2566],
8	ranibizumab	NN	O	ranibizumab	prep_with	6	SENT_138	[p6l1235t2510r1635b2566],
9	only	RB	O	only	advmod	6	SENT_138	[p6l1660t2510r1798b2583],
10	during	IN	O	during	_	0	SENT_138	[p6l1823t2510r2029b2583],
11	the	DT	O	the	det	12	SENT_138	[p6l2052t2510r2148b2566],
12	course	NN	O	course	prep_during	6	SENT_138	[p6l7t2616r214b2654],
13	of	IN	O	of	_	0	SENT_138	[p6l259t2598r328b2654],
14	treatment	NN	O	treatment	prep_of	12	SENT_138	[p6l365t2606r683b2654],
15	.	.	O	.	_	0	SENT_138	[p6l365t2606r683b2654],

1	However	RB	O	however	advmod	9	SENT_139	[p6l730t2599r1040b2664],
2	,	,	O	,	_	0	SENT_139	[p6l730t2599r1040b2664],
3	39	CD	NUMBER	39	num	4	SENT_139	[p6l1088t2598r1163b2655],
4	patients	NNS	O	patient	nsubj	9	SENT_139	[p6l1207t2598r1454b2671],
5	(	IN	O	(	_	0	SENT_139	[p6l1501t2598r1756b2667],
6	19.4	CD	PERCENT	19.4	number	7	SENT_139	[p6l1501t2598r1756b2667],
7	%	NN	PERCENT	%	num	8	SENT_139	[p6l1501t2598r1756b2667],
8	)	CD	NUMBER	)	prep_(	4	SENT_139	[p6l1501t2598r1756b2667],
9	received	VBD	O	receive	_	0	SENT_139	[p6l1800t2598r2072b2654],
10	a	DT	O	a	det	12	SENT_139	[p6l2116t2616r2150b2654],
11	single	JJ	O	single	amod	12	SENT_139	[p6l9t2685r196b2758],
12	injection	NN	O	injection	dobj	9	SENT_139	[p6l229t2685r508b2758],
13	of	IN	O	of	_	0	SENT_139	[p6l541t2685r611b2741],
14	bevacizumab	NN	O	bevacizumab	prep_of	12	SENT_139	[p6l636t2685r1058b2742],
15	during	IN	O	during	_	0	SENT_139	[p6l1093t2685r1299b2758],
16	their	PRP$	O	they	poss	18	SENT_139	[p6l1332t2685r1479b2742],
17	baseline	NN	O	baseline	nn	18	SENT_139	[p6l1509t2685r1770b2742],
18	visit	NN	O	visit	prep_during	9	SENT_139	[p6l1803t2685r1941b2742],
19	while	IN	O	while	mark	20	SENT_139	[p6l1972t2685r2148b2742],
20	waiting	VBG	O	wait	advcl	9	SENT_139	[p6l7t2774r244b2847],
21	for	IN	O	for	_	0	SENT_139	[p6l288t2774r380b2830],
22	government	NN	O	government	nn	23	SENT_139	[p6l422t2782r804b2847],
23	approval	NN	O	approval	prep_for	20	SENT_139	[p6l846t2774r1123b2847],
24	for	IN	O	for	_	0	SENT_139	[p6l1165t2774r1258b2830],
25	ranibizumab	NN	O	ranibizumab	prep_for	23	SENT_139	[p6l1297t2774r1714b2830],
26	.	.	O	.	_	0	SENT_139	[p6l1297t2774r1714b2830],

1	In	IN	O	in	_	0	SENT_140	[p6l1760t2775r1825b2829],
2	addition	NN	O	addition	prep_in	12	SENT_140	[p6l1869t2774r2145b2840],
3	,	,	O	,	_	0	SENT_140	[p6l1869t2774r2145b2840],
4	during	IN	O	during	_	0	SENT_140	[p6l7t2862r213b2935],
5	the	DT	O	the	det	6	SENT_140	[p6l249t2862r345b2918],
6	course	NN	O	course	prep_during	12	SENT_140	[p6l380t2880r587b2918],
7	of	IN	O	of	_	0	SENT_140	[p6l623t2862r692b2918],
8	treatment	NN	O	treatment	prep_of	6	SENT_140	[p6l721t2870r1040b2928],
9	,	,	O	,	_	0	SENT_140	[p6l721t2870r1040b2928],
10	bevacizumab	NN	O	bevacizumab	nsubjpass	12	SENT_140	[p6l1076t2862r1498b2918],
11	was	VBD	O	be	auxpass	12	SENT_140	[p6l1534t2880r1655b2918],
12	used	VBN	O	use	_	0	SENT_140	[p6l1691t2862r1837b2918],
13	in	IN	O	in	_	0	SENT_140	[p6l1871t2862r1932b2917],
14	a	DT	O	a	det	16	SENT_140	[p6l1968t2880r2001b2918],
15	follow-up	JJ	O	follow-up	amod	16	SENT_140	[p6l2035t2862r2146b2918, p6l7t2949r231b3022],
16	visit	NN	O	visit	prep_in	12	SENT_140	[p6l253t2949r390b3006],
17	if	IN	O	if	mark	23	SENT_140	[p6l410t2949r462b3005],
18	no	DT	O	no	det	21	SENT_140	[p6l477t2967r555b3005],
19	approved	VBN	O	approve	amod	21	SENT_140	[p6l578t2949r873b3022],
20	ranibizumab	NN	O	ranibizumab	nn	21	SENT_140	[p6l893t2949r1292b3006],
21	prescription	NN	O	prescription	nsubj	23	SENT_140	[p6l1313t2949r1696b3022],
22	was	VBD	O	be	cop	23	SENT_140	[p6l1717t2967r1838b3006],
23	available	JJ	O	available	advcl	12	SENT_140	[p6l1862t2949r2148b3006],
24	(	NN	O	(	dep	25	SENT_140	[p6l9t3037r202b3107],
25	<	JJR	O	<	nsubj	31	SENT_140	[p6l9t3037r202b3107],
26	5	CD	PERCENT	5	number	27	SENT_140	[p6l9t3037r202b3107],
27	%	NN	PERCENT	%	amod	25	SENT_140	[p6l9t3037r202b3107],
28	of	IN	O	of	_	0	SENT_140	[p6l236t3037r305b3094],
29	total	JJ	O	total	amod	30	SENT_140	[p6l331t3037r471b3094],
30	injections	NNS	O	injection	prep_of	25	SENT_140	[p6l501t3037r855b3110],
31	)	VBP	O	)	ccomp	23	SENT_140	[p6l501t3037r855b3110],
32	.	.	O	.	_	0	SENT_140	[p6l501t3037r855b3110],

1	All	DT	O	all	det	2	SENT_141	[p6l889t3037r989b3093],
2	patients	NNS	O	patient	nsubj	3	SENT_141	[p6l1019t3037r1266b3110],
3	received	VBD	O	receive	_	0	SENT_141	[p6l1297t3037r1569b3094],
4	3	CD	NUMBER	3	num	7	SENT_141	[p6l1601t3038r1632b3094],
5	initial	JJ	O	initial	amod	7	SENT_141	[p6l1667t3037r1852b3094],
6	monthly	JJ	SET	monthly	amod	7	SENT_141	[p6l1883t3038r2148b3110],
7	injections	NNS	O	injection	dobj	3	SENT_141	[p6l6t3126r315b3199],
8	followed	VBN	O	follow	_	0	SENT_141	[p6l339t3126r623b3182],
9	by	IN	O	by	prepc_followed_by	3	SENT_141	[p6l644t3126r723b3199],
10	a	DT	O	a	det	12	SENT_141	[p6l748t3144r781b3182],
11	ﬂexible	JJ	O	ﬂexible	amod	12	SENT_141	[p6l803t3126r1040b3182],
12	(	NN	O	(	pobj	3	SENT_141	[p6l1066t3127r1153b3195],
13	as	IN	O	as	_	0	SENT_141	[p6l1066t3127r1153b3195],
14	required	VBN	O	require	amod	16	SENT_141	[p6l1176t3126r1467b3199],
15	)	NN	O	)	nn	16	SENT_141	[p6l1176t3126r1467b3199],
16	period	NN	O	period	prep_as	12	SENT_141	[p6l1491t3126r1711b3199],
17	.	.	O	.	_	0	SENT_141	[p6l1491t3126r1711b3199],

1	The	DT	O	the	det	2	SENT_142	[p6l1737t3126r1860b3182],
2	decision	NN	O	decision	nsubj	9	SENT_142	[p6l1884t3126r2149b3182],
3	to	TO	O	to	aux	4	SENT_142	[p6l6t3222r66b3269],
4	re-treat	VB	O	re-treat	infmod	2	SENT_142	[p6l88t3222r319b3270],
5	in	IN	O	in	_	0	SENT_142	[p6l340t3213r400b3269],
6	the	DT	O	the	det	8	SENT_142	[p6l422t3213r518b3269],
7	ﬂexible	JJ	O	ﬂexible	amod	8	SENT_142	[p6l541t3213r778b3269],
8	period	NN	O	period	prep_in	4	SENT_142	[p6l799t3213r1004b3286],
9	was	VBD	O	be	ccomp	41	SENT_142	[p6l1025t3231r1146b3270],
10	at	IN	O	at	_	0	SENT_142	[p6l1171t3222r1226b3269],
11	the	DT	O	the	det	12	SENT_142	[p6l1247t3213r1343b3270],
12	discretion	NN	O	discretion	prep_at	9	SENT_142	[p6l1365t3213r1680b3270],
13	of	IN	O	of	_	0	SENT_142	[p6l1702t3213r1772b3270],
14	the	DT	O	the	det	17	SENT_142	[p6l1787t3213r1883b3269],
15	treating	VBG	O	treat	amod	17	SENT_142	[p6l1905t3213r2148b3286],
16	retinal	JJ	O	retinal	amod	17	SENT_142	[p6l6t3301r210b3358],
17	specialist	NN	O	specialist	prep_of	12	SENT_142	[p6l232t3301r528b3374],
18	at	IN	O	at	_	0	SENT_142	[p6l548t3310r604b3358],
19	each	DT	O	each	prep_at	17	SENT_142	[p6l623t3301r768b3358],
20	follow	VBP	O	follow	dep	19	SENT_142	[p6l788t3301r1102b3374],
21	—	CD	NUMBER	—	dobj	20	SENT_142	[p6l788t3301r1102b3374],
22	up	IN	O	up	_	0	SENT_142	[p6l788t3301r1102b3374],
23	visit	NN	O	visit	prep_up	20	SENT_142	[p6l1123t3301r1260b3358],
24	on	IN	O	on	_	0	SENT_142	[p6l1280t3319r1358b3358],
25	the	DT	O	the	det	26	SENT_142	[p6l1378t3302r1474b3358],
26	basis	NN	O	basis	prep_on	23	SENT_142	[p6l1493t3301r1650b3358],
27	of	IN	O	of	_	0	SENT_142	[p6l1674t3301r1743b3358],
28	re	NN	O	re	nn	31	SENT_142	[p6l1757t3310r2149b3358],
29	—	NN	O	—	nn	31	SENT_142	[p6l1757t3310r2149b3358],
30	treatment	NN	O	treatment	nn	31	SENT_142	[p6l1757t3310r2149b3358],
31	criteria	NNS	O	criterion	prep_of	26	SENT_142	[p6l7t3390r249b3456],
32	,	,	O	,	_	0	SENT_142	[p6l7t3390r249b3456],
33	including	VBG	O	include	_	0	SENT_142	[p6l280t3390r581b3463],
34	VA	NNP	ORGANIZATION	VA	nn	35	SENT_142	[p6l610t3390r724b3446],
35	loss	NN	O	loss	prep_including	19	SENT_142	[p6l752t3390r873b3446],
36	of	IN	O	of	_	0	SENT_142	[p6l904t3390r973b3446],
37	>	JJR	O	>	amod	39	SENT_142	[p6l1001t3390r1097b3446],
38	5	CD	NUMBER	5	amod	39	SENT_142	[p6l1001t3390r1097b3446],
39	letters	NNS	O	letter	prep_of	35	SENT_142	[p6l1129t3390r1340b3457],
40	,	,	O	,	_	0	SENT_142	[p6l1129t3390r1340b3457],
41	increased	VBD	O	increase	_	0	SENT_142	[p6l1371t3390r1673b3446],
42	central	JJ	O	central	amod	44	SENT_142	[p6l1701t3390r1917b3446],
43	retinal	JJ	O	retinal	amod	44	SENT_142	[p6l1945t3390r2149b3446],
44	thickness	NN	O	thickness	dobj	41	SENT_142	[p6l6t3477r302b3534],
45	of	IN	O	of	_	0	SENT_142	[p6l338t3477r407b3533],
46	>	JJR	O	>	prep_of	44	SENT_142	[p6l441t3478r620b3534],
47	100	CD	NUMBER	100	num	48	SENT_142	[p6l441t3478r620b3534],
48	jam	NN	O	jam	dep	46	SENT_142	[p6l658t3495r786b3550],
49	,	,	O	,	_	0	SENT_142	[p6l658t3495r786b3550],
50	or	CC	O	or	_	0	SENT_142	[p6l824t3495r889b3534],
51	the	DT	O	the	det	52	SENT_142	[p6l921t3477r1017b3533],
52	presence	NN	O	presence	conj_or	46	SENT_142	[p6l1050t3495r1329b3550],
53	of	IN	O	of	_	0	SENT_142	[p6l1364t3477r1434b3533],
54	retinal	JJ	O	retinal	amod	55	SENT_142	[p6l1461t3477r1664b3533],
55	ﬂuid	NN	O	ﬂuid	prep_of	52	SENT_142	[p6l1700t3477r1845b3533],
56	on	IN	O	on	_	0	SENT_142	[p6l1878t3495r1956b3533],
57	OCT	NN	DATE	oct	prep_on	41	SENT_142	[p6l1991t3478r2148b3534],
58	(	CD	NUMBER	(	num	62	SENT_142	[p6l9t3566r383b3635],
59	intraretinal	JJ	O	intraretinal	amod	62	SENT_142	[p6l9t3566r383b3635],
60	or	CC	O	or	_	0	SENT_142	[p6l416t3583r481b3622],
61	subretinal	JJ	O	subretinal	conj_or	59	SENT_142	[p6l513t3566r850b3635],
62	)	NN	O	)	nsubj	41	SENT_142	[p6l513t3566r850b3635],
63	or	CC	O	or	_	0	SENT_142	[p6l884t3583r949b3622],
64	ophthalmic	JJ	O	ophthalmic	amod	66	SENT_142	[p6l980t3566r1337b3639],
65	examination	NN	O	examination	nn	66	SENT_142	[p6l1370t3566r1765b3622],
66	ﬁndings	NNS	O	ﬁndings	nsubj	41	SENT_142	[p6l1797t3566r2051b3639],
67	of	IN	O	of	_	0	SENT_142	[p6l2085t3566r2154b3622],
68	new	JJ	O	new	amod	71	SENT_142	[p6l6t3672r137b3710],
69	or	CC	O	or	_	0	SENT_142	[p6l168t3672r233b3710],
70	persistent	JJ	O	persistent	conj_or	68	SENT_142	[p6l260t3654r568b3727],
71	hemorrhage	NN	O	hemorrhage	prep_of	66	SENT_142	[p6l594t3654r993b3727],
72	.	.	O	.	_	0	SENT_142	[p6l594t3654r993b3727],

1	Extension	NNP	O	Extension	nsubjpass	6	SENT_143	[p6l1025t3654r1346b3710],
2	of	IN	O	of	_	0	SENT_143	[p6l1375t3654r1444b3710],
3	2	CD	DURATION	2	num	4	SENT_143	[p6l1469t3654r1505b3709],
4	weeks	NNS	NUMBER	week	prep_of	1	SENT_143	[p6l1535t3654r1731b3710],
5	was	VBD	O	be	auxpass	6	SENT_143	[p6l1762t3672r1883b3710],
6	considered	VBN	O	consider	_	0	SENT_143	[p6l1914t3654r2146b3710, p6l7t3741r143b3798],
7	for	IN	O	for	_	0	SENT_143	[p6l180t3741r273b3797],
8	the	DT	O	the	det	11	SENT_143	[p6l309t3741r405b3797],
9	subsequent	JJ	O	subsequent	amod	11	SENT_143	[p6l445t3741r799b3814],
10	clinic	NN	O	clinic	nn	11	SENT_143	[p6l836t3741r1011b3797],
11	visit	NN	O	visit	prep_for	6	SENT_143	[p6l1050t3741r1187b3798],
12	if	IN	O	if	mark	17	SENT_143	[p6l1224t3741r1275b3797],
13	the	DT	O	the	det	15	SENT_143	[p6l1308t3741r1404b3798],
14	clinical	JJ	O	clinical	amod	15	SENT_143	[p6l1442t3741r1676b3798],
15	situation	NN	O	situation	nsubj	17	SENT_143	[p6l1716t3741r1988b3797],
16	was	VBD	O	be	cop	17	SENT_143	[p6l2026t3759r2147b3798],
17	stable	JJ	O	stable	advcl	6	SENT_143	[p7l9t15r192b71],
18	and	CC	O	and	_	0	SENT_143	[p7l222t15r335b71],
19	OCT	NN	DATE	oct	nsubj	21	SENT_143	[p7l365t15r522b71],
20	was	VBD	O	be	cop	21	SENT_143	[p7l552t32r672b71],
21	free	JJ	O	free	advcl	6	SENT_143	[p7l703t15r825b71],
22	of	IN	O	of	_	0	SENT_143	[p7l856t15r925b71],
23	intraretinal	JJ	O	intraretinal	amod	26	SENT_143	[p7l948t15r1299b71],
24	or	CC	O	or	_	0	SENT_143	[p7l1329t32r1394b71],
25	subretinal	JJ	O	subretinal	conj_or	23	SENT_143	[p7l1424t15r1736b71],
26	ﬂuid	NN	O	ﬂuid	prep_of	21	SENT_143	[p7l1767t15r1927b71],
27	.	.	O	.	_	0	SENT_143	[p7l1767t15r1927b71],

1	Genotyping	VBG	O	genotype	_	0	SENT_144	[p7l8t222r485b313],

1	Brieﬂy	NNP	PERSON	Brieﬂy	nsubjpass	9	SENT_145	[p7l6t379r245b452],
2	,	,	O	,	_	0	SENT_145	[p7l6t379r245b452],
3	10	CD	NUMBER	10	num	4	SENT_145	[p7l290t380r360b436],
4	ng	NN	O	ng	appos	1	SENT_145	[p7l394t397r471b452],
5	of	IN	O	of	_	0	SENT_145	[p7l507t379r577b435],
6	genomic	JJ	O	genomic	amod	7	SENT_145	[p7l606t379r879b452],
7	DNA	NN	O	dna	prep_of	4	SENT_145	[p7l915t380r1087b435],
8	were	VBD	O	be	auxpass	9	SENT_145	[p7l1121t397r1274b436],
9	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_145	[p7l1310t379r1611b452],
10	using	VBG	O	use	xcomp	9	SENT_145	[p7l1644t379r1815b452],
11	the	DT	O	the	det	14	SENT_145	[p7l1851t379r1946b435],
12	polymerase	NN	O	polymerase	nn	14	SENT_145	[p7l1980t379r2146b452, p7l6t485r232b524],
13	chain	NN	O	chain	nn	14	SENT_145	[p7l267t467r438b524],
14	reaction	NN	O	reaction	dobj	10	SENT_145	[p7l471t467r729b524],
15	in	IN	O	in	_	0	SENT_145	[p7l763t467r823b523],
16	a	DT	O	a	det	18	SENT_145	[p7l859t485r892b524],
17	multiplex	JJ	O	multiplex	amod	18	SENT_145	[p7l924t467r1230b540],
18	reaction	NN	O	reaction	prep_in	10	SENT_145	[p7l1263t467r1522b524],
19	using	VBG	O	use	partmod	18	SENT_145	[p7l1555t467r1727b540],
20	Hotstart	NNP	O	Hotstart	nn	22	SENT_145	[p7l1762t469r2019b524],
21	taq	NN	O	taq	nn	22	SENT_145	[p7l2052t476r2149b540],
22	polymerase	NN	O	polymerase	dobj	19	SENT_145	[p7l6t556r375b629],
23	(	CD	NUMBER	(	num	26	SENT_145	[p7l416t556r692b625],
24	Bioline	NNP	PERSON	Bioline	nn	26	SENT_145	[p7l416t556r692b625],
25	,	,	O	,	_	0	SENT_145	[p7l416t556r692b625],
26	London	NNP	LOCATION	London	tmod	19	SENT_145	[p7l734t556r999b622],
27	,	,	O	,	_	0	SENT_145	[p7l734t556r999b622],
28	UK	NNP	LOCATION	UK	nn	29	SENT_145	[p7l1040t556r1197b625],
29	)	NNP	O	)	appos	26	SENT_145	[p7l1040t556r1197b625],
30	.	.	O	.	_	0	SENT_145	[p7l1040t556r1197b625],

1	A	DT	O	a	det	3	SENT_146	[p7l1240t556r1296b611],
2	MassEXTEND	NN	O	massextend	nn	3	SENT_146	[p7l1336t557r1838b612],
3	reaction	NN	O	reaction	nsubjpass	5	SENT_146	[p7l1879t556r2149b612],
4	was	VBD	O	be	auxpass	5	SENT_146	[p7l7t661r130b699],
5	undertaken	VBN	O	undertake	_	0	SENT_146	[p7l183t643r554b699],
6	using	VBG	O	use	xcomp	5	SENT_146	[p7l604t643r782b716],
7	the	DT	O	the	det	9	SENT_146	[p7l835t643r933b699],
8	designed	VBN	O	design	amod	9	SENT_146	[p7l987t643r1281b716],
9	primers	NNS	O	primer	dobj	6	SENT_146	[p7l1331t643r1602b716],
10	.	.	O	.	_	0	SENT_146	[p7l1331t643r1602b716],

1	Samples	NNS	O	sample	nsubj	9	SENT_147	[p7l1660t643r1936b716],
2	were	VBD	O	be	cop	9	SENT_147	[p7l1990t661r2148b699],
3	spotted	JJ	O	spotted	amod	9	SENT_147	[p7l9t731r247b804],
4	onto	IN	O	onto	_	0	SENT_147	[p7l278t740r422b787],
5	a	DT	O	a	det	7	SENT_147	[p7l456t749r489b788],
6	384	CD	NUMBER	384	num	7	SENT_147	[p7l521t732r640b788],
7	SpectroCHIP	NN	O	spectrochip	prep_onto	3	SENT_147	[p7l674t732r1115b804],
8	II	CD	NUMBER	ii	num	7	SENT_147	[p7l1145t733r1199b787],
9	microarray	NN	O	microarray	dep	13	SENT_147	[p7l1230t731r1594b804],
10	and	CC	O	and	_	0	SENT_147	[p7l1628t731r1744b788],
11	genotyping	NN	O	genotyping	conj_and	9	SENT_147	[p7l1775t731r2148b804],
12	was	VBD	O	be	auxpass	13	SENT_147	[p7l9t837r132b876],
13	performed	VBN	O	perform	_	0	SENT_147	[p7l163t820r510b893],
14	on	IN	O	on	_	0	SENT_147	[p7l540t837r619b876],
15	the	DT	O	the	det	16	SENT_147	[p7l649t820r748b876],
16	MassArray	NNP	O	MassArray	prep_on	13	SENT_147	[p7l777t820r1144b892],
17	platform	NN	O	platform	nn	19	SENT_147	[p7l1174t820r1462b893],
18	(	CD	NUMBER	(	num	19	SENT_147	[p7l1493t820r1992b889],
19	SEQUENOM	NNP	ORGANIZATION	SEQUENOM	nsubjpass	13	SENT_147	[p7l1493t820r1992b889],
20	,	,	O	,	_	0	SENT_147	[p7l1493t820r1992b889],
21	San	NNP	LOCATION	San	nn	22	SENT_147	[p7l2027t820r2147b876],
22	Diego	NNP	LOCATION	Diego	appos	19	SENT_147	[p7l8t907r228b980],
23	,	,	O	,	_	0	SENT_147	[p7l8t907r228b980],
24	CA	NNP	LOCATION	CA	nn	25	SENT_147	[p7l257t907r393b976],
25	)	NNP	O	)	appos	19	SENT_147	[p7l257t907r393b976],
26	at	IN	O	at	_	0	SENT_147	[p7l422t915r479b963],
27	the	DT	O	the	det	29	SENT_147	[p7l503t907r602b963],
28	Murdoch	NNP	ORGANIZATION	Murdoch	nn	29	SENT_147	[p7l628t907r930b963],
29	Children	NNP	ORGANIZATION	Children	poss	34	SENT_147	[p7l956t907r1304b964],
30	’s	POS	ORGANIZATION	’s	_	0	SENT_147	[p7l956t907r1304b964],
31	Research	NNP	ORGANIZATION	Research	nn	34	SENT_147	[p7l1331t907r1635b963],
32	Institute	NNP	ORGANIZATION	Institute	nn	34	SENT_147	[p7l1660t907r1933b963],
33	(	NNP	O	(	nn	34	SENT_147	[p7l1962t907r2144b977, p7l7t995r256b1062],
34	Melbourne	NNP	LOCATION	Melbourne	prep_at	25	SENT_147	[p7l1962t907r2144b977, p7l7t995r256b1062],
35	,	,	O	,	_	0	SENT_147	[p7l1962t907r2144b977, p7l7t995r256b1062],
36	Victoria	NNP	LOCATION	Victoria	appos	19	SENT_147	[p7l291t995r582b1062],
37	,	,	O	,	_	0	SENT_147	[p7l291t995r582b1062],
38	Australia	NNP	LOCATION	Australia	appos	36	SENT_147	[p7l617t995r967b1065],
39	)	CD	NUMBER	)	num	38	SENT_147	[p7l617t995r967b1065],
40	.	.	O	.	_	0	SENT_147	[p7l617t995r967b1065],

1	Seven	CD	NUMBER	seven	num	2	SENT_148	[p7l118t1084r310b1140],
2	SNPs	NNS	O	snp	nsubj	31	SENT_148	[p7l349t1084r959b1149],
3	—	CD	NUMBER	—	nsubjpass	24	SENT_148	[p7l349t1084r959b1149],
4	rs3024994	NN	O	rs3024994	dep	3	SENT_148	[p7l349t1084r959b1149],
5	,	,	O	,	_	0	SENT_148	[p7l349t1084r959b1149],
6	rs3025000	NN	O	rs3025000	dep	3	SENT_148	[p7l1000t1083r1354b1150],
7	,	,	O	,	_	0	SENT_148	[p7l1000t1083r1354b1150],
8	rs3025042	NN	O	rs3025042	conj_and	4	SENT_148	[p7l1394t1084r1749b1150],
9	,	,	O	,	_	0	SENT_148	[p7l1394t1084r1749b1150],
10	rs3025047	NN	O	rs3025047	conj_and	4	SENT_148	[p7l1788t1084r2143b1150],
11	,	,	O	,	_	0	SENT_148	[p7l1788t1084r2143b1150],
12	rs3025035	NN	O	rs3025035	conj_and	4	SENT_148	[p7l8t1170r362b1237],
13	,	,	O	,	_	0	SENT_148	[p7l8t1170r362b1237],
14	rs3025030	NN	O	rs3025030	conj_and	4	SENT_148	[p7l389t1170r743b1237],
15	,	,	O	,	_	0	SENT_148	[p7l389t1170r743b1237],
16	and	CC	O	and	_	0	SENT_148	[p7l772t1170r885b1226],
17	rs30250lO	NN	O	rs30250lo	conj_and	4	SENT_148	[p7l908t1170r1398b1227],
18	—	NN	O	—	dep	3	SENT_148	[p7l908t1170r1398b1227],
19	in	IN	O	in	_	0	SENT_148	[p7l908t1170r1398b1227],
20	the	DT	O	the	det	22	SENT_148	[p7l1422t1170r1518b1226],
21	VEGFA	NN	O	vegfa	nn	22	SENT_148	[p7l1547t1171r1792b1227],
22	gene	NN	O	gene	prep_in	18	SENT_148	[p7l1819t1188r1967b1243],
23	were	VBD	O	be	auxpass	24	SENT_148	[p7l1993t1188r2146b1227],
24	identiﬁed	VBN	O	identiﬁed	rcmod	2	SENT_148	[p7l9t1258r310b1314],
25	through	IN	O	through	_	0	SENT_148	[p7l333t1258r581b1331],
26	the	DT	O	the	det	27	SENT_148	[p7l604t1258r699b1314],
27	selection	NN	O	selection	prep_through	24	SENT_148	[p7l727t1258r1007b1315],
28	of	IN	O	of	_	0	SENT_148	[p7l1032t1258r1101b1315],
29	tag	NN	O	tag	nn	30	SENT_148	[p7l1119t1267r1214b1331],
30	SNPs	NNS	O	snp	prep_of	27	SENT_148	[p7l1240t1259r1413b1315],
31	(	VBP	O	(	_	0	SENT_148	[p7l1441t1259r1688b1328],
32	tSNPs	NNS	O	tsnp	dobj	31	SENT_148	[p7l1441t1259r1688b1328],
33	)	CD	NUMBER	)	num	32	SENT_148	[p7l1441t1259r1688b1328],
34	via	IN	O	via	_	0	SENT_148	[p7l1714t1258r1811b1315],
35	the	DT	O	the	det	36	SENT_148	[p7l1833t1258r1929b1315],
36	use	NN	O	use	prep_via	32	SENT_148	[p7l1953t1276r2057b1315],
37	of	IN	O	of	_	0	SENT_148	[p7l2082t1258r2151b1314],
38	the	DT	O	the	det	41	SENT_148	[p7l8t1347r104b1403],
39	Intemational	NNP	O	Intemational	nn	41	SENT_148	[p7l139t1347r546b1403],
40	HapMAP	NNP	O	HapMAP	nn	41	SENT_148	[p7l581t1347r887b1419],
41	Project	NNP	O	Project	prep_of	36	SENT_148	[p7l921t1347r1147b1420],
42	(	CD	NUMBER	(	num	43	SENT_148	[p7l1183t1347r2013b1419],
43	http://www.hapmap.org/;	NN	O	http://www.hapmap.org/;	nsubj	44	SENT_148	[p7l1183t1347r2013b1419],
44	accessed	VBD	O	access	rcmod	41	SENT_148	[p7l2052t1364r2144b1403, p7l9t1434r216b1490],
45	July	NNP	DATE	July	tmod	44	SENT_148	[p7l238t1434r370b1507],
46	20	CD	DATE	20	num	45	SENT_148	[p7l394t1434r488b1501],
47	,	,	DATE	,	_	0	SENT_148	[p7l394t1434r488b1501],
48	2010	CD	DATE	2010	num	45	SENT_148	[p7l515t1435r714b1503],
49	)	NN	O	)	dep	32	SENT_148	[p7l515t1435r714b1503],
50	.	.	O	.	_	0	SENT_148	[p7l515t1435r714b1503],

1	The	DT	O	the	det	2	SENT_149	[p7l742t1434r864b1490],
2	tSNPs	NNS	O	tsnp	nsubjpass	4	SENT_149	[p7l887t1434r1083b1491],
3	were	VBD	O	be	auxpass	4	SENT_149	[p7l1109t1452r1262b1490],
4	selected	VBN	O	select	_	0	SENT_149	[p7l1287t1434r1542b1490],
5	using	VBG	O	use	xcomp	4	SENT_149	[p7l1563t1434r1735b1507],
6	the	DT	O	the	det	8	SENT_149	[p7l1758t1434r1854b1490],
7	pairwise	JJ	O	pairwise	amod	8	SENT_149	[p7l1876t1434r2146b1507],
8	algorithm	NN	O	algorithm	dobj	5	SENT_149	[p7l10t1522r319b1595],
9	and	CC	O	and	_	0	SENT_149	[p7l345t1522r458b1579],
10	a	DT	O	a	det	14	SENT_149	[p7l485t1540r518b1579],
11	CEU	NNP	O	CEU	nn	14	SENT_149	[p7l543t1523r700b1579],
12	(	CD	NUMBER	(	num	14	SENT_149	[p7l728t1522r907b1592],
13	Utah	NNP	LOCATION	Utah	nn	14	SENT_149	[p7l728t1522r907b1592],
14	residents	NNS	O	resident	dobj	5	SENT_149	[p7l931t1522r1213b1579],
15	with	IN	O	with	_	0	SENT_149	[p7l1241t1522r1381b1579],
16	ancestry	NN	O	ancestry	prep_with	5	SENT_149	[p7l1408t1531r1671b1595],
17	from	IN	O	from	_	0	SENT_149	[p7l1697t1522r1852b1579],
18	northern	JJ	O	northern	prep_from	5	SENT_149	[p7l1877t1522r2146b1579],
19	and	CC	O	and	_	0	SENT_149	[p7l10t1611r123b1667],
20	western	JJ	O	western	conj_and	18	SENT_149	[p7l152t1619r399b1667],
21	Europe	NNP	LOCATION	Europe	nn	23	SENT_149	[p7l428t1611r682b1684],
22	)	CD	NUMBER	)	num	23	SENT_149	[p7l428t1611r682b1684],
23	population	NN	O	population	dep	18	SENT_149	[p7l713t1611r1071b1684],
24	.	.	O	.	_	0	SENT_149	[p7l713t1611r1071b1684],

1	A	DT	O	a	det	4	SENT_150	[p7l1104t1611r1160b1666],
2	strong	JJ	O	strong	amod	4	SENT_150	[p7l1192t1619r1386b1684],
3	linkage	NN	O	linkage	nn	4	SENT_150	[p7l1417t1611r1651b1684],
4	disequilibrium	NN	O	disequilibrium	nsubj	5	SENT_150	[p7l1681t1611r2147b1684],
5	tagging	VBG	O	tag	_	0	SENT_150	[p7l8t1698r246b1771],
6	criteria	NNS	O	criterion	nsubj	9	SENT_150	[p7l276t1698r502b1754],
7	of	IN	O	of	_	0	SENT_150	[p7l531t1698r600b1754],
8	r2	NN	O	r2	prep_of	6	SENT_150	[p7l625t1691r848b1755],
9	>	JJR	O	>	xcomp	5	SENT_150	[p7l625t1691r848b1755],
10	O.	NNP	O	O.	nsubjpass	13	SENT_150	[p7l625t1691r848b1755],
11	8	CD	NUMBER	8	num	10	SENT_150	[p7l625t1691r848b1755],
12	was	VBD	O	be	auxpass	13	SENT_150	[p7l880t1716r1000b1754],
13	used	VBN	O	use	dep	5	SENT_150	[p7l1030t1698r1176b1754],
14	and	CC	O	and	_	0	SENT_150	[p7l1206t1698r1319b1754],
15	a	DT	O	a	det	18	SENT_150	[p7l1348t1716r1382b1754],
16	minor	JJ	O	minor	amod	18	SENT_150	[p7l1409t1698r1600b1754],
17	allele	NN	O	allele	nn	18	SENT_150	[p7l1629t1698r1799b1754],
18	frequency	NN	O	frequency	nsubjpass	22	SENT_150	[p7l1828t1698r2146b1771],
19	of	IN	O	of	_	0	SENT_150	[p7l9t1786r79b1843],
20	0.01	CD	NUMBER	0.01	prep_of	18	SENT_150	[p7l103t1787r234b1843],
21	was	VBD	O	be	auxpass	22	SENT_150	[p7l271t1804r392b1843],
22	chosen	VBN	O	choose	conj_and	5	SENT_150	[p7l424t1787r660b1843],
23	.	.	O	.	_	0	SENT_150	[p7l424t1787r660b1843],

1	The	DT	O	the	det	3	SENT_151	[p7l694t1787r816b1843],
2	HapMAP	NNP	O	HapMAP	nn	3	SENT_151	[p7l847t1787r1152b1859],
3	data	NNS	O	datum	nsubjpass	5	SENT_151	[p7l1183t1786r1315b1843],
4	was	VBD	O	be	auxpass	5	SENT_151	[p7l1344t1804r1464b1843],
5	sourced	VBN	O	source	_	0	SENT_151	[p7l1498t1786r1743b1843],
6	from	IN	O	from	_	0	SENT_151	[p7l1773t1786r1928b1843],
7	NCBI	NN	O	ncbus	nn	8	SENT_151	[p7l1956t1787r2146b1843],
8	Build35	NN	O	build35	prep_from	5	SENT_151	[p7l8t1875r281b1931],
9	.	.	O	.	_	0	SENT_151	[p7l8t1875r281b1931],

1	Table	NNP	O	Table	nn	2	SENT_152	[p7l314t1875r494b1931],
2	l	NN	O	l	_	0	SENT_152	[p7l531t1875r554b1930],
3	and	CC	O	and	_	0	SENT_152	[p7l592t1875r705b1931],
4	Figure	NN	O	figure	conj_and	2	SENT_152	[p7l733t1875r940b1947],
5	2	CD	NUMBER	2	number	6	SENT_152	[p7l971t1875r1006b1930],
6	(	CD	NUMBER	(	num	2	SENT_152	[p7l1039t1875r1351b1944],
7	available	JJ	O	available	amod	2	SENT_152	[p7l1039t1875r1351b1944],
8	at	IN	O	at	_	0	SENT_152	[p7l1382t1883r1436b1931],
9	http://aaojournal.org	NN	O	http://aaojournal.org	npadvmod	11	SENT_152	[p7l1464t1875r2144b1947],
10	)	CD	NUMBER	)	num	9	SENT_152	[p7l1464t1875r2144b1947],
11	present	JJ	DATE	present	amod	13	SENT_152	[p7l8t1971r239b2035],
12	the	DT	O	the	det	13	SENT_152	[p7l268t1962r363b2018],
13	details	NNS	O	detail	prep_at	7	SENT_152	[p7l394t1962r599b2018],
14	of	IN	O	of	_	0	SENT_152	[p7l632t1962r701b2018],
15	the	DT	O	the	det	17	SENT_152	[p7l725t1962r821b2018],
16	assessed	VBN	O	assess	amod	17	SENT_152	[p7l853t1962r1121b2018],
17	SNPs	NNS	O	snp	prep_of	13	SENT_152	[p7l1153t1962r1325b2019],
18	and	CC	O	and	_	0	SENT_152	[p7l1358t1962r1471b2018],
19	the	DT	O	the	det	22	SENT_152	[p7l1500t1962r1596b2018],
20	linkage	NN	O	linkage	nn	22	SENT_152	[p7l1626t1962r1860b2035],
21	disequilibrium	NN	O	disequilibrium	nn	22	SENT_152	[p7l1891t1962r2144b2035, p7l9t2050r244b2107],
22	plot	NN	O	plot	prep_of	13	SENT_152	[p7l270t2051r395b2123],
23	for	IN	O	for	_	0	SENT_152	[p7l423t2050r516b2107],
24	our	PRP$	O	we	poss	25	SENT_152	[p7l544t2068r650b2107],
25	cohort	NN	O	cohort	prep_for	22	SENT_152	[p7l678t2051r897b2117],
26	,	,	O	,	_	0	SENT_152	[p7l678t2051r897b2117],
27	respectively	RB	O	respectively	advmod	25	SENT_152	[p7l928t2050r1330b2123],
28	.	.	O	.	_	0	SENT_152	[p7l928t2050r1330b2123],

1	Statistical	JJ	O	statistical	amod	2	SENT_153	[p7l12t2244r409b2319],
2	Analysis	NN	O	analysis	_	0	SENT_153	[p7l444t2244r794b2337],

1	The	DT	O	the	det	3	SENT_154	[p7l8t2400r131b2456],
2	nongenetic	JJ	O	nongenetic	amod	3	SENT_154	[p7l171t2400r520b2473],
3	covariates	NNS	O	covariate	nsubj	12	SENT_154	[p7l562t2400r882b2456],
4	that	WDT	O	that	nsubjpass	6	SENT_154	[p7l924t2400r1043b2456],
5	were	VBD	O	be	auxpass	6	SENT_154	[p7l1083t2418r1235b2456],
6	used	VBN	O	use	rcmod	3	SENT_154	[p7l1275t2400r1421b2456],
7	in	IN	O	in	_	0	SENT_154	[p7l1461t2400r1521b2455],
8	the	DT	O	the	det	9	SENT_154	[p7l1561t2400r1656b2456],
9	analysis	NN	O	analysis	prep_in	6	SENT_154	[p7l1698t2400r1951b2473],
10	were	VBD	O	be	cop	12	SENT_154	[p7l1994t2418r2146b2456],
11	baseline	JJ	O	baseline	amod	12	SENT_154	[p7l7t2487r269b2543],
12	VA	NNP	O	VA	_	0	SENT_154	[p7l294t2488r424b2554],
13	,	,	O	,	_	0	SENT_154	[p7l294t2488r424b2554],
14	age	NN	O	age	conj_and	12	SENT_154	[p7l454t2505r578b2560],
15	,	,	O	,	_	0	SENT_154	[p7l454t2505r578b2560],
16	sex	NN	O	sex	conj_and	12	SENT_154	[p7l608t2505r727b2554],
17	,	,	O	,	_	0	SENT_154	[p7l608t2505r727b2554],
18	smoking	NN	O	smoking	nn	19	SENT_154	[p7l758t2487r1028b2560],
19	status	NN	O	status	conj_and	12	SENT_154	[p7l1056t2495r1251b2554],
20	,	,	O	,	_	0	SENT_154	[p7l1056t2495r1251b2554],
21	lesion	NN	O	lesion	nn	22	SENT_154	[p7l1279t2487r1468b2543],
22	type	NN	O	type	conj_and	12	SENT_154	[p7l1493t2496r1646b2560],
23	,	,	O	,	_	0	SENT_154	[p7l1493t2496r1646b2560],
24	and	CC	O	and	_	0	SENT_154	[p7l1675t2487r1788b2543],
25	CNV	NNP	O	CNV	nn	26	SENT_154	[p7l1813t2488r1978b2544],
26	size	NN	O	size	conj_and	12	SENT_154	[p7l2006t2487r2142b2544],
27	.	.	O	.	_	0	SENT_154	[p7l2006t2487r2142b2544],

1	In	IN	O	in	_	0	SENT_155	[p7l9t2577r73b2631],
2	addition	NN	O	addition	prep_in	13	SENT_155	[p7l96t2576r372b2642],
3	,	,	O	,	_	0	SENT_155	[p7l96t2576r372b2642],
4	the	DT	O	the	det	6	SENT_155	[p7l396t2576r492b2632],
5	7	CD	NUMBER	7	num	6	SENT_155	[p7l514t2577r549b2632],
6	tSNPs	NNS	O	tsnp	nsubjpass	13	SENT_155	[p7l573t2576r770b2632],
7	from	IN	O	from	_	0	SENT_155	[p7l793t2576r948b2632],
8	the	DT	O	the	det	10	SENT_155	[p7l968t2576r1063b2632],
9	VEGFA	NN	O	vegfa	nn	10	SENT_155	[p7l1090t2577r1335b2632],
10	gene	NN	O	gene	prep_from	6	SENT_155	[p7l1359t2593r1507b2649],
11	were	VBD	O	be	auxpass	13	SENT_155	[p7l1529t2593r1682b2632],
12	also	RB	O	also	advmod	13	SENT_155	[p7l1706t2576r1830b2632],
13	included	VBN	O	include	_	0	SENT_155	[p7l1852t2576r2142b2632],
14	.	.	O	.	_	0	SENT_155	[p7l1852t2576r2142b2632],

1	The	DT	O	the	det	2	SENT_156	[p7l8t2664r131b2720],
2	outcomes	NNS	O	outcome	nsubj	6	SENT_156	[p7l155t2673r457b2720],
3	of	IN	O	of	_	0	SENT_156	[p7l483t2664r552b2720],
4	interest	NN	O	interest	prep_of	2	SENT_156	[p7l569t2664r804b2720],
5	were	VBD	O	be	cop	6	SENT_156	[p7l826t2682r980b2720],
6	change	NN	O	change	_	0	SENT_156	[p7l1003t2664r1227b2737],
7	in	IN	O	in	_	0	SENT_156	[p7l1250t2664r1311b2719],
8	VA	NNP	O	VA	prep_in	6	SENT_156	[p7l1333t2664r1447b2720],
9	from	IN	O	from	_	0	SENT_156	[p7l1470t2664r1625b2720],
10	baseline	NN	O	baseline	prep_from	6	SENT_156	[p7l1645t2664r1906b2720],
11	at	IN	O	at	_	0	SENT_156	[p7l1931t2672r1986b2720],
12	3	CD	NUMBER	3	prep_at	10	SENT_156	[p7l2010t2664r2063b2730],
13	,	,	O	,	_	0	SENT_156	[p7l2010t2664r2063b2730],
14	6	CD	NUMBER	6	prep_at	10	SENT_156	[p7l2090t2664r2144b2730],
15	,	,	O	,	_	0	SENT_156	[p7l2090t2664r2144b2730],
16	and	CC	DURATION	and	_	0	SENT_156	[p7l10t2751r123b2807],
17	12	CD	DURATION	12	num	18	SENT_156	[p7l161t2752r231b2807],
18	months	NNS	NUMBER	month	prep_at	10	SENT_156	[p7l262t2751r512b2808],
19	.	.	O	.	_	0	SENT_156	[p7l262t2751r512b2808],

1	We	PRP	O	we	nsubj	2	SENT_157	[p7l546t2753r656b2808],
2	chose	VBD	O	choose	_	0	SENT_157	[p7l688t2751r867b2808],
3	a	DT	O	a	det	7	SENT_157	[p7l901t2769r934b2808],
4	standard	JJ	O	standard	amod	7	SENT_157	[p7l966t2751r1234b2808],
5	dominant	JJ	O	dominant	amod	7	SENT_157	[p7l1265t2751r1566b2808],
6	genetic	JJ	O	genetic	amod	7	SENT_157	[p7l1597t2751r1824b2824],
7	model	NN	O	model	dobj	2	SENT_157	[p7l1857t2751r2055b2807],
8	in	IN	O	in	_	0	SENT_157	[p7l2086t2751r2146b2807],
9	which	WDT	O	which	rel	14	SENT_157	[p7l9t2840r203b2896],
10	the	DT	O	the	det	12	SENT_157	[p7l228t2840r324b2896],
11	SNP	NN	ORGANIZATION	snp	nn	12	SENT_157	[p7l352t2840r495b2896],
12	covariates	NNS	O	covariate	nsubjpass	14	SENT_157	[p7l521t2840r842b2896],
13	were	VBD	O	be	auxpass	14	SENT_157	[p7l870t2857r1023b2896],
14	converted	VBN	O	convert	rcmod	7	SENT_157	[p7l1050t2840r1364b2896],
15	to	TO	O	to	aux	16	SENT_157	[p7l1389t2848r1448b2896],
16	contain	VB	O	contain	xcomp	14	SENT_157	[p7l1476t2840r1709b2896],
17	a	DT	O	a	det	18	SENT_157	[p7l1737t2857r1769b2896],
18	zero	NN	NUMBER	zero	dobj	16	SENT_157	[p7l1795t2857r1929b2896],
19	for	IN	O	for	_	0	SENT_157	[p7l1956t2840r2048b2896],
20	an	DT	O	a	det	21	SENT_157	[p7l2075t2857r2147b2896],
21	individual	JJ	O	individual	prep_for	16	SENT_157	[p7l8t2928r349b2994],
22	,	,	O	,	_	0	SENT_157	[p7l8t2928r349b2994],
23	where	WRB	O	where	advmod	25	SENT_157	[p7l377t2928r570b2984],
24	there	EX	O	there	expl	25	SENT_157	[p7l595t2928r754b2984],
25	was	VBD	O	be	rcmod	21	SENT_157	[p7l779t2946r899b2984],
26	no	DT	O	no	det	28	SENT_157	[p7l926t2946r1003b2984],
27	minor	JJ	O	minor	amod	28	SENT_157	[p7l1029t2928r1220b2984],
28	allele	NN	O	allele	npadvmod	29	SENT_157	[p7l1246t2928r1415b2984],
29	present	JJ	DATE	present	acomp	25	SENT_157	[p7l1439t2936r1687b3001],
30	,	,	O	,	_	0	SENT_157	[p7l1439t2936r1687b3001],
31	and	CC	O	and	_	0	SENT_157	[p7l1717t2928r1829b2984],
32	1	CD	NUMBER	1	dobj	2	SENT_157	[p7l1861t2928r1885b2983],
33	if	IN	O	if	mark	35	SENT_157	[p7l1916t2928r1969b2983],
34	there	EX	O	there	expl	35	SENT_157	[p7l1988t2928r2146b2984],
35	was	VBD	O	be	dep	32	SENT_157	[p7l9t3033r129b3072],
36	21	CD	NUMBER	21	num	38	SENT_157	[p7l175t3016r267b3071],
37	minor	JJ	O	minor	amod	38	SENT_157	[p7l313t3015r504b3071],
38	allele	NN	O	allele	nsubj	39	SENT_157	[p7l543t3015r712b3072],
39	present	JJ	DATE	present	xcomp	35	SENT_157	[p7l750t3023r997b3088],
40	.	.	O	.	_	0	SENT_157	[p7l750t3023r997b3088],

1	There	EX	O	there	expl	2	SENT_158	[p7l1039t3015r1224b3071],
2	was	VBD	O	be	dep	12	SENT_158	[p7l1264t3033r1384b3072],
3	a	DT	O	a	det	5	SENT_158	[p7l1426t3033r1459b3071],
4	small	JJ	O	small	amod	5	SENT_158	[p7l1499t3015r1668b3072],
5	proportion	NN	O	proportion	nsubj	2	SENT_158	[p7l1706t3015r2043b3088],
6	of	IN	O	of	_	0	SENT_158	[p7l2083t3015r2152b3071],
7	missing	VBG	O	miss	amod	8	SENT_158	[p7l8t3103r255b3176],
8	data	NNS	O	datum	prep_of	5	SENT_158	[p7l285t3103r417b3160],
9	for	IN	O	for	_	0	SENT_158	[p7l444t3103r537b3160],
10	the	DT	O	the	det	11	SENT_158	[p7l563t3104r659b3160],
11	SNP	NN	ORGANIZATION	snp	prep_for	8	SENT_158	[p7l689t3104r832b3160],
12	covariates	VBZ	O	covariate	_	0	SENT_158	[p7l861t3103r1182b3160],
13	(	NN	O	(	dobj	12	SENT_158	[p7l1214t3103r1485b3176],
14	missing	VBG	O	miss	amod	15	SENT_158	[p7l1214t3103r1485b3176],
15	data	NNS	O	datum	nsubj	17	SENT_158	[p7l1514t3104r1646b3160],
16	were	VBD	O	be	cop	17	SENT_158	[p7l1674t3121r1827b3160],
17	<	JJR	O	<	rcmod	13	SENT_158	[p7l1861t3104r2024b3160],
18	3	CD	PERCENT	3	num	19	SENT_158	[p7l1861t3104r2024b3160],
19	%	NN	PERCENT	%	dep	17	SENT_158	[p7l1861t3104r2024b3160],
20	for	IN	O	for	_	0	SENT_158	[p7l2055t3103r2148b3160],
21	each	DT	O	each	det	23	SENT_158	[p7l9t3192r154b3248],
22	SNP	NN	O	snp	nn	23	SENT_158	[p7l185t3192r353b3261],
23	)	NN	O	)	prep_for	17	SENT_158	[p7l185t3192r353b3261],
24	and	CC	O	and	_	0	SENT_158	[p7l387t3192r499b3248],
25	this	DT	O	this	nsubj	27	SENT_158	[p7l529t3192r641b3248],
26	was	VBD	O	be	cop	27	SENT_158	[p7l673t3210r793b3248],
27	imputed	JJ	O	imputed	rcmod	13	SENT_158	[p7l825t3192r1086b3265],
28	using	VBG	O	use	xcomp	27	SENT_158	[p7l1115t3192r1287b3265],
29	the	DT	O	the	det	31	SENT_158	[p7l1318t3192r1413b3248],
30	“	NN	O	“	nn	31	SENT_158	[p7l1446t3192r1768b3248],
31	k	NN	O	k	dobj	28	SENT_158	[p7l1446t3192r1768b3248],
32	—	CD	NUMBER	—	dep	36	SENT_158	[p7l1446t3192r1768b3248],
33	nearest	JJS	O	nearest	amod	34	SENT_158	[p7l1446t3192r1768b3248],
34	neighbors	NNS	O	neighbor	dep	32	SENT_158	[p7l1797t3192r2145b3265],
35	”	CD	NUMBER	”	dep	36	SENT_158	[p7l1797t3192r2145b3265],
36	approach	NN	O	approach	dep	28	SENT_158	[p7l10t3279r317b3352],
37	,	,	O	,	_	0	SENT_158	[p7l10t3279r317b3352],
38	with	IN	O	with	_	0	SENT_158	[p7l341t3279r481b3336],
39	k	NN	O	k	prep_with	36	SENT_158	[p7l501t3279r537b3336],
40	=	JJ	O	=	amod	41	SENT_158	[p7l563t3299r611b3318],
41	l	NN	O	l	tmod	27	SENT_158	[p7l647t3280r670b3335],
42	(	CD	NUMBER	(	nsubj	12	SENT_158	[p7l700t3279r837b3349],
43	i.e.	FW	O	i.e.	dep	42	SENT_158	[p7l700t3279r837b3349],
44	,	,	O	,	_	0	SENT_158	[p7l700t3279r837b3349],
45	using	VBG	O	use	dep	43	SENT_158	[p7l859t3279r1031b3352],
46	the	DT	O	the	det	47	SENT_158	[p7l1052t3279r1147b3335],
47	value	NN	O	value	dobj	45	SENT_158	[p7l1168t3279r1339b3336],
48	of	IN	O	of	_	0	SENT_158	[p7l1360t3279r1429b3335],
49	the	DT	O	the	det	53	SENT_158	[p7l1444t3279r1540b3336],
50	genetically	RB	O	genetically	advmod	51	SENT_158	[p7l1561t3279r1909b3352],
51	closest	JJS	O	closest	amod	53	SENT_158	[p7l1931t3279r2147b3336],
52	neighbor	NN	O	neighbor	nn	53	SENT_158	[p7l9t3367r335b3440],
53	)	NN	O	)	prep_of	47	SENT_158	[p7l9t3367r335b3440],
54	,	,	O	,	_	0	SENT_158	[p7l9t3367r335b3440],
55	and	CC	O	and	_	0	SENT_158	[p7l367t3368r480b3424],
56	using	VBG	O	use	dep	43	SENT_158	[p7l506t3367r678b3440],
57	the	DT	O	the	det	59	SENT_158	[p7l706t3368r801b3424],
58	Hamming	VBG	O	ham	amod	59	SENT_158	[p7l829t3367r1147b3440],
59	distance	NN	O	distance	dobj	56	SENT_158	[p7l1176t3367r1453b3434],
60	,	,	O	,	_	0	SENT_158	[p7l1176t3367r1453b3434],
61	which	WDT	O	which	nsubj	63	SENT_158	[p7l1484t3367r1678b3424],
62	is	VBZ	O	be	cop	63	SENT_158	[p7l1705t3367r1754b3424],
63	appropriate	JJ	O	appropriate	rcmod	59	SENT_158	[p7l1785t3367r2147b3440],
64	for	IN	O	for	mark	67	SENT_158	[p7l9t3456r101b3512],
65	genetic	JJ	O	genetic	amod	66	SENT_158	[p7l121t3456r349b3529],
66	data	NNS	O	datum	nsubj	67	SENT_158	[p7l371t3456r503b3512],
67	(	VBP	O	(	advcl	63	SENT_158	[p7l525t3456r853b3529],
68	removing	VBG	O	remove	csubj	76	SENT_158	[p7l525t3456r853b3529],
69	patients	NNS	O	patient	dobj	68	SENT_158	[p7l874t3456r1121b3529],
70	with	IN	O	with	_	0	SENT_158	[p7l1144t3456r1284b3512],
71	missing	VBG	O	miss	amod	72	SENT_158	[p7l1304t3456r1551b3529],
72	data	NNS	O	datum	prep_with	68	SENT_158	[p7l1573t3456r1705b3512],
73	for	IN	O	for	_	0	SENT_158	[p7l1725t3456r1817b3512],
74	each	DT	O	each	det	75	SENT_158	[p7l1837t3456r1982b3512],
75	SNP	NN	ORGANIZATION	snp	prep_for	72	SENT_158	[p7l2004t3456r2147b3512],
76	did	VBD	O	do	ccomp	67	SENT_158	[p7l9t3543r110b3600],
77	not	RB	O	not	neg	79	SENT_158	[p7l138t3552r239b3599],
78	signiﬁcantly	JJ	O	signiﬁcantly	amod	79	SENT_158	[p7l270t3543r661b3616],
79	change	NN	O	change	dobj	76	SENT_158	[p7l691t3543r915b3616],
80	the	DT	O	the	det	81	SENT_158	[p7l944t3543r1040b3599],
81	results	NNS	O	result	nsubj	82	SENT_158	[p7l1068t3543r1319b3613],
82	)	VBP	O	)	dep	76	SENT_158	[p7l1068t3543r1319b3613],
83	.	.	O	.	_	0	SENT_158	[p7l1068t3543r1319b3613],

1	For	IN	O	for	_	0	SENT_159	[p7l115t3633r226b3688],
2	the	DT	O	the	det	4	SENT_159	[p7l270t3632r366b3688],
3	primary	JJ	O	primary	amod	4	SENT_159	[p7l411t3631r664b3704],
4	analysis	NN	O	analysis	prep_for	7	SENT_159	[p7l712t3631r984b3704],
5	,	,	O	,	_	0	SENT_159	[p7l712t3631r984b3704],
6	we	PRP	O	we	nsubj	7	SENT_159	[p7l1033t3649r1124b3688],
7	used	VBD	O	use	_	0	SENT_159	[p7l1169t3632r1315b3688],
8	least-squares	NNS	O	least-square	nsubj	10	SENT_159	[p7l1361t3631r1771b3704],
9	regression	NN	O	regression	nn	10	SENT_159	[p7l1818t3631r2147b3704],
10	modeling	NN	O	modeling	xcomp	7	SENT_159	[p7l8t3720r325b3793],
11	.	.	O	.	_	0	SENT_159	[p7l8t3720r325b3793],

1	The	DT	O	the	det	2	SENT_160	[p7l361t3720r483b3776],
2	analysis	NN	O	analysis	nsubj	3	SENT_160	[p7l516t3720r769b3793],
3	was	VBD	O	be	_	0	SENT_160	[p7l803t3738r923b3776],
4	on	IN	O	on	_	0	SENT_160	[p7l957t3738r1034b3776],
5	a	DT	O	a	det	7	SENT_160	[p7l1067t3738r1100b3776],
6	SNP-by-SNP	NN	O	snp-by-snp	nn	7	SENT_160	[p7l1132t3720r1556b3793],
7	basis	NN	O	basis	prep_on	3	SENT_160	[p7l1586t3720r1762b3787],
8	,	,	O	,	_	0	SENT_160	[p7l1586t3720r1762b3787],
9	in	IN	O	in	_	0	SENT_160	[p7l1797t3720r1857b3775],
10	which	WDT	O	which	rel	15	SENT_160	[p7l1889t3720r2082b3776],
11	a	DT	O	a	det	13	SENT_160	[p7l2115t3738r2148b3776],
12	regression	NN	O	regression	nn	13	SENT_160	[p8l8t14r336b87],
13	model	NN	O	model	nsubjpass	15	SENT_160	[p8l373t14r571b70],
14	was	VBD	O	be	auxpass	15	SENT_160	[p8l609t32r729b70],
15	ﬁtted	VBN	O	ﬁtted	rcmod	7	SENT_160	[p8l769t14r931b70],
16	for	IN	O	for	_	0	SENT_160	[p8l968t14r1061b70],
17	each	DT	O	each	det	18	SENT_160	[p8l1097t14r1241b70],
18	SNP	NN	ORGANIZATION	snp	prep_for	15	SENT_160	[p8l1280t14r1423b71],
19	independently	RB	O	independently	advmod	18	SENT_160	[p8l1460t14r1911b87],
20	of	IN	O	of	_	0	SENT_160	[p8l1950t14r2019b70],
21	the	DT	O	the	det	23	SENT_160	[p8l2050t14r2146b70],
22	other	JJ	O	other	amod	23	SENT_160	[p8l9t103r173b159],
23	SNPS	NN	O	snp	prep_of	18	SENT_160	[p8l206t103r397b169],
24	,	,	O	,	_	0	SENT_160	[p8l206t103r397b169],
25	while	IN	O	while	_	0	SENT_160	[p8l434t102r609b159],
26	adjusting	VBG	O	adjust	prepc_while	3	SENT_160	[p8l644t102r934b175],
27	for	IN	O	for	_	0	SENT_160	[p8l968t102r1060b159],
28	age	NN	O	age	prep_for	26	SENT_160	[p8l1093t120r1218b175],
29	,	,	O	,	_	0	SENT_160	[p8l1093t120r1218b175],
30	sex	NN	O	sex	prep_for	26	SENT_160	[p8l1256t120r1376b169],
31	,	,	O	,	_	0	SENT_160	[p8l1256t120r1376b169],
32	baseline	NN	O	baseline	nn	33	SENT_160	[p8l1410t102r1672b159],
33	VA	NNP	O	VA	conj_and	28	SENT_160	[p8l1705t103r1836b169],
34	,	,	O	,	_	0	SENT_160	[p8l1705t103r1836b169],
35	smoking	NN	O	smoking	nn	36	SENT_160	[p8l1875t102r2145b175],
36	status	NN	O	status	conj_and	28	SENT_160	[p8l11t199r206b257],
37	,	,	O	,	_	0	SENT_160	[p8l11t199r206b257],
38	lesion	NN	O	lesion	nn	39	SENT_160	[p8l253t191r442b247],
39	type	NN	O	type	prep_for	26	SENT_160	[p8l485t199r638b264],
40	,	,	O	,	_	0	SENT_160	[p8l485t199r638b264],
41	and	CC	O	and	_	0	SENT_160	[p8l686t191r799b247],
42	CNV	NNP	O	CNV	nn	43	SENT_160	[p8l842t191r1008b247],
43	size	NN	O	size	prep_for	26	SENT_160	[p8l1055t191r1190b247],
44	.	.	O	.	_	0	SENT_160	[p8l1055t191r1190b247],

1	A	DT	O	a	det	3	SENT_161	[p8l1237t191r1294b246],
2	t	NN	O	t	nn	3	SENT_161	[p8l1339t202r1360b247],
3	test	NN	O	test	nsubjpass	6	SENT_161	[p8l1400t199r1510b247],
4	was	VBD	O	be	auxpass	6	SENT_161	[p8l1553t209r1673b247],
5	then	RB	O	then	advmod	6	SENT_161	[p8l1718t191r1855b247],
6	used	VBN	O	use	_	0	SENT_161	[p8l1897t191r2043b247],
7	to	TO	O	to	aux	8	SENT_161	[p8l2086t199r2145b247],
8	compute	VB	O	compute	xcomp	6	SENT_161	[p8l9t286r282b351],
9	a	DT	O	a	det	11	SENT_161	[p8l309t296r342b334],
10	P	NN	O	p	nn	11	SENT_161	[p8l364t280r414b334],
11	value	NN	O	value	dobj	8	SENT_161	[p8l437t278r608b334],
12	of	IN	O	of	_	0	SENT_161	[p8l635t278r704b334],
13	association	NN	O	association	prep_of	11	SENT_161	[p8l725t278r1078b334],
14	for	IN	O	for	_	0	SENT_161	[p8l1102t278r1195b334],
15	that	DT	O	that	det	17	SENT_161	[p8l1218t278r1338b334],
16	particular	JJ	O	particular	amod	17	SENT_161	[p8l1360t278r1668b351],
17	SNP	NN	O	snp	prep_for	8	SENT_161	[p8l1693t278r1852b335],
18	.	.	O	.	_	0	SENT_161	[p8l1693t278r1852b335],

1	Because	IN	O	because	mark	4	SENT_162	[p8l1881t280r2146b334],
2	we	PRP	O	we	nsubj	4	SENT_162	[p8l9t384r99b423],
3	simultaneously	RB	O	simultaneously	advmod	4	SENT_162	[p8l134t366r614b439],
4	considered	VBD	O	consider	advcl	9	SENT_162	[p8l647t366r992b423],
5	7	CD	NUMBER	7	num	6	SENT_162	[p8l1023t368r1058b423],
6	hypotheses	NNS	O	hypothesis	dobj	4	SENT_162	[p8l1091t367r1463b439],
7	,	,	O	,	_	0	SENT_162	[p8l1091t367r1463b439],
8	there	EX	O	there	expl	9	SENT_162	[p8l1497t367r1656b423],
9	was	VBD	O	be	_	0	SENT_162	[p8l1688t384r1808b423],
10	a	DT	O	a	det	11	SENT_162	[p8l1843t384r1876b423],
11	need	NN	O	need	nsubj	9	SENT_162	[p8l1906t367r2055b423],
12	to	TO	O	to	aux	13	SENT_162	[p8l2086t375r2145b423],
13	account	VB	O	account	infmod	11	SENT_162	[p8l10t463r257b511],
14	for	IN	O	for	_	0	SENT_162	[p8l303t455r396b511],
15	multiple	JJ	O	multiple	amod	16	SENT_162	[p8l441t455r706b528],
16	testing	NN	O	testing	prep_for	13	SENT_162	[p8l753t455r981b528],
17	.	.	O	.	_	0	SENT_162	[p8l753t455r981b528],

1	Using	VBG	O	use	dep	12	SENT_163	[p8l1032t455r1220b528],
2	the	DT	O	the	det	4	SENT_163	[p8l1268t455r1364b511],
3	Bonferroni	NNP	MISC	Bonferroni	nn	4	SENT_163	[p8l1411t455r1760b511],
4	procedure	NN	O	procedure	dobj	1	SENT_163	[p8l1807t455r2144b528],
5	,	,	O	,	_	0	SENT_163	[p8l1807t455r2144b528],
6	when	WRB	O	when	advmod	7	SENT_163	[p8l9t542r180b598],
7	performing	VBG	O	perform	advcl	12	SENT_163	[p8l207t542r566b615],
8	q	NN	O	q	nn	9	SENT_163	[p8l596t561r633b614],
9	tests	NNS	O	test	dobj	7	SENT_163	[p8l662t550r819b609],
10	,	,	O	,	_	0	SENT_163	[p8l662t550r819b609],
11	we	PRP	O	we	nsubj	12	SENT_163	[p8l851t560r942b598],
12	rejected	VBD	O	reject	_	0	SENT_163	[p8l970t542r1223b615],
13	the	DT	O	the	det	15	SENT_163	[p8l1250t542r1346b598],
14	null	JJ	O	null	amod	15	SENT_163	[p8l1375t542r1497b598],
15	hypothesis	NN	O	hypothesis	dobj	12	SENT_163	[p8l1525t542r1865b615],
16	at	IN	O	at	_	0	SENT_163	[p8l1897t550r1952b598],
17	some	DT	O	some	det	18	SENT_163	[p8l1982t560r2146b598],
18	level	NN	O	level	prep_at	12	SENT_163	[p8l9t630r162b687],
19	at	IN	O	at	prep	12	SENT_163	[p8l203t650r263b697],
20	,	,	O	,	_	0	SENT_163	[p8l203t650r263b697],
21	only	RB	O	only	advmod	28	SENT_163	[p8l304t631r443b703],
22	if	IN	O	if	dep	28	SENT_163	[p8l481t631r534b686],
23	the	DT	O	the	det	26	SENT_163	[p8l565t631r661b687],
24	associated	VBN	O	associate	amod	26	SENT_163	[p8l700t631r1027b687],
25	P	NN	O	p	nn	26	SENT_163	[p8l1062t633r1111b686],
26	value	NN	O	value	nsubj	28	SENT_163	[p8l1147t631r1319b687],
27	was	VBD	O	be	cop	28	SENT_163	[p8l1357t648r1477b687],
28	less	JJR	O	less	dep	12	SENT_163	[p8l1516t631r1632b687],
29	than	IN	O	than	_	0	SENT_163	[p8l1671t631r1808b687],
30	oz/q	NN	O	oz/q	prep_than	28	SENT_163	[p8l1848t631r1969b704],
31	.	.	O	.	_	0	SENT_163	[p8l1848t631r1969b704],

1	It	PRP	O	it	nsubj	3	SENT_164	[p8l2011t632r2059b687],
2	is	VBZ	O	be	cop	3	SENT_164	[p8l2095t631r2144b687],
3	conventional	JJ	O	conventional	_	0	SENT_164	[p8l9t719r420b775],
4	to	TO	O	to	aux	5	SENT_164	[p8l445t727r505b775],
5	choose	VB	O	choose	conj_and	5	SENT_164	[p8l530t719r750b775],
6	on	IN	O	on	_	0	SENT_164	[p8l778t739r821b775],
7	=	JJ	O	=	amod	8	SENT_164	[p8l854t738r902b757],
8	0.05	CD	NUMBER	0.05	prep_on	5	SENT_164	[p8l935t719r1090b785],
9	,	,	O	,	_	0	SENT_164	[p8l935t719r1090b785],
10	and	CC	O	and	_	0	SENT_164	[p8l1119t719r1232b775],
11	in	IN	O	in	_	0	SENT_164	[p8l1255t719r1316b774],
12	this	DT	O	this	det	14	SENT_164	[p8l1340t719r1452b775],
13	case	NN	O	case	nn	14	SENT_164	[p8l1479t737r1614b775],
14	q	NN	O	q	prep_in	5	SENT_164	[p8l1639t738r1676b791],
15	=	JJ	O	=	amod	14	SENT_164	[p8l1709t738r1757b757],
16	7	CD	NUMBER	7	tmod	15	SENT_164	[p8l1790t720r1845b785],
17	,	,	O	,	_	0	SENT_164	[p8l1790t720r1845b785],
18	meaning	VBG	O	mean	xcomp	5	SENT_164	[p8l1872t719r2145b792],
19	that	IN	O	that	complm	30	SENT_164	[p8l8t806r128b863],
20	P	NN	O	p	nn	21	SENT_164	[p8l154t808r203b862],
21	values	NNS	O	value	nsubjpass	30	SENT_164	[p8l231t806r432b863],
22	needed	VBN	O	need	partmod	21	SENT_164	[p8l463t806r689b863],
23	to	TO	O	to	aux	25	SENT_164	[p8l717t814r776b862],
24	be	VB	O	be	cop	25	SENT_164	[p8l805t806r879b862],
25	<	JJR	O	<	xcomp	22	SENT_164	[p8l914t807r1186b863],
26	0.007	CD	NUMBER	0.007	num	27	SENT_164	[p8l914t807r1186b863],
27	l	NN	O	l	tmod	25	SENT_164	[p8l914t807r1186b863],
28	to	TO	O	to	aux	30	SENT_164	[p8l1223t814r1282b863],
29	be	VB	O	be	auxpass	30	SENT_164	[p8l1311t806r1385b862],
30	considered	VBN	O	consider	ccomp	18	SENT_164	[p8l1415t806r1760b863],
31	signiﬁcant	NN	O	signiﬁcant	dobj	30	SENT_164	[p8l1791t806r2136b879],
32	.	.	O	.	_	0	SENT_164	[p8l1791t806r2136b879],

1	For	IN	O	for	_	0	SENT_165	[p8l115t896r226b951],
2	the	DT	O	the	det	4	SENT_165	[p8l257t895r352b951],
3	secondary	JJ	O	secondary	amod	4	SENT_165	[p8l387t895r707b967],
4	analysis	NN	O	analysis	prep_for	7	SENT_165	[p8l741t895r1013b968],
5	,	,	O	,	_	0	SENT_165	[p8l741t895r1013b968],
6	we	PRP	O	we	nsubj	7	SENT_165	[p8l1048t912r1139b951],
7	deﬁned	VBD	O	deﬁned	_	0	SENT_165	[p8l1172t895r1406b951],
8	the	DT	O	the	det	9	SENT_165	[p8l1437t895r1533b951],
9	level	NN	O	level	dobj	7	SENT_165	[p8l1565t895r1719b951],
10	of	IN	O	of	_	0	SENT_165	[p8l1752t895r1821b951],
11	response	NN	O	response	prep_of	9	SENT_165	[p8l1846t912r2142b968],
12	.	.	O	.	_	0	SENT_165	[p8l1846t912r2142b968],

1	We	PRP	O	we	nsubj	2	SENT_166	[p8l8t984r117b1039],
2	used	VBD	O	use	_	0	SENT_166	[p8l146t983r292b1039],
3	a	DT	O	a	det	4	SENT_166	[p8l321t1001r354b1039],
4	margin	NN	O	margin	dobj	2	SENT_166	[p8l381t983r606b1056],
5	of	IN	O	of	_	0	SENT_166	[p8l636t983r705b1039],
6	5	CD	NUMBER	5	num	7	SENT_166	[p8l729t983r762b1039],
7	letters	NNS	O	letter	prep_of	4	SENT_166	[p8l795t983r986b1039],
8	for	IN	O	for	_	0	SENT_166	[p8l1017t983r1109b1039],
9	our	PRP$	O	we	poss	11	SENT_166	[p8l1138t1001r1243b1039],
10	secondary	JJ	O	secondary	amod	11	SENT_166	[p8l1272t983r1592b1056],
11	analysis	NN	O	analysis	prep_for	7	SENT_166	[p8l1623t983r1894b1056],
12	,	,	O	,	_	0	SENT_166	[p8l1623t983r1894b1056],
13	similar	JJ	O	similar	amod	7	SENT_166	[p8l1929t983r2148b1039],
14	to	TO	O	to	_	0	SENT_166	[p8l8t1078r68b1127],
15	the	DT	O	the	det	18	SENT_166	[p8l99t1070r195b1127],
16	EXCITE	NNP	MISC	EXCITE	nn	18	SENT_166	[p8l225t1071r509b1127],
17	study	NN	O	study	nn	18	SENT_166	[p8l543t1070r711b1143],
18	group	NN	O	group	prep_to	13	SENT_166	[p8l743t1088r944b1143],
19	,	,	O	,	_	0	SENT_166	[p8l743t1088r944b1143],
20	which	WDT	O	which	nsubj	21	SENT_166	[p8l978t1070r1172b1127],
21	used	VBD	O	use	rcmod	7	SENT_166	[p8l1202t1070r1348b1127],
22	a	DT	O	a	det	23	SENT_166	[p8l1379t1088r1413b1126],
23	margin	NN	O	margin	dobj	21	SENT_166	[p8l1442t1070r1667b1143],
24	of	IN	O	of	_	0	SENT_166	[p8l1699t1070r1768b1126],
25	5	CD	NUMBER	5	num	26	SENT_166	[p8l1794t1070r1827b1127],
26	letters	NNS	O	letter	prep_of	23	SENT_166	[p8l1862t1070r2054b1127],
27	to	TO	O	to	aux	28	SENT_166	[p8l2086t1079r2146b1126],
28	compare	VB	O	compare	xcomp	21	SENT_166	[p8l9t1176r282b1231],
29	different	JJ	O	different	amod	31	SENT_166	[p8l325t1158r600b1214],
30	treatment	NN	O	treatment	nn	31	SENT_166	[p8l640t1167r942b1214],
31	protocols	NNS	O	protocol	dobj	28	SENT_166	[p8l981t1150r1330b1231],
32	.6	CD	NUMBER	.6	tmod	28	SENT_166	[p8l981t1150r1330b1231],
33	Therefore	RB	O	therefore	advmod	32	SENT_166	[p8l1372t1158r1704b1224],
34	,	,	O	,	_	0	SENT_166	[p8l1372t1158r1704b1224],
35	a	DT	O	a	det	36	SENT_166	[p8l1750t1176r1783b1214],
36	responder	NN	O	responder	nsubjpass	38	SENT_166	[p8l1826t1158r2150b1230],
37	was	VBD	O	be	auxpass	38	SENT_166	[p8l9t1263r129b1301],
38	deﬁned	VBN	O	deﬁned	ccomp	2	SENT_166	[p8l164t1245r398b1301],
39	as	IN	O	as	_	0	SENT_166	[p8l431t1263r493b1301],
40	a	DT	O	a	det	41	SENT_166	[p8l529t1263r561b1301],
41	patient	NN	O	patient	prep_as	38	SENT_166	[p8l592t1245r810b1318],
42	with	IN	O	with	_	0	SENT_166	[p8l841t1245r982b1302],
43	a	DT	O	a	det	44	SENT_166	[p8l1016t1263r1049b1301],
44	gain	NN	O	gain	prep_with	41	SENT_166	[p8l1081t1245r1216b1318],
45	of	IN	O	of	_	0	SENT_166	[p8l1249t1245r1318b1301],
46	25	CD	NUMBER	25	num	48	SENT_166	[p8l1350t1245r1446b1302],
47	ETDRS	NN	O	etdr	nn	48	SENT_166	[p8l1482t1245r1730b1302],
48	letters	NNS	O	letter	prep_of	44	SENT_166	[p8l1767t1245r1958b1301],
49	from	IN	O	from	_	0	SENT_166	[p8l1993t1245r2148b1301],
50	baseline	NN	O	baseline	prep_from	38	SENT_166	[p8l7t1333r286b1400],
51	,	,	O	,	_	0	SENT_166	[p8l7t1333r286b1400],
52	stable	NN	O	stable	nsubjpass	54	SENT_166	[p8l322t1333r510b1390],
53	was	VBD	O	be	auxpass	54	SENT_166	[p8l545t1351r665b1390],
54	deﬁned	VBN	O	deﬁned	ccomp	2	SENT_166	[p8l700t1333r934b1390],
55	as	IN	O	as	_	0	SENT_166	[p8l968t1351r1029b1389],
56	a	DT	O	a	det	57	SENT_166	[p8l1065t1351r1098b1389],
57	gain	NN	O	gain	prep_as	54	SENT_166	[p8l1130t1333r1266b1406],
58	or	CC	O	or	_	0	SENT_166	[p8l1299t1351r1364b1389],
59	loss	NN	O	loss	conj_or	57	SENT_166	[p8l1396t1333r1516b1389],
60	of	IN	O	of	_	0	SENT_166	[p8l1552t1333r1621b1389],
61	<	JJR	O	<	amod	63	SENT_166	[p8l1653t1333r1750b1390],
62	5	CD	NUMBER	5	amod	63	SENT_166	[p8l1653t1333r1750b1390],
63	letters	NNS	O	letter	prep_of	57	SENT_166	[p8l1786t1333r1997b1400],
64	,	,	O	,	_	0	SENT_166	[p8l1786t1333r1997b1400],
65	and	CC	O	and	_	0	SENT_166	[p8l2034t1333r2147b1390],
66	nonresponder	NN	O	nonresponder	nsubjpass	68	SENT_166	[p8l8t1422r455b1494],
67	was	VBD	O	be	auxpass	68	SENT_166	[p8l483t1439r604b1478],
68	deﬁned	VBN	O	deﬁned	conj_and	2	SENT_166	[p8l638t1422r872b1478],
69	as	IN	O	as	_	0	SENT_166	[p8l904t1439r965b1478],
70	a	DT	O	a	det	71	SENT_166	[p8l1000t1439r1033b1478],
71	patient	NN	O	patient	prep_as	68	SENT_166	[p8l1062t1422r1280b1495],
72	with	IN	O	with	_	0	SENT_166	[p8l1311t1422r1451b1478],
73	a	DT	O	a	det	74	SENT_166	[p8l1483t1439r1517b1478],
74	loss	NN	O	loss	prep_with	71	SENT_166	[p8l1547t1422r1667b1478],
75	of	IN	O	of	_	0	SENT_166	[p8l1701t1422r1770b1478],
76	>	JJR	O	>	amod	78	SENT_166	[p8l1802t1422r1897b1478],
77	5	CD	NUMBER	5	amod	78	SENT_166	[p8l1802t1422r1897b1478],
78	letters	NNS	O	letter	prep_of	74	SENT_166	[p8l1932t1422r2142b1478],
79	.	.	O	.	_	0	SENT_166	[p8l1932t1422r2142b1478],

1	We	PRP	O	we	nsubj	2	SENT_167	[p8l7t1511r117b1566],
2	used	VBD	O	use	_	0	SENT_167	[p8l141t1510r286b1566],
3	ordinary	JJ	O	ordinary	amod	6	SENT_167	[p8l310t1510r578b1583],
4	logistic	JJ	O	logistic	amod	6	SENT_167	[p8l603t1510r835b1583],
5	regression	NN	O	regression	nn	6	SENT_167	[p8l859t1510r1188b1583],
6	modeling	NN	O	modeling	dobj	2	SENT_167	[p8l1211t1510r1511b1583],
7	where	WRB	O	where	advmod	10	SENT_167	[p8l1536t1510r1729b1566],
8	the	DT	O	the	det	9	SENT_167	[p8l1753t1510r1848b1566],
9	outcome	NN	O	outcome	nsubj	10	SENT_167	[p8l1873t1518r2146b1566],
10	was	VBD	O	be	rcmod	6	SENT_167	[p8l9t1615r129b1654],
11	either	CC	O	either	prep	10	SENT_167	[p8l152t1597r333b1653],
12	zero	CD	NUMBER	zero	dep	11	SENT_167	[p8l353t1615r487b1653],
13	if	IN	O	if	mark	18	SENT_167	[p8l509t1597r560b1653],
14	the	DT	O	the	det	15	SENT_167	[p8l576t1597r671b1653],
15	patient	NN	O	patient	nsubj	18	SENT_167	[p8l691t1597r909b1670],
16	was	VBD	O	be	cop	18	SENT_167	[p8l929t1615r1049b1654],
17	a	DT	O	a	det	18	SENT_167	[p8l1073t1615r1106b1653],
18	responder	NN	O	responder	advcl	10	SENT_167	[p8l1125t1597r1441b1670],
19	or	CC	O	or	_	0	SENT_167	[p8l1461t1615r1526b1654],
20	1	CD	NUMBER	1	advcl	10	SENT_167	[p8l1553t1598r1576b1653],
21	if	IN	O	if	mark	24	SENT_167	[p8l1603t1597r1656b1653],
22	the	DT	O	the	det	23	SENT_167	[p8l1671t1597r1766b1653],
23	patient	NN	O	patient	nsubj	24	SENT_167	[p8l1786t1597r2004b1670],
24	was	VBD	O	be	advcl	18	SENT_167	[p8l2024t1615r2144b1654],
25	in	IN	O	in	_	0	SENT_167	[p8l8t1686r69b1741],
26	the	DT	O	the	det	28	SENT_167	[p8l107t1686r203b1742],
27	stable/nonresponder	JJ	O	stable/nonresponder	amod	28	SENT_167	[p8l245t1686r888b1759],
28	(	NN	O	(	nn	33	SENT_167	[p8l928t1686r1137b1755],
29	stable	JJ	O	stable	amod	33	SENT_167	[p8l928t1686r1137b1755],
30	or	CC	O	or	_	0	SENT_167	[p8l1177t1703r1242b1742],
31	nonresponder	JJ	O	nonresponder	amod	33	SENT_167	[p8l1280t1686r1738b1759],
32	)	NN	O	)	nn	33	SENT_167	[p8l1280t1686r1738b1759],
33	group	NN	O	group	prep_in	24	SENT_167	[p8l1781t1703r1981b1759],
34	.	.	O	.	_	0	SENT_167	[p8l1781t1703r1981b1759],

1	The	DT	O	the	det	2	SENT_168	[p8l2024t1686r2146b1742],
2	analysis	NN	O	analysis	nsubjpass	5	SENT_168	[p8l10t1774r263b1847],
3	was	VBD	O	be	auxpass	5	SENT_168	[p8l294t1792r415b1830],
4	also	RB	O	also	advmod	5	SENT_168	[p8l448t1774r572b1830],
5	performed	VBN	O	perform	_	0	SENT_168	[p8l601t1774r935b1847],
6	in	IN	O	in	_	0	SENT_168	[p8l963t1774r1024b1829],
7	a	DT	O	a	det	9	SENT_168	[p8l1055t1792r1088b1830],
8	SNP-by-SNP	JJ	O	snp-by-snp	amod	9	SENT_168	[p8l1118t1774r1542b1847],
9	fashion	NN	O	fashion	prep_in	5	SENT_168	[p8l1571t1774r1822b1841],
10	,	,	O	,	_	0	SENT_168	[p8l1571t1774r1822b1841],
11	adjusting	VBG	O	adjust	xcomp	5	SENT_168	[p8l1856t1774r2146b1847],
12	for	IN	O	for	_	0	SENT_168	[p8l9t1861r101b1917],
13	age	NN	O	age	prep_for	11	SENT_168	[p8l131t1879r255b1934],
14	,	,	O	,	_	0	SENT_168	[p8l131t1879r255b1934],
15	sex	NN	O	sex	conj_and	13	SENT_168	[p8l291t1879r410b1928],
16	,	,	O	,	_	0	SENT_168	[p8l291t1879r410b1928],
17	baseline	NN	O	baseline	nn	18	SENT_168	[p8l441t1861r703b1918],
18	VA	NNP	O	VA	prep_for	11	SENT_168	[p8l733t1862r864b1928],
19	,	,	O	,	_	0	SENT_168	[p8l733t1862r864b1928],
20	smoking	NN	O	smoking	nn	21	SENT_168	[p8l899t1861r1170b1934],
21	status	NN	O	status	prep_for	11	SENT_168	[p8l1203t1870r1398b1928],
22	,	,	O	,	_	0	SENT_168	[p8l1203t1870r1398b1928],
23	lesion	NN	O	lesion	nn	24	SENT_168	[p8l1431t1861r1620b1917],
24	type	NN	O	type	conj_and	13	SENT_168	[p8l1649t1869r1803b1934],
25	,	,	O	,	_	0	SENT_168	[p8l1649t1869r1803b1934],
26	and	CC	O	and	_	0	SENT_168	[p8l1837t1861r1950b1918],
27	CNV	NNP	O	CNV	nn	28	SENT_168	[p8l1980t1862r2146b1918],
28	size	NN	O	size	prep_for	11	SENT_168	[p8l11t1950r147b2006],
29	.	.	O	.	_	0	SENT_168	[p8l11t1950r147b2006],

1	Because	IN	O	because	mark	9	SENT_169	[p8l179t1951r444b2006],
2	the	DT	O	the	det	3	SENT_169	[p8l471t1950r567b2006],
3	patients	NNS	O	patient	nsubj	9	SENT_169	[p8l594t1950r840b2023],
4	in	IN	O	in	_	0	SENT_169	[p8l870t1950r930b2005],
5	the	DT	O	the	det	6	SENT_169	[p8l958t1950r1053b2006],
6	study	NN	O	study	prep_in	3	SENT_169	[p8l1084t1950r1252b2022],
7	did	VBD	O	do	aux	9	SENT_169	[p8l1281t1950r1382b2006],
8	not	RB	O	not	neg	9	SENT_169	[p8l1409t1958r1510b2006],
9	receive	VB	O	receive	advcl	27	SENT_169	[p8l1536t1950r1766b2006],
10	exactly	RB	O	exactly	advmod	13	SENT_169	[p8l1794t1950r2023b2022],
11	the	DT	O	the	det	13	SENT_169	[p8l2051t1950r2147b2006],
12	same	JJ	O	same	amod	13	SENT_169	[p8l11t2056r171b2094],
13	number	NN	O	number	nsubj	16	SENT_169	[p8l202t2038r447b2094],
14	of	IN	O	of	_	0	SENT_169	[p8l477t2038r546b2094],
15	injections	NNS	O	injection	prep_of	13	SENT_169	[p8l572t2038r879b2111],
16	(	VBP	O	(	ccomp	9	SENT_169	[p8l915t2038r1035b2107],
17	the	DT	O	the	det	18	SENT_169	[p8l915t2038r1035b2107],
18	result	NN	O	result	dobj	16	SENT_169	[p8l1065t2038r1243b2094],
19	of	IN	O	of	_	0	SENT_169	[p8l1274t2038r1343b2094],
20	the	DT	O	the	det	23	SENT_169	[p8l1369t2038r1464b2094],
21	as-needed	JJ	O	as-needed	amod	23	SENT_169	[p8l1497t2038r1815b2094],
22	treatment	NN	O	treatment	nn	23	SENT_169	[p8l1845t2046r2147b2094],
23	regimen	NN	O	regimen	prep_of	18	SENT_169	[p8l7t2125r313b2198],
24	)	CD	NUMBER	)	dep	23	SENT_169	[p8l7t2125r313b2198],
25	,	,	O	,	_	0	SENT_169	[p8l7t2125r313b2198],
26	we	PRP	O	we	nsubj	27	SENT_169	[p8l339t2143r429b2182],
27	repeated	VBD	O	repeat	_	0	SENT_169	[p8l451t2125r722b2198],
28	all	PDT	O	all	predet	30	SENT_169	[p8l745t2125r821b2182],
29	the	DT	O	the	det	30	SENT_169	[p8l844t2125r940b2181],
30	analyses	NNS	O	analysis	dobj	27	SENT_169	[p8l964t2125r1249b2198],
31	,	,	O	,	_	0	SENT_169	[p8l964t2125r1249b2198],
32	adjusting	VBG	O	adjust	partmod	27	SENT_169	[p8l1276t2125r1566b2198],
33	the	DT	O	the	det	34	SENT_169	[p8l1589t2125r1684b2182],
34	results	NNS	O	result	dobj	32	SENT_169	[p8l1706t2125r1912b2182],
35	for	IN	O	for	_	0	SENT_169	[p8l1937t2125r2029b2182],
36	the	DT	O	the	det	37	SENT_169	[p8l2050t2125r2146b2181],
37	number	NN	O	number	prep_for	32	SENT_169	[p8l8t2213r253b2270],
38	of	IN	O	of	_	0	SENT_169	[p8l281t2213r350b2270],
39	injections	NNS	O	injection	prep_of	37	SENT_169	[p8l374t2213r682b2286],
40	at	IN	O	at	_	0	SENT_169	[p8l714t2222r769b2270],
41	each	DT	O	each	det	43	SENT_169	[p8l798t2214r942b2270],
42	time	NN	O	time	nn	43	SENT_169	[p8l971t2213r1111b2270],
43	point	NN	O	point	prep_at	39	SENT_169	[p8l1139t2213r1304b2286],
44	in	IN	O	in	_	0	SENT_169	[p8l1332t2213r1392b2269],
45	the	DT	O	the	det	47	SENT_169	[p8l1421t2214r1517b2270],
46	statistical	JJ	O	statistical	amod	47	SENT_169	[p8l1548t2213r1846b2270],
47	model	NN	O	model	prep_in	43	SENT_169	[p8l1876t2214r2090b2270],
48	.	.	O	.	_	0	SENT_169	[p8l1876t2214r2090b2270],

1	Results	NNS	O	result	_	0	SENT_170	[p8l9t2447r349b2528],

1	The	DT	O	the	det	3	SENT_171	[p8l8t2639r131b2695],
2	study	NN	O	study	nn	3	SENT_171	[p8l166t2639r334b2712],
3	population	NN	O	population	nsubj	4	SENT_171	[p8l366t2639r708b2712],
4	comprised	VBD	O	comprise	_	0	SENT_171	[p8l740t2639r1072b2712],
5	201	CD	NUMBER	201	num	6	SENT_171	[p8l1105t2640r1215b2696],
6	patients	NNS	O	patient	dobj	4	SENT_171	[p8l1253t2639r1500b2712],
7	who	WP	O	who	nsubj	8	SENT_171	[p8l1534t2639r1668b2695],
8	met	VBD	O	meet	rcmod	6	SENT_171	[p8l1701t2648r1820b2695],
9	the	DT	O	the	det	11	SENT_171	[p8l1851t2639r1947b2695],
10	eligibility	NN	O	eligibility	nn	11	SENT_171	[p8l1980t2639r2144b2712, p8l7t2727r175b2800],
11	criteria	NNS	O	criterion	dobj	8	SENT_171	[p8l214t2727r454b2784],
12	.	.	O	.	_	0	SENT_171	[p8l214t2727r454b2784],

1	Patient	NN	O	patient	nn	2	SENT_172	[p8l496t2727r718b2784],
2	demographics	NNS	O	demographic	_	0	SENT_172	[p8l756t2727r1201b2800],
3	and	CC	O	and	_	0	SENT_172	[p8l1242t2728r1354b2784],
4	baseline	NN	O	baseline	nn	5	SENT_172	[p8l1390t2727r1652b2784],
5	characteristics	NNS	O	characteristic	conj_and	2	SENT_172	[p8l1691t2727r2145b2784],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_173	[p8l559t3103r851b3147],
2	Volume	NN	O	volume	dep	1	SENT_173	[p8l897t3103r1030b3138],
3	120	CD	NUMBER	120	num	2	SENT_173	[p8l1052t3105r1126b3144],
4	,	,	O	,	_	0	SENT_173	[p8l1052t3105r1126b3144],
5	Number	NNP	O	Number	appos	2	SENT_173	[p8l1146t3103r1291b3138],
6	1	CD	NUMBER	1	num	5	SENT_173	[p8l1311t3105r1340b3144],
7	,	,	O	,	_	0	SENT_173	[p8l1311t3105r1340b3144],
8	January	NNP	DATE	January	tmod	2	SENT_173	[p8l1357t3105r1495b3147],
9	2013	CD	DATE	2013	num	8	SENT_173	[p8l1514t3105r1601b3138],

1	are	VBP	O	be	auxpass	2	SENT_174	[p9l8t88r102b127],
2	presented	VBN	O	present	_	0	SENT_174	[p9l127t71r435b143],
3	in	IN	O	in	_	0	SENT_174	[p9l460t71r521b126],
4	Table	NNP	O	Table	prep_in	2	SENT_174	[p9l546t71r726b127],
5	2	CD	NUMBER	2	number	6	SENT_174	[p9l754t71r790b126],
6	(	CD	NUMBER	(	dep	7	SENT_174	[p9l818t71r1131b140],
7	available	JJ	O	available	dep	4	SENT_174	[p9l818t71r1131b140],
8	at	IN	O	at	_	0	SENT_174	[p9l1158t79r1214b127],
9	http://aaojournal.org	NN	O	http://aaojournal.org	nn	10	SENT_174	[p9l1238t71r1938b143],
10	)	NN	O	)	prep_at	2	SENT_174	[p9l1238t71r1938b143],
11	.	.	O	.	_	0	SENT_174	[p9l1238t71r1938b143],

1	Mean	NN	O	mean	nn	3	SENT_175	[p9l1967t72r2149b127],
2	patient	NN	O	patient	nn	3	SENT_175	[p9l6t158r224b231],
3	age	NN	O	age	nsubj	6	SENT_175	[p9l254t176r362b231],
4	was	VBD	O	be	cop	6	SENT_175	[p9l393t176r513b215],
5	78:7	CD	NUMBER	78:7	num	6	SENT_175	[p9l545t158r727b215],
6	years	NNS	NUMBER	year	_	0	SENT_175	[p9l760t176r926b231],
7	with	IN	O	with	_	0	SENT_175	[p9l958t158r1098b214],
8	a	DT	O	a	det	11	SENT_175	[p9l1129t176r1163b214],
9	mean	JJ	O	mean	amod	11	SENT_175	[p9l1191t176r1363b214],
10	baseline	NN	O	baseline	nn	11	SENT_175	[p9l1392t158r1654b214],
11	VA	NN	O	va	prep_with	6	SENT_175	[p9l1684t159r1798b214],
12	of	IN	O	of	_	0	SENT_175	[p9l1829t158r1898b214],
13	51	CD	NUMBER	51	prep_of	11	SENT_175	[p9l1923t158r2059b215],
14	:	:	O	:	_	0	SENT_175	[p9l1923t158r2059b215],
15	17	CD	NUMBER	17	num	16	SENT_175	[p9l2078t159r2146b214],
16	ETDRS	NNS	O	etdr	dep	6	SENT_175	[p9l6t247r255b303],
17	letter	NN	O	letter	nn	18	SENT_175	[p9l298t247r463b303],
18	scores	NNS	O	score	nsubj	19	SENT_175	[p9l504t264r698b303],
19	(	VBP	O	(	rcmod	16	SENT_175	[p9l742t246r1166b319],
20	approximate	JJ	O	approximate	amod	22	SENT_175	[p9l742t246r1166b319],
21	Snellen	NNP	MISC	Snellen	nn	22	SENT_175	[p9l1207t246r1445b303],
22	equivalent	NN	O	equivalent	dobj	19	SENT_175	[p9l1485t246r1818b319],
23	of	IN	O	of	_	0	SENT_175	[p9l1857t246r1927b303],
24	6/30	CD	NUMBER	6/30	num	25	SENT_175	[p9l1962t246r2144b316],
25	)	CD	NUMBER	)	prep_of	22	SENT_175	[p9l1962t246r2144b316],
26	.	.	O	.	_	0	SENT_175	[p9l1962t246r2144b316],

1	Overall	RB	O	overall	advmod	9	SENT_176	[p9l8t335r262b401],
2	,	,	O	,	_	0	SENT_176	[p9l8t335r262b401],
3	mean	VB	O	mean	csubj	9	SENT_176	[p9l301t352r474b391],
4	change	NN	O	change	dobj	3	SENT_176	[p9l510t335r734b408],
5	in	IN	O	in	_	0	SENT_176	[p9l771t335r831b390],
6	VA	NNP	O	VA	prep_in	3	SENT_176	[p9l867t335r981b391],
7	was	VBD	O	be	cop	9	SENT_176	[p9l1018t352r1138b391],
8	+6.5	CD	NUMBER	+6.5	num	9	SENT_176	[p9l1185t334r1338b391],
9	:12.0	CD	NUMBER	:12.0	_	0	SENT_176	[p9l1352t335r1566b401],
10	,	,	O	,	_	0	SENT_176	[p9l1352t335r1566b401],
11	+4.4:13.4	CD	TIME	+4.4:13.4	conj_and	9	SENT_176	[p9l1614t335r1995b401],
12	,	,	O	,	_	0	SENT_176	[p9l1614t335r1995b401],
13	and	CC	O	and	_	0	SENT_176	[p9l2036t335r2149b391],
14	+2.3:14.6	CD	TIME	+2.3:14.6	num	15	SENT_176	[p9l15t422r378b479],
15	letters	NNS	O	letter	conj_and	9	SENT_176	[p9l409t422r601b478],
16	at	IN	O	at	_	0	SENT_176	[p9l633t431r689b478],
17	3	CD	NUMBER	3	prep_at	15	SENT_176	[p9l719t423r772b489],
18	,	,	O	,	_	0	SENT_176	[p9l719t423r772b489],
19	6	CD	NUMBER	6	conj_and	17	SENT_176	[p9l805t422r858b489],
20	,	,	O	,	_	0	SENT_176	[p9l805t422r858b489],
21	and	CC	DURATION	and	_	0	SENT_176	[p9l892t422r1005b478],
22	12	CD	DURATION	12	num	23	SENT_176	[p9l1041t423r1111b478],
23	months	NNS	NUMBER	month	prep_at	15	SENT_176	[p9l1141t422r1393b489],
24	,	,	O	,	_	0	SENT_176	[p9l1141t422r1393b489],
25	respectively	RB	O	respectively	advmod	9	SENT_176	[p9l1424t422r1827b495],
26	.	.	O	.	_	0	SENT_176	[p9l1424t422r1827b495],

1	On	IN	O	on	_	0	SENT_177	[p9l1861t423r1956b479],
2	average	NN	O	average	prep_on	5	SENT_177	[p9l1987t440r2146b478, p9l8t528r133b583],
3	,	,	O	,	_	0	SENT_177	[p9l1987t440r2146b478, p9l8t528r133b583],
4	patients	NNS	O	patient	nsubj	5	SENT_177	[p9l160t510r407b583],
5	received	VBD	O	receive	_	0	SENT_177	[p9l434t510r705b567],
6	4.3	CD	NUMBER	4.3	iobj	5	SENT_177	[p9l729t511r886b567],
7	i	FW	O	i	dobj	5	SENT_177	[p9l729t511r886b567],
8	1.0	CD	NUMBER	1.0	num	9	SENT_177	[p9l905t511r995b567],
9	injections	NNS	O	injection	dep	7	SENT_177	[p9l1021t510r1329b583],
10	in	IN	O	in	_	0	SENT_177	[p9l1356t510r1417b566],
11	the	DT	O	the	det	12	SENT_177	[p9l1442t510r1538b567],
12	ﬁrst	NN	O	ﬁrst	prep_in	9	SENT_177	[p9l1564t510r1687b567],
13	6	CD	DURATION	6	num	14	SENT_177	[p9l1713t510r1748b567],
14	months	NNS	NUMBER	month	tmod	12	SENT_177	[p9l1775t510r2007b567],
15	and	CC	O	and	_	0	SENT_177	[p9l2036t510r2149b567],
16	2.4	CD	NUMBER	2.4	conj_and	7	SENT_177	[p9l7t599r163b655],
17	:	:	O	:	_	0	SENT_177	[p9l7t599r163b655],
18	1.4	CD	NUMBER	1.4	num	19	SENT_177	[p9l182t599r271b655],
19	injections	NNS	O	injection	dep	16	SENT_177	[p9l294t599r603b671],
20	in	IN	O	in	_	0	SENT_177	[p9l628t599r688b654],
21	the	DT	O	the	det	24	SENT_177	[p9l710t599r806b655],
22	second	JJ	ORDINAL	second	amod	24	SENT_177	[p9l832t599r1051b655],
23	6	CD	DURATION	6	num	24	SENT_177	[p9l1074t599r1109b655],
24	months	NNS	NUMBER	month	prep_in	19	SENT_177	[p9l1133t599r1366b655],
25	of	IN	O	of	_	0	SENT_177	[p9l1391t599r1461b655],
26	the	DT	O	the	det	28	SENT_177	[p9l1477t599r1573b655],
27	treatment	NN	O	treatment	nn	28	SENT_177	[p9l1596t607r1899b655],
28	course	NN	O	course	prep_of	19	SENT_177	[p9l1921t616r2144b655],
29	.	.	O	.	_	0	SENT_177	[p9l1921t616r2144b655],

1	Univariate	JJ	O	univariate	amod	3	SENT_178	[p9l6t686r343b743],
2	regression	NN	O	regression	nn	3	SENT_178	[p9l370t686r699b759],
3	analysis	NN	O	analysis	nsubj	21	SENT_178	[p9l727t686r981b759],
4	of	IN	O	of	_	0	SENT_178	[p9l1011t686r1080b742],
5	age	NN	O	age	prep_of	3	SENT_178	[p9l1103t704r1228b759],
6	,	,	O	,	_	0	SENT_178	[p9l1103t704r1228b759],
7	sex	NN	O	sex	prep_of	3	SENT_178	[p9l1261t704r1380b753],
8	,	,	O	,	_	0	SENT_178	[p9l1261t704r1380b753],
9	lesion	NN	O	lesion	nn	10	SENT_178	[p9l1411t686r1600b742],
10	type	NN	O	type	prep_of	3	SENT_178	[p9l1627t695r1781b759],
11	,	,	O	,	_	0	SENT_178	[p9l1627t695r1781b759],
12	CNV	NNP	ORGANIZATION	CNV	nn	13	SENT_178	[p9l1812t686r1978b743],
13	size	NN	O	size	conj_and	5	SENT_178	[p9l2008t686r2146b753],
14	,	,	O	,	_	0	SENT_178	[p9l2008t686r2146b753],
15	smoking	NN	O	smoking	nn	16	SENT_178	[p9l9t774r280b847],
16	status	NN	O	status	conj_and	5	SENT_178	[p9l306t783r501b841],
17	,	,	O	,	_	0	SENT_178	[p9l306t783r501b841],
18	and	CC	O	and	_	0	SENT_178	[p9l528t774r641b831],
19	baseline	NN	O	baseline	nn	20	SENT_178	[p9l661t774r923b831],
20	VA	NN	ORGANIZATION	va	conj_and	5	SENT_178	[p9l946t775r1060b831],
21	showed	VBD	O	show	_	0	SENT_178	[p9l1084t774r1326b831],
22	that	IN	O	that	complm	28	SENT_178	[p9l1347t774r1467b831],
23	baseline	NN	O	baseline	nn	24	SENT_178	[p9l1487t774r1749b831],
24	VA	NN	O	va	nsubj	28	SENT_178	[p9l1771t775r1885b830],
25	was	VBD	O	be	cop	28	SENT_178	[p9l1907t792r2028b831],
26	the	DT	O	the	det	28	SENT_178	[p9l2052t774r2148b830],
27	only	JJ	O	only	amod	28	SENT_178	[p9l7t863r146b935],
28	variable	NN	O	variable	ccomp	21	SENT_178	[p9l170t863r426b919],
29	with	IN	O	with	_	0	SENT_178	[p9l449t863r589b919],
30	signiﬁcant	JJ	O	signiﬁcant	amod	31	SENT_178	[p9l614t863r945b936],
31	contribution	NN	O	contribution	prep_with	28	SENT_178	[p9l966t863r1357b919],
32	to	TO	O	to	_	0	SENT_178	[p9l1379t871r1438b919],
33	the	DT	O	the	det	35	SENT_178	[p9l1461t863r1557b919],
34	VA	NNP	LOCATION	VA	nn	35	SENT_178	[p9l1579t863r1693b919],
35	outcome	NN	O	outcome	prep_to	28	SENT_178	[p9l1716t871r1990b919],
36	at	IN	O	at	_	0	SENT_178	[p9l2014t871r2069b919],
37	3	CD	NUMBER	3	prep_at	28	SENT_178	[p9l2093t863r2145b929],
38	,	,	O	,	_	0	SENT_178	[p9l2093t863r2145b929],
39	6	CD	NUMBER	6	prep_at	28	SENT_178	[p9l8t950r62b1017],
40	,	,	O	,	_	0	SENT_178	[p9l8t950r62b1017],
41	and	CC	DURATION	and	_	0	SENT_178	[p9l96t950r209b1006],
42	12	CD	DURATION	12	num	43	SENT_178	[p9l246t951r316b1006],
43	months	NNS	NUMBER	month	prep_at	28	SENT_178	[p9l347t950r597b1006],
44	.	.	O	.	_	0	SENT_178	[p9l347t950r597b1006],

1	For	IN	O	for	_	0	SENT_179	[p9l631t952r743b1006],
2	the	DT	O	the	det	3	SENT_179	[p9l771t950r867b1006],
3	impact	NN	O	impact	prep_for	11	SENT_179	[p9l897t950r1115b1023],
4	of	IN	O	of	_	0	SENT_179	[p9l1145t950r1214b1006],
5	baseline	NN	O	baseline	nn	6	SENT_179	[p9l1238t950r1499b1006],
6	VA	NNP	ORGANIZATION	VA	prep_of	3	SENT_179	[p9l1530t951r1661b1017],
7	,	,	O	,	_	0	SENT_179	[p9l1530t951r1661b1017],
8	the	DT	O	the	det	10	SENT_179	[p9l1694t950r1790b1006],
9	regression	NN	O	regression	nn	10	SENT_179	[p9l1819t950r2149b1023],
10	model	NN	O	model	nsubj	11	SENT_179	[p9l7t1038r205b1095],
11	predicted	VBD	O	predict	_	0	SENT_179	[p9l226t1038r524b1111],
12	that	IN	O	that	complm	74	SENT_179	[p9l545t1038r665b1095],
13	with	IN	O	with	_	0	SENT_179	[p9l686t1038r827b1095],
14	each	DT	O	each	det	15	SENT_179	[p9l849t1038r993b1095],
15	increment	NN	O	increment	prep_with	74	SENT_179	[p9l1015t1038r1335b1095],
16	of	IN	O	of	_	0	SENT_179	[p9l1357t1038r1426b1094],
17	1	CD	NUMBER	1	num	18	SENT_179	[p9l1450t1039r1473b1094],
18	letter	NN	O	letter	prep_of	15	SENT_179	[p9l1502t1038r1667b1094],
19	in	IN	O	in	_	0	SENT_179	[p9l1687t1038r1747b1094],
20	the	DT	O	the	det	22	SENT_179	[p9l1769t1038r1865b1094],
21	baseline	NN	O	baseline	nn	22	SENT_179	[p9l1886t1038r2148b1095],
22	VA	NNP	ORGANIZATION	VA	prep_in	18	SENT_179	[p9l6t1127r137b1193],
23	,	,	O	,	_	0	SENT_179	[p9l6t1127r137b1193],
24	there	EX	O	there	expl	74	SENT_179	[p9l198t1127r356b1183],
25	would	MD	O	would	aux	74	SENT_179	[p9l414t1127r613b1183],
26	be	VB	O	be	cop	74	SENT_179	[p9l669t1127r761b1193],
27	,	,	O	,	_	0	SENT_179	[p9l669t1127r761b1193],
28	on	IN	O	on	dep	74	SENT_179	[p9l823t1144r900b1183],
29	average	NN	O	average	pobj	28	SENT_179	[p9l959t1144r1222b1200],
30	,	,	O	,	_	0	SENT_179	[p9l959t1144r1222b1200],
31	a	DT	O	a	det	35	SENT_179	[p9l1284t1144r1317b1183],
32	0.33	CD	NUMBER	0.33	number	33	SENT_179	[p9l1374t1127r1508b1183],
33	(	CD	NUMBER	(	num	34	SENT_179	[p9l1572t1115r1949b1196],
34	P	NN	O	p	npadvmod	35	SENT_179	[p9l1572t1115r1949b1196],
35	<	JJR	O	<	appos	29	SENT_179	[p9l1572t1115r1949b1196],
36	10_1	CD	NUMBER	10_1	num	35	SENT_179	[p9l1572t1115r1949b1196],
37	°	NN	O	°	nn	38	SENT_179	[p9l1572t1115r1949b1196],
38	)	NN	O	)	dep	35	SENT_179	[p9l1572t1115r1949b1196],
39	,	,	O	,	_	0	SENT_179	[p9l1572t1115r1949b1196],
40	0.32	CD	NUMBER	0.32	number	41	SENT_179	[p9l2010t1127r2147b1183],
41	(	CD	NUMBER	(	num	42	SENT_179	[p9l9t1202r355b1284],
42	P	NN	O	p	npadvmod	43	SENT_179	[p9l9t1202r355b1284],
43	<	JJR	O	<	amod	29	SENT_179	[p9l9t1202r355b1284],
44	10_8	CD	NUMBER	10_8	num	45	SENT_179	[p9l9t1202r355b1284],
45	)	NN	O	)	dep	29	SENT_179	[p9l9t1202r355b1284],
46	,	,	O	,	_	0	SENT_179	[p9l9t1202r355b1284],
47	and	CC	O	and	_	0	SENT_179	[p9l408t1214r521b1270],
48	0.31	CD	NUMBER	0.31	number	49	SENT_179	[p9l569t1214r700b1271],
49	(	CD	NUMBER	(	dep	29	SENT_179	[p9l758t1203r1084b1284],
50	P	NN	O	p	dep	54	SENT_179	[p9l758t1203r1084b1284],
51	<	JJR	O	<	dep	50	SENT_179	[p9l758t1203r1084b1284],
52	10_7	CD	NUMBER	10_7	num	53	SENT_179	[p9l758t1203r1084b1284],
53	)	NN	O	)	dep	54	SENT_179	[p9l758t1203r1084b1284],
54	letters	NNS	O	letter	dep	45	SENT_179	[p9l1135t1214r1328b1270],
55	greater	JJR	O	greater	amod	56	SENT_179	[p9l1379t1222r1600b1287],
56	decline	NN	O	decline	dep	54	SENT_179	[p9l1648t1214r1877b1270],
57	in	IN	O	in	_	0	SENT_179	[p9l1926t1214r1986b1270],
58	VA	NNP	O	VA	nn	59	SENT_179	[p9l2035t1215r2149b1270],
59	change	NN	O	change	prep_in	56	SENT_179	[p9l7t1303r231b1375],
60	after	IN	O	after	_	0	SENT_179	[p9l260t1302r405b1359],
61	3	CD	NUMBER	3	prep_after	45	SENT_179	[p9l433t1303r486b1369],
62	,	,	O	,	_	0	SENT_179	[p9l433t1303r486b1369],
63	6	CD	NUMBER	6	prep_after	45	SENT_179	[p9l517t1302r571b1369],
64	,	,	O	,	_	0	SENT_179	[p9l517t1302r571b1369],
65	and	CC	DURATION	and	_	0	SENT_179	[p9l602t1303r715b1359],
66	12	CD	DURATION	12	num	67	SENT_179	[p9l749t1303r819b1358],
67	months	NNS	NUMBER	month	prep_after	45	SENT_179	[p9l846t1302r1098b1369],
68	,	,	O	,	_	0	SENT_179	[p9l846t1302r1098b1369],
69	respectively	RB	O	respectively	advmod	29	SENT_179	[p9l1127t1302r1513b1375],
70	(	CD	NUMBER	(	num	71	SENT_179	[p9l1544t1303r1748b1372],
71	Table	NNP	O	Table	dep	29	SENT_179	[p9l1544t1303r1748b1372],
72	3	CD	NUMBER	3	num	71	SENT_179	[p9l1778t1303r1831b1369],
73	,	,	O	,	_	0	SENT_179	[p9l1778t1303r1831b1369],
74	available	JJ	O	available	ccomp	11	SENT_179	[p9l1862t1302r2148b1359],
75	at	IN	O	at	_	0	SENT_179	[p9l8t1399r63b1447],
76	http://aaojournal.org	NN	O	http://aaojournal.org	nn	77	SENT_179	[p9l84t1391r783b1463],
77	)	NN	O	)	prep_at	74	SENT_179	[p9l84t1391r783b1463],
78	.	.	O	.	_	0	SENT_179	[p9l84t1391r783b1463],

1	Accordingly	RB	O	accordingly	advmod	10	SENT_180	[p9l810t1391r1227b1464],
2	,	,	O	,	_	0	SENT_180	[p9l810t1391r1227b1464],
3	patients	NNS	O	patient	nsubj	10	SENT_180	[p9l1250t1391r1497b1464],
4	with	IN	O	with	_	0	SENT_180	[p9l1522t1391r1663b1447],
5	better	JJR	O	better	amod	7	SENT_180	[p9l1683t1391r1867b1447],
6	baseline	NN	O	baseline	nn	7	SENT_180	[p9l1886t1391r2148b1447],
7	VA	NN	O	va	prep_with	3	SENT_180	[p9l6t1479r121b1534],
8	were	VBD	O	be	cop	10	SENT_180	[p9l141t1496r294b1534],
9	less	RBR	O	less	advmod	10	SENT_180	[p9l315t1478r431b1534],
10	likely	JJ	O	likely	_	0	SENT_180	[p9l453t1478r633b1551],
11	to	TO	O	to	aux	12	SENT_180	[p9l654t1486r713b1534],
12	show	VB	O	show	xcomp	10	SENT_180	[p9l737t1478r901b1535],
13	VA	NNP	O	VA	nn	14	SENT_180	[p9l922t1479r1036b1534],
14	gains	NNS	O	gain	dobj	12	SENT_180	[p9l1057t1478r1222b1551],
15	compared	VBN	O	compare	_	0	SENT_180	[p9l1245t1478r1559b1551],
16	with	IN	O	with	prepc_compared_with	12	SENT_180	[p9l1579t1478r1720b1535],
17	patients	NNS	O	patient	pobj	12	SENT_180	[p9l1739t1478r1986b1551],
18	with	IN	O	with	_	0	SENT_180	[p9l2008t1478r2149b1534],
19	lower	JJR	O	lower	amod	21	SENT_180	[p9l7t1566r189b1623],
20	baseline	NN	O	baseline	nn	21	SENT_180	[p9l221t1566r484b1623],
21	VA	NN	O	va	prep_with	17	SENT_180	[p9l519t1567r652b1633],
22	;	:	O	;	_	0	SENT_180	[p9l519t1567r652b1633],
23	patients	NNS	O	patient	nsubj	30	SENT_180	[p9l690t1566r938b1639],
24	with	IN	O	with	_	0	SENT_180	[p9l975t1566r1116b1623],
25	poorer	JJR	O	poorer	amod	27	SENT_180	[p9l1150t1584r1360b1639],
26	baseline	NN	O	baseline	nn	27	SENT_180	[p9l1393t1566r1655b1623],
27	VA	NN	O	va	prep_with	23	SENT_180	[p9l1691t1567r1805b1623],
28	were	VBD	O	be	cop	30	SENT_180	[p9l1841t1584r1994b1623],
29	less	RBR	O	less	advmod	30	SENT_180	[p9l2030t1567r2147b1623],
30	likely	JJ	O	likely	parataxis	10	SENT_180	[p9l7t1655r187b1728],
31	to	TO	O	to	aux	33	SENT_180	[p9l213t1663r272b1711],
32	further	RB	O	further	advmod	33	SENT_180	[p9l299t1655r517b1711],
33	lose	VB	O	lose	xcomp	30	SENT_180	[p9l541t1655r668b1711],
34	VA	NNP	ORGANIZATION	VA	dobj	33	SENT_180	[p9l694t1655r825b1721],
35	,	,	O	,	_	0	SENT_180	[p9l694t1655r825b1721],
36	the	DT	O	the	det	38	SENT_180	[p9l853t1655r949b1711],
37	so-called	JJ	O	so-called	amod	38	SENT_180	[p9l978t1655r1264b1711],
38	ﬂoor	NN	O	ﬂoor	conj_and	34	SENT_180	[p9l1290t1655r1440b1711],
39	and	CC	O	and	_	0	SENT_180	[p9l1466t1655r1579b1711],
40	ceiling	NN	O	ceiling	nn	41	SENT_180	[p9l1604t1655r1819b1728],
41	effects	NNS	O	effect	conj_and	34	SENT_180	[p9l1846t1655r2056b1711],
42	as	IN	O	as	mark	65	SENT_180	[p9l2085t1672r2146b1711],
43	observed	VBN	O	observe	partmod	65	SENT_180	[p9l7t1742r295b1798],
44	in	IN	O	in	_	0	SENT_180	[p9l332t1742r393b1798],
45	the	DT	O	the	det	47	SENT_180	[p9l430t1742r526b1798],
46	subgroup	NN	O	subgroup	nn	47	SENT_180	[p9l567t1742r860b1815],
47	analysis	NN	O	analysis	prep_in	43	SENT_180	[p9l901t1742r1154b1815],
48	of	IN	O	of	_	0	SENT_180	[p9l1196t1742r1265b1798],
49	ANCHOR	NN	O	anchor	nn	52	SENT_180	[p9l1297t1742r1635b1799],
50	and	CC	O	and	_	0	SENT_180	[p9l1674t1742r1787b1798],
51	MARINA	NN	O	marina	nn	52	SENT_180	[p9l1824t1743r2148b1798],
52	studies	NNS	O	study	prep_of	47	SENT_180	[p9l9t1824r386b1887],
53	.17	CD	NUMBER	.17	number	54	SENT_180	[p9l9t1824r386b1887],
54	’18	CD	NUMBER	’18	dobj	43	SENT_180	[p9l9t1824r386b1887],
55	However	RB	O	however	advmod	54	SENT_180	[p9l414t1832r723b1897],
56	,	,	O	,	_	0	SENT_180	[p9l414t1832r723b1897],
57	the	DT	O	the	det	59	SENT_180	[p9l752t1831r848b1887],
58	ﬁnal	JJ	O	ﬁnal	amod	59	SENT_180	[p9l875t1831r1015b1887],
59	VA	NN	ORGANIZATION	va	nsubj	65	SENT_180	[p9l1041t1831r1155b1887],
60	achieved	VBN	O	achieve	partmod	59	SENT_180	[p9l1183t1831r1465b1887],
61	after	IN	O	after	_	0	SENT_180	[p9l1492t1831r1637b1887],
62	12	CD	DURATION	12	num	63	SENT_180	[p9l1668t1831r1738b1886],
63	months	NNS	NUMBER	month	prep_after	60	SENT_180	[p9l1765t1831r1998b1887],
64	was	VBD	O	be	cop	65	SENT_180	[p9l2025t1849r2146b1888],
65	higher	JJR	O	higher	ccomp	30	SENT_180	[p9l6t1919r211b1992],
66	in	IN	O	in	_	0	SENT_180	[p9l234t1919r295b1974],
67	patients	NNS	O	patient	prep_in	65	SENT_180	[p9l318t1919r565b1992],
68	with	IN	O	with	_	0	SENT_180	[p9l592t1919r733b1975],
69	better	JJR	O	better	amod	70	SENT_180	[p9l756t1919r940b1975],
70	baseline	NN	O	baseline	prep_with	67	SENT_180	[p9l961t1919r1224b1975],
71	VA.	NNP	O	VA.	dep	70	SENT_180	[p9l1248t1919r1378b1975],
72	.	.	O	.	_	0	SENT_180	[p9l1248t1919r1378b1975],

1	For	IN	O	for	_	0	SENT_181	[p9l1407t1920r1518b1975],
2	example	NN	O	example	prep_for	26	SENT_181	[p9l1542t1919r1828b1992],
3	,	,	O	,	_	0	SENT_181	[p9l1542t1919r1828b1992],
4	the	DT	O	the	det	6	SENT_181	[p9l1856t1919r1952b1975],
5	mean	JJ	O	mean	amod	6	SENT_181	[p9l1977t1936r2149b1975],
6	change	NN	O	change	nsubj	26	SENT_181	[p9l7t2006r231b2079],
7	in	IN	O	in	_	0	SENT_181	[p9l259t2006r320b2062],
8	VA	NNP	O	VA	prep_in	6	SENT_181	[p9l347t2007r461b2062],
9	and	CC	O	and	_	0	SENT_181	[p9l489t2006r602b2062],
10	the	DT	O	the	det	12	SENT_181	[p9l629t2006r724b2062],
11	ﬁnal	JJ	O	ﬁnal	amod	12	SENT_181	[p9l753t2006r893b2062],
12	VA	NN	ORGANIZATION	va	nsubj	26	SENT_181	[p9l920t2007r1034b2062],
13	for	IN	O	for	_	0	SENT_181	[p9l1062t2006r1154b2062],
14	the	DT	O	the	det	15	SENT_181	[p9l1180t2006r1275b2062],
15	patients	NNS	O	patient	prep_for	12	SENT_181	[p9l1302t2006r1549b2079],
16	with	IN	O	with	_	0	SENT_181	[p9l1578t2006r1719b2063],
17	baseline	NN	O	baseline	nn	18	SENT_181	[p9l1745t2006r2007b2062],
18	VA	NN	O	va	prep_with	15	SENT_181	[p9l2035t2007r2149b2062],
19	of	IN	O	of	_	0	SENT_181	[p9l7t2094r77b2151],
20	<	JJR	O	<	prep_of	18	SENT_181	[p9l99t2094r236b2151],
21	55	CD	NUMBER	55	num	24	SENT_181	[p9l99t2094r236b2151],
22	ETDRS	NN	O	etdr	nn	24	SENT_181	[p9l262t2095r511b2151],
23	letter	NN	O	letter	nn	24	SENT_181	[p9l538t2095r702b2151],
24	scores	NNS	O	score	dep	20	SENT_181	[p9l726t2112r920b2151],
25	were	VBD	O	be	cop	26	SENT_181	[p9l946t2112r1099b2151],
26	+6	CD	NUMBER	+6	_	0	SENT_181	[p9l1130t2094r1226b2151],
27	and	CC	O	and	_	0	SENT_181	[p9l1252t2095r1365b2151],
28	50	CD	NUMBER	50	num	29	SENT_181	[p9l1388t2094r1465b2151],
29	ETDRS	NNS	O	etdr	conj_and	26	SENT_181	[p9l1488t2095r1737b2151],
30	letter	NN	O	letter	nn	31	SENT_181	[p9l1764t2095r1928b2151],
31	scores	NNS	O	score	dep	29	SENT_181	[p9l1952t2112r2146b2151],
32	after	IN	O	after	_	0	SENT_181	[p9l8t2183r153b2239],
33	12	CD	DURATION	12	num	35	SENT_181	[p9l181t2183r250b2238],
34	months	NNS	NUMBER	month	nn	35	SENT_181	[p9l273t2183r505b2239],
35	treatment	NN	O	treatment	prep_after	26	SENT_181	[p9l529t2191r831b2239],
36	compared	VBN	O	compare	_	0	SENT_181	[p9l852t2183r1167b2256],
37	with	IN	O	with	prepc_compared_with	26	SENT_181	[p9l1188t2183r1329b2239],
38	-2	CD	NUMBER	-2	nn	44	SENT_181	[p9l1358t2183r1454b2238],
39	and	CC	O	and	_	0	SENT_181	[p9l1478t2183r1591b2239],
40	65	CD	NUMBER	65	nn	44	SENT_181	[p9l1613t2183r1686b2239],
41	ET	NNP	O	ET	nn	44	SENT_181	[p9l1711t2184r1808b2238],
42	DRS	NNP	O	DRS	nn	44	SENT_181	[p9l1810t2183r1960b2239],
43	letter	NN	O	letter	nn	44	SENT_181	[p9l1986t2183r2150b2239],
44	scores	NNS	O	score	pobj	26	SENT_181	[p9l9t2288r203b2326],
45	in	IN	O	in	_	0	SENT_181	[p9l227t2270r288b2326],
46	patients	NNS	O	patient	prep_in	44	SENT_181	[p9l308t2270r555b2343],
47	with	IN	O	with	_	0	SENT_181	[p9l579t2270r720b2327],
48	a	DT	O	a	det	50	SENT_181	[p9l743t2288r777b2326],
49	baseline	NN	O	baseline	nn	50	SENT_181	[p9l796t2270r1058b2326],
50	VA	NN	O	va	prep_with	46	SENT_181	[p9l1081t2271r1195b2326],
51	of	IN	O	of	_	0	SENT_181	[p9l1217t2270r1287b2326],
52	255	CD	NUMBER	255	num	53	SENT_181	[p9l1308t2270r1445b2327],
53	ETDRS	NNS	O	etdr	prep_of	50	SENT_181	[p9l1470t2271r1719b2327],
54	letter	NN	O	letter	nn	55	SENT_181	[p9l1745t2270r1909b2326],
55	scores	NNS	O	score	dep	53	SENT_181	[p9l1932t2288r2144b2326],
56	.	.	O	.	_	0	SENT_181	[p9l1932t2288r2144b2326],

1	Lesion	NN	O	lesion	nn	2	SENT_182	[p9l6t2358r223b2415],
2	type	NN	O	type	nsubjpass	6	SENT_182	[p9l260t2367r396b2431],
3	was	VBD	O	be	auxpass	6	SENT_182	[p9l435t2376r555b2415],
4	also	RB	O	also	advmod	6	SENT_182	[p9l596t2358r721b2415],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_182	[p9l762t2358r1154b2431],
6	associated	VBN	O	associate	_	0	SENT_182	[p9l1194t2358r1521b2415],
7	with	IN	O	with	_	0	SENT_182	[p9l1558t2358r1699b2415],
8	the	DT	O	the	det	10	SENT_182	[p9l1736t2359r1832b2415],
9	VA	NNP	ORGANIZATION	VA	nn	10	SENT_182	[p9l1870t2359r1984b2415],
10	outcome	NN	O	outcome	prep_with	6	SENT_182	[p9l2022t2367r2146b2415, p9l7t2464r197b2513],
11	;	:	O	;	_	0	SENT_182	[p9l2022t2367r2146b2415, p9l7t2464r197b2513],
12	patients	NNS	O	patient	nsubj	17	SENT_182	[p9l228t2447r475b2520],
13	with	IN	O	with	_	0	SENT_182	[p9l505t2447r645b2503],
14	predominantly	RB	O	predominantly	advmod	16	SENT_182	[p9l671t2447r1139b2520],
15	classic	JJ	O	classic	amod	16	SENT_182	[p9l1168t2447r1378b2503],
16	lesions	NNS	O	lesion	prep_with	12	SENT_182	[p9l1408t2447r1627b2503],
17	showed	VBD	O	show	parataxis	6	SENT_182	[p9l1659t2447r1900b2503],
18	greater	JJR	O	greater	amod	19	SENT_182	[p9l1928t2455r2150b2520],
19	improvement	NN	O	improvement	dobj	17	SENT_182	[p9l6t2534r434b2607],
20	in	IN	O	in	_	0	SENT_182	[p9l454t2534r514b2590],
21	VA	NNP	O	VA	prep_in	17	SENT_182	[p9l534t2535r649b2590],
22	from	IN	O	from	_	0	SENT_182	[p9l670t2534r825b2590],
23	baseline	NN	O	baseline	prep_from	17	SENT_182	[p9l843t2534r1105b2590],
24	at	IN	O	at	_	0	SENT_182	[p9l1128t2542r1183b2590],
25	3	CD	NUMBER	3	num	27	SENT_182	[p9l1205t2534r1237b2591],
26	(	NN	O	(	nn	27	SENT_182	[p9l1264t2535r1336b2603],
27	P	NN	O	p	prep_at	23	SENT_182	[p9l1264t2535r1336b2603],
28	=	JJ	O	=	amod	30	SENT_182	[p9l1365t2554r1413b2573],
29	8	CD	NUMBER	8	num	30	SENT_182	[p9l1445t2534r1477b2591],
30	X	NN	O	x	tmod	17	SENT_182	[p9l1509t2539r1557b2587],
31	10-4	CD	NUMBER	10-4	num	32	SENT_182	[p9l1594t2522r1772b2603],
32	)	NN	O	)	nsubj	37	SENT_182	[p9l1594t2522r1772b2603],
33	and	CC	O	and	_	0	SENT_182	[p9l1797t2534r1910b2590],
34	6	CD	NUMBER	6	num	36	SENT_182	[p9l1932t2534r1967b2591],
35	(	NN	O	(	nn	36	SENT_182	[p9l1991t2535r2063b2603],
36	P	NN	O	p	conj_and	32	SENT_182	[p9l1991t2535r2063b2603],
37	=	JJ	O	=	dep	17	SENT_182	[p9l2092t2554r2140b2573],
38	5	CD	NUMBER	5	num	39	SENT_182	[p9l8t2622r41b2679],
39	X	NN	O	x	dobj	37	SENT_182	[p9l78t2628r125b2676],
40	10-3	CD	NUMBER	10-3	num	42	SENT_182	[p9l166t2610r345b2692],
41	)	CD	NUMBER	)	num	42	SENT_182	[p9l166t2610r345b2692],
42	months	NNS	NUMBER	month	nsubj	52	SENT_182	[p9l372t2622r604b2679],
43	compared	VBN	O	compare	_	0	SENT_182	[p9l632t2622r946b2695],
44	with	IN	O	with	prepc_compared_with	42	SENT_182	[p9l971t2622r1111b2679],
45	those	DT	O	those	pobj	42	SENT_182	[p9l1136t2622r1303b2679],
46	with	IN	O	with	_	0	SENT_182	[p9l1328t2622r1469b2679],
47	minimally	RB	O	minimally	advmod	48	SENT_182	[p9l1494t2622r1821b2695],
48	classic	JJ	O	classic	amod	51	SENT_182	[p9l1847t2622r2057b2679],
49	or	CC	O	or	_	0	SENT_182	[p9l2084t2640r2150b2679],
50	occult	JJ	O	occult	conj_or	48	SENT_182	[p9l7t2711r202b2767],
51	lesions	NNS	O	lesion	prep_with	45	SENT_182	[p9l230t2711r449b2767],
52	(	VBP	O	(	rcmod	39	SENT_182	[p9l482t2711r687b2780],
53	Table	NNP	O	Table	dobj	52	SENT_182	[p9l482t2711r687b2780],
54	3	CD	NUMBER	3	num	53	SENT_182	[p9l719t2711r771b2777],
55	,	,	O	,	_	0	SENT_182	[p9l719t2711r771b2777],
56	available	JJ	O	available	amod	53	SENT_182	[p9l805t2711r1091b2767],
57	at	IN	O	at	_	0	SENT_182	[p9l1122t2719r1178b2767],
58	http://aaojournal.org	NN	O	http://aaojournal.org	nn	59	SENT_182	[p9l1204t2711r1904b2783],
59	)	NN	O	)	prep_at	56	SENT_182	[p9l1204t2711r1904b2783],
60	.	.	O	.	_	0	SENT_182	[p9l1204t2711r1904b2783],

1	Genetic	JJ	O	genetic	amod	2	SENT_183	[p9l8t2931r324b3003],
2	Analysis	NN	O	analysis	_	0	SENT_183	[p9l361t2928r711b3022],

1	A	DT	O	a	det	2	SENT_184	[p9l6t3094r63b3149],
2	summary	NN	O	summary	nsubjpass	8	SENT_184	[p9l90t3111r383b3166],
3	of	IN	O	of	_	0	SENT_184	[p9l410t3093r479b3149],
4	the	DT	O	the	det	6	SENT_184	[p9l499t3093r595b3149],
5	SNP	NN	ORGANIZATION	snp	nn	6	SENT_184	[p9l622t3094r765b3150],
6	statistics	NNS	O	statistics	prep_of	2	SENT_184	[p9l793t3093r1063b3149],
7	is	VBZ	O	be	auxpass	8	SENT_184	[p9l1090t3093r1139b3149],
8	shown	VBN	O	show	_	0	SENT_184	[p9l1169t3093r1374b3149],
9	in	IN	O	in	_	0	SENT_184	[p9l1399t3093r1459b3149],
10	Table	NNP	O	Table	prep_in	8	SENT_184	[p9l1484t3093r1664b3149],
11	4	CD	NUMBER	4	number	12	SENT_184	[p9l1690t3094r1727b3148],
12	(	CD	NUMBER	(	dep	13	SENT_184	[p9l1755t3093r2067b3163],
13	available	JJ	O	available	dep	10	SENT_184	[p9l1755t3093r2067b3163],
14	at	IN	O	at	_	0	SENT_184	[p9l2094t3102r2150b3149],
15	http://aaojournal.org	NN	O	http://aaojournal.org	nn	16	SENT_184	[p9l6t3181r706b3254],
16	)	NN	O	)	prep_at	8	SENT_184	[p9l6t3181r706b3254],
17	.	.	O	.	_	0	SENT_184	[p9l6t3181r706b3254],

1	Ordinary	JJ	O	ordinary	amod	2	SENT_185	[p9l738t3181r1024b3254],
2	least-squares	NNS	O	least-square	_	0	SENT_185	[p9l1052t3182r1463b3254],
3	regression	NN	O	regression	nn	4	SENT_185	[p9l1491t3181r1820b3254],
4	modeling	NN	O	modeling	dep	2	SENT_185	[p9l1847t3181r2148b3254],
5	with	IN	O	with	_	0	SENT_185	[p9l7t3270r148b3326],
6	a	DT	O	a	det	7	SENT_185	[p9l181t3287r214b3326],
7	SNP	NN	O	snp	prep_with	4	SENT_185	[p9l246t3270r671b3343],
8	.	.	O	.	_	0	SENT_185	[p9l246t3270r671b3343],

1	—	NN	O	—	_	0	SENT_186	[p9l246t3270r671b3343],
2	.	.	O	.	_	0	SENT_186	[p9l246t3270r671b3343],

1	by	IN	O	by	_	0	SENT_187	[p9l246t3270r671b3343],
2	.	.	O	.	_	0	SENT_187	[p9l246t3270r671b3343],

1	—	NN	O	—	_	0	SENT_188	[p9l246t3270r671b3343],
2	.	.	O	.	_	0	SENT_188	[p9l246t3270r671b3343],

1	SNP	NN	ORGANIZATION	snp	nn	2	SENT_189	[p9l246t3270r671b3343],
2	approach	NN	O	approach	nsubjpass	4	SENT_189	[p9l704t3270r995b3343],
3	was	VBD	O	be	auxpass	4	SENT_189	[p9l1027t3287r1148b3326],
4	used	VBN	O	use	_	0	SENT_189	[p9l1181t3270r1327b3326],
5	to	TO	O	to	aux	6	SENT_189	[p9l1358t3278r1418b3326],
6	determine	VB	O	determine	xcomp	4	SENT_189	[p9l1451t3270r1769b3326],
7	the	DT	O	the	det	8	SENT_189	[p9l1801t3270r1897b3326],
8	role	NN	O	role	dobj	6	SENT_189	[p9l1929t3270r2052b3326],
9	of	IN	O	of	_	0	SENT_189	[p9l2085t3270r2154b3326],
10	each	DT	O	each	det	11	SENT_189	[p9l7t3357r152b3413],
11	SNP	NN	ORGANIZATION	snp	prep_of	8	SENT_189	[p9l184t3357r327b3414],
12	on	IN	O	on	_	0	SENT_189	[p9l358t3375r435b3413],
13	the	DT	O	the	det	14	SENT_189	[p9l465t3357r561b3413],
14	outcome	NN	O	outcome	prep_on	6	SENT_189	[p9l592t3366r865b3413],
15	of	IN	O	of	_	0	SENT_189	[p9l897t3357r966b3413],
16	the	DT	O	the	det	17	SENT_189	[p9l990t3357r1086b3413],
17	treatment	NN	O	treatment	prep_of	14	SENT_189	[p9l1116t3365r1434b3413],
18	.	.	O	.	_	0	SENT_189	[p9l1116t3365r1434b3413],

1	Table	NNP	O	Table	nsubj	3	SENT_190	[p9l1468t3357r1648b3413],
2	5	CD	NUMBER	5	num	1	SENT_190	[p9l1680t3357r1713b3414],
3	shows	VBZ	O	show	_	0	SENT_190	[p9l1749t3357r1943b3414],
4	the	DT	O	the	det	5	SENT_190	[p9l1975t3357r2071b3413],
5	P	NN	O	p	dobj	3	SENT_190	[p9l2100t3359r2149b3413],

1	values	NNS	O	value	conj_and	1	SENT_191	[p10l7t22r208b79],
2	for	IN	O	for	_	0	SENT_191	[p10l231t22r324b78],
3	the	DT	O	the	det	4	SENT_191	[p10l343t22r439b79],
4	contribution	NN	O	contribution	prep_for	1	SENT_191	[p10l460t22r851b79],
5	of	IN	O	of	_	0	SENT_191	[p10l873t22r942b78],
6	different	JJ	O	different	amod	7	SENT_191	[p10l958t22r1233b79],
7	SNPs	NNS	O	snp	prep_of	1	SENT_191	[p10l1255t23r1427b79],
8	to	TO	O	to	_	0	SENT_191	[p10l1450t31r1510b78],
9	the	DT	O	the	det	11	SENT_191	[p10l1531t22r1627b78],
10	mean	JJ	O	mean	amod	11	SENT_191	[p10l1649t40r1821b78],
11	change	NN	O	change	prep_to	1	SENT_191	[p10l1842t22r2066b95],
12	in	IN	O	in	_	0	SENT_191	[p10l2088t22r2148b78],
13	VA	NNP	O	VA	prep_in	1	SENT_191	[p10l6t112r120b168],
14	from	IN	O	from	_	0	SENT_191	[p10l150t112r305b168],
15	baseline	NN	O	baseline	prep_from	1	SENT_191	[p10l333t112r595b168],
16	at	IN	O	at	_	0	SENT_191	[p10l626t120r681b168],
17	3	CD	NUMBER	3	prep_at	1	SENT_191	[p10l712t112r765b178],
18	,	,	O	,	_	0	SENT_191	[p10l712t112r765b178],
19	6	CD	NUMBER	6	appos	17	SENT_191	[p10l799t112r853b178],
20	,	,	O	,	_	0	SENT_191	[p10l799t112r853b178],
21	and	CC	DURATION	and	_	0	SENT_191	[p10l887t112r1000b168],
22	12	CD	DURATION	12	num	23	SENT_191	[p10l1036t112r1106b167],
23	months	NNS	NUMBER	month	npadvmod	1	SENT_191	[p10l1137t112r1369b168],
24	after	IN	O	after	_	0	SENT_191	[p10l1402t112r1547b168],
25	adjusting	VBG	O	adjust	prepc_after	1	SENT_191	[p10l1577t112r1867b185],
26	for	IN	O	for	_	0	SENT_191	[p10l1898t112r1990b168],
27	age	NN	O	age	prep_for	25	SENT_191	[p10l2020t129r2145b185],
28	,	,	O	,	_	0	SENT_191	[p10l2020t129r2145b185],
29	sex	NN	O	sex	conj_and	27	SENT_191	[p10l9t218r128b267],
30	,	,	O	,	_	0	SENT_191	[p10l9t218r128b267],
31	baseline	NN	O	baseline	nn	32	SENT_191	[p10l152t201r414b257],
32	VA	NNP	O	VA	conj_and	27	SENT_191	[p10l436t201r567b267],
33	,	,	O	,	_	0	SENT_191	[p10l436t201r567b267],
34	smoking	NN	O	smoking	nn	35	SENT_191	[p10l594t201r866b274],
35	status	NN	O	status	conj_and	27	SENT_191	[p10l891t209r1086b267],
36	,	,	O	,	_	0	SENT_191	[p10l891t209r1086b267],
37	lesion	NN	O	lesion	nn	38	SENT_191	[p10l1111t201r1301b257],
38	type	NN	O	type	prep_for	25	SENT_191	[p10l1322t209r1476b274],
39	,	,	O	,	_	0	SENT_191	[p10l1322t209r1476b274],
40	and	CC	O	and	_	0	SENT_191	[p10l1502t201r1615b257],
41	CNV	NNP	O	CNV	nn	42	SENT_191	[p10l1636t201r1803b257],
42	size	NN	O	size	prep_for	25	SENT_191	[p10l1828t201r1964b257],
43	.	.	O	.	_	0	SENT_191	[p10l1828t201r1964b257],

1	Only	RB	O	only	advmod	4	SENT_192	[p10l1991t201r2147b273],
2	SNP	NN	O	snp	nsubj	4	SENT_192	[p10l8t290r152b346],
3	rs3025000	CD	NUMBER	rs3025000	num	2	SENT_192	[p10l178t289r516b346],
4	attained	VBD	O	attain	_	0	SENT_192	[p10l545t290r796b346],
5	the	DT	O	the	det	7	SENT_192	[p10l823t290r919b346],
6	P-value	JJ	MISC	p-value	amod	7	SENT_192	[p10l945t290r1194b346],
7	requirement	NN	O	requirement	nsubj	22	SENT_192	[p10l1221t290r1609b363],
8	of	IN	O	of	_	0	SENT_192	[p10l1636t290r1705b346],
9	0.007	CD	NUMBER	0.007	prep_of	7	SENT_192	[p10l1728t290r1903b346],
10	for	IN	O	for	_	0	SENT_192	[p10l1934t290r2027b346],
11	the	DT	O	the	det	12	SENT_192	[p10l2052t290r2148b346],
12	outcome	NN	O	outcome	prep_for	9	SENT_192	[p10l7t387r281b435],
13	at	IN	O	at	_	0	SENT_192	[p10l313t387r368b435],
14	6	CD	DURATION	6	num	15	SENT_192	[p10l398t378r434b435],
15	months	NNS	NUMBER	month	prep_at	12	SENT_192	[p10l465t379r698b435],
16	(	CD	NUMBER	(	num	17	SENT_192	[p10l732t367r1077b448],
17	P	NN	O	p	npadvmod	18	SENT_192	[p10l732t367r1077b448],
18	<	JJR	O	<	amod	15	SENT_192	[p10l732t367r1077b448],
19	10	CD	NUMBER	10	dep	7	SENT_192	[p10l732t367r1077b448],
20	'	''	O	'	_	0	SENT_192	[p10l732t367r1077b448],
21	4	CD	NUMBER	4	num	22	SENT_192	[p10l732t367r1077b448],
22	)	NN	O	)	xcomp	4	SENT_192	[p10l732t367r1077b448],
23	.	.	O	.	_	0	SENT_192	[p10l732t367r1077b448],

1	The	DT	O	the	det	3	SENT_193	[p10l1111t379r1234b435],
2	B	NN	O	b	nn	3	SENT_193	[p10l1267t379r1311b451],
3	coefﬁcient	NN	O	coefﬁcient	nsubj	5	SENT_193	[p10l1342t378r1679b435],
4	was	VBD	O	be	cop	5	SENT_193	[p10l1709t396r1829b435],
5	+7.1	CD	NUMBER	+7.1	_	0	SENT_193	[p10l1870t379r2019b435],
6	for	IN	O	for	_	0	SENT_193	[p10l2057t378r2150b435],
7	SNP	NN	O	snp	prep_for	5	SENT_193	[p10l8t468r152b524],
8	rs3025000	CD	NUMBER	rs3025000	num	7	SENT_193	[p10l185t467r522b524],
9	at	IN	O	at	_	0	SENT_193	[p10l558t476r613b524],
10	6	CD	DURATION	6	num	11	SENT_193	[p10l647t468r683b524],
11	months	NNS	NUMBER	month	prep_at	5	SENT_193	[p10l717t468r969b534],
12	,	,	O	,	_	0	SENT_193	[p10l717t468r969b534],
13	indicating	VBG	O	indicate	partmod	5	SENT_193	[p10l1006t468r1324b541],
14	that	IN	O	that	complm	33	SENT_193	[p10l1359t468r1479b524],
15	the	DT	O	the	det	16	SENT_193	[p10l1511t468r1607b524],
16	presence	NN	O	presence	nsubj	33	SENT_193	[p10l1640t485r1919b541],
17	of	IN	O	of	_	0	SENT_193	[p10l1955t468r2023b524],
18	the	DT	O	the	det	23	SENT_193	[p10l2052t468r2148b524],
19	minor	JJ	O	minor	amod	23	SENT_193	[p10l6t557r198b613],
20	(	NN	O	(	nn	23	SENT_193	[p10l219t557r314b626],
21	T	NN	O	t	nn	23	SENT_193	[p10l219t557r314b626],
22	)	CD	NUMBER	)	num	23	SENT_193	[p10l219t557r314b626],
23	allele	NN	O	allele	prep_of	16	SENT_193	[p10l339t557r509b613],
24	at	IN	O	at	_	0	SENT_193	[p10l531t565r586b613],
25	SNP	NN	O	snp	prep_at	23	SENT_193	[p10l607t557r750b613],
26	rs3025000	CD	NUMBER	rs3025000	num	25	SENT_193	[p10l769t557r1107b613],
27	(	CD	NUMBER	(	num	29	SENT_193	[p10l1130t557r1201b626],
28	T	NN	O	t	nn	29	SENT_193	[p10l1130t557r1201b626],
29	T	NN	O	t	dep	25	SENT_193	[p10l1203t558r1251b612],
30	or	CC	O	or	_	0	SENT_193	[p10l1272t574r1337b613],
31	TC	NN	O	tc	nn	32	SENT_193	[p10l1355t557r1454b613],
32	genotypes	NNS	O	genotype	conj_or	29	SENT_193	[p10l1477t557r1824b630],
33	)	VBP	O	)	ccomp	13	SENT_193	[p10l1477t557r1824b630],
34	led	VBN	O	lead	dep	33	SENT_193	[p10l1847t557r1944b613],
35	to	TO	O	to	_	0	SENT_193	[p10l1963t565r2022b613],
36	+7	CD	NUMBER	+7	num	37	SENT_193	[p10l2051t558r2146b613],
37	letters	NNS	O	letter	prep_to	34	SENT_193	[p10l7t646r199b702],
38	greater	JJR	O	greater	amod	39	SENT_193	[p10l222t654r443b719],
39	increase	NN	O	increase	dobj	34	SENT_193	[p10l462t646r723b702],
40	in	IN	O	in	_	0	SENT_193	[p10l743t646r804b701],
41	the	DT	O	the	det	43	SENT_193	[p10l824t646r919b702],
42	visual	JJ	O	visual	amod	43	SENT_193	[p10l940t646r1129b702],
43	outcome	NN	O	outcome	prep_in	39	SENT_193	[p10l1151t654r1424b702],
44	at	IN	O	at	_	0	SENT_193	[p10l1446t654r1501b702],
45	6	CD	DURATION	6	num	46	SENT_193	[p10l1522t646r1557b702],
46	months	NNS	NUMBER	month	prep_at	34	SENT_193	[p10l1578t646r1811b702],
47	compared	VBN	O	compare	_	0	SENT_193	[p10l1834t646r2149b719],
48	with	IN	O	with	prepc_compared_with	46	SENT_193	[p10l7t735r148b791],
49	patients	NNS	O	patient	pobj	46	SENT_193	[p10l176t735r423b808],
50	with	IN	O	with	_	0	SENT_193	[p10l455t735r596b791],
51	the	DT	O	the	det	53	SENT_193	[p10l625t735r721b791],
52	CC	NN	O	cc	nn	53	SENT_193	[p10l752t735r855b791],
53	genotype	NN	O	genotype	prep_with	49	SENT_193	[p10l887t743r1179b808],
54	at	IN	O	at	_	0	SENT_193	[p10l1211t743r1266b791],
55	this	DT	O	this	det	56	SENT_193	[p10l1295t735r1407b791],
56	SNP	NN	O	snp	prep_at	53	SENT_193	[p10l1441t735r1600b791],
57	.	.	O	.	_	0	SENT_193	[p10l1441t735r1600b791],

1	The	DT	O	the	det	2	SENT_194	[p10l1634t735r1756b791],
2	role	NN	O	role	nsubj	22	SENT_194	[p10l1785t735r1909b791],
3	of	IN	O	of	_	0	SENT_194	[p10l1940t735r2009b791],
4	this	DT	O	this	det	5	SENT_194	[p10l2034t735r2146b791],
5	SNP	NN	O	snp	prep_of	2	SENT_194	[p10l8t824r152b880],
6	in	IN	O	in	_	0	SENT_194	[p10l177t824r238b879],
7	the	DT	O	the	det	9	SENT_194	[p10l263t824r359b880],
8	mean	JJ	O	mean	amod	9	SENT_194	[p10l385t841r557b880],
9	change	NN	O	change	prep_in	5	SENT_194	[p10l583t824r808b897],
10	in	IN	O	in	_	0	SENT_194	[p10l833t824r894b879],
11	VA	NNP	O	VA	prep_in	9	SENT_194	[p10l919t824r1033b880],
12	from	IN	O	from	_	0	SENT_194	[p10l1059t824r1214b880],
13	baseline	NN	O	baseline	prep_from	11	SENT_194	[p10l1237t824r1499b880],
14	at	IN	O	at	_	0	SENT_194	[p10l1527t832r1582b880],
15	3	CD	NUMBER	3	nn	18	SENT_194	[p10l1609t824r1641b880],
16	and	CC	O	and	_	0	SENT_194	[p10l1672t824r1785b880],
17	12	CD	DURATION	12	nn	18	SENT_194	[p10l1817t824r1887b879],
18	months	NNS	NUMBER	month	prep_at	13	SENT_194	[p10l1913t824r2146b880],
19	was	VBD	O	be	cop	22	SENT_194	[p10l7t930r127b969],
20	also	RB	O	also	advmod	22	SENT_194	[p10l151t913r276b969],
21	marginally	RB	O	marginally	advmod	22	SENT_194	[p10l297t913r643b986],
22	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_194	[p10l666t913r998b986],
23	(	NN	O	(	nn	24	SENT_194	[p10l1019t913r1091b982],
24	P	NN	O	p	npadvmod	22	SENT_194	[p10l1019t913r1091b982],
25	=	JJ	O	=	amod	24	SENT_194	[p10l1119t932r1167b951],
26	0.01	CD	NUMBER	0.01	tmod	25	SENT_194	[p10l1196t913r1327b969],
27	at	IN	O	at	_	0	SENT_194	[p10l1356t921r1411b969],
28	3	CD	NUMBER	3	nn	31	SENT_194	[p10l1433t913r1464b969],
29	and	CC	O	and	_	0	SENT_194	[p10l1490t913r1603b969],
30	12	CD	DURATION	12	conj_and	28	SENT_194	[p10l1631t913r1701b968],
31	months	NNS	NUMBER	month	prep_at	22	SENT_194	[p10l1722t913r1980b982],
32	)	RB	O	)	advmod	31	SENT_194	[p10l1722t913r1980b982],
33	after	IN	O	after	_	0	SENT_194	[p10l2005t913r2150b969],
34	Bonferroni	NNP	PERSON	Bonferroni	nn	35	SENT_194	[p10l6t1002r356b1058],
35	correction	NN	O	correction	prep_after	22	SENT_194	[p10l385t1002r724b1058],
36	.	.	O	.	_	0	SENT_194	[p10l385t1002r724b1058],

1	Mean	NN	O	mean	nn	2	SENT_195	[p10l755t1003r937b1058],
2	change	NN	O	change	nsubj	21	SENT_195	[p10l965t1002r1189b1075],
3	in	IN	O	in	_	0	SENT_195	[p10l1217t1002r1278b1057],
4	VA	NNP	O	VA	prep_in	2	SENT_195	[p10l1305t1002r1419b1058],
5	in	IN	O	in	_	0	SENT_195	[p10l1446t1002r1507b1057],
6	patients	NNS	O	patient	prep_in	4	SENT_195	[p10l1533t1002r1780b1075],
7	with	IN	O	with	_	0	SENT_195	[p10l1810t1002r1951b1058],
8	the	DT	O	the	det	12	SENT_195	[p10l1978t1002r2074b1058],
9	T	NN	O	t	nn	12	SENT_195	[p10l2101t1003r2149b1057],
10	allele	NN	O	allele	nn	12	SENT_195	[p10l8t1091r178b1147],
11	(	CD	NUMBER	(	num	12	SENT_195	[p10l219t1091r340b1160],
12	TT	NN	O	tt	prep_with	6	SENT_195	[p10l219t1091r340b1160],
13	or	CC	O	or	_	0	SENT_195	[p10l379t1108r445b1147],
14	CT	NN	O	ct	nn	16	SENT_195	[p10l483t1091r583b1147],
15	genotype	NN	O	genotype	nn	16	SENT_195	[p10l622t1091r938b1164],
16	)	NN	O	)	prep_with	6	SENT_195	[p10l622t1091r938b1164],
17	at	IN	O	at	_	0	SENT_195	[p10l981t1099r1036b1147],
18	SNP	NN	O	snp	nn	19	SENT_195	[p10l1076t1091r1219b1147],
19	rs3025000	NN	O	rs3025000	prep_at	12	SENT_195	[p10l1257t1090r1594b1147],
20	was	VBD	O	be	cop	21	SENT_195	[p10l1634t1108r1754b1147],
21	+8.8:1.2	CD	NUMBER	+8.8:1.2	ccomp	47	SENT_195	[p10l1803t1091r2145b1157],
22	,	,	O	,	_	0	SENT_195	[p10l1803t1091r2145b1157],
23	+8.3:1.3	CD	NUMBER	+8.3:1.3	conj_and	21	SENT_195	[p10l15t1181r356b1248],
24	,	,	O	,	_	0	SENT_195	[p10l15t1181r356b1248],
25	and	CC	O	and	_	0	SENT_195	[p10l396t1181r509b1237],
26	+4.9:1.3	CD	NUMBER	+4.9:1.3	num	27	SENT_195	[p10l552t1181r872b1238],
27	letters	NNS	O	letter	ccomp	47	SENT_195	[p10l912t1181r1104b1237],
28	after	IN	O	after	_	0	SENT_195	[p10l1143t1181r1288b1237],
29	3	CD	NUMBER	3	prep_after	21	SENT_195	[p10l1324t1181r1377b1248],
30	,	,	O	,	_	0	SENT_195	[p10l1324t1181r1377b1248],
31	6	CD	NUMBER	6	prep_after	21	SENT_195	[p10l1416t1181r1470b1247],
32	,	,	O	,	_	0	SENT_195	[p10l1416t1181r1470b1247],
33	and	CC	DURATION	and	_	0	SENT_195	[p10l1510t1181r1623b1237],
34	12	CD	DURATION	12	num	35	SENT_195	[p10l1665t1181r1735b1236],
35	months	NNS	NUMBER	month	conj_and	29	SENT_195	[p10l1771t1181r2023b1247],
36	,	,	O	,	_	0	SENT_195	[p10l1771t1181r2023b1247],
37	respectively	RB	O	respectively	advmod	21	SENT_195	[p10l2060t1198r2146b1237, p10l9t1270r347b1343],
38	,	,	O	,	_	0	SENT_195	[p10l2060t1198r2146b1237, p10l9t1270r347b1343],
39	compared	VBN	O	compare	_	0	SENT_195	[p10l383t1270r697b1343],
40	with	IN	O	with	prepc_compared_with	21	SENT_195	[p10l729t1270r870b1326],
41	+3.9:1.3	CD	NUMBER	+3.9:1.3	pobj	21	SENT_195	[p10l909t1270r1251b1336],
42	,	,	O	,	_	0	SENT_195	[p10l909t1270r1251b1336],
43	+0.2:1.3	CD	NUMBER	+0.2:1.3	nsubj	47	SENT_195	[p10l1294t1270r1635b1336],
44	,	,	O	,	_	0	SENT_195	[p10l1294t1270r1635b1336],
45	and	CC	O	and	_	0	SENT_195	[p10l1671t1270r1784b1326],
46	>	JJR	O	>	conj_and	43	SENT_195	[p10l1824t1269r2144b1326],
47	<	JJR	O	<	_	0	SENT_195	[p10l1824t1269r2144b1326],
48	0.6:1.5	CD	NUMBER	0.6:1.5	num	49	SENT_195	[p10l1824t1269r2144b1326],
49	letters	NNS	O	letter	dobj	47	SENT_195	[p10l7t1359r199b1415],
50	in	IN	O	in	_	0	SENT_195	[p10l230t1359r290b1414],
51	patients	NNS	O	patient	prep_in	49	SENT_195	[p10l318t1359r565b1432],
52	without	IN	O	without	_	0	SENT_195	[p10l596t1359r840b1415],
53	the	DT	O	the	det	58	SENT_195	[p10l868t1359r964b1415],
54	T	NN	O	t	nn	58	SENT_195	[p10l993t1360r1040b1414],
55	allele	NN	O	allele	nn	58	SENT_195	[p10l1071t1359r1241b1415],
56	(	CD	NUMBER	(	num	58	SENT_195	[p10l1273t1359r1400b1428],
57	CC	NN	O	cc	nn	58	SENT_195	[p10l1273t1359r1400b1428],
58	genotype	NN	O	genotype	prep_without	47	SENT_195	[p10l1431t1367r1742b1432],
59	;	:	O	;	_	0	SENT_195	[p10l1431t1367r1742b1432],
60	Figure	NNP	O	Figure	dep	58	SENT_195	[p10l1774t1359r1982b1431],
61	1	CD	NUMBER	1	number	62	SENT_195	[p10l2019t1359r2092b1428],
62	)	CD	NUMBER	)	dep	60	SENT_195	[p10l2019t1359r2092b1428],
63	.	.	O	.	_	0	SENT_195	[p10l2019t1359r2092b1428],

1	In	IN	O	in	_	0	SENT_196	[p10l113t1449r179b1503],
2	an	DT	O	a	det	3	SENT_196	[p10l211t1465r283b1504],
3	analysis	NN	O	analysis	prep_in	12	SENT_196	[p10l316t1448r569b1521],
4	of	IN	O	of	_	0	SENT_196	[p10l603t1448r672b1504],
5	the	DT	O	the	det	6	SENT_196	[p10l697t1448r793b1504],
6	subgroups	NNS	O	subgroup	prep_of	3	SENT_196	[p10l827t1448r1151b1521],
7	of	IN	O	of	_	0	SENT_196	[p10l1184t1448r1254b1504],
8	the	DT	O	the	det	9	SENT_196	[p10l1279t1448r1375b1504],
9	cohort	NN	O	cohort	prep_of	6	SENT_196	[p10l1407t1448r1626b1514],
10	,	,	O	,	_	0	SENT_196	[p10l1407t1448r1626b1514],
11	we	PRP	O	we	nsubj	12	SENT_196	[p10l1661t1465r1751b1504],
12	divided	VBD	O	divide	_	0	SENT_196	[p10l1783t1448r2022b1504],
13	the	DT	O	the	det	14	SENT_196	[p10l2052t1448r2148b1504],
14	patients	NNS	O	patient	dobj	12	SENT_196	[p10l6t1537r252b1610],
15	into	IN	O	into	_	0	SENT_196	[p10l277t1537r399b1593],
16	the	DT	O	the	det	19	SENT_196	[p10l423t1537r518b1593],
17	responder	NN	O	responder	nn	19	SENT_196	[p10l541t1537r858b1610],
18	(	CD	NUMBER	(	num	19	SENT_196	[p10l882t1537r1043b1610],
19	gain	NN	O	gain	prep_into	12	SENT_196	[p10l882t1537r1043b1610],
20	of	IN	O	of	_	0	SENT_196	[p10l1066t1537r1135b1593],
21	25	CD	NUMBER	25	num	22	SENT_196	[p10l1158t1537r1254b1593],
22	letters	NNS	O	letter	prep_of	19	SENT_196	[p10l1280t1537r1518b1606],
23	)	RB	O	)	advmod	22	SENT_196	[p10l1280t1537r1518b1606],
24	,	,	O	,	_	0	SENT_196	[p10l1280t1537r1518b1606],
25	stable	JJ	O	stable	amod	27	SENT_196	[p10l1547t1537r1729b1593],
26	(	NN	O	(	nn	27	SENT_196	[p10l1754t1537r1915b1610],
27	gain	NN	O	gain	conj_and	19	SENT_196	[p10l1754t1537r1915b1610],
28	or	CC	O	or	_	0	SENT_196	[p10l1939t1554r2004b1593],
29	loss	NN	O	loss	conj_and	19	SENT_196	[p10l2025t1537r2147b1593],
30	of	IN	O	of	_	0	SENT_196	[p10l7t1626r77b1682],
31	<	JJR	O	<	prep_of	27	SENT_196	[p10l124t1625r220b1682],
32	5	CD	NUMBER	5	num	33	SENT_196	[p10l124t1625r220b1682],
33	letters	NNS	O	letter	dep	34	SENT_196	[p10l271t1626r509b1695],
34	)	RB	O	)	amod	31	SENT_196	[p10l271t1626r509b1695],
35	,	,	O	,	_	0	SENT_196	[p10l271t1626r509b1695],
36	and	CC	O	and	_	0	SENT_196	[p10l560t1626r673b1682],
37	nonresponder	JJ	O	nonresponder	amod	39	SENT_196	[p10l720t1626r1157b1699],
38	(	NN	O	(	nn	39	SENT_196	[p10l1205t1626r1350b1695],
39	loss	NN	O	loss	prep_into	12	SENT_196	[p10l1205t1626r1350b1695],
40	of	IN	O	of	_	0	SENT_196	[p10l1400t1626r1470b1682],
41	25	CD	NUMBER	25	num	42	SENT_196	[p10l1517t1625r1613b1682],
42	letters	NNS	O	letter	npadvmod	43	SENT_196	[p10l1664t1626r1882b1695],
43	)	JJ	O	)	amod	44	SENT_196	[p10l1664t1626r1882b1695],
44	groups	NNS	O	group	prep_of	39	SENT_196	[p10l1933t1643r2147b1699],
45	separately	RB	O	separately	advmod	12	SENT_196	[p10l9t1715r330b1787],
46	at	IN	O	at	_	0	SENT_196	[p10l362t1723r417b1771],
47	each	DT	O	each	det	49	SENT_196	[p10l446t1715r591b1771],
48	time	NN	O	time	nn	49	SENT_196	[p10l620t1715r761b1771],
49	point	NN	O	point	prep_at	12	SENT_196	[p10l790t1715r970b1787],
50	.	.	O	.	_	0	SENT_196	[p10l790t1715r970b1787],

1	After	IN	O	after	_	0	SENT_197	[p10l1004t1715r1173b1771],
2	3	CD	NUMBER	3	prep_after	11	SENT_197	[p10l1203t1715r1256b1781],
3	,	,	O	,	_	0	SENT_197	[p10l1203t1715r1256b1781],
4	6	CD	NUMBER	6	conj_and	2	SENT_197	[p10l1290t1715r1344b1781],
5	,	,	O	,	_	0	SENT_197	[p10l1290t1715r1344b1781],
6	and	CC	DURATION	and	_	0	SENT_197	[p10l1378t1715r1491b1771],
7	12	CD	DURATION	12	num	8	SENT_197	[p10l1528t1715r1598b1770],
8	months	NNS	NUMBER	month	prep_after	11	SENT_197	[p10l1628t1715r1880b1781],
9	,	,	O	,	_	0	SENT_197	[p10l1628t1715r1880b1781],
10	we	PRP	O	we	nsubj	11	SENT_197	[p10l1913t1732r2004b1771],
11	had	VBD	O	have	_	0	SENT_197	[p10l2034t1715r2149b1771],
12	117	CD	PERCENT	117	dobj	11	SENT_197	[p10l14t1804r122b1860],
13	(	CD	PERCENT	(	number	14	SENT_197	[p10l149t1804r423b1873],
14	58.2	CD	PERCENT	58.2	num	15	SENT_197	[p10l149t1804r423b1873],
15	%	NN	PERCENT	%	dep	12	SENT_197	[p10l149t1804r423b1873],
16	)	CD	NUMBER	)	dep	12	SENT_197	[p10l149t1804r423b1873],
17	,	,	O	,	_	0	SENT_197	[p10l149t1804r423b1873],
18	94	CD	PERCENT	94	conj_and	12	SENT_197	[p10l448t1804r525b1861],
19	(	CD	PERCENT	(	number	20	SENT_197	[p10l550t1804r823b1873],
20	46.8	CD	PERCENT	46.8	num	21	SENT_197	[p10l550t1804r823b1873],
21	%	NN	PERCENT	%	dep	18	SENT_197	[p10l550t1804r823b1873],
22	)	CD	NUMBER	)	dep	18	SENT_197	[p10l550t1804r823b1873],
23	,	,	O	,	_	0	SENT_197	[p10l550t1804r823b1873],
24	and	CC	O	and	_	0	SENT_197	[p10l850t1804r962b1860],
25	99	CD	PERCENT	99	dobj	11	SENT_197	[p10l985t1804r1060b1861],
26	(	CD	PERCENT	(	number	27	SENT_197	[p10l1086t1804r1340b1873],
27	49.3	CD	PERCENT	49.3	dep	28	SENT_197	[p10l1086t1804r1340b1873],
28	%	NN	PERCENT	%	dep	25	SENT_197	[p10l1086t1804r1340b1873],
29	)	CD	NUMBER	)	num	30	SENT_197	[p10l1086t1804r1340b1873],
30	patients	NNS	O	patient	advmod	25	SENT_197	[p10l1363t1804r1610b1877],
31	in	IN	O	in	_	0	SENT_197	[p10l1634t1804r1694b1859],
32	the	DT	O	the	det	34	SENT_197	[p10l1716t1804r1812b1860],
33	responder	NN	O	responder	nn	34	SENT_197	[p10l1833t1804r2150b1877],
34	group	NN	O	group	prep_in	30	SENT_197	[p10l7t1910r191b1966],
35	and	CC	O	and	_	0	SENT_197	[p10l222t1893r335b1949],
36	84	CD	PERCENT	84	number	37	SENT_197	[p10l366t1893r440b1949],
37	(	CD	PERCENT	(	conj_and	34	SENT_197	[p10l473t1893r746b1962],
38	41.8	CD	PERCENT	41.8	num	39	SENT_197	[p10l473t1893r746b1962],
39	%	NN	PERCENT	%	dep	37	SENT_197	[p10l473t1893r746b1962],
40	)	CD	NUMBER	)	dep	37	SENT_197	[p10l473t1893r746b1962],
41	,	,	O	,	_	0	SENT_197	[p10l473t1893r746b1962],
42	107	CD	PERCENT	107	num	43	SENT_197	[p10l786t1893r894b1949],
43	(	CD	PERCENT	(	conj_and	34	SENT_197	[p10l928t1892r1201b1962],
44	53.2	CD	PERCENT	53.2	number	45	SENT_197	[p10l928t1892r1201b1962],
45	%	NN	PERCENT	%	amod	43	SENT_197	[p10l928t1892r1201b1962],
46	)	CD	NUMBER	)	dep	43	SENT_197	[p10l928t1892r1201b1962],
47	,	,	O	,	_	0	SENT_197	[p10l928t1892r1201b1962],
48	and	CC	O	and	_	0	SENT_197	[p10l1235t1893r1348b1949],
49	102	CD	PERCENT	102	number	50	SENT_197	[p10l1383t1893r1493b1949],
50	(	CD	PERCENT	(	conj_and	34	SENT_197	[p10l1526t1892r1780b1962],
51	50.7	CD	PERCENT	50.7	num	52	SENT_197	[p10l1526t1892r1780b1962],
52	%	NN	PERCENT	%	dep	50	SENT_197	[p10l1526t1892r1780b1962],
53	)	CD	NUMBER	)	num	54	SENT_197	[p10l1526t1892r1780b1962],
54	patients	NNS	O	patient	dep	25	SENT_197	[p10l1810t1893r2057b1966],
55	in	IN	O	in	_	0	SENT_197	[p10l2087t1893r2148b1948],
56	the	DT	O	the	det	58	SENT_197	[p10l6t1982r102b2038],
57	stable/nonresponder	JJ	O	stable/nonresponder	amod	58	SENT_197	[p10l143t1982r787b2055],
58	(	NN	O	(	nn	63	SENT_197	[p10l826t1982r1035b2051],
59	stable	JJ	O	stable	amod	63	SENT_197	[p10l826t1982r1035b2051],
60	or	CC	O	or	_	0	SENT_197	[p10l1074t1999r1139b2038],
61	nonresponder	JJ	O	nonresponder	conj_or	59	SENT_197	[p10l1175t1982r1635b2055],
62	)	NN	O	)	nn	63	SENT_197	[p10l1175t1982r1635b2055],
63	group	NN	O	group	prep_in	11	SENT_197	[p10l1676t1999r1878b2055],
64	,	,	O	,	_	0	SENT_197	[p10l1676t1999r1878b2055],
65	respectively	RB	O	respectively	advmod	11	SENT_197	[p10l1918t1999r2146b2055, p10l6t2071r203b2144],
66	.	.	O	.	_	0	SENT_197	[p10l1918t1999r2146b2055, p10l6t2071r203b2144],

1	A	DT	O	a	det	4	SENT_198	[p10l233t2071r290b2126],
2	multivariate	JJ	O	multivariate	amod	4	SENT_198	[p10l316t2071r702b2127],
3	data	NN	O	datum	nn	4	SENT_198	[p10l729t2071r862b2127],
4	analysis	NN	O	analysis	nsubjpass	24	SENT_198	[p10l888t2071r1141b2143],
5	adjusted	VBN	O	adjust	partmod	4	SENT_198	[p10l1171t2071r1436b2144],
6	for	IN	O	for	_	0	SENT_198	[p10l1462t2071r1555b2127],
7	age	NN	O	age	prep_for	5	SENT_198	[p10l1581t2088r1706b2144],
8	,	,	O	,	_	0	SENT_198	[p10l1581t2088r1706b2144],
9	sex	NN	O	sex	prep_for	5	SENT_198	[p10l1738t2088r1857b2137],
10	,	,	O	,	_	0	SENT_198	[p10l1738t2088r1857b2137],
11	baseline	NN	O	baseline	nn	12	SENT_198	[p10l1886t2071r2148b2127],
12	VA	NNP	O	VA	prep_for	5	SENT_198	[p10l6t2160r137b2226],
13	,	,	O	,	_	0	SENT_198	[p10l6t2160r137b2226],
14	smoking	NN	O	smoking	nn	15	SENT_198	[p10l170t2160r441b2233],
15	status	NN	O	status	prep_for	5	SENT_198	[p10l471t2168r666b2226],
16	,	,	O	,	_	0	SENT_198	[p10l471t2168r666b2226],
17	lesion	NN	O	lesion	nn	18	SENT_198	[p10l696t2160r886b2216],
18	type	NN	O	type	conj_and	7	SENT_198	[p10l913t2168r1066b2233],
19	,	,	O	,	_	0	SENT_198	[p10l913t2168r1066b2233],
20	and	CC	O	and	_	0	SENT_198	[p10l1097t2160r1210b2216],
21	CNV	NNP	ORGANIZATION	CNV	nn	22	SENT_198	[p10l1237t2160r1403b2216],
22	size	NN	O	size	conj_and	7	SENT_198	[p10l1433t2160r1553b2216],
23	was	VBD	O	be	auxpass	24	SENT_198	[p10l1580t2177r1701b2216],
24	performed	VBN	O	perform	_	0	SENT_198	[p10l1728t2160r2062b2233],
25	to	TO	O	to	aux	26	SENT_198	[p10l2088t2168r2148b2216],
26	determine	VB	O	determine	xcomp	24	SENT_198	[p10l7t2249r326b2305],
27	the	DT	O	the	det	28	SENT_198	[p10l351t2249r447b2305],
28	association	NN	O	association	dobj	26	SENT_198	[p10l474t2249r828b2305],
29	of	IN	O	of	_	0	SENT_198	[p10l854t2249r923b2305],
30	the	DT	O	the	det	32	SENT_198	[p10l943t2249r1038b2305],
31	7	CD	NUMBER	7	num	32	SENT_198	[p10l1065t2250r1100b2305],
32	tSNPs	NNS	O	tsnp	prep_of	28	SENT_198	[p10l1127t2249r1325b2305],
33	and	CC	O	and	_	0	SENT_198	[p10l1353t2249r1466b2305],
34	the	DT	O	the	det	35	SENT_198	[p10l1491t2249r1587b2305],
35	likelihood	NN	O	likelihood	conj_and	28	SENT_198	[p10l1613t2249r1937b2305],
36	of	IN	O	of	_	0	SENT_198	[p10l1963t2249r2032b2305],
37	the	DT	O	the	det	38	SENT_198	[p10l2052t2249r2148b2305],
38	patients	NNS	O	patient	prep_of	35	SENT_198	[p10l6t2338r253b2411],
39	being	VBG	O	be	xcomp	26	SENT_198	[p10l296t2338r473b2411],
40	in	IN	O	in	_	0	SENT_198	[p10l517t2338r578b2393],
41	the	DT	O	the	det	42	SENT_198	[p10l620t2338r716b2394],
42	responder	NN	O	responder	prep_in	39	SENT_198	[p10l758t2338r1076b2411],
43	versus	CC	O	versus	prep	42	SENT_198	[p10l1118t2355r1319b2394],
44	the	DT	O	the	det	46	SENT_198	[p10l1364t2338r1460b2394],
45	stable/nonresponder	JJ	O	stable/nonresponder	amod	46	SENT_198	[p10l1506t2338r2150b2411],
46	group	NN	O	group	dep	43	SENT_198	[p10l7t2444r208b2500],
47	.	.	O	.	_	0	SENT_198	[p10l7t2444r208b2500],

1	Table	NNP	O	Table	nsubj	3	SENT_199	[p10l237t2427r417b2483],
2	6	CD	NUMBER	6	num	1	SENT_199	[p10l444t2427r479b2483],
3	presents	VBZ	O	present	_	0	SENT_199	[p10l504t2435r764b2500],
4	the	DT	O	the	det	6	SENT_199	[p10l791t2427r887b2483],
5	odds	NNS	O	odds	nn	6	SENT_199	[p10l913t2427r1060b2483],
6	ratios	NNS	O	ratio	nsubj	7	SENT_199	[p10l1085t2427r1261b2483],
7	(	VBP	O	(	ccomp	3	SENT_199	[p10l1290t2427r1480b2496],
8	ORs	NNS	O	or	dobj	7	SENT_199	[p10l1290t2427r1480b2496],
9	)	CD	NUMBER	)	dep	8	SENT_199	[p10l1290t2427r1480b2496],
10	and	CC	O	and	_	0	SENT_199	[p10l1508t2427r1621b2483],
11	P	NN	O	p	nn	12	SENT_199	[p10l1644t2429r1693b2482],
12	values	NNS	O	value	dobj	7	SENT_199	[p10l1717t2427r1918b2483],
13	of	IN	O	of	_	0	SENT_199	[p10l1946t2427r2015b2483],
14	this	DT	O	this	det	15	SENT_199	[p10l2034t2427r2147b2483],
15	analysis	NN	O	analysis	prep_of	12	SENT_199	[p10l8t2516r279b2588],
16	.	.	O	.	_	0	SENT_199	[p10l8t2516r279b2588],

1	The	DT	O	the	dep	101	SENT_200	[p10l304t2516r426b2572],
2	presence	NN	O	presence	dep	101	SENT_200	[p10l445t2533r725b2589],
3	of	IN	O	of	dep	101	SENT_200	[p10l747t2516r816b2572],
4	the	DT	O	the	dep	101	SENT_200	[p10l831t2516r927b2572],
5	T	NN	O	t	dep	101	SENT_200	[p10l947t2517r994b2571],
6	allele	NN	O	allele	dep	101	SENT_200	[p10l1016t2516r1186b2572],
7	(	CD	NUMBER	(	dep	101	SENT_200	[p10l1209t2516r1330b2585],
8	TT	NN	O	tt	dep	101	SENT_200	[p10l1209t2516r1330b2585],
9	or	CC	O	or	dep	101	SENT_200	[p10l1351t2533r1416b2572],
10	TC	NN	O	tc	dep	101	SENT_200	[p10l1435t2516r1534b2572],
11	genotypes	NNS	O	genotype	dep	101	SENT_200	[p10l1557t2516r1904b2589],
12	)	VBP	O	)	dep	101	SENT_200	[p10l1557t2516r1904b2589],
13	at	IN	O	at	dep	101	SENT_200	[p10l1928t2524r1984b2572],
14	SNP	NN	O	snp	dep	101	SENT_200	[p10l2005t2516r2148b2572],
15	rs3025000	NN	O	rs3025000	dep	101	SENT_200	[p10l6t2604r343b2661],
16	was	VBD	O	be	dep	101	SENT_200	[p10l392t2622r512b2661],
17	signiﬁcantly	RB	O	signiﬁcantly	dep	101	SENT_200	[p10l564t2605r956b2678],
18	associated	VBN	O	associate	dep	101	SENT_200	[p10l1006t2605r1333b2661],
19	with	IN	O	with	dep	101	SENT_200	[p10l1381t2605r1521b2661],
20	the	DT	O	the	dep	101	SENT_200	[p10l1568t2605r1664b2661],
21	likelihood	NN	O	likelihood	dep	101	SENT_200	[p10l1712t2605r2036b2661],
22	of	IN	O	of	dep	101	SENT_200	[p10l2084t2605r2153b2661],
23	patients	NNS	O	patient	dep	101	SENT_200	[p10l6t2694r253b2767],
24	to	TO	O	to	dep	101	SENT_200	[p10l276t2702r335b2750],
25	be	VB	O	be	dep	101	SENT_200	[p10l357t2694r432b2750],
26	in	IN	O	in	dep	101	SENT_200	[p10l454t2694r515b2749],
27	the	DT	O	the	dep	101	SENT_200	[p10l536t2694r632b2750],
28	responder	NN	O	responder	dep	101	SENT_200	[p10l654t2694r971b2767],
29	group	NN	O	group	dep	101	SENT_200	[p10l992t2711r1176b2767],
30	after	IN	O	after	dep	101	SENT_200	[p10l1200t2694r1345b2750],
31	3	CD	DURATION	3	dep	101	SENT_200	[p10l1368t2694r1400b2750],
32	months	NNS	NUMBER	month	dep	101	SENT_200	[p10l1426t2694r1658b2750],
33	(	CD	NUMBER	(	dep	101	SENT_200	[p10l1685t2694r1836b2763],
34	OR	NN	O	or	dep	101	SENT_200	[p10l1685t2694r1836b2763],
35	,	,	O	,	_	0	SENT_200	[p10l1685t2694r1836b2763],
36	2.7	CD	NUMBER	2.7	dep	101	SENT_200	[p10l1861t2694r1978b2760],
37	;	:	O	;	_	0	SENT_200	[p10l1861t2694r1978b2760],
38	95	CD	PERCENT	95	dep	101	SENT_200	[p10l2004t2694r2145b2751],
39	%	NN	PERCENT	%	dep	101	SENT_200	[p10l2004t2694r2145b2751],
40	conﬁdence	NN	O	conﬁdence	dep	101	SENT_200	[p10l7t2783r352b2839],
41	interval	NN	O	interval	dep	101	SENT_200	[p10l374t2783r617b2839],
42	[	CD	NUMBER	[	dep	101	SENT_200	[p10l645t2784r788b2851],
43	CI	NN	O	ci	dep	101	SENT_200	[p10l645t2784r788b2851],
44	]	NN	O	]	dep	101	SENT_200	[p10l645t2784r788b2851],
45	,	,	O	,	_	0	SENT_200	[p10l645t2784r788b2851],
46	1.46	CD	NUMBER	1.46	dep	101	SENT_200	[p10l820t2783r949b2839],
47	-5.07	CD	NUMBER	-5.07	dep	101	SENT_200	[p10l961t2783r1160b2850],
48	;	:	O	;	_	0	SENT_200	[p10l961t2783r1160b2850],
49	P	NN	O	p	dep	101	SENT_200	[p10l1184t2784r1332b2838],
50	<	JJR	O	<	dep	101	SENT_200	[p10l1184t2784r1332b2838],
51	1	CD	NUMBER	1	dep	101	SENT_200	[p10l1184t2784r1332b2838],
52	X	NN	O	x	dep	101	SENT_200	[p10l1369t2789r1417b2836],
53	10-3	CD	NUMBER	10-3	dep	101	SENT_200	[p10l1454t2772r1652b2852],
54	)	NN	O	)	dep	101	SENT_200	[p10l1454t2772r1652b2852],
55	,	,	O	,	_	0	SENT_200	[p10l1454t2772r1652b2852],
56	6	CD	DURATION	6	dep	101	SENT_200	[p10l1678t2783r1713b2839],
57	months	NNS	NUMBER	month	dep	101	SENT_200	[p10l1736t2783r1969b2839],
58	(	CD	NUMBER	(	dep	101	SENT_200	[p10l1994t2784r2145b2852],
59	OR	NN	O	or	dep	101	SENT_200	[p10l1994t2784r2145b2852],
60	,	,	O	,	_	0	SENT_200	[p10l1994t2784r2145b2852],
61	3.5	CD	NUMBER	3.5	dep	101	SENT_200	[p10l9t2872r124b2938],
62	;	:	O	;	_	0	SENT_200	[p10l9t2872r124b2938],
63	95	CD	PERCENT	95	dep	101	SENT_200	[p10l155t2872r296b2929],
64	%	NN	PERCENT	%	dep	101	SENT_200	[p10l155t2872r296b2929],
65	CI	NN	O	ci	dep	101	SENT_200	[p10l327t2873r421b2938],
66	,	,	O	,	_	0	SENT_200	[p10l327t2873r421b2938],
67	1.82-6	CD	NUMBER	1.82-6	dep	101	SENT_200	[p10l459t2872r799b2938],
68	.71	CD	NUMBER	.71	dep	101	SENT_200	[p10l459t2872r799b2938],
69	;	:	O	;	_	0	SENT_200	[p10l459t2872r799b2938],
70	P	NN	O	p	dep	101	SENT_200	[p10l828t2873r976b2927],
71	<	JJR	O	<	dep	101	SENT_200	[p10l828t2873r976b2927],
72	1	CD	NUMBER	1	dep	101	SENT_200	[p10l828t2873r976b2927],
73	x	NN	O	x	dep	101	SENT_200	[p10l1019t2878r1066b2925],
74	10	CD	NUMBER	10	dep	101	SENT_200	[p10l1110t2860r1307b2941],
75	*	CD	NUMBER	*	dep	101	SENT_200	[p10l1110t2860r1307b2941],
76	‘	CD	NUMBER	‘	dep	101	SENT_200	[p10l1110t2860r1307b2941],
77	)	NN	O	)	dep	101	SENT_200	[p10l1110t2860r1307b2941],
78	,	,	O	,	_	0	SENT_200	[p10l1110t2860r1307b2941],
79	and	CC	O	and	dep	101	SENT_200	[p10l1339t2873r1452b2928],
80	12	CD	DURATION	12	dep	101	SENT_200	[p10l1485t2873r1555b2927],
81	months	NNS	NUMBER	month	dep	101	SENT_200	[p10l1583t2873r1816b2928],
82	(	CD	NUMBER	(	dep	101	SENT_200	[p10l1847t2873r1998b2941],
83	OR	NN	O	or	dep	101	SENT_200	[p10l1847t2873r1998b2941],
84	,	,	O	,	_	0	SENT_200	[p10l1847t2873r1998b2941],
85	2.4	CD	NUMBER	2.4	dep	101	SENT_200	[p10l2028t2873r2145b2938],
86	;	:	O	;	_	0	SENT_200	[p10l2028t2873r2145b2938],
87	95	CD	PERCENT	95	dep	101	SENT_200	[p10l7t2960r148b3018],
88	%	NN	PERCENT	%	dep	101	SENT_200	[p10l7t2960r148b3018],
89	CI	NN	O	ci	dep	101	SENT_200	[p10l174t2961r269b3027],
90	,	,	O	,	_	0	SENT_200	[p10l174t2961r269b3027],
91	1.27-4	CD	NUMBER	1.27-4	dep	101	SENT_200	[p10l301t2960r642b3027],
92	.57	CD	NUMBER	.57	dep	101	SENT_200	[p10l301t2960r642b3027],
93	;	:	O	;	_	0	SENT_200	[p10l301t2960r642b3027],
94	P	NN	O	p	dep	101	SENT_200	[p10l665t2963r715b3016],
95	=	JJ	O	=	dep	101	SENT_200	[p10l744t2980r792b2999],
96	6	CD	NUMBER	6	dep	101	SENT_200	[p10l824t2960r859b3017],
97	X	NN	O	x	dep	101	SENT_200	[p10l891t2966r938b3014],
98	10	CD	NUMBER	10	dep	101	SENT_200	[p10l977t2948r1173b3030],
99	'	''	O	'	_	0	SENT_200	[p10l977t2948r1173b3030],
100	3	CD	NUMBER	3	dep	101	SENT_200	[p10l977t2948r1173b3030],
101	)	NN	O	)	_	0	SENT_200	[p10l977t2948r1173b3030],
102	.	.	O	.	_	0	SENT_200	[p10l977t2948r1173b3030],

1	Other	JJ	O	other	amod	2	SENT_201	[p10l1200t2961r1381b3017],
2	SNPs	NNS	O	snp	nsubj	5	SENT_201	[p10l1404t2961r1576b3017],
3	did	VBD	O	do	aux	5	SENT_201	[p10l1601t2961r1701b3017],
4	not	RB	O	not	neg	5	SENT_201	[p10l1722t2969r1824b3017],
5	show	VB	O	show	_	0	SENT_201	[p10l1848t2961r2012b3017],
6	any	DT	O	any	det	8	SENT_201	[p10l2036t2978r2148b3033],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_201	[p10l9t3050r340b3123],
8	association	NN	O	association	dobj	5	SENT_201	[p10l370t3050r723b3106],
9	with	IN	O	with	_	0	SENT_201	[p10l753t3050r894b3106],
10	the	DT	O	the	det	12	SENT_201	[p10l922t3050r1018b3106],
11	VA	NNP	LOCATION	VA	nn	12	SENT_201	[p10l1047t3050r1161b3106],
12	outcome	NN	O	outcome	prep_with	5	SENT_201	[p10l1191t3058r1480b3106],
13	.	.	O	.	_	0	SENT_201	[p10l1191t3058r1480b3106],

1	Out	IN	O	out	_	0	SENT_202	[p10l115t3139r233b3195],
2	of	IN	O	of	prepc_out_of	35	SENT_202	[p10l265t3139r334b3195],
3	105	CD	NUMBER	105	num	4	SENT_202	[p10l369t3139r477b3195],
4	patients	NNS	O	patient	pobj	35	SENT_202	[p10l511t3139r759b3212],
5	with	IN	O	with	_	0	SENT_202	[p10l793t3139r934b3195],
6	the	DT	O	the	det	7	SENT_202	[p10l966t3139r1062b3195],
7	presence	NN	O	presence	prep_with	4	SENT_202	[p10l1093t3156r1373b3212],
8	of	IN	O	of	_	0	SENT_202	[p10l1407t3139r1476b3195],
9	the	DT	O	the	det	11	SENT_202	[p10l1503t3139r1599b3195],
10	T	NN	O	t	nn	11	SENT_202	[p10l1631t3140r1678b3194],
11	allele	NN	O	allele	prep_of	7	SENT_202	[p10l1712t3139r1882b3195],
12	at	IN	O	at	_	0	SENT_202	[p10l1917t3147r1972b3195],
13	SNP	NN	ORGANIZATION	snp	prep_at	11	SENT_202	[p10l2005t3139r2149b3195],
14	rs3025000	CD	NUMBER	rs3025000	num	13	SENT_202	[p10l6t3227r361b3294],
15	,	,	O	,	_	0	SENT_202	[p10l6t3227r361b3294],
16	73	CD	PERCENT	73	prep_of	7	SENT_202	[p10l392t3228r465b3284],
17	(	CD	PERCENT	(	number	18	SENT_202	[p10l500t3227r773b3297],
18	69.5	CD	PERCENT	69.5	num	19	SENT_202	[p10l500t3227r773b3297],
19	%	NN	PERCENT	%	dep	16	SENT_202	[p10l500t3227r773b3297],
20	)	CD	NUMBER	)	dep	16	SENT_202	[p10l500t3227r773b3297],
21	,	,	O	,	_	0	SENT_202	[p10l500t3227r773b3297],
22	64	CD	PERCENT	64	number	23	SENT_202	[p10l805t3228r882b3284],
23	(	CD	PERCENT	(	prep_of	7	SENT_202	[p10l913t3228r1126b3297],
24	61	CD	PERCENT	61	num	25	SENT_202	[p10l913t3228r1126b3297],
25	%	NN	PERCENT	%	dep	23	SENT_202	[p10l913t3228r1126b3297],
26	)	CD	NUMBER	)	dep	23	SENT_202	[p10l913t3228r1126b3297],
27	,	,	O	,	_	0	SENT_202	[p10l913t3228r1126b3297],
28	and	CC	O	and	_	0	SENT_202	[p10l1158t3228r1271b3284],
29	62	CD	PERCENT	62	number	30	SENT_202	[p10l1299t3228r1375b3284],
30	(	CD	PERCENT	(	conj_and	11	SENT_202	[p10l1407t3227r1600b3297],
31	59	CD	PERCENT	59	num	32	SENT_202	[p10l1407t3227r1600b3297],
32	%	NN	PERCENT	%	dep	30	SENT_202	[p10l1407t3227r1600b3297],
33	)	CD	NUMBER	)	num	34	SENT_202	[p10l1407t3227r1600b3297],
34	patients	NNS	O	patient	nsubj	35	SENT_202	[p10l1629t3228r1876b3301],
35	were	VBD	O	be	_	0	SENT_202	[p10l1906t3245r2060b3284],
36	in	IN	O	in	_	0	SENT_202	[p10l2087t3228r2148b3283],
37	the	DT	O	the	det	39	SENT_202	[p10l6t3317r102b3373],
38	responder	NN	O	responder	nn	39	SENT_202	[p10l148t3317r466b3390],
39	group	NN	O	group	prep_in	35	SENT_202	[p10l513t3334r696b3390],
40	after	IN	O	after	_	0	SENT_202	[p10l746t3317r891b3373],
41	3	CD	NUMBER	3	prep_after	35	SENT_202	[p10l938t3317r991b3383],
42	,	,	O	,	_	0	SENT_202	[p10l938t3317r991b3383],
43	6	CD	NUMBER	6	conj_and	41	SENT_202	[p10l1043t3317r1096b3383],
44	,	,	O	,	_	0	SENT_202	[p10l1043t3317r1096b3383],
45	and	CC	DURATION	and	_	0	SENT_202	[p10l1148t3317r1261b3373],
46	12	CD	DURATION	12	num	47	SENT_202	[p10l1315t3317r1385b3372],
47	months	NNS	NUMBER	month	conj_and	41	SENT_202	[p10l1433t3317r1665b3373],
48	of	IN	O	of	_	0	SENT_202	[p10l1716t3317r1785b3373],
49	treatment	NN	O	treatment	prep_of	47	SENT_202	[p10l1827t3325r2145b3383],
50	,	,	O	,	_	0	SENT_202	[p10l1827t3325r2145b3383],
51	respectively	RB	O	respectively	advmod	35	SENT_202	[p10l6t3405r409b3478],
52	.	.	O	.	_	0	SENT_202	[p10l6t3405r409b3478],

1	However	RB	O	however	dep	5	SENT_203	[p10l450t3407r759b3472],
2	,	,	O	,	_	0	SENT_203	[p10l450t3407r759b3472],
3	in	IN	O	in	dep	1	SENT_203	[p10l798t3405r859b3461],
4	96	CD	NUMBER	96	pobj	3	SENT_203	[p10l896t3405r972b3463],
5	patients	NNS	O	patient	dep	17	SENT_203	[p10l1009t3405r1256b3478],
6	with	IN	O	with	_	0	SENT_203	[p10l1295t3405r1435b3462],
7	CC	NN	O	cc	nn	8	SENT_203	[p10l1472t3406r1575b3462],
8	genotype	NN	O	genotype	prep_with	5	SENT_203	[p10l1614t3414r1905b3478],
9	at	IN	O	at	_	0	SENT_203	[p10l1944t3414r1999b3462],
10	this	DT	O	this	det	11	SENT_203	[p10l2035t3405r2147b3462],
11	SNP	NN	O	snp	prep_at	8	SENT_203	[p10l8t3495r152b3551],
12	only	RB	O	only	quantmod	14	SENT_203	[p10l182t3495r320b3567],
13	44	CD	PERCENT	44	number	14	SENT_203	[p10l350t3495r427b3550],
14	(	CD	PERCENT	(	num	11	SENT_203	[p10l459t3494r733b3564],
15	45.8	CD	PERCENT	45.8	num	16	SENT_203	[p10l459t3494r733b3564],
16	%	NN	PERCENT	%	dep	17	SENT_203	[p10l459t3494r733b3564],
17	)	CD	NUMBER	)	dep	31	SENT_203	[p10l459t3494r733b3564],
18	,	,	O	,	_	0	SENT_203	[p10l459t3494r733b3564],
19	30	CD	PERCENT	30	num	20	SENT_203	[p10l767t3495r843b3551],
20	(	CD	PERCENT	(	appos	17	SENT_203	[p10l874t3495r1148b3564],
21	31.2	CD	PERCENT	31.2	number	22	SENT_203	[p10l874t3495r1148b3564],
22	%	NN	PERCENT	%	amod	20	SENT_203	[p10l874t3495r1148b3564],
23	)	CD	NUMBER	)	dep	20	SENT_203	[p10l874t3495r1148b3564],
24	,	,	O	,	_	0	SENT_203	[p10l874t3495r1148b3564],
25	and	CC	O	and	_	0	SENT_203	[p10l1181t3495r1294b3551],
26	37	CD	PERCENT	37	dep	31	SENT_203	[p10l1324t3495r1398b3551],
27	(	CD	PERCENT	(	number	28	SENT_203	[p10l1432t3494r1686b3564],
28	38.5	CD	PERCENT	38.5	dep	29	SENT_203	[p10l1432t3494r1686b3564],
29	%	NN	PERCENT	%	dep	26	SENT_203	[p10l1432t3494r1686b3564],
30	)	CD	NUMBER	)	num	31	SENT_203	[p10l1432t3494r1686b3564],
31	patients	NNS	O	patient	dep	32	SENT_203	[p10l1716t3494r1963b3567],
32	were	VBD	O	be	_	0	SENT_203	[p10l1994t3512r2148b3551],

1	Table	NNP	O	Table	_	0	SENT_204	[p10l55t3642r141b3671],
2	5	CD	NUMBER	5	dep	1	SENT_204	[p10l156t3642r181b3670],
3	.	.	O	.	_	0	SENT_204	[p10l156t3642r181b3670],

1	P	NN	O	p	nn	2	SENT_205	[p10l202t3643r222b3670],
2	Values	NNS	O	value	_	0	SENT_205	[p10l235t3642r336b3671],
3	for	IN	O	for	_	0	SENT_205	[p10l350t3642r391b3671],
4	Association	NNP	O	Association	prep_for	2	SENT_205	[p10l404t3643r583b3671],
5	of	IN	O	of	_	0	SENT_205	[p10l596t3642r627b3671],
6	Each	DT	O	each	det	11	SENT_205	[p10l638t3642r712b3671],
7	Tag	NNP	O	Tag	nn	11	SENT_205	[p10l725t3643r783b3678],
8	Single	JJ	O	single	amod	11	SENT_205	[p10l796t3642r890b3678],
9	Nucleotide	NN	O	nucleotide	nn	11	SENT_205	[p10l904t3642r1071b3671],
10	Polymorphism	NN	O	polymorphism	nn	11	SENT_205	[p10l1086t3642r1304b3678],
11	(	NN	O	(	prep_of	4	SENT_205	[p10l1319t3642r1426b3675],
12	tSNP	NN	O	tsnp	nn	13	SENT_205	[p10l1319t3642r1426b3675],
13	)	NN	O	)	dep	2	SENT_205	[p10l1319t3642r1426b3675],
14	of	IN	O	of	_	0	SENT_205	[p10l1442t3642r1473b3671],
15	the	DT	O	the	det	19	SENT_205	[p10l1484t3642r1532b3671],
16	Vascular	JJ	O	vascular	amod	19	SENT_205	[p10l1546t3642r1677b3671],
17	Endothelial	JJ	O	endothelial	amod	19	SENT_205	[p10l1690t3642r1866b3671],
18	Growth	NN	O	growth	nn	19	SENT_205	[p10l1880t3642r1998b3671],
19	Factor	NN	O	factor	prep_of	13	SENT_205	[p10l2011t3643r2106b3671],

1	A	DT	O	a	det	3	SENT_206	[p10l142t3683r170b3710],
2	(	JJ	O	(	amod	3	SENT_206	[p10l186t3682r335b3716],
3	VEGFA	NN	O	vegfa	dep	12	SENT_206	[p10l186t3682r335b3716],
4	)	CD	NUMBER	)	num	5	SENT_206	[p10l186t3682r335b3716],
5	Gene	NN	O	gene	dep	3	SENT_206	[p10l351t3683r432b3711],
6	with	IN	O	with	_	0	SENT_206	[p10l446t3682r515b3711],
7	Mean	NN	O	mean	prep_with	5	SENT_206	[p10l528t3684r615b3711],
8	Change	NNP	O	Change	dep	12	SENT_206	[p10l628t3682r745b3718],
9	in	IN	O	in	_	0	SENT_206	[p10l760t3686r790b3710],
10	Visual	NNP	O	Visual	nn	11	SENT_206	[p10l802t3682r898b3711],
11	Acuity	NNP	O	Acuity	prep_in	12	SENT_206	[p10l911t3683r1014b3718],
12	after	IN	O	after	dep	23	SENT_206	[p10l1029t3682r1096b3711],
13	3	CD	NUMBER	3	pobj	12	SENT_206	[p10l1109t3684r1134b3716],
14	,	,	O	,	_	0	SENT_206	[p10l1109t3684r1134b3716],
15	6	CD	NUMBER	6	appos	13	SENT_206	[p10l1150t3683r1175b3716],
16	,	,	O	,	_	0	SENT_206	[p10l1150t3683r1175b3716],
17	and	CC	DURATION	and	_	0	SENT_206	[p10l1191t3682r1246b3711],
18	12	CD	DURATION	12	num	19	SENT_206	[p10l1262t3684r1294b3710],
19	Months	NNS	DURATION	month	conj_and	12	SENT_206	[p10l1309t3682r1426b3711],
20	of	IN	O	of	_	0	SENT_206	[p10l1441t3682r1472b3711],
21	Anti	NNP	O	Anti	prep_of	19	SENT_206	[p10l1482t3682r1698b3711],
22	—	CD	NUMBER	—	num	21	SENT_206	[p10l1482t3682r1698b3711],
23	\	CD	NUMBER	\	dep	27	SENT_206	[p10l1482t3682r1698b3711],
24	/	:	O	/	punct	27	SENT_206	[p10l1482t3682r1698b3711],
25	ascular	JJ	O	ascular	amod	27	SENT_206	[p10l1482t3682r1698b3711],
26	Endothelial	JJ	O	endothelial	amod	27	SENT_206	[p10l1711t3682r1887b3711],
27	Growth	NN	O	growth	_	0	SENT_206	[p10l1901t3682r2019b3711],

1	Factor	NN	O	factor	nn	4	SENT_207	[p10l945t3724r1041b3751],
2	Treatment	NN	O	treatment	nn	4	SENT_207	[p10l1053t3724r1215b3751],
3	tSNP	NN	O	tsnp	nn	4	SENT_207	[p11l79t21r155b45],
4	rs3OZ4-994	NN	O	rs3oz4-994	dep	11	SENT_207	[p11l309t22r463b47],
5	3	CD	DURATION	3	num	6	SENT_207	[p11l43t87r56b112],
6	months	NNS	NUMBER	month	dep	4	SENT_207	[p11l71t86r171b112],
7	P	NN	O	p	dep	11	SENT_207	[p11l76t127r109b151],
8	*	CD	NUMBER	*	num	7	SENT_207	[p11l76t127r109b151],
9	0.77	CD	NUMBER	0.77	num	11	SENT_207	[p11l358t127r413b152],
10	3	CD	NUMBER	3	num	11	SENT_207	[p11l77t160r107b196],
11	*	NN	O	*	dep	17	SENT_207	[p11l77t160r107b196],
12	0.79	CD	NUMBER	0.79	num	13	SENT_207	[p11l358t165r414b191],
13	SE	NN	O	se	dep	11	SENT_207	[p11l76t204r112b229],
14	2.76	CD	NUMBER	2.76	number	15	SENT_207	[p11l358t204r414b230],
15	6	CD	DURATION	6	num	16	SENT_207	[p11l43t236r58b260],
16	months	NNS	NUMBER	month	tmod	13	SENT_207	[p11l71t235r171b260],
17	P	NN	O	p	dep	21	SENT_207	[p11l76t275r108b300],
18	*	CD	NUMBER	*	num	17	SENT_207	[p11l76t275r108b300],
19	0.25	CD	NUMBER	0.25	num	21	SENT_207	[p11l357t275r412b300],
20	3	CD	NUMBER	3	num	21	SENT_207	[p11l77t310r107b346],
21	*	NN	O	*	dep	27	SENT_207	[p11l77t310r107b346],
22	3.51	CD	NUMBER	3.51	num	23	SENT_207	[p11l357t314r412b339],
23	SE	NN	O	se	dep	21	SENT_207	[p11l76t354r112b378],
24	3.02	CD	NUMBER	3.02	number	25	SENT_207	[p11l357t354r414b378],
25	12	CD	DURATION	12	num	26	SENT_207	[p11l46t385r74b410],
26	months	NNS	NUMBER	month	tmod	23	SENT_207	[p11l87t384r188b410],
27	P	NN	O	p	dep	33	SENT_207	[p11l76t425r108b450],
28	*	CD	NUMBER	*	num	27	SENT_207	[p11l76t425r108b450],
29	0.12	CD	NUMBER	0.12	number	30	SENT_207	[p11l357t425r413b450],
30	3	CD	NUMBER	3	dep	27	SENT_207	[p11l77t459r107b495],
31	*	NN	O	*	dep	30	SENT_207	[p11l77t459r107b495],
32	5.10	CD	NUMBER	5.10	num	31	SENT_207	[p11l358t463r414b488],
33	SE	NN	O	se	_	0	SENT_207	[p11l76t502r112b527],
34	3.30	CD	NUMBER	3.30	num	33	SENT_207	[p11l357t503r414b527],

1	SE	NN	O	se	_	0	SENT_208	[p11l43t602r79b627],
2	=	JJ	O	=	amod	4	SENT_208	[p11l94t611r114b619],
3	standard	JJ	O	standard	amod	4	SENT_208	[p11l130t601r243b627],
4	error	NN	O	error	dep	1	SENT_208	[p11l256t611r326b627],
5	.	.	O	.	_	0	SENT_208	[p11l256t611r326b627],

1	rs3025000	NN	O	rs3025000	nn	2	SENT_209	[p11l588t21r742b45],
2	rs3025010	NN	O	rs3025010	_	0	SENT_209	[p11l867t21r1022b45],

1	0.01	CD	NUMBER	0.01	num	2	SENT_210	[p11l637t127r691b151],
2	0.58	CD	NUMBER	0.58	dep	12	SENT_210	[p11l930t126r987b151],
3	3.96	CD	NUMBER	3.96	number	4	SENT_210	[p11l637t165r693b190],
4	-0.93	CD	NUMBER	-0.93	num	6	SENT_210	[p11l906t165r985b190],
5	1.58	CD	NUMBER	1.58	number	6	SENT_210	[p11l640t203r693b229],
6	1.71	CD	NUMBER	1.71	npadvmod	7	SENT_210	[p11l933t204r984b230],
7	<	JJR	O	<	amod	2	SENT_210	[p11l585t276r624b300],
8	1	CD	NUMBER	1	dep	2	SENT_210	[p11l585t276r624b300],
9	x	NN	O	x	dep	12	SENT_210	[p11l643t279r662b298],
10	10	CD	NUMBER	10	num	9	SENT_210	[p11l681t271r749b300],
11	“‘	CD	NUMBER	“‘	num	12	SENT_210	[p11l681t271r749b300],
12	0.88	CD	NUMBER	0.88	dep	17	SENT_210	[p11l930t275r987b300],
13	7.11	CD	NUMBER	7.11	num	14	SENT_210	[p11l638t315r691b341],
14	-0.29	CD	NUMBER	-0.29	dep	12	SENT_210	[p11l906t315r987b339],
15	1.69	CD	NUMBER	1.69	number	16	SENT_210	[p11l640t354r693b378],
16	1.88	CD	NUMBER	1.88	num	17	SENT_210	[p11l933t354r987b378],
17	0.01	CD	NUMBER	0.01	dep	19	SENT_210	[p11l637t425r691b450],
18	0.12	CD	NUMBER	0.12	dep	17	SENT_210	[p11l930t425r986b450],
19	4.57	CD	NUMBER	4.57	dep	20	SENT_210	[p11l637t463r692b490],
20	-3.16	CD	NUMBER	-3.16	dep	22	SENT_210	[p11l906t464r987b488],
21	1.91	CD	NUMBER	1.91	num	22	SENT_210	[p11l640t503r691b527],
22	2.05	CD	NUMBER	2.05	_	0	SENT_210	[p11l931t502r985b527],

1	rs3025030	NN	O	rs3025030	nn	2	SENT_211	[p11l1141t21r1295b45],
2	rs3025035	NN	O	rs3025035	_	0	SENT_211	[p11l1414t21r1566b45],

1	rs3025	NN	O	rs3025	_	0	SENT_212	[p11l1687t21r1784b45],
2	042	CD	NUMBER	042	num	1	SENT_212	[p11l1788t22r1841b47],

1	rs3025	NN	O	rs3025	_	0	SENT_213	[p11l1961t21r2057b45],
2	047	CD	NUMBER	047	num	1	SENT_213	[p11l2061t22r2113b47],

1	Least	VB	O	least	csubjpass	27	SENT_214	[p11l43t639r219b670],
2	—	CD	NUMBER	—	num	5	SENT_214	[p11l43t639r219b670],
3	squares	NNS	O	square	nn	5	SENT_214	[p11l43t639r219b670],
4	regression	NN	O	regression	nn	5	SENT_214	[p11l230t642r363b670],
5	modeling	NN	O	modeling	dobj	1	SENT_214	[p11l373t638r498b670],
6	adjusted	VBN	O	adjust	partmod	5	SENT_214	[p11l510t638r619b670],
7	for	IN	O	for	_	0	SENT_214	[p11l630t638r666b663],
8	age	NN	O	age	prep_for	6	SENT_214	[p11l677t648r727b670],
9	,	,	O	,	_	0	SENT_214	[p11l677t648r727b670],
10	sex	NN	O	sex	conj_and	8	SENT_214	[p11l740t648r788b668],
11	,	,	O	,	_	0	SENT_214	[p11l740t648r788b668],
12	smoking	NN	O	smoking	nn	13	SENT_214	[p11l800t638r912b670],
13	status	NN	O	status	prep_for	6	SENT_214	[p11l923t646r1005b668],
14	,	,	O	,	_	0	SENT_214	[p11l923t646r1005b668],
15	baseline	NN	O	baseline	nn	17	SENT_214	[p11l1017t638r1125b663],
16	visual	JJ	O	visual	amod	17	SENT_214	[p11l1136t638r1213b663],
17	acuity	NN	O	acuity	prep_for	6	SENT_214	[p11l1224t642r1311b670],
18	,	,	O	,	_	0	SENT_214	[p11l1224t642r1311b670],
19	lesion	NN	O	lesion	nn	20	SENT_214	[p11l1324t638r1402b663],
20	type	NN	O	type	conj_and	8	SENT_214	[p11l1413t646r1476b670],
21	,	,	O	,	_	0	SENT_214	[p11l1413t646r1476b670],
22	and	CC	O	and	_	0	SENT_214	[p11l1489t638r1537b663],
23	choroidal	JJ	O	choroidal	amod	25	SENT_214	[p11l1548t638r1675b663],
24	neovascularization	NN	O	neovascularization	nn	25	SENT_214	[p11l1685t638r1935b663],
25	size	NN	O	size	conj_and	8	SENT_214	[p11l1945t642r1990b663],
26	was	VBD	O	be	auxpass	27	SENT_214	[p11l2001t648r2048b663],
27	used	VBN	O	use	_	0	SENT_214	[p11l2059t638r2118b663],
28	for	IN	O	for	_	0	SENT_214	[p11l42t675r79b701],
29	the	DT	O	the	det	30	SENT_214	[p11l91t675r134b701],
30	analysis	NN	O	analysis	prep_for	27	SENT_214	[p11l147t675r256b707],
31	.	.	O	.	_	0	SENT_214	[p11l147t675r256b707],

1	*	NN	O	*	nn	2	SENT_215	[p11l44t712r223b744],
2	Signiﬁcance	NN	O	signiﬁcance	nsubj	3	SENT_215	[p11l44t712r223b744],
3	accepted	VBN	O	accept	_	0	SENT_215	[p11l236t712r353b744],
4	at	IN	O	at	_	0	SENT_215	[p11l365t720r390b737],
5	P	NN	O	p	prep_at	3	SENT_215	[p11l402t713r520b738],
6	<	VBG	O	<	partmod	5	SENT_215	[p11l402t713r520b738],
7	0.007	CD	NUMBER	0.007	number	8	SENT_215	[p11l402t713r520b738],
8	(	CD	NUMBER	(	num	10	SENT_215	[p11l536t712r625b742],
9	bold	JJ	O	bold	amod	10	SENT_215	[p11l536t712r625b742],
10	)	NN	O	)	dobj	6	SENT_215	[p11l536t712r625b742],
11	.	.	O	.	_	0	SENT_215	[p11l536t712r625b742],

1	T3	NN	O	t3	nsubj	8	SENT_216	[p11l43t745r74b781],
2	is	VBZ	O	be	cop	6	SENT_216	[p11l85t752r102b774],
3	the	DT	O	the	det	6	SENT_216	[p11l112t749r154b774],
4	linear	JJ	O	linear	amod	6	SENT_216	[p11l165t748r241b774],
5	regression	NN	O	regression	nn	6	SENT_216	[p11l250t752r382b781],
6	coefficient	NN	O	coefficient	_	0	SENT_216	[p11l391t749r531b774],
7	and	CC	O	and	_	0	SENT_216	[p11l540t748r588b774],
8	represents	VBZ	O	represent	conj_and	6	SENT_216	[p11l597t757r731b781],
9	the	DT	O	the	det	10	SENT_216	[p11l741t748r783b774],
10	change	NN	O	change	dobj	8	SENT_216	[p11l793t748r887b781],
11	in	IN	O	in	_	0	SENT_216	[p11l898t752r924b774],
12	visual	JJ	O	visual	amod	13	SENT_216	[p11l932t748r1009b774],
13	acuity	NN	O	acuity	prep_in	10	SENT_216	[p11l1018t752r1098b781],
14	in	IN	O	in	_	0	SENT_216	[p11l1108t752r1134b774],
15	the	DT	O	the	det	16	SENT_216	[p11l1143t749r1186b774],
16	presence	NN	O	presence	prep_in	8	SENT_216	[p11l1195t759r1310b781],
17	of	IN	O	of	_	0	SENT_216	[p11l1320t749r1347b774],
18	the	DT	O	the	det	21	SENT_216	[p11l1354t748r1396b774],
19	minor	JJ	O	minor	amod	21	SENT_216	[p11l1406t752r1486b774],
20	allele	NN	O	allele	nn	21	SENT_216	[p11l1495t748r1565b774],
21	(	NN	O	(	prep_of	16	SENT_216	[p11l1577t749r1749b781],
22	homozygous	JJ	O	homozygous	amod	25	SENT_216	[p11l1577t749r1749b781],
23	or	CC	O	or	_	0	SENT_216	[p11l1759t759r1786b774],
24	heterozygous	JJ	O	heterozygous	amod	25	SENT_216	[p11l1794t748r1976b781],
25	)	NN	O	)	dobj	6	SENT_216	[p11l1794t748r1976b781],
26	compared	VBN	O	compare	_	0	SENT_216	[p11l1987t749r2118b781],
27	with	IN	O	with	prepc_compared_with	6	SENT_216	[p11l42t786r103b811],
28	homozygous	JJ	O	homozygous	amod	30	SENT_216	[p11l115t786r277b818],
29	major	JJ	O	major	amod	30	SENT_216	[p11l289t790r366b818],
30	allele	NN	O	allele	pobj	6	SENT_216	[p11l378t786r449b811],
31	at	IN	O	at	_	0	SENT_216	[p11l462t794r486b811],
32	each	DT	O	each	det	33	SENT_216	[p11l499t786r561b811],
33	tSNP	NN	O	tsnp	prep_at	30	SENT_216	[p11l573t787r652b811],
34	.	.	O	.	_	0	SENT_216	[p11l573t787r652b811],

1	Abedi	NNP	PERSON	Abedi	nn	3	SENT_217	[p11l433t969r535b1004],
2	et	NNP	O	et	nn	3	SENT_217	[p11l552t980r581b1004],
3	al	NNP	O	al	_	0	SENT_217	[p11l597t969r627b1004],
4	-	:	O	-	_	0	SENT_217	[p11l654t984r661b991],
5	VEGFA	NNP	O	VEGFA	nn	7	SENT_217	[p11l687t970r840b1004],
6	Gene	NNP	O	Gene	nn	7	SENT_217	[p11l856t970r956b1004],
7	Variants	NNS	O	variant	dep	3	SENT_217	[p11l973t971r1129b1004],
8	and	CC	O	and	_	0	SENT_217	[p11l1147t969r1214b1004],
9	Anti	NNP	O	Anti	dep	3	SENT_217	[p11l1230t970r1451b1004],
10	.	.	O	.	_	0	SENT_217	[p11l1230t970r1451b1004],

1	—	NN	O	—	_	0	SENT_218	[p11l1230t970r1451b1004],
2	.	.	O	.	_	0	SENT_218	[p11l1230t970r1451b1004],

1	VEGF	NN	O	vegf	_	0	SENT_219	[p11l1230t970r1451b1004],
2	in	IN	O	in	_	0	SENT_219	[p11l1469t974r1505b1004],
3	Wet	NNP	O	Wet	nn	4	SENT_219	[p11l1520t971r1601b1004],
4	AMD	NNP	O	AMD	prep_in	1	SENT_219	[p11l1617t970r1726b1004],

1	Table	NNP	O	Table	_	0	SENT_220	[p11l104t1071r190b1100],
2	6	CD	NUMBER	6	dep	1	SENT_220	[p11l205t1072r230b1100],
3	.	.	O	.	_	0	SENT_220	[p11l205t1072r230b1100],

1	Odds	NNS	O	odds	nn	2	SENT_221	[p11l251t1071r329b1100],
2	Ratios	NNS	O	ratio	dep	17	SENT_221	[p11l343t1072r437b1100],
3	and	CC	O	and	_	0	SENT_221	[p11l452t1071r506b1100],
4	P	NN	O	p	nn	5	SENT_221	[p11l520t1072r540b1099],
5	Values	NNS	O	value	conj_and	2	SENT_221	[p11l553t1071r654b1100],
6	for	IN	O	for	_	0	SENT_221	[p11l667t1071r709b1100],
7	the	DT	O	the	det	8	SENT_221	[p11l722t1071r770b1100],
8	Association	NNP	O	Association	prep_for	2	SENT_221	[p11l784t1072r963b1100],
9	of	IN	O	of	_	0	SENT_221	[p11l976t1071r1007b1100],
10	Each	DT	O	each	det	13	SENT_221	[p11l1018t1071r1092b1100],
11	Tag	NNP	O	Tag	nn	13	SENT_221	[p11l1105t1072r1163b1107],
12	Single	JJ	O	single	amod	13	SENT_221	[p11l1177t1071r1270b1107],
13	Nucleotide	NN	O	nucleotide	prep_of	8	SENT_221	[p11l1284t1071r1452b1100],
14	Polymorphism	NN	O	polymorphism	nn	15	SENT_221	[p11l1466t1071r1684b1107],
15	(	NN	O	(	dep	17	SENT_221	[p11l1699t1071r1806b1105],
16	tSNP	NN	O	tsnp	nn	17	SENT_221	[p11l1699t1071r1806b1105],
17	)	NN	O	)	dep	32	SENT_221	[p11l1699t1071r1806b1105],
18	of	IN	O	of	_	0	SENT_221	[p11l1822t1071r1853b1100],
19	the	DT	O	the	det	24	SENT_221	[p11l1864t1071r1912b1100],
20	Vascular	JJ	O	vascular	amod	24	SENT_221	[p11l1926t1071r2057b1100],
21	Endothelial	JJ	O	endothelial	amod	24	SENT_221	[p11l82t1112r258b1141],
22	Growth	NN	O	growth	nn	24	SENT_221	[p11l272t1112r389b1141],
23	Factor	NN	O	factor	nn	24	SENT_221	[p11l403t1114r498b1141],
24	A	NN	O	a	prep_of	17	SENT_221	[p11l511t1113r539b1141],
25	Gene	NN	O	gene	dep	32	SENT_221	[p11l553t1113r635b1141],
26	with	IN	O	with	_	0	SENT_221	[p11l649t1112r717b1141],
27	the	DT	O	the	det	28	SENT_221	[p11l730t1112r778b1141],
28	Likelihood	NN	O	likelihood	prep_with	25	SENT_221	[p11l792t1112r956b1141],
29	of	IN	O	of	_	0	SENT_221	[p11l970t1113r1001b1141],
30	a	DT	O	a	det	31	SENT_221	[p11l1012t1124r1027b1141],
31	Patient	NN	O	patient	prep_of	28	SENT_221	[p11l1041t1114r1150b1141],
32	Being	VBG	O	be	_	0	SENT_221	[p11l1164t1114r1250b1148],
33	in	IN	O	in	_	0	SENT_221	[p11l1265t1116r1294b1141],
34	the	DT	O	the	det	38	SENT_221	[p11l1308t1112r1355b1141],
35	Responder	NNP	O	Responder	nn	38	SENT_221	[p11l1369t1112r1529b1148],
36	Versus	NNP	O	Versus	nn	38	SENT_221	[p11l1543t1124r1632b1141],
37	Stable/Nonresponder	NNP	O	Stable/Nonresponder	nn	38	SENT_221	[p11l1647t1112r1969b1148],
38	Group	NNP	O	Group	prep_in	32	SENT_221	[p11l1982t1113r2078b1148],
39	after	IN	O	after	_	0	SENT_221	[p11l630t1153r698b1182],
40	Anti	NNP	O	Anti	prep_after	32	SENT_221	[p11l711t1153r927b1182],
41	»	CD	NUMBER	»	num	49	SENT_221	[p11l711t1153r927b1182],
42	Vascular	JJ	O	vascular	amod	49	SENT_221	[p11l711t1153r927b1182],
43	Endothelial	JJ	O	endothelial	amod	49	SENT_221	[p11l940t1153r1116b1182],
44	Growth	NN	O	growth	nn	49	SENT_221	[p11l1130t1153r1248b1182],
45	Factor	NN	O	factor	nn	49	SENT_221	[p11l1261t1154r1356b1182],
46	Treatment	NN	O	treatment	nn	49	SENT_221	[p11l1369t1154r1531b1182],
47	tSNP	NN	O	tsnp	nn	49	SENT_221	[p11l75t1322r152b1346],
48	Genotype	NN	O	genotype	nn	49	SENT_221	[p11l276t1322r410b1353],
49	rs3024994	NN	O	rs3024994	dep	40	SENT_221	[p11l8t1408r322b1468],

1	rs3025000	NN	O	rs3025000	_	0	SENT_222	[p11l8t1585r322b1642],

1	rs3025010	NN	O	rs3025010	_	0	SENT_223	[p11l8t1762r322b1819],

1	rs3025030	NN	O	rs3025030	_	0	SENT_224	[p11l7t1942r322b1999],

1	rs3025035	NN	O	rs3025035	_	0	SENT_225	[p11l8t2121r318b2178],

1	rs3025047	NN	O	rs3025047	_	0	SENT_226	[p11l8t2300r319b2362],

1	CI	NN	O	ci	_	0	SENT_227	[p11l8t2619r84b2674],
2	=	SYM	O	=	dep	1	SENT_227	[p11l121t2640r167b2658],

1	1.41	CD	NUMBER	1.41	num	2	SENT_228	[p11l14t3277r121b3332],
2	(	CD	NUMBER	(	_	0	SENT_228	[p11l151t3274r472b3337],
3	O.	NNP	O	O.	dep	2	SENT_228	[p11l151t3274r472b3337],
4	71	CD	NUMBER	71	num	3	SENT_228	[p11l151t3274r472b3337],
5	—	CD	NUMBER	—	number	6	SENT_228	[p11l151t3274r472b3337],
6	2.83	CD	NUMBER	2.83	num	7	SENT_228	[p11l151t3274r472b3337],
7	)	NN	O	)	dep	3	SENT_228	[p11l151t3274r472b3337],

1	3	CD	DURATION	3	num	2	SENT_229	[p11l675t1240r691b1264],
2	Months	NNS	DURATION	month	_	0	SENT_229	[p11l705t1238r811b1264],

1	OR	NN	O	or	dep	15	SENT_230	[p11l522t1322r567b1346],
2	(	CD	PERCENT	(	number	3	SENT_230	[p11l581t1321r651b1350],
3	95	CD	PERCENT	95	num	4	SENT_230	[p11l581t1321r651b1350],
4	%	NN	PERCENT	%	dep	1	SENT_230	[p11l581t1321r651b1350],
5	CI	NN	O	ci	nn	8	SENT_230	[p11l664t1321r708b1350],
6	)	CD	NUMBER	)	num	8	SENT_230	[p11l664t1321r708b1350],
7	P	NN	O	p	nn	8	SENT_230	[p11l844t1322r861b1346],
8	value	NN	O	value	dep	4	SENT_230	[p11l873t1321r954b1346],
9	*	CD	NUMBER	*	num	10	SENT_230	[p11l873t1321r954b1346],
10	CC	NN	O	cc	dep	15	SENT_230	[p11l522t1407r629b1463],
11	TT	NN	O	tt	nn	15	SENT_230	[p11l521t1498r621b1553],
12	or	CC	O	or	_	0	SENT_230	[p11l650t1519r711b1554],
13	TC	NN	O	tc	nn	15	SENT_230	[p11l737t1497r841b1554],
14	CC	NN	O	cc	nn	15	SENT_230	[p11l522t1586r629b1642],
15	TT	NN	O	tt	_	0	SENT_230	[p11l521t1675r621b1730],
16	or	CC	O	or	_	0	SENT_230	[p11l650t1695r711b1730],
17	TC	NN	O	tc	nn	19	SENT_230	[p11l737t1674r841b1730],
18	TT	NN	O	tt	nn	19	SENT_230	[p11l521t1764r621b1819],
19	CC	NN	O	cc	conj_or	15	SENT_230	[p11l522t1854r629b1910],
20	or	CC	O	or	_	0	SENT_230	[p11l658t1875r719b1910],
21	CT	NN	O	ct	nn	23	SENT_230	[p11l747t1854r850b1910],
22	GG	NNS	O	gg	nn	23	SENT_230	[p11l522t1943r636b1999],
23	CC	NN	O	cc	conj_or	19	SENT_230	[p11l522t2033r629b2090],
24	or	CC	O	or	_	0	SENT_230	[p11l658t2055r719b2090],
25	CG	NN	O	cg	nn	27	SENT_230	[p11l747t2033r857b2090],
26	CC	NN	O	cc	nn	27	SENT_230	[p11l522t2122r629b2178],
27	TT	NN	O	tt	conj_or	15	SENT_230	[p11l521t2213r621b2268],
28	or	CC	O	or	_	0	SENT_230	[p11l649t2234r711b2269],
29	CT	NN	O	ct	nn	31	SENT_230	[p11l738t2212r842b2269],
30	CC	NN	O	cc	nn	31	SENT_230	[p11l522t2302r629b2358],
31	TT	NN	O	tt	conj_or	27	SENT_230	[p11l521t2391r621b2446],
32	or	CC	O	or	_	0	SENT_230	[p11l649t2412r711b2446],
33	TC	NN	O	tc	conj_or	27	SENT_230	[p11l737t2391r841b2446],

1	<	JJR	O	<	_	0	SENT_231	[p11l665t2951r746b2999],
2	1	CD	NUMBER	1	num	3	SENT_231	[p11l665t2951r746b2999],
3	x	NN	O	x	dep	1	SENT_231	[p11l786t2958r824b2996],
4	10-4	CD	NUMBER	10-4	dep	1	SENT_231	[p11l865t2940r1005b3000],

1	6	CD	DURATION	6	num	2	SENT_232	[p11l1242t1240r1259b1264],
2	Months	NNS	DURATION	month	_	0	SENT_232	[p11l1271t1238r1377b1264],

1	OR	NN	O	or	_	0	SENT_233	[p11l1088t1322r1133b1346],
2	(	CD	PERCENT	(	number	3	SENT_233	[p11l1147t1321r1217b1350],
3	95	CD	PERCENT	95	num	4	SENT_233	[p11l1147t1321r1217b1350],
4	%	NN	PERCENT	%	dep	1	SENT_233	[p11l1147t1321r1217b1350],
5	CI	NN	O	ci	nn	8	SENT_233	[p11l1230t1321r1274b1350],
6	)	CD	NUMBER	)	num	8	SENT_233	[p11l1230t1321r1274b1350],
7	P	NN	O	p	nn	8	SENT_233	[p11l1410t1322r1427b1346],
8	value	NN	O	value	dep	4	SENT_233	[p11l1440t1321r1520b1346],
9	*	CD	NUMBER	*	number	10	SENT_233	[p11l1440t1321r1520b1346],
10	0.92	CD	NUMBER	0.92	dep	1	SENT_233	[p11l1063t1498r1190b1554],
11	(	CD	NUMBER	(	num	13	SENT_233	[p11l1219t1408r1552b1564],
12	0312	CD	DATE	0312	num	13	SENT_233	[p11l1219t1408r1552b1564],
13	—	NN	O	—	dep	10	SENT_233	[p11l1219t1408r1552b1564],
14	2.60	CD	NUMBER	2.60	number	15	SENT_233	[p11l1219t1408r1552b1564],
15	)	CD	NUMBER	)	dep	1	SENT_233	[p11l1219t1408r1552b1564],
16	2.72	CD	NUMBER	2.72	num	17	SENT_233	[p11l1064t1675r1190b1732],
17	(	NN	O	(	dep	15	SENT_233	[p11l1219t1587r1571b1740],
18	1.46	CD	NUMBER	1.46	number	19	SENT_233	[p11l1219t1587r1571b1740],
19	—	CD	NUMBER	—	dep	1	SENT_233	[p11l1219t1587r1571b1740],
20	5.07	CD	NUMBER	5.07	num	21	SENT_233	[p11l1219t1587r1571b1740],
21	)	NN	O	)	dep	19	SENT_233	[p11l1219t1587r1571b1740],
22	0.77	CD	NUMBER	0.77	number	23	SENT_233	[p11l1062t1855r1189b1913],
23	(	CD	NUMBER	(	dep	1	SENT_233	[p11l1219t1765r1571b1921],
24	0.40	CD	NUMBER	0.40	num	25	SENT_233	[p11l1219t1765r1571b1921],
25	—	NN	O	—	dep	23	SENT_233	[p11l1219t1765r1571b1921],
26	1.47	CD	NUMBER	1.47	number	27	SENT_233	[p11l1219t1765r1571b1921],
27	)	CD	NUMBER	)	dep	1	SENT_233	[p11l1219t1765r1571b1921],
28	1.14	CD	NUMBER	1.14	num	29	SENT_233	[p11l1068t2034r1192b2094],
29	(	NN	O	(	dep	27	SENT_233	[p11l1219t1944r1571b2100],
30	0.58	CD	NUMBER	0.58	dep	1	SENT_233	[p11l1219t1944r1571b2100],
31	—	CD	NUMBER	—	number	32	SENT_233	[p11l1219t1944r1571b2100],
32	2.23	CD	NUMBER	2.23	num	33	SENT_233	[p11l1219t1944r1571b2100],
33	)	NN	O	)	dep	30	SENT_233	[p11l1219t1944r1571b2100],
34	1.24	CD	NUMBER	1.24	number	35	SENT_233	[p11l1068t2213r1192b2273],
35	(	CD	NUMBER	(	dep	1	SENT_233	[p11l1219t2123r1571b2279],
36	0.52	CD	NUMBER	0.52	num	37	SENT_233	[p11l1219t2123r1571b2279],
37	—	NN	O	—	dep	35	SENT_233	[p11l1219t2123r1571b2279],
38	2.95	CD	NUMBER	2.95	number	39	SENT_233	[p11l1219t2123r1571b2279],
39	)	CD	NUMBER	)	dep	1	SENT_233	[p11l1219t2123r1571b2279],
40	0.58	CD	NUMBER	0.58	num	41	SENT_233	[p11l1062t2390r1191b2446],
41	(	NN	O	(	dep	39	SENT_233	[p11l1219t2302r1571b2456],
42	0	CD	NUMBER	0	dep	39	SENT_233	[p11l1219t2302r1571b2456],
43	.	.	O	.	_	0	SENT_233	[p11l1219t2302r1571b2456],

1	l2	NN	O	l2	_	0	SENT_234	[p11l1219t2302r1571b2456],
2	—	CD	NUMBER	—	number	3	SENT_234	[p11l1219t2302r1571b2456],
3	2.87	CD	NUMBER	2.87	dep	1	SENT_234	[p11l1219t2302r1571b2456],
4	)	NN	O	)	dep	3	SENT_234	[p11l1219t2302r1571b2456],

1	conﬁdence	NN	O	conﬁdence	nn	2	SENT_235	[p11l203t2617r533b2674],
2	interval	NN	O	interval	_	0	SENT_235	[p11l565t2617r817b2683],
3	;	:	O	;	_	0	SENT_235	[p11l565t2617r817b2683],
4	OR	NN	O	or	dep	2	SENT_235	[p11l848t2619r956b2674],
5	=	JJ	O	=	amod	7	SENT_235	[p11l991t2640r1036b2658],
6	odds	NNS	O	odds	nn	7	SENT_235	[p11l1073t2617r1209b2674],
7	ratio	NN	O	ratio	dep	4	SENT_235	[p11l1237t2625r1394b2674],
8	.	.	O	.	_	0	SENT_235	[p11l1237t2625r1394b2674],

1	OR	NN	O	or	_	0	SENT_236	[p11l1654t1322r1699b1346],
2	(	CD	PERCENT	(	number	3	SENT_236	[p11l1713t1321r1783b1350],
3	95	CD	PERCENT	95	num	4	SENT_236	[p11l1713t1321r1783b1350],
4	%	NN	PERCENT	%	dep	1	SENT_236	[p11l1713t1321r1783b1350],
5	CI	NN	O	ci	nn	6	SENT_236	[p11l1796t1321r1840b1350],
6	)	NN	O	)	dep	4	SENT_236	[p11l1796t1321r1840b1350],

1	12	CD	DURATION	12	num	2	SENT_237	[p11l1802t1240r1833b1264],
2	Months	NNS	DURATION	month	_	0	SENT_237	[p11l1846t1238r1952b1264],

1	P	NN	O	p	_	0	SENT_238	[p11l1976t1322r1993b1346],
2	value	NN	O	value	nn	3	SENT_238	[p11l2006t1321r2086b1346],
3	*	NN	O	*	dep	1	SENT_238	[p11l2006t1321r2086b1346],

1	<	JJR	O	<	_	0	SENT_239	[p11l1783t1677r1872b1730],
2	1	CD	NUMBER	1	num	3	SENT_239	[p11l1783t1677r1872b1730],
3	x	NN	O	x	dep	1	SENT_239	[p11l1916t1684r1958b1726],
4	lo	FW	O	lo	nn	5	SENT_239	[p11l2003t1666r2153b1730],
5	‘	FW	O	‘	dep	3	SENT_239	[p11l2003t1666r2153b1730],
6	3	CD	NUMBER	3	dep	1	SENT_239	[p11l2003t1666r2153b1730],

1	6	CD	NUMBER	6	_	0	SENT_240	[p11l1866t2950r1901b3000],
2	x	CC	O	x	cc	1	SENT_240	[p11l1936t2958r1974b2996],
3	1O	CD	NUMBER	1o	number	4	SENT_240	[p11l2015t2941r2152b3000],
4	‘	CD	NUMBER	‘	dep	1	SENT_240	[p11l2015t2941r2152b3000],
5	3	CD	NUMBER	3	dep	4	SENT_240	[p11l2015t2941r2152b3000],

1	Ordinary	JJ	O	ordinary	amod	4	SENT_241	[p12l43t44r164b76],
2	logistic	JJ	O	logistic	amod	4	SENT_241	[p12l176t44r271b76],
3	regression	NN	O	regression	nn	4	SENT_241	[p12l283t48r415b76],
4	modeling	NN	O	modeling	nsubjpass	26	SENT_241	[p12l427t44r552b76],
5	adjusted	VBN	O	adjust	partmod	4	SENT_241	[p12l564t44r674b76],
6	for	IN	O	for	_	0	SENT_241	[p12l685t44r722b70],
7	age	NN	O	age	prep_for	5	SENT_241	[p12l734t54r784b76],
8	,	,	O	,	_	0	SENT_241	[p12l734t54r784b76],
9	sex	NN	O	sex	prep_for	5	SENT_241	[p12l797t54r845b74],
10	,	,	O	,	_	0	SENT_241	[p12l797t54r845b74],
11	smoking	NN	O	smoking	nn	12	SENT_241	[p12l859t44r971b76],
12	status	NN	O	status	prep_for	5	SENT_241	[p12l983t52r1064b74],
13	,	,	O	,	_	0	SENT_241	[p12l983t52r1064b74],
14	baseline	NN	O	baseline	nn	16	SENT_241	[p12l1077t44r1185b70],
15	visual	JJ	O	visual	amod	16	SENT_241	[p12l1197t44r1274b70],
16	acuity	NN	O	acuity	prep_for	5	SENT_241	[p12l1286t47r1373b76],
17	,	,	O	,	_	0	SENT_241	[p12l1286t47r1373b76],
18	lesion	NN	O	lesion	nn	19	SENT_241	[p12l1387t44r1465b70],
19	type	NN	O	type	conj_and	7	SENT_241	[p12l1477t52r1540b76],
20	,	,	O	,	_	0	SENT_241	[p12l1477t52r1540b76],
21	and	CC	O	and	_	0	SENT_241	[p12l1554t44r1602b70],
22	choroidal	JJ	O	choroidal	amod	24	SENT_241	[p12l1614t44r1741b70],
23	neovascularization	NN	O	neovascularization	nn	24	SENT_241	[p12l1753t44r2002b70],
24	size	NN	O	size	prep_for	5	SENT_241	[p12l2014t47r2058b70],
25	was	VBD	O	be	auxpass	26	SENT_241	[p12l2070t54r2117b70],
26	used	VBN	O	use	_	0	SENT_241	[p12l43t81r101b107],
27	for	IN	O	for	_	0	SENT_241	[p12l114t81r151b107],
28	the	DT	O	the	det	29	SENT_241	[p12l165t81r207b107],
29	analysis	NN	O	analysis	prep_for	26	SENT_241	[p12l222t81r331b113],
30	.	.	O	.	_	0	SENT_241	[p12l222t81r331b113],

1	The	DT	O	the	det	2	SENT_242	[p12l345t81r400b107],
2	results	NNS	O	result	nsubjpass	8	SENT_242	[p12l414t81r498b107],
3	for	IN	O	for	_	0	SENT_242	[p12l512t81r548b107],
4	SNP	NN	O	snp	nn	5	SENT_242	[p12l562t82r623b107],
5	rs3025042	NN	O	rs3025042	prep_for	2	SENT_242	[p12l637t81r774b109],
6	are	VBP	O	be	auxpass	8	SENT_242	[p12l789t91r828b107],
7	not	RB	O	not	neg	8	SENT_242	[p12l842t89r887b107],
8	included	VBN	O	include	_	0	SENT_242	[p12l902t81r1017b107],
9	because	IN	O	because	mark	16	SENT_242	[p12l1030t81r1132b107],
10	the	DT	O	the	det	13	SENT_242	[p12l1147t81r1189b107],
11	minor	JJ	O	minor	amod	13	SENT_242	[p12l1204t84r1284b107],
12	allele	NN	O	allele	nn	13	SENT_242	[p12l1298t81r1368b107],
13	frequency	NN	O	frequency	nsubj	16	SENT_242	[p12l1382t81r1513b113],
14	was	VBD	O	be	cop	16	SENT_242	[p12l1526t91r1573b107],
15	very	RB	O	very	advmod	16	SENT_242	[p12l1587t91r1644b113],
16	small	JJ	O	small	advcl	8	SENT_242	[p12l1658t81r1727b107],
17	and	CC	O	and	_	0	SENT_242	[p12l1741t81r1789b107],
18	the	DT	O	the	det	19	SENT_242	[p12l1804t81r1846b107],
19	results	NNS	O	result	nsubj	22	SENT_242	[p12l1860t81r1944b107],
20	were	VBD	O	be	cop	22	SENT_242	[p12l1957t91r2019b107],
21	highly	RB	O	highly	advmod	22	SENT_242	[p12l2033t81r2118b113],
22	unreliable	JJ	O	unreliable	advcl	8	SENT_242	[p12l43t118r184b143],
23	.	.	O	.	_	0	SENT_242	[p12l43t118r184b143],

1	*	NN	O	*	nn	2	SENT_243	[p12l44t155r223b187],
2	Signiﬁcance	NN	O	signiﬁcance	nsubj	3	SENT_243	[p12l44t155r223b187],
3	accepted	VBN	O	accept	_	0	SENT_243	[p12l236t155r353b187],
4	at	IN	O	at	_	0	SENT_243	[p12l366t163r390b181],
5	P	NN	O	p	prep_at	3	SENT_243	[p12l402t156r521b182],
6	<	VBG	O	<	partmod	5	SENT_243	[p12l402t156r521b182],
7	0.007	CD	NUMBER	0.007	number	8	SENT_243	[p12l402t156r521b182],
8	(	CD	NUMBER	(	num	10	SENT_243	[p12l536t155r625b185],
9	bold	JJ	O	bold	amod	10	SENT_243	[p12l536t155r625b185],
10	)	NN	O	)	dobj	6	SENT_243	[p12l536t155r625b185],
11	.	.	O	.	_	0	SENT_243	[p12l536t155r625b185],

1	in	IN	O	in	_	0	SENT_244	[p12l7t380r68b436],
2	the	DT	O	the	det	4	SENT_244	[p12l115t380r211b436],
3	responder	NN	O	responder	nn	4	SENT_244	[p12l259t380r576b453],
4	group	NN	O	group	pobj	1	SENT_244	[p12l623t398r807b453],
5	after	IN	O	after	_	0	SENT_244	[p12l857t380r1002b436],
6	3	CD	NUMBER	3	prep_after	4	SENT_244	[p12l1051t381r1104b447],
7	,	,	O	,	_	0	SENT_244	[p12l1051t381r1104b447],
8	6	CD	NUMBER	6	prep_after	4	SENT_244	[p12l1156t380r1210b447],
9	,	,	O	,	_	0	SENT_244	[p12l1156t380r1210b447],
10	and	CC	DURATION	and	_	0	SENT_244	[p12l1262t380r1375b436],
11	12	CD	DURATION	12	num	12	SENT_244	[p12l1430t381r1500b436],
12	months	NNS	NUMBER	month	conj_and	6	SENT_244	[p12l1548t380r1781b436],
13	treatment	NN	O	treatment	dep	12	SENT_244	[p12l1831t388r2150b447],
14	,	,	O	,	_	0	SENT_244	[p12l1831t388r2150b447],
15	respectively	RB	O	respectively	advmod	12	SENT_244	[p12l7t468r410b541],
16	.	.	O	.	_	0	SENT_244	[p12l7t468r410b541],

1	The	DT	O	the	det	4	SENT_245	[p12l115t557r237b613],
2	ﬂexible	JJ	O	ﬂexible	amod	4	SENT_245	[p12l278t557r516b613],
3	treatment	NN	O	treatment	nn	4	SENT_245	[p12l555t565r858b613],
4	regimen	NN	O	regimen	nsubj	9	SENT_245	[p12l895t557r1158b630],
5	in	IN	O	in	_	0	SENT_245	[p12l1197t557r1258b612],
6	this	DT	O	this	det	7	SENT_245	[p12l1296t557r1409b613],
7	study	NN	O	study	prep_in	4	SENT_245	[p12l1452t557r1621b629],
8	could	MD	O	could	aux	9	SENT_245	[p12l1662t557r1838b613],
9	result	VB	O	result	_	0	SENT_245	[p12l1876t557r2054b613],
10	in	IN	O	in	_	0	SENT_245	[p12l2093t557r2153b612],
11	different	JJ	O	different	amod	12	SENT_245	[p12l8t644r284b700],
12	numbers	NNS	O	number	prep_in	9	SENT_245	[p12l304t644r577b700],
13	of	IN	O	of	_	0	SENT_245	[p12l602t644r671b700],
14	injections	NNS	O	injection	prep_of	12	SENT_245	[p12l687t644r996b717],
15	in	IN	O	in	_	0	SENT_245	[p12l1020t644r1080b700],
16	different	JJ	O	different	amod	18	SENT_245	[p12l1103t644r1378b700],
17	genotype	NN	O	genotype	nn	18	SENT_245	[p12l1399t653r1691b717],
18	groups	NNS	O	group	prep_in	14	SENT_245	[p12l1714t662r1946b717],
19	.	.	O	.	_	0	SENT_245	[p12l1714t662r1946b717],

1	However	RB	O	however	advmod	35	SENT_246	[p12l1972t646r2151b701, p12l8t750r161b799],
2	,	,	O	,	_	0	SENT_246	[p12l1972t646r2151b701, p12l8t750r161b799],
3	the	DT	O	the	det	4	SENT_246	[p12l203t732r299b788],
4	number	NN	O	number	nsubj	35	SENT_246	[p12l339t732r584b788],
5	of	IN	O	of	_	0	SENT_246	[p12l622t732r691b788],
6	injections	NNS	O	injection	prep_of	4	SENT_246	[p12l725t732r1034b805],
7	the	DT	O	the	det	8	SENT_246	[p12l1075t732r1171b788],
8	patients	NNS	O	patient	nsubj	18	SENT_246	[p12l1209t732r1457b805],
9	with	IN	O	with	_	0	SENT_246	[p12l1498t732r1639b789],
10	the	DT	O	the	det	14	SENT_246	[p12l1677t732r1773b788],
11	TT	NN	O	tt	nn	14	SENT_246	[p12l1813t734r1909b788],
12	or	CC	O	or	_	0	SENT_246	[p12l1949t750r2015b788],
13	TC	NN	O	tc	nn	14	SENT_246	[p12l2052t733r2151b789],
14	genotype	NN	O	genotype	prep_with	8	SENT_246	[p12l8t829r300b894],
15	at	IN	O	at	_	0	SENT_246	[p12l337t829r393b877],
16	SNP	NN	O	snp	prep_at	14	SENT_246	[p12l429t821r573b877],
17	rs3025000	CD	NUMBER	rs3025000	num	16	SENT_246	[p12l607t820r945b877],
18	received	VBD	O	receive	rcmod	6	SENT_246	[p12l980t821r1252b877],
19	(	CD	NUMBER	(	number	20	SENT_246	[p12l1289t821r1572b890],
20	4.1:1.1	CD	NUMBER	4.1:1.1	num	21	SENT_246	[p12l1289t821r1572b890],
21	injections	NNS	O	injection	dobj	18	SENT_246	[p12l1614t821r1923b893],
22	in	IN	O	in	_	0	SENT_246	[p12l1961t821r2021b876],
23	the	DT	O	the	det	24	SENT_246	[p12l2056t821r2152b877],
24	ﬁrst	NN	O	ﬁrst	prep_in	18	SENT_246	[p12l9t908r132b964],
25	6	CD	DURATION	6	num	26	SENT_246	[p12l155t908r191b965],
26	months	NNS	NUMBER	month	tmod	24	SENT_246	[p12l215t908r448b964],
27	and	CC	O	and	_	0	SENT_246	[p12l475t908r588b964],
28	6.3:2.1	CD	NUMBER	6.3:2.1	num	29	SENT_246	[p12l612t908r870b965],
29	injections	NNS	O	injection	conj_and	24	SENT_246	[p12l900t908r1209b981],
30	over	IN	O	over	_	0	SENT_246	[p12l1235t926r1377b964],
31	12	CD	DURATION	12	num	33	SENT_246	[p12l1406t909r1476b964],
32	months	NNS	NUMBER	month	nn	33	SENT_246	[p12l1500t908r1759b977],
33	)	NN	O	)	prep_over	29	SENT_246	[p12l1500t908r1759b977],
34	was	VBD	O	be	cop	35	SENT_246	[p12l1786t926r1906b964],
35	similar	JJ	O	similar	_	0	SENT_246	[p12l1934t908r2154b964],
36	to	TO	O	to	_	0	SENT_246	[p12l7t1005r67b1053],
37	that	IN	O	that	complm	46	SENT_246	[p12l118t996r237b1053],
38	the	DT	O	the	det	39	SENT_246	[p12l286t996r382b1053],
39	patients	NNS	O	patient	nsubj	46	SENT_246	[p12l431t996r678b1069],
40	with	IN	O	with	_	0	SENT_246	[p12l730t996r871b1053],
41	CC	NN	O	cc	nn	42	SENT_246	[p12l921t997r1024b1053],
42	genotype	NN	O	genotype	prep_with	39	SENT_246	[p12l1076t1005r1367b1069],
43	at	IN	O	at	_	0	SENT_246	[p12l1419t1005r1474b1052],
44	this	DT	O	this	det	45	SENT_246	[p12l1523t996r1635b1052],
45	SNP	NN	O	snp	prep_at	42	SENT_246	[p12l1689t997r1832b1053],
46	received	VBD	O	receive	prepc_to	35	SENT_246	[p12l1881t996r2153b1053],
47	(	CD	NUMBER	(	number	48	SENT_246	[p12l10t1085r299b1154],
48	4.1:1.2	CD	NUMBER	4.1:1.2	num	49	SENT_246	[p12l10t1085r299b1154],
49	injections	NNS	O	injection	dobj	46	SENT_246	[p12l333t1085r643b1158],
50	in	IN	O	in	_	0	SENT_246	[p12l677t1085r738b1140],
51	the	DT	O	the	det	52	SENT_246	[p12l771t1085r867b1141],
52	ﬁrst	NN	O	ﬁrst	prep_in	49	SENT_246	[p12l901t1085r1024b1141],
53	6	CD	DURATION	6	num	54	SENT_246	[p12l1058t1085r1093b1141],
54	months	NNS	NUMBER	month	tmod	49	SENT_246	[p12l1127t1085r1360b1141],
55	and	CC	O	and	_	0	SENT_246	[p12l1397t1085r1510b1141],
56	6.2:2.5	CD	NUMBER	6.2:2.5	num	57	SENT_246	[p12l1544t1085r1805b1141],
57	injections	NNS	O	injection	dobj	46	SENT_246	[p12l1841t1085r2151b1158],
58	over	IN	O	over	_	0	SENT_246	[p12l8t1190r150b1228],
59	12	CD	DURATION	12	num	60	SENT_246	[p12l177t1172r247b1228],
60	months	NNS	NUMBER	month	prep_over	57	SENT_246	[p12l268t1172r545b1242],
61	)	RB	O	)	advmod	46	SENT_246	[p12l268t1172r545b1242],
62	.	.	O	.	_	0	SENT_246	[p12l268t1172r545b1242],

1	To	TO	O	to	aux	2	SENT_247	[p12l570t1174r656b1228],
2	ensure	VB	O	ensure	purpcl	26	SENT_247	[p12l678t1190r885b1228],
3	that	IN	O	that	complm	10	SENT_247	[p12l905t1172r1026b1228],
4	different	JJ	O	different	amod	5	SENT_247	[p12l1045t1172r1321b1228],
5	numbers	NNS	O	number	nsubj	10	SENT_247	[p12l1340t1172r1613b1228],
6	of	IN	O	of	_	0	SENT_247	[p12l1636t1172r1706b1228],
7	injections	NNS	O	injection	prep_of	5	SENT_247	[p12l1721t1172r2030b1245],
8	did	VBD	O	do	aux	10	SENT_247	[p12l2053t1172r2153b1228],
9	not	RB	O	not	neg	10	SENT_247	[p12l7t1269r109b1316],
10	affect	VB	O	affect	ccomp	2	SENT_247	[p12l147t1260r328b1317],
11	the	DT	O	the	det	12	SENT_247	[p12l364t1260r460b1317],
12	results	NNS	O	result	dobj	10	SENT_247	[p12l497t1260r704b1317],
13	for	IN	O	for	_	0	SENT_247	[p12l743t1260r837b1316],
14	any	DT	O	any	prep_for	10	SENT_247	[p12l874t1278r986b1333],
15	of	IN	O	of	_	0	SENT_247	[p12l1025t1260r1094b1316],
16	the	DT	O	the	det	17	SENT_247	[p12l1126t1260r1222b1316],
17	7	CD	NUMBER	7	prep_of	14	SENT_247	[p12l1261t1262r1295b1316],
18	examined	VBN	O	examine	partmod	17	SENT_247	[p12l1336t1260r1647b1317],
19	tSNPs	NNS	O	tsnp	dobj	18	SENT_247	[p12l1684t1261r1900b1327],
20	,	,	O	,	_	0	SENT_247	[p12l1684t1261r1900b1327],
21	all	PDT	O	all	predet	24	SENT_247	[p12l1942t1260r2018b1317],
22	the	DT	O	the	det	24	SENT_247	[p12l2056t1260r2152b1316],
23	multivariate	JJ	O	multivariate	amod	24	SENT_247	[p12l7t1349r394b1405],
24	analyses	NNS	O	analysis	nsubjpass	26	SENT_247	[p12l423t1349r691b1422],
25	were	VBD	O	be	auxpass	26	SENT_247	[p12l720t1366r874b1405],
26	repeated	VBN	O	repeat	_	0	SENT_247	[p12l901t1349r1173b1422],
27	for	IN	O	for	_	0	SENT_247	[p12l1200t1349r1293b1405],
28	each	DT	O	each	det	29	SENT_247	[p12l1320t1349r1465b1405],
29	tSNP	NN	O	tsnp	prep_for	26	SENT_247	[p12l1491t1349r1660b1405],
30	after	IN	O	after	_	0	SENT_247	[p12l1688t1349r1833b1405],
31	adjusting	VBG	O	adjust	prepc_after	26	SENT_247	[p12l1861t1349r2152b1422],
32	for	IN	O	for	_	0	SENT_247	[p12l8t1437r101b1493],
33	the	DT	O	the	det	34	SENT_247	[p12l130t1437r226b1493],
34	number	NN	O	number	prep_for	31	SENT_247	[p12l258t1437r503b1493],
35	of	IN	O	of	_	0	SENT_247	[p12l533t1437r603b1493],
36	injections	NNS	O	injection	prep_of	34	SENT_247	[p12l628t1437r955b1510],
37	.	.	O	.	_	0	SENT_247	[p12l628t1437r955b1510],

1	We	PRP	O	we	nsubj	4	SENT_248	[p12l989t1438r1100b1493],
2	did	VBD	O	do	aux	4	SENT_248	[p12l1132t1437r1233b1493],
3	not	RB	O	not	neg	4	SENT_248	[p12l1263t1445r1365b1493],
4	observe	VB	O	observe	_	0	SENT_248	[p12l1396t1437r1642b1493],
5	any	DT	O	any	det	7	SENT_248	[p12l1676t1455r1788b1510],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_248	[p12l1822t1437r2154b1510],
7	differences	NNS	O	difference	dobj	4	SENT_248	[p12l8t1524r361b1581],
8	in	IN	O	in	_	0	SENT_248	[p12l389t1524r450b1580],
9	the	DT	O	the	det	10	SENT_248	[p12l476t1524r572b1580],
10	results	NNS	O	result	prep_in	4	SENT_248	[p12l598t1524r805b1581],
11	for	IN	O	for	mark	16	SENT_248	[p12l833t1524r926b1581],
12	any	DT	O	any	nsubj	16	SENT_248	[p12l953t1542r1065b1597],
13	of	IN	O	of	_	0	SENT_248	[p12l1093t1524r1162b1580],
14	the	DT	O	the	det	15	SENT_248	[p12l1183t1524r1279b1580],
15	SNPs	NNS	O	snp	prep_of	12	SENT_248	[p12l1308t1525r1481b1581],
16	(	VBP	O	(	advcl	4	SENT_248	[p12l1512t1524r1742b1594],
17	results	VBZ	O	result	ccomp	16	SENT_248	[p12l1512t1524r1742b1594],
18	not	RB	O	not	neg	17	SENT_248	[p12l1771t1532r1872b1581],
19	shown	VBN	O	show	dep	17	SENT_248	[p12l1900t1524r2148b1594],
20	)	NN	O	)	dobj	19	SENT_248	[p12l1900t1524r2148b1594],
21	.	.	O	.	_	0	SENT_248	[p12l1900t1524r2148b1594],

1	Comparison	NN	O	comparison	_	0	SENT_249	[p12l9t1745r502b1835],
2	with	IN	O	with	_	0	SENT_249	[p12l537t1742r721b1818],
3	the	DT	O	the	det	7	SENT_249	[p12l757t1742r884b1817],
4	ANCHOR	NN	O	anchor	nn	7	SENT_249	[p12l920t1744r1377b1817],
5	and	CC	O	and	_	0	SENT_249	[p12l1413t1742r1558b1817],
6	MARINA	NN	O	marina	conj_and	4	SENT_249	[p12l7t1850r437b1923],
7	Outcomes	NNS	O	outcome	prep_with	1	SENT_249	[p12l473t1851r883b1923],

1	The	DT	O	the	dep	108	SENT_250	[p12l7t2014r130b2070],
2	promising	JJ	O	promising	dep	108	SENT_250	[p12l158t2014r483b2087],
3	outcomes	NNS	O	outcome	dep	108	SENT_250	[p12l514t2022r818b2070],
4	of	IN	O	of	dep	108	SENT_250	[p12l850t2014r919b2070],
5	the	DT	O	the	dep	108	SENT_250	[p12l942t2014r1039b2070],
6	pivotal	JJ	O	pivotal	dep	108	SENT_250	[p12l1066t2014r1289b2087],
7	ANCHOR	NN	O	anchor	dep	108	SENT_250	[p12l1318t2014r1657b2070],
8	and	CC	O	and	dep	108	SENT_250	[p12l1687t2014r1800b2070],
9	MARINA	NN	O	marina	dep	108	SENT_250	[p12l1828t2014r2153b2070],
10	studies	NNS	O	study	dep	108	SENT_250	[p12l10t2101r246b2168],
11	,	,	O	,	_	0	SENT_250	[p12l10t2101r246b2168],
12	achieved	VBN	O	achieve	dep	108	SENT_250	[p12l277t2101r560b2157],
13	with	IN	O	with	dep	108	SENT_250	[p12l585t2101r726b2157],
14	monthly	JJ	SET	monthly	dep	108	SENT_250	[p12l752t2101r1017b2174],
15	ranibizumab	NN	O	ranibizumab	dep	108	SENT_250	[p12l1043t2101r1443b2157],
16	injections	NNS	O	injection	dep	108	SENT_250	[p12l1470t2101r1798b2174],
17	,	,	O	,	_	0	SENT_250	[p12l1470t2101r1798b2174],
18	have	VBP	O	have	dep	108	SENT_250	[p12l1827t2101r1977b2158],
19	been	VBN	O	be	dep	108	SENT_250	[p12l2002t2101r2153b2157],
20	used	VBN	O	use	dep	108	SENT_250	[p12l7t2190r153b2246],
21	by	IN	O	by	dep	108	SENT_250	[p12l186t2190r265b2262],
22	various	JJ	O	various	dep	108	SENT_250	[p12l300t2189r533b2246],
23	clinical	JJ	O	clinical	dep	108	SENT_250	[p12l570t2189r804b2246],
24	trials	NNS	O	trial	dep	108	SENT_250	[p12l839t2189r996b2246],
25	as	IN	O	as	dep	108	SENT_250	[p12l1034t2207r1095b2246],
26	the	DT	O	the	dep	108	SENT_250	[p12l1131t2189r1228b2246],
27	standard	JJ	O	standard	dep	108	SENT_250	[p12l1265t2189r1533b2246],
28	reference	NN	O	reference	dep	108	SENT_250	[p12l1566t2189r1864b2246],
29	for	IN	O	for	dep	108	SENT_250	[p12l1899t2189r1992b2246],
30	best	JJS	O	best	dep	108	SENT_250	[p12l2024t2189r2154b2246],
31	outcomes	NNS	O	outcome	dep	108	SENT_250	[p12l8t2286r331b2344],
32	,	,	O	,	_	0	SENT_250	[p12l8t2286r331b2344],
33	when	WRB	O	when	dep	108	SENT_250	[p12l379t2278r551b2334],
34	comparing	VBG	O	compare	dep	108	SENT_250	[p12l596t2278r937b2351],
35	the	DT	O	the	dep	108	SENT_250	[p12l983t2278r1079b2334],
36	efﬁcacy	NN	O	efﬁcacy	dep	108	SENT_250	[p12l1125t2278r1376b2350],
37	of	IN	O	of	dep	108	SENT_250	[p12l1423t2278r1492b2334],
38	different	JJ	O	different	dep	108	SENT_250	[p12l1532t2278r1807b2334],
39	treatment	NN	O	treatment	dep	108	SENT_250	[p12l1851t2286r2154b2334],
40	protocols	NNS	O	protocol	dep	108	SENT_250	[p12l7t2358r402b2439],
41	.5	CD	NUMBER	.5	dep	108	SENT_250	[p12l7t2358r402b2439],
42	’	CD	NUMBER	’	dep	108	SENT_250	[p12l7t2358r402b2439],
43	6	CD	NUMBER	6	dep	108	SENT_250	[p12l7t2358r402b2439],
44	We	PRP	O	we	dep	108	SENT_250	[p12l438t2367r548b2422],
45	have	VBP	O	have	dep	108	SENT_250	[p12l583t2365r733b2423],
46	compared	VBN	O	compare	dep	108	SENT_250	[p12l770t2365r1085b2439],
47	the	DT	O	the	dep	108	SENT_250	[p12l1120t2366r1216b2422],
48	Visual	JJ	O	visual	dep	108	SENT_250	[p12l1252t2365r1442b2422],
49	outcomes	NNS	O	outcome	dep	108	SENT_250	[p12l1479t2374r1782b2422],
50	of	IN	O	of	dep	108	SENT_250	[p12l1821t2365r1890b2422],
51	the	DT	O	the	dep	108	SENT_250	[p12l1920t2365r2016b2422],
52	patients	NNS	O	patient	dep	108	SENT_250	[p12l2051t2384r2150b2439, p12l7t2454r178b2511],
53	harboring	VBG	O	harbor	dep	108	SENT_250	[p12l204t2454r515b2527],
54	the	DT	O	the	dep	108	SENT_250	[p12l540t2455r636b2511],
55	minor	JJ	O	minor	dep	108	SENT_250	[p12l662t2454r853b2511],
56	(	NN	O	(	dep	108	SENT_250	[p12l880t2455r975b2524],
57	T	NN	O	t	dep	108	SENT_250	[p12l880t2455r975b2524],
58	)	CD	NUMBER	)	dep	108	SENT_250	[p12l880t2455r975b2524],
59	allele	NN	O	allele	dep	108	SENT_250	[p12l1004t2454r1174b2511],
60	at	IN	O	at	dep	108	SENT_250	[p12l1201t2463r1257b2511],
61	SNP	NN	O	snp	dep	108	SENT_250	[p12l1283t2455r1426b2511],
62	rs3025000	CD	NUMBER	rs3025000	dep	108	SENT_250	[p12l1450t2454r1788b2511],
63	(	CD	NUMBER	(	dep	108	SENT_250	[p12l1816t2455r1937b2524],
64	TT	NN	O	tt	dep	108	SENT_250	[p12l1816t2455r1937b2524],
65	or	CC	O	or	dep	108	SENT_250	[p12l1963t2472r2028b2511],
66	TC	NN	O	tc	dep	108	SENT_250	[p12l2052t2455r2151b2511],
67	genotypes	NNS	O	genotype	dep	108	SENT_250	[p12l8t2543r356b2616],
68	)	CD	NUMBER	)	dep	108	SENT_250	[p12l8t2543r356b2616],
69	and	CC	O	and	dep	108	SENT_250	[p12l389t2543r502b2599],
70	those	DT	O	those	dep	108	SENT_250	[p12l530t2543r697b2599],
71	without	IN	O	without	dep	108	SENT_250	[p12l727t2543r971b2599],
72	the	DT	O	the	dep	108	SENT_250	[p12l999t2543r1095b2599],
73	minor	JJ	O	minor	dep	108	SENT_250	[p12l1123t2543r1315b2599],
74	(	NN	O	(	dep	108	SENT_250	[p12l1345t2543r1440b2612],
75	T	NN	O	t	dep	108	SENT_250	[p12l1345t2543r1440b2612],
76	)	CD	NUMBER	)	dep	108	SENT_250	[p12l1345t2543r1440b2612],
77	allele	NN	O	allele	dep	108	SENT_250	[p12l1473t2543r1643b2599],
78	(	CD	NUMBER	(	dep	108	SENT_250	[p12l1675t2543r1803b2612],
79	CC	NN	O	cc	dep	108	SENT_250	[p12l1675t2543r1803b2612],
80	genotype	NN	O	genotype	dep	108	SENT_250	[p12l1834t2543r2150b2616],
81	)	NN	O	)	dep	108	SENT_250	[p12l1834t2543r2150b2616],
82	at	IN	O	at	dep	108	SENT_250	[p12l9t2639r65b2686],
83	this	DT	O	this	dep	108	SENT_250	[p12l90t2630r202b2686],
84	SNP	NN	O	snp	dep	108	SENT_250	[p12l233t2631r376b2687],
85	in	IN	O	in	dep	108	SENT_250	[p12l402t2630r463b2686],
86	the	DT	O	the	dep	108	SENT_250	[p12l489t2630r585b2686],
87	VEGFA	NN	O	vegfa	dep	108	SENT_250	[p12l617t2631r862b2687],
88	gene	NN	O	gene	dep	108	SENT_250	[p12l892t2648r1040b2703],
89	with	IN	O	with	dep	108	SENT_250	[p12l1068t2630r1209b2687],
90	the	DT	O	the	dep	108	SENT_250	[p12l1235t2630r1331b2686],
91	outcomes	NNS	O	outcome	dep	108	SENT_250	[p12l1358t2639r1662b2686],
92	of	IN	O	of	dep	108	SENT_250	[p12l1691t2630r1760b2686],
93	the	DT	O	the	dep	108	SENT_250	[p12l1781t2630r1877b2686],
94	patients	NNS	O	patient	dep	108	SENT_250	[p12l1903t2630r2151b2703],
95	who	WP	O	who	dep	108	SENT_250	[p12l8t2719r143b2775],
96	received	VBD	O	receive	dep	108	SENT_250	[p12l181t2718r453b2775],
97	monthly	JJ	SET	monthly	dep	108	SENT_250	[p12l490t2718r755b2791],
98	0.5	CD	NUMBER	0.5	dep	108	SENT_250	[p12l795t2718r889b2775],
99	mg	NN	O	mg	dep	108	SENT_250	[p12l930t2736r1030b2791],
100	of	IN	O	of	dep	108	SENT_250	[p12l1070t2718r1139b2775],
101	ranibizumab	NN	O	ranibizumab	dep	108	SENT_250	[p12l1171t2718r1570b2775],
102	injections	NNS	O	injection	dep	108	SENT_250	[p12l1610t2718r1918b2791],
103	in	IN	O	in	dep	108	SENT_250	[p12l1958t2718r2019b2774],
104	the	DT	O	the	dep	108	SENT_250	[p12l2056t2719r2152b2775],
105	ANCHOR	NN	O	anchor	dep	108	SENT_250	[p12l7t2807r346b2863],
106	and	CC	O	and	dep	108	SENT_250	[p12l391t2807r504b2863],
107	MARINA	NN	O	marina	dep	108	SENT_250	[p12l548t2807r873b2863],
108	studies	NNS	O	study	_	0	SENT_250	[p12l919t2807r1155b2863],
109	.	.	O	.	_	0	SENT_250	[p12l919t2807r1155b2863],

1	Our	PRP$	O	we	poss	2	SENT_251	[p12l1205t2807r1328b2863],
2	aim	NN	O	aim	nsubj	3	SENT_251	[p12l1372t2807r1490b2863],
3	was	VBD	O	be	_	0	SENT_251	[p12l1534t2824r1655b2863],
4	to	TO	O	to	aux	5	SENT_251	[p12l1701t2815r1760b2863],
5	investigate	VB	O	investigate	xcomp	3	SENT_251	[p12l1806t2807r2152b2880],
6	whether	IN	O	whether	complm	18	SENT_251	[p12l8t2894r266b2950],
7	patients	NNS	O	patient	nsubj	18	SENT_251	[p12l295t2894r542b2967],
8	with	IN	O	with	_	0	SENT_251	[p12l575t2894r716b2950],
9	the	DT	O	the	det	13	SENT_251	[p12l746t2894r842b2950],
10	TT	NN	O	tt	nn	13	SENT_251	[p12l873t2896r970b2950],
11	or	CC	O	or	_	0	SENT_251	[p12l1002t2912r1067b2950],
12	TC	NN	O	tc	conj_or	10	SENT_251	[p12l1096t2894r1196b2951],
13	genotype	NN	O	genotype	prep_with	7	SENT_251	[p12l1229t2903r1520b2967],
14	at	IN	O	at	_	0	SENT_251	[p12l1553t2902r1609b2950],
15	SNP	NN	O	snp	nn	16	SENT_251	[p12l1641t2894r1784b2951],
16	rs3025000	NN	O	rs3025000	prep_at	13	SENT_251	[p12l1814t2894r2152b2951],
17	could	MD	O	could	aux	18	SENT_251	[p12l8t2982r185b3039],
18	achieve	VB	O	achieve	ccomp	5	SENT_251	[p12l230t2982r472b3039],
19	comparable	JJ	O	comparable	amod	20	SENT_251	[p12l517t2982r889b3055],
20	outcomes	NNS	O	outcome	dobj	18	SENT_251	[p12l935t2991r1239b3039],
21	with	IN	O	with	_	0	SENT_251	[p12l1285t2982r1426b3039],
22	those	DT	O	those	prep_with	18	SENT_251	[p12l1470t2982r1637b3039],
23	of	IN	O	of	_	0	SENT_251	[p12l1683t2982r1752b3038],
24	the	DT	O	the	det	26	SENT_251	[p12l1791t2982r1887b3038],
25	pivotal	JJ	O	pivotal	amod	26	SENT_251	[p12l1930t2982r2152b3055],
26	studies	NNS	O	study	prep_of	22	SENT_251	[p12l10t3071r227b3127],
27	even	RB	O	even	advmod	18	SENT_251	[p12l265t3088r414b3127],
28	with	IN	O	with	_	0	SENT_251	[p12l450t3071r591b3127],
29	a	DT	O	a	det	32	SENT_251	[p12l627t3088r661b3127],
30	different	JJ	O	different	amod	32	SENT_251	[p12l695t3071r971b3127],
31	treatment	NN	O	treatment	nn	32	SENT_251	[p12l1005t3079r1308b3127],
32	protocol	NN	O	protocol	prep_with	18	SENT_251	[p12l1341t3071r1608b3144],
33	requiring	VBG	O	require	partmod	32	SENT_251	[p12l1643t3071r1935b3144],
34	fewer	JJR	O	fewer	amod	35	SENT_251	[p12l1972t3071r2154b3127],
35	injections	NNS	O	injection	dobj	33	SENT_251	[p12l7t3158r335b3231],
36	.	.	O	.	_	0	SENT_251	[p12l7t3158r335b3231],

1	Mean	NN	O	mean	nn	2	SENT_252	[p12l367t3160r549b3214],
2	age	NN	O	age	nsubj	7	SENT_252	[p12l579t3176r687b3231],
3	and	CC	O	and	_	0	SENT_252	[p12l718t3158r831b3214],
4	baseline	NN	O	baseline	nn	5	SENT_252	[p12l858t3158r1120b3214],
5	VA	NN	O	va	conj_and	2	SENT_252	[p12l1149t3159r1264b3214],
6	were	VBD	O	be	cop	7	SENT_252	[p12l1293t3176r1447b3214],
7	similar	JJ	O	similar	_	0	SENT_252	[p12l1479t3158r1699b3214],
8	in	IN	O	in	_	0	SENT_252	[p12l1726t3158r1787b3214],
9	our	PRP$	O	we	poss	10	SENT_252	[p12l1817t3176r1922b3214],
10	cohort	NN	O	cohort	prep_in	7	SENT_252	[p12l1950t3158r2154b3214],
11	harboring	VBG	O	harbor	dep	10	SENT_252	[p12l7t3246r317b3319],
12	the	DT	O	the	det	14	SENT_252	[p12l357t3246r453b3302],
13	T	NN	O	t	nn	14	SENT_252	[p12l491t3248r538b3302],
14	allele	NN	O	allele	dobj	11	SENT_252	[p12l578t3246r748b3303],
15	at	IN	O	at	_	0	SENT_252	[p12l788t3255r844b3302],
16	SNP	NN	O	snp	prep_at	11	SENT_252	[p12l883t3247r1027b3303],
17	rs3025000	CD	NUMBER	rs3025000	num	16	SENT_252	[p12l1064t3246r1402b3303],
18	(	CD	NUMBER	(	num	20	SENT_252	[p12l1443t3247r1640b3316],
19	mean	NN	O	mean	nn	20	SENT_252	[p12l1443t3247r1640b3316],
20	age	NN	O	age	tmod	11	SENT_252	[p12l1680t3264r1804b3319],
21	,	,	O	,	_	0	SENT_252	[p12l1680t3264r1804b3319],
22	78.3:6.8	CD	NUMBER	78.3:6.8	num	23	SENT_252	[p12l1846t3246r2149b3303],
23	years	NNS	NUMBER	year	appos	20	SENT_252	[p12l7t3352r194b3407],
24	;	:	O	;	_	0	SENT_252	[p12l7t3352r194b3407],
25	mean	VB	O	mean	parataxis	11	SENT_252	[p12l224t3352r397b3391],
26	baseline	NN	O	baseline	nn	27	SENT_252	[p12l421t3335r684b3391],
27	VA	NNP	O	VA	dobj	25	SENT_252	[p12l710t3335r841b3401],
28	,	,	O	,	_	0	SENT_252	[p12l710t3335r841b3401],
29	50.3	CD	NUMBER	50.3	appos	27	SENT_252	[p12l872t3335r1068b3391],
30	:	:	O	:	_	0	SENT_252	[p12l872t3335r1068b3391],
31	17.9	CD	NUMBER	17.9	num	32	SENT_252	[p12l1087t3335r1216b3392],
32	ETDRS	NNS	O	etdr	dep	27	SENT_252	[p12l1244t3335r1493b3391],
33	letter	NN	O	letter	nn	34	SENT_252	[p12l1523t3335r1688b3391],
34	scores	NNS	O	score	nsubj	35	SENT_252	[p12l1715t3335r1956b3404],
35	)	VBP	O	)	rcmod	32	SENT_252	[p12l1715t3335r1956b3404],
36	,	,	O	,	_	0	SENT_252	[p12l1715t3335r1956b3404],
37	those	DT	O	those	dobj	46	SENT_252	[p12l1985t3335r2152b3391],
38	without	IN	O	without	_	0	SENT_252	[p12l8t3422r253b3478],
39	the	DT	O	the	det	41	SENT_252	[p12l276t3422r372b3478],
40	T	NN	O	t	nn	41	SENT_252	[p12l397t3424r444b3478],
41	allele	NN	O	allele	prep_without	37	SENT_252	[p12l471t3422r641b3478],
42	at	IN	O	at	_	0	SENT_252	[p12l667t3431r723b3478],
43	this	DT	O	this	det	44	SENT_252	[p12l747t3422r859b3478],
44	SNP	NN	O	snp	prep_at	41	SENT_252	[p12l888t3423r1031b3479],
45	(	FW	O	(	nsubj	46	SENT_252	[p12l1059t3423r1255b3491],
46	mean	VB	O	mean	parataxis	35	SENT_252	[p12l1059t3423r1255b3491],
47	age	NN	O	age	dobj	46	SENT_252	[p12l1281t3440r1407b3495],
48	,	,	O	,	_	0	SENT_252	[p12l1281t3440r1407b3495],
49	77.8:6.8	CD	NUMBER	77.8:6.8	num	50	SENT_252	[p12l1435t3422r1738b3479],
50	years	NNS	NUMBER	year	tmod	35	SENT_252	[p12l1765t3440r1952b3495],
51	;	:	O	;	_	0	SENT_252	[p12l1765t3440r1952b3495],
52	mean	VB	O	mean	parataxis	11	SENT_252	[p12l1980t3440r2153b3478],
53	baseline	NN	O	baseline	nn	54	SENT_252	[p12l6t3510r269b3567],
54	VA	NNP	O	VA	dobj	52	SENT_252	[p12l293t3511r425b3577],
55	,	,	O	,	_	0	SENT_252	[p12l293t3511r425b3577],
56	52.5	CD	NUMBER	52.5	appos	54	SENT_252	[p12l453t3510r649b3567],
57	:	:	O	:	_	0	SENT_252	[p12l453t3510r649b3567],
58	15.6	CD	NUMBER	15.6	num	59	SENT_252	[p12l667t3510r797b3567],
59	ETDRS	NNS	O	etdr	dobj	52	SENT_252	[p12l822t3511r1071b3567],
60	letter	NN	O	letter	nn	61	SENT_252	[p12l1100t3510r1264b3567],
61	scores	NNS	O	score	nsubj	62	SENT_252	[p12l1290t3511r1529b3580],
62	)	VBP	O	)	rcmod	59	SENT_252	[p12l1290t3511r1529b3580],
63	,	,	O	,	_	0	SENT_252	[p12l1290t3511r1529b3580],
64	and	CC	O	and	_	0	SENT_252	[p12l1558t3510r1671b3567],
65	the	DT	O	the	det	66	SENT_252	[p12l1695t3510r1790b3567],
66	ANCHOR	NN	O	anchor	conj_and	54	SENT_252	[p12l1815t3511r2153b3567],
67	(	FW	O	(	nsubj	68	SENT_252	[p12l10t3599r207b3668],
68	mean	VB	O	mean	rcmod	66	SENT_252	[p12l10t3599r207b3668],
69	age	NN	O	age	dobj	68	SENT_252	[p12l235t3616r360b3672],
70	,	,	O	,	_	0	SENT_252	[p12l235t3616r360b3672],
71	76:8.6	CD	NUMBER	76:8.6	num	72	SENT_252	[p12l390t3599r634b3655],
72	years	NNS	NUMBER	year	appos	69	SENT_252	[p12l662t3616r849b3671],
73	;	:	O	;	_	0	SENT_252	[p12l662t3616r849b3671],
74	mean	VB	O	mean	parataxis	11	SENT_252	[p12l879t3616r1051b3655],
75	baseline	NN	O	baseline	dobj	74	SENT_252	[p12l1076t3599r1339b3655],
76	VA	NNP	O	VA	dep	75	SENT_252	[p12l1366t3599r1497b3665],
77	,	,	O	,	_	0	SENT_252	[p12l1366t3599r1497b3665],
78	47.1	CD	NUMBER	47.1	dobj	74	SENT_252	[p12l1526t3599r1658b3655],
79	:	:	O	:	_	0	SENT_252	[p12l1676t3604r1724b3652],
80	13.2	CD	NUMBER	13.2	num	81	SENT_252	[p12l1742t3599r1872b3655],
81	ETDRS	NNS	O	etdr	dep	78	SENT_252	[p12l1899t3599r2149b3655],
82	letter	NN	O	letter	nn	84	SENT_252	[p12l8t3687r172b3743],
83	scores	NNS	O	score	nn	84	SENT_252	[p12l194t3688r414b3756],
84	)	NN	O	)	dep	81	SENT_252	[p12l194t3688r414b3756],
85	and	CC	O	and	_	0	SENT_252	[p12l438t3687r551b3743],
86	MARINA	NN	O	marina	nn	89	SENT_252	[p12l570t3687r895b3743],
87	(	CD	NUMBER	(	num	89	SENT_252	[p12l917t3688r1114b3756],
88	mean	NN	O	mean	nn	89	SENT_252	[p12l917t3688r1114b3756],
89	age	NN	O	age	dobj	74	SENT_252	[p12l1136t3705r1261b3760],
90	,	,	O	,	_	0	SENT_252	[p12l1136t3705r1261b3760],
91	77:8	CD	NUMBER	77:8	num	92	SENT_252	[p12l1284t3687r1466b3743],
92	years	NNS	NUMBER	year	appos	89	SENT_252	[p12l1489t3705r1676b3760],
93	;	:	O	;	_	0	SENT_252	[p12l1489t3705r1676b3760],
94	mean	VB	O	mean	parataxis	11	SENT_252	[p12l1699t3705r1872b3743],
95	baseline	NN	O	baseline	dobj	94	SENT_252	[p12l1890t3687r2153b3743],

1	VA	NNP	O	VA	dep	164	SENT_253	[p13l7t18r139b84],
2	,	,	O	,	_	0	SENT_253	[p13l7t18r139b84],
3	53.7	CD	NUMBER	53.7	dep	164	SENT_253	[p13l188t17r530b74],
4	:	:	O	:	_	0	SENT_253	[p13l188t17r530b74],
5	l2	CD	NUMBER	l2	dep	164	SENT_253	[p13l188t17r530b74],
6	.8	CD	NUMBER	.8	dep	164	SENT_253	[p13l188t17r530b74],
7	ETDRS	NNS	O	etdr	dep	164	SENT_253	[p13l578t18r827b74],
8	letter	NN	O	letter	dep	164	SENT_253	[p13l876t18r1041b74],
9	scores	NNS	O	score	dep	164	SENT_253	[p13l1087t18r1308b86],
10	)	JJ	O	)	dep	164	SENT_253	[p13l1087t18r1308b86],
11	studies	NNS	O	study	dep	164	SENT_253	[p13l1358t11r1672b74],
12	.23	CD	NUMBER	.23	dep	164	SENT_253	[p13l1358t11r1672b74],
13	We	PRP	O	we	dep	164	SENT_253	[p13l1719t19r1830b74],
14	had	VBD	O	have	dep	164	SENT_253	[p13l1874t18r1990b74],
15	105	CD	NUMBER	105	dep	164	SENT_253	[p13l2041t18r2149b74],
16	patients	NNS	O	patient	dep	164	SENT_253	[p13l8t105r254b178],
17	with	IN	O	with	dep	164	SENT_253	[p13l283t105r424b162],
18	TT	NN	O	tt	dep	164	SENT_253	[p13l450t107r546b161],
19	or	CC	O	or	dep	164	SENT_253	[p13l574t123r639b161],
20	TC	NN	O	tc	dep	164	SENT_253	[p13l665t105r764b162],
21	genotypes	NNS	O	genotype	dep	164	SENT_253	[p13l793t113r1113b178],
22	at	IN	O	at	dep	164	SENT_253	[p13l1144t113r1199b161],
23	SNP	NN	O	snp	dep	164	SENT_253	[p13l1227t105r1370b162],
24	rs3025000	CD	NUMBER	rs3025000	dep	164	SENT_253	[p13l1396t105r1750b162],
25	:	:	O	:	_	0	SENT_253	[p13l1396t105r1750b162],
26	31	CD	PERCENT	31	dep	164	SENT_253	[p13l1785t106r1854b162],
27	(	CD	PERCENT	(	dep	164	SENT_253	[p13l1891t105r2144b175],
28	29.5	CD	PERCENT	29.5	dep	164	SENT_253	[p13l1891t105r2144b175],
29	%	NN	PERCENT	%	dep	164	SENT_253	[p13l1891t105r2144b175],
30	)	CD	NUMBER	)	dep	164	SENT_253	[p13l1891t105r2144b175],
31	with	IN	O	with	dep	164	SENT_253	[p13l9t193r149b250],
32	predominantly	RB	O	predominantly	dep	164	SENT_253	[p13l168t193r634b266],
33	classic	JJ	O	classic	dep	164	SENT_253	[p13l655t193r865b250],
34	(	IN	O	(	dep	164	SENT_253	[p13l889t193r1009b263],
35	the	DT	O	the	dep	164	SENT_253	[p13l889t193r1009b263],
36	lesion	NN	O	lesion	dep	164	SENT_253	[p13l1030t193r1219b250],
37	type	NN	O	type	dep	164	SENT_253	[p13l1239t202r1374b266],
38	in	IN	O	in	dep	164	SENT_253	[p13l1395t193r1456b249],
39	the	DT	O	the	dep	164	SENT_253	[p13l1476t193r1571b250],
40	ANCHOR	NN	O	anchor	dep	164	SENT_253	[p13l1591t194r1929b250],
41	study	NN	O	study	dep	164	SENT_253	[p13l1951t194r2144b266],
42	)	NN	O	)	dep	164	SENT_253	[p13l1951t194r2144b266],
43	and	CC	O	and	dep	164	SENT_253	[p13l10t282r123b338],
44	74	CD	PERCENT	74	dep	164	SENT_253	[p13l149t282r226b338],
45	(	CD	PERCENT	(	dep	164	SENT_253	[p13l256t281r510b351],
46	70.5	CD	PERCENT	70.5	dep	164	SENT_253	[p13l256t281r510b351],
47	%	NN	PERCENT	%	dep	164	SENT_253	[p13l256t281r510b351],
48	)	CD	NUMBER	)	dep	164	SENT_253	[p13l256t281r510b351],
49	with	IN	O	with	dep	164	SENT_253	[p13l540t282r680b338],
50	nonpredominantly	JJ	O	nonpredominantly	dep	164	SENT_253	[p13l706t282r1292b355],
51	classic	JJ	O	classic	dep	164	SENT_253	[p13l1320t282r1530b338],
52	(	NN	O	(	dep	164	SENT_253	[p13l1560t282r1680b351],
53	the	DT	O	the	dep	164	SENT_253	[p13l1560t282r1680b351],
54	lesion	NN	O	lesion	dep	164	SENT_253	[p13l1707t282r1897b338],
55	type	NN	O	type	dep	164	SENT_253	[p13l1923t290r2059b355],
56	in	IN	O	in	dep	164	SENT_253	[p13l2086t282r2146b337],
57	the	DT	O	the	dep	164	SENT_253	[p13l8t369r104b425],
58	MARINA	NNP	O	MARINA	dep	164	SENT_253	[p13l159t370r482b425],
59	study	NN	O	study	dep	164	SENT_253	[p13l539t369r733b442],
60	)	CD	NUMBER	)	dep	164	SENT_253	[p13l539t369r733b442],
61	lesions	NNS	O	lesion	dep	164	SENT_253	[p13l790t362r1105b425],
62	.2	NN	NUMBER	.2	dep	164	SENT_253	[p13l790t362r1105b425],
63	’	CD	NUMBER	’	dep	164	SENT_253	[p13l790t362r1105b425],
64	3	CD	NUMBER	3	dep	164	SENT_253	[p13l790t362r1105b425],
65	Weighted	JJ	O	weighted	dep	164	SENT_253	[p13l1162t369r1473b442],
66	calculation	NN	O	calculation	dep	164	SENT_253	[p13l1528t369r1877b425],
67	of	IN	O	of	dep	164	SENT_253	[p13l1932t369r2001b425],
68	the	DT	O	the	dep	164	SENT_253	[p13l2050t369r2146b425],
69	ANCHOR	NN	O	anchor	dep	164	SENT_253	[p13l8t458r346b514],
70	and	CC	O	and	dep	164	SENT_253	[p13l377t458r489b514],
71	MARINA	NN	O	marina	dep	164	SENT_253	[p13l518t458r842b514],
72	visual	JJ	O	visual	dep	164	SENT_253	[p13l872t457r1061b514],
73	outcomes	NNS	O	outcome	dep	164	SENT_253	[p13l1092t466r1394b514],
74	for	IN	O	for	dep	164	SENT_253	[p13l1426t457r1519b514],
75	our	PRP$	O	we	dep	164	SENT_253	[p13l1548t475r1654b514],
76	cohort	NN	O	cohort	dep	164	SENT_253	[p13l1682t457r1886b514],
77	(	NN	O	(	dep	164	SENT_253	[p13l1917t457r2143b527],
78	29.5	CD	PERCENT	29.5	dep	164	SENT_253	[p13l1917t457r2143b527],
79	%	NN	PERCENT	%	dep	164	SENT_253	[p13l1917t457r2143b527],
80	ANCHOR/70	NN	PERCENT	anchor/70	dep	164	SENT_253	[p13l8t546r571b602],
81	.5	CD	PERCENT	.5	dep	164	SENT_253	[p13l8t546r571b602],
82	%	NN	PERCENT	%	dep	164	SENT_253	[p13l8t546r571b602],
83	MARINA	NN	O	marina	dep	164	SENT_253	[p13l644t546r992b615],
84	)	CD	NUMBER	)	dep	164	SENT_253	[p13l644t546r992b615],
85	predicts	VBZ	O	predict	dep	164	SENT_253	[p13l1063t546r1314b619],
86	theoretical	JJ	O	theoretical	dep	164	SENT_253	[p13l1385t546r1722b602],
87	mean	NN	O	mean	dep	164	SENT_253	[p13l1791t563r1964b602],
88	VA	NN	O	va	dep	164	SENT_253	[p13l2033t546r2147b602],
89	changes	NNS	O	change	dep	164	SENT_253	[p13l9t633r263b706],
90	of	IN	O	of	dep	164	SENT_253	[p13l305t633r374b689],
91	7.1	CD	NUMBER	7.1	dep	164	SENT_253	[p13l408t634r523b700],
92	,	,	O	,	_	0	SENT_253	[p13l408t634r523b700],
93	7.7	CD	NUMBER	7.7	dep	164	SENT_253	[p13l565t635r680b700],
94	,	,	O	,	_	0	SENT_253	[p13l565t635r680b700],
95	and	CC	O	and	dep	164	SENT_253	[p13l724t633r836b689],
96	8.4	CD	NUMBER	8.4	dep	164	SENT_253	[p13l878t633r972b690],
97	letters	NNS	O	letter	dep	164	SENT_253	[p13l1012t633r1204b689],
98	after	IN	O	after	dep	164	SENT_253	[p13l1246t633r1391b689],
99	3	CD	NUMBER	3	dep	164	SENT_253	[p13l1431t633r1483b700],
100	,	,	O	,	_	0	SENT_253	[p13l1431t633r1483b700],
101	6	CD	NUMBER	6	dep	164	SENT_253	[p13l1527t633r1580b700],
102	,	,	O	,	_	0	SENT_253	[p13l1527t633r1580b700],
103	and	CC	DURATION	and	dep	164	SENT_253	[p13l1624t633r1737b689],
104	12	CD	DURATION	12	dep	164	SENT_253	[p13l1783t634r1853b689],
105	months	NNS	NUMBER	month	dep	164	SENT_253	[p13l1892t633r2143b700],
106	,	,	O	,	_	0	SENT_253	[p13l1892t633r2143b700],
107	respectively	RB	O	respectively	dep	164	SENT_253	[p13l8t721r411b794],
108	,	,	O	,	_	0	SENT_253	[p13l8t721r411b794],
109	with	IN	O	with	dep	164	SENT_253	[p13l438t721r578b778],
110	monthly	JJ	SET	monthly	dep	164	SENT_253	[p13l601t721r865b794],
111	injections	NNS	O	injection	dep	164	SENT_253	[p13l889t721r1197b794],
112	similar	JJ	O	similar	dep	164	SENT_253	[p13l1225t721r1445b778],
113	to	TO	O	to	dep	164	SENT_253	[p13l1466t730r1525b778],
114	those	DT	O	those	dep	164	SENT_253	[p13l1549t721r1716b778],
115	RCTs	NNS	O	rct	dep	164	SENT_253	[p13l1740t722r1923b778],
116	(	VBP	O	(	dep	164	SENT_253	[p13l1951t722r2147b791],
117	mean	JJ	O	mean	dep	164	SENT_253	[p13l1951t722r2147b791],
118	VA	NN	O	va	dep	164	SENT_253	[p13l8t810r123b866],
119	change	NN	O	change	dep	164	SENT_253	[p13l149t810r373b883],
120	in	IN	O	in	dep	164	SENT_253	[p13l400t810r461b865],
121	the	DT	O	the	dep	164	SENT_253	[p13l486t810r582b866],
122	ANCHOR	NN	O	anchor	dep	164	SENT_253	[p13l608t810r946b866],
123	study	NN	O	study	dep	164	SENT_253	[p13l974t810r1142b883],
124	X	NN	O	x	dep	164	SENT_253	[p13l1178t815r1226b863],
125	29.5	CD	PERCENT	29.5	dep	164	SENT_253	[p13l1262t810r1462b867],
126	%	NN	PERCENT	%	dep	164	SENT_253	[p13l1262t810r1462b867],
127	+	CC	O	+	dep	164	SENT_253	[p13l1500t815r1548b863],
128	mean	VB	O	mean	dep	164	SENT_253	[p13l1583t827r1755b866],
129	VA	JJ	O	va	dep	164	SENT_253	[p13l1781t810r1895b866],
130	change	NN	O	change	dep	164	SENT_253	[p13l1922t810r2146b883],
131	in	IN	O	in	dep	164	SENT_253	[p13l8t897r69b953],
132	the	DT	O	the	dep	164	SENT_253	[p13l108t897r203b953],
133	MARINA	NNP	O	MARINA	dep	164	SENT_253	[p13l243t898r567b953],
134	study	NN	O	study	dep	164	SENT_253	[p13l608t897r777b970],
135	X	NN	O	x	dep	164	SENT_253	[p13l825t902r872b950],
136	70.5	CD	PERCENT	70.5	dep	164	SENT_253	[p13l921t897r1142b964],
137	%	NN	PERCENT	%	dep	164	SENT_253	[p13l921t897r1142b964],
138	,	,	O	,	_	0	SENT_253	[p13l921t897r1142b964],
139	which	WDT	O	which	dep	164	SENT_253	[p13l1185t897r1379b954],
140	was	VBD	O	be	dep	164	SENT_253	[p13l1418t915r1538b953],
141	used	VBN	O	use	dep	164	SENT_253	[p13l1579t897r1725b953],
142	to	TO	O	to	dep	164	SENT_253	[p13l1764t906r1823b953],
143	calculate	VB	O	calculate	dep	164	SENT_253	[p13l1864t897r2146b953],
144	the	DT	O	the	dep	164	SENT_253	[p13l8t985r104b1041],
145	Weighted	JJ	O	weighted	dep	164	SENT_253	[p13l142t985r435b1058],
146	outcomes	NNS	O	outcome	dep	164	SENT_253	[p13l473t994r775b1042],
147	at	IN	O	at	dep	164	SENT_253	[p13l817t994r872b1041],
148	each	DT	O	each	dep	164	SENT_253	[p13l909t985r1053b1041],
149	time	NN	O	time	dep	164	SENT_253	[p13l1091t985r1231b1041],
150	point	NN	O	point	dep	164	SENT_253	[p13l1267t985r1448b1058],
151	,	,	O	,	_	0	SENT_253	[p13l1267t985r1448b1058],
152	as	IN	O	as	dep	164	SENT_253	[p13l1491t1003r1552b1041],
153	described	VBN	O	describe	dep	164	SENT_253	[p13l1592t985r1897b1042],
154	by	IN	O	by	dep	164	SENT_253	[p13l1933t985r2012b1058],
155	the	DT	O	the	dep	164	SENT_253	[p13l2050t985r2146b1041],
156	SUSTAIN	NNP	O	SUSTAIN	dep	164	SENT_253	[p13l10t1074r345b1130],
157	study	NN	O	study	dep	164	SENT_253	[p13l378t1074r546b1147],
158	group5	NN	O	group5	dep	164	SENT_253	[p13l577t1067r789b1147],
159	and	CC	O	and	dep	164	SENT_253	[p13l824t1074r937b1130],
160	Gerding	NNP	PERSON	Gerding	dep	164	SENT_253	[p13l967t1074r1225b1147],
161	et	FW	O	et	dep	164	SENT_253	[p13l1256t1083r1313b1130],
162	al	FW	O	al	dep	164	SENT_253	[p13l1343t1067r1503b1143],
163	”	FW	O	”	dep	164	SENT_253	[p13l1343t1067r1503b1143],
164	)	FW	O	)	_	0	SENT_253	[p13l1343t1067r1503b1143],
165	.	.	O	.	_	0	SENT_253	[p13l1343t1067r1503b1143],

1	Figure	NNP	O	Figure	nsubj	3	SENT_254	[p13l1536t1074r1743b1146],
2	1	CD	NUMBER	1	num	1	SENT_254	[p13l1781t1075r1804b1129],
3	compares	VBZ	O	compare	_	0	SENT_254	[p13l1842t1092r2144b1147],
4	the	DT	O	the	det	6	SENT_254	[p13l8t1161r104b1217],
5	visual	JJ	O	visual	amod	6	SENT_254	[p13l136t1161r325b1217],
6	outcomes	NNS	O	outcome	dobj	3	SENT_254	[p13l359t1169r661b1217],
7	of	IN	O	of	_	0	SENT_254	[p13l696t1161r765b1217],
8	our	PRP$	O	we	poss	9	SENT_254	[p13l792t1179r897b1217],
9	patients	NNS	O	patient	prep_of	6	SENT_254	[p13l927t1161r1173b1234],
10	with	IN	O	with	_	0	SENT_254	[p13l1207t1161r1348b1217],
11	TT	NN	O	tt	nn	14	SENT_254	[p13l1379t1163r1475b1217],
12	or	CC	O	or	_	0	SENT_254	[p13l1508t1179r1573b1217],
13	TC	NN	O	tc	conj_or	11	SENT_254	[p13l1603t1162r1702b1218],
14	genotypes	NNS	O	genotype	prep_with	9	SENT_254	[p13l1736t1169r2057b1234],
15	at	IN	O	at	_	0	SENT_254	[p13l2092t1169r2147b1217],
16	SNP	NN	O	snp	prep_at	3	SENT_254	[p13l10t1250r154b1306],
17	rs3025000	CD	NUMBER	rs3025000	num	16	SENT_254	[p13l174t1249r511b1306],
18	with	IN	O	with	_	0	SENT_254	[p13l533t1249r674b1306],
19	those	DT	O	those	prep_with	16	SENT_254	[p13l695t1249r862b1306],
20	harboring	VBG	O	harbor	partmod	19	SENT_254	[p13l883t1249r1192b1322],
21	CC	NN	O	cc	nn	22	SENT_254	[p13l1215t1250r1318b1306],
22	genotype	NN	O	genotype	dobj	20	SENT_254	[p13l1341t1258r1632b1322],
23	at	IN	O	at	_	0	SENT_254	[p13l1655t1258r1710b1306],
24	this	DT	O	this	det	25	SENT_254	[p13l1731t1249r1843b1306],
25	SNP	NN	O	snp	nsubj	31	SENT_254	[p13l1868t1250r2011b1306],
26	and	CC	O	and	_	0	SENT_254	[p13l2034t1249r2147b1306],
27	the	DT	O	the	det	30	SENT_254	[p13l8t1338r104b1394],
28	weighted	JJ	O	weighted	amod	30	SENT_254	[p13l135t1338r428b1411],
29	ANCHOR/MARINA	NN	O	anchor/marina	nn	30	SENT_254	[p13l457t1338r1142b1394],
30	outcomes	NNS	O	outcome	conj_and	25	SENT_254	[p13l1173t1346r1476b1394],
31	using	VBG	O	use	prepc_at	20	SENT_254	[p13l1508t1338r1679b1411],
32	95	CD	PERCENT	95	number	33	SENT_254	[p13l1712t1338r1852b1395],
33	%	NN	PERCENT	%	amod	35	SENT_254	[p13l1712t1338r1852b1395],
34	CI	NN	O	ci	nn	35	SENT_254	[p13l1887t1338r1964b1394],
35	bars	NNS	O	bar	dobj	31	SENT_254	[p13l1994t1338r2142b1394],
36	.	.	O	.	_	0	SENT_254	[p13l1994t1338r2142b1394],

1	The	DT	O	the	det	3	SENT_255	[p13l8t1425r131b1481],
2	visual	JJ	O	visual	amod	3	SENT_255	[p13l152t1425r341b1481],
3	outcomes	NNS	O	outcome	nsubj	24	SENT_255	[p13l363t1433r665b1481],
4	of	IN	O	of	_	0	SENT_255	[p13l689t1425r758b1481],
5	those	DT	O	those	prep_of	3	SENT_255	[p13l773t1425r957b1492],
6	,	,	O	,	_	0	SENT_255	[p13l773t1425r957b1492],
7	with	IN	O	with	_	0	SENT_255	[p13l981t1425r1122b1481],
8	the	DT	O	the	det	12	SENT_255	[p13l1142t1425r1238b1481],
9	TT	NN	O	tt	nn	12	SENT_255	[p13l1259t1427r1354b1481],
10	or	CC	O	or	_	0	SENT_255	[p13l1376t1443r1442b1481],
11	TC	NN	O	tc	nn	12	SENT_255	[p13l1461t1425r1559b1482],
12	genotypes	NNS	O	genotype	prep_with	5	SENT_255	[p13l1582t1434r1903b1498],
13	at	IN	O	at	_	0	SENT_255	[p13l1927t1433r1982b1481],
14	SNP	NN	O	snp	prep_at	12	SENT_255	[p13l2004t1425r2147b1482],
15	rs3025000	CD	NUMBER	rs3025000	num	14	SENT_255	[p13l8t1513r344b1570],
16	over	IN	O	over	_	0	SENT_255	[p13l373t1531r513b1570],
17	the	DT	O	the	det	19	SENT_255	[p13l538t1513r634b1570],
18	12-month	JJ	DURATION	12-month	amod	19	SENT_255	[p13l668t1514r970b1570],
19	course	NN	O	course	prep_over	14	SENT_255	[p13l997t1531r1203b1570],
20	of	IN	O	of	_	0	SENT_255	[p13l1231t1513r1300b1570],
21	this	DT	O	this	det	22	SENT_255	[p13l1321t1513r1433b1570],
22	study	NN	O	study	prep_of	19	SENT_255	[p13l1464t1514r1632b1586],
23	were	VBD	O	be	cop	24	SENT_255	[p13l1660t1531r1813b1570],
24	similar	JJ	O	similar	_	0	SENT_255	[p13l1842t1513r2061b1570],
25	to	TO	O	to	_	0	SENT_255	[p13l2086t1522r2146b1570],
26	those	DT	O	those	prep_to	24	SENT_255	[p13l8t1602r175b1658],
27	of	IN	O	of	_	0	SENT_255	[p13l206t1602r275b1658],
28	the	DT	O	the	det	31	SENT_255	[p13l299t1602r395b1658],
29	weighted	JJ	O	weighted	amod	31	SENT_255	[p13l425t1602r718b1675],
30	ANCHOR/MARINA	NN	O	anchor/marina	nn	31	SENT_255	[p13l746t1602r1431b1658],
31	outcomes	NNS	O	outcome	prep_of	26	SENT_255	[p13l1462t1610r1764b1658],
32	and	CC	O	and	_	0	SENT_255	[p13l1797t1602r1910b1658],
33	significantly	RB	O	significantly	advmod	34	SENT_255	[p13l1942t1602r2144b1675, p13l8t1689r224b1762],
34	better	JJR	O	better	conj_and	24	SENT_255	[p13l269t1689r452b1745],
35	than	IN	O	than	_	0	SENT_255	[p13l496t1689r632b1745],
36	the	DT	O	the	det	37	SENT_255	[p13l678t1689r773b1745],
37	outcomes	NNS	O	outcome	prep_than	34	SENT_255	[p13l820t1698r1122b1745],
38	of	IN	O	of	_	0	SENT_255	[p13l1171t1689r1240b1745],
39	the	DT	O	the	det	40	SENT_255	[p13l1280t1689r1375b1745],
40	patients	NNS	O	patient	prep_of	37	SENT_255	[p13l1420t1689r1666b1762],
41	with	IN	O	with	_	0	SENT_255	[p13l1714t1689r1855b1745],
42	the	DT	O	the	det	44	SENT_255	[p13l1899t1689r1995b1745],
43	CC	NN	O	cc	nn	44	SENT_255	[p13l2042t1689r2144b1746],
44	genotype	NN	O	genotype	prep_with	40	SENT_255	[p13l9t1786r300b1850],
45	at	IN	O	at	_	0	SENT_255	[p13l331t1785r386b1833],
46	this	DT	O	this	det	49	SENT_255	[p13l414t1777r526b1833],
47	SNP	NN	O	snp	nn	49	SENT_255	[p13l559t1778r702b1834],
48	(	CD	NUMBER	(	num	49	SENT_255	[p13l733t1777r964b1850],
49	Figure	NN	O	figure	prep_at	44	SENT_255	[p13l733t1777r964b1850],
50	1	CD	NUMBER	1	num	51	SENT_255	[p13l1001t1778r1074b1847],
51	)	NN	O	)	dep	24	SENT_255	[p13l1001t1778r1074b1847],
52	.	.	O	.	_	0	SENT_255	[p13l1001t1778r1074b1847],

1	Discussion	NN	O	discussion	_	0	SENT_256	[p13l8t2011r517b2088],

1	We	PRP	O	we	nsubj	2	SENT_257	[p13l8t2215r129b2275],
2	identiﬁed	VBD	O	identiﬁed	_	0	SENT_257	[p13l152t2213r487b2275],
3	a	DT	O	a	det	5	SENT_257	[p13l511t2233r547b2275],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_257	[p13l572t2213r939b2293],
5	association	NN	O	association	dobj	2	SENT_257	[p13l961t2213r1354b2275],
6	for	IN	O	for	_	0	SENT_257	[p13l1376t2213r1479b2275],
7	SNP	NN	O	snp	prep_for	2	SENT_257	[p13l1502t2213r1661b2275],
8	rs3025000	CD	NUMBER	rs3025000	num	7	SENT_257	[p13l1682t2213r2057b2275],
9	in	IN	O	in	_	0	SENT_257	[p13l2079t2213r2147b2274],
10	the	DT	O	the	det	12	SENT_257	[p13l9t2310r114b2372],
11	VEGFA	NN	O	vegfa	nn	12	SENT_257	[p13l144t2311r415b2373],
12	gene	NN	O	gene	prep_in	7	SENT_257	[p13l442t2329r606b2390],
13	in	IN	O	in	_	0	SENT_257	[p13l629t2310r696b2371],
14	the	DT	O	the	det	15	SENT_257	[p13l719t2310r825b2372],
15	outcome	NN	O	outcome	prep_in	2	SENT_257	[p13l850t2319r1153b2372],
16	of	IN	O	of	_	0	SENT_257	[p13l1177t2310r1254b2372],
17	anti-VEGF	JJ	O	anti-vegf	amod	18	SENT_257	[p13l1272t2310r1665b2372],
18	treatment	NN	O	treatment	prep_of	15	SENT_257	[p13l1687t2319r2023b2372],
19	for	IN	O	for	_	0	SENT_257	[p13l2045t2310r2148b2372],
20	neovascular	JJ	O	neovascular	amod	21	SENT_257	[p13l9t2406r434b2469],
21	AMD	NNP	O	AMD	prep_for	18	SENT_257	[p13l458t2407r681b2468],
22	.	.	O	.	_	0	SENT_257	[p13l458t2407r681b2468],

1	The	DT	O	the	det	2	SENT_258	[p13l713t2406r848b2468],
2	presence	NN	O	presence	nsubj	16	SENT_258	[p13l874t2426r1184b2487],
3	of	IN	O	of	_	0	SENT_258	[p13l1212t2406r1289b2468],
4	21	CD	NUMBER	21	num	5	SENT_258	[p13l1315t2407r1418b2468],
5	copies	NNS	O	copy	prep_of	2	SENT_258	[p13l1453t2406r1676b2487],
6	of	IN	O	of	_	0	SENT_258	[p13l1705t2406r1782b2468],
7	the	DT	O	the	det	12	SENT_258	[p13l1802t2406r1908b2468],
8	minor	JJ	O	minor	amod	12	SENT_258	[p13l1935t2406r2148b2468],
9	(	NN	O	(	nn	12	SENT_258	[p13l11t2505r117b2581],
10	T	NN	O	t	nn	12	SENT_258	[p13l11t2505r117b2581],
11	)	CD	NUMBER	)	num	12	SENT_258	[p13l11t2505r117b2581],
12	allele	NN	O	allele	prep_of	5	SENT_258	[p13l174t2504r362b2566],
13	in	IN	O	in	_	0	SENT_258	[p13l414t2504r482b2565],
14	this	DT	O	this	det	15	SENT_258	[p13l533t2504r658b2566],
15	SNP	NN	O	snp	prep_in	12	SENT_258	[p13l714t2504r874b2566],
16	predicted	VBD	O	predict	_	0	SENT_258	[p13l924t2504r1255b2584],
17	a	DT	O	a	det	21	SENT_258	[p13l1308t2524r1345b2566],
18	clinically	RB	O	clinically	advmod	19	SENT_258	[p13l1396t2504r1724b2584],
19	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_258	[p13l1780t2504r2147b2584],
20	greater	JJR	O	greater	amod	21	SENT_258	[p13l10t2610r255b2681],
21	increase	NN	O	increase	dobj	16	SENT_258	[p13l278t2601r567b2663],
22	in	IN	O	in	_	0	SENT_258	[p13l592t2601r660b2662],
23	VA	NNP	O	VA	prep_in	16	SENT_258	[p13l684t2601r810b2663],
24	of	IN	O	of	_	0	SENT_258	[p13l836t2601r912b2663],
25	+7	CD	NUMBER	+7	num	26	SENT_258	[p13l940t2602r1045b2663],
26	letters	NNS	O	letter	prep_of	23	SENT_258	[p13l1072t2601r1285b2663],
27	at	IN	O	at	_	0	SENT_258	[p13l1314t2610r1375b2663],
28	month	NN	DURATION	month	prep_at	16	SENT_258	[p13l1399t2601r1624b2663],
29	6	CD	NUMBER	6	num	28	SENT_258	[p13l1650t2601r1708b2663],
30	.	.	O	.	_	0	SENT_258	[p13l1650t2601r1708b2663],

1	In	IN	O	in	_	0	SENT_259	[p13l1738t2602r1810b2662],
2	addition	NN	O	addition	prep_in	13	SENT_259	[p13l1835t2601r2143b2674],
3	,	,	O	,	_	0	SENT_259	[p13l1835t2601r2143b2674],
4	the	DT	O	the	det	5	SENT_259	[p13l9t2697r115b2759],
5	presence	NN	O	presence	nsubj	13	SENT_259	[p13l149t2717r459b2778],
6	of	IN	O	of	_	0	SENT_259	[p13l495t2697r572b2759],
7	the	DT	O	the	det	12	SENT_259	[p13l601t2697r707b2759],
8	minor	JJ	O	minor	amod	12	SENT_259	[p13l742t2697r954b2759],
9	(	NN	O	(	nn	12	SENT_259	[p13l990t2698r1096b2774],
10	T	NN	O	t	nn	12	SENT_259	[p13l990t2698r1096b2774],
11	)	CD	NUMBER	)	num	12	SENT_259	[p13l990t2698r1096b2774],
12	allele	NN	O	allele	prep_of	5	SENT_259	[p13l1135t2697r1323b2759],
13	indicated	VBD	O	indicate	_	0	SENT_259	[p13l1358t2697r1684b2759],
14	a	DT	O	a	det	15	SENT_259	[p13l1720t2717r1756b2759],
15	2.7	CD	NUMBER	2.7	dobj	13	SENT_259	[p13l1791t2698r1947b2771],
16	-	:	O	-	_	0	SENT_259	[p13l1791t2698r1947b2771],
17	,	,	O	,	_	0	SENT_259	[p13l1791t2698r1947b2771],
18	3.5	CD	NUMBER	3.5	dep	13	SENT_259	[p13l1988t2697r2143b2771],
19	-	:	O	-	_	0	SENT_259	[p13l1988t2697r2143b2771],
20	,	,	O	,	_	0	SENT_259	[p13l1988t2697r2143b2771],
21	and	CC	O	and	_	0	SENT_259	[p13l10t2795r136b2857],
22	2.4-fold	JJ	O	2.4-fold	amod	23	SENT_259	[p13l188t2795r470b2857],
23	increase	NN	O	increase	conj_and	13	SENT_259	[p13l520t2795r810b2857],
24	in	IN	O	in	_	0	SENT_259	[p13l862t2795r929b2856],
25	the	DT	O	the	det	26	SENT_259	[p13l980t2795r1087b2857],
26	likelihood	NN	O	likelihood	prep_in	23	SENT_259	[p13l1139t2795r1499b2857],
27	of	IN	O	of	_	0	SENT_259	[p13l1551t2795r1628b2857],
28	being	VBG	O	be	prepc_of	26	SENT_259	[p13l1672t2795r1868b2875],
29	in	IN	O	in	_	0	SENT_259	[p13l1921t2795r1988b2856],
30	the	DT	O	the	det	32	SENT_259	[p13l2039t2795r2146b2857],
31	responder	NN	O	responder	nn	32	SENT_259	[p13l8t2892r359b2972],
32	group	NN	O	group	prep_in	28	SENT_259	[p13l384t2911r587b2972],
33	than	IN	O	than	dep	28	SENT_259	[p13l613t2892r765b2954],
34	in	IN	O	in	_	0	SENT_259	[p13l790t2892r857b2953],
35	the	DT	O	the	det	37	SENT_259	[p13l882t2892r988b2954],
36	stable/nonresponder	JJ	O	stable/nonresponder	amod	37	SENT_259	[p13l1017t2892r1731b2972],
37	group	NN	O	group	prep_in	28	SENT_259	[p13l1755t2911r1959b2972],
38	after	IN	O	after	_	0	SENT_259	[p13l1987t2892r2148b2954],
39	treatment	NN	O	treatment	prep_after	37	SENT_259	[p13l9t2998r344b3050],
40	in	IN	O	in	_	0	SENT_259	[p13l378t2988r446b3050],
41	our	PRP$	O	we	poss	42	SENT_259	[p13l482t3008r599b3050],
42	cohort	NN	O	cohort	prep_in	39	SENT_259	[p13l633t2988r859b3050],
43	after	IN	O	after	dep	23	SENT_259	[p13l895t2988r1056b3050],
44	3	CD	NUMBER	3	pobj	43	SENT_259	[p13l1092t2989r1151b3062],
45	,	,	O	,	_	0	SENT_259	[p13l1092t2989r1151b3062],
46	6	CD	NUMBER	6	pobj	43	SENT_259	[p13l1191t2988r1250b3062],
47	,	,	O	,	_	0	SENT_259	[p13l1191t2988r1250b3062],
48	and	CC	DURATION	and	_	0	SENT_259	[p13l1291t2988r1416b3050],
49	12	CD	DURATION	12	num	50	SENT_259	[p13l1460t2989r1537b3050],
50	months	NNS	NUMBER	month	conj_and	44	SENT_259	[p13l1573t2988r1852b3062],
51	,	,	O	,	_	0	SENT_259	[p13l1573t2988r1852b3062],
52	respectively	RB	O	respectively	dep	53	SENT_259	[p13l1890t3008r2143b3069, p13l9t3086r208b3166],
53	(	CD	NUMBER	(	num	56	SENT_259	[p13l244t3086r471b3163],
54	Table	NNP	O	Table	nn	56	SENT_259	[p13l244t3086r471b3163],
55	6	CD	NUMBER	6	num	56	SENT_259	[p13l506t3086r594b3162],
56	)	NN	O	)	appos	50	SENT_259	[p13l506t3086r594b3162],
57	.	.	O	.	_	0	SENT_259	[p13l506t3086r594b3162],

1	We	PRP	O	we	nsubj	3	SENT_260	[p13l630t3088r752b3148],
2	were	VBD	O	be	cop	3	SENT_260	[p13l785t3106r955b3148],
3	unable	JJ	O	unable	_	0	SENT_260	[p13l988t3086r1223b3148],
4	to	TO	O	to	aux	5	SENT_260	[p13l1256t3095r1322b3148],
5	ﬁnd	VB	O	ﬁnd	xcomp	3	SENT_260	[p13l1357t3086r1492b3148],
6	any	DT	O	any	det	9	SENT_260	[p13l1526t3106r1649b3166],
7	other	JJ	O	other	amod	9	SENT_260	[p13l1684t3086r1865b3148],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_260	[p13l1899t3086r2144b3166, p13l9t3192r156b3245],
9	association	NN	O	association	dobj	5	SENT_260	[p13l195t3183r587b3245],
10	between	IN	O	between	_	0	SENT_260	[p13l624t3183r920b3245],
11	other	JJ	O	other	amod	12	SENT_260	[p13l959t3183r1140b3245],
12	SNPs	NNS	O	snp	prep_between	9	SENT_260	[p13l1179t3183r1371b3245],
13	in	IN	O	in	_	0	SENT_260	[p13l1411t3183r1478b3244],
14	the	DT	O	the	det	16	SENT_260	[p13l1516t3183r1623b3245],
15	VEGFA	NN	O	vegfa	nn	16	SENT_260	[p13l1667t3184r1939b3245],
16	gene	NN	O	gene	prep_in	5	SENT_260	[p13l1981t3202r2146b3263],
17	and	CC	O	and	_	0	SENT_260	[p13l10t3279r136b3341],
18	VA	NN	ORGANIZATION	va	nn	19	SENT_260	[p13l167t3280r294b3341],
19	outcome	NN	O	outcome	prep_in	5	SENT_260	[p13l327t3289r648b3341],
20	.	.	O	.	_	0	SENT_260	[p13l327t3289r648b3341],

1	This	DT	O	this	nsubj	5	SENT_261	[p13l116t3377r269b3439],
2	is	VBZ	O	be	cop	5	SENT_261	[p13l311t3377r366b3439],
3	the	DT	O	the	det	5	SENT_261	[p13l407t3377r513b3439],
4	ﬁrst	NN	O	ﬁrst	nn	5	SENT_261	[p13l554t3377r691b3439],
5	study	NN	O	study	_	0	SENT_261	[p13l732t3377r919b3457],
6	that	WDT	O	that	nsubj	8	SENT_261	[p13l959t3377r1092b3439],
7	has	VBZ	O	have	aux	8	SENT_261	[p13l1129t3377r1244b3439],
8	investigated	VBN	O	investigate	rcmod	5	SENT_261	[p13l1285t3377r1715b3457],
9	the	DT	O	the	det	10	SENT_261	[p13l1753t3377r1859b3439],
10	role	NN	O	role	dobj	8	SENT_261	[p13l1898t3377r2035b3439],
11	of	IN	O	of	_	0	SENT_261	[p13l2076t3377r2152b3439],
12	SNP	NN	O	snp	prep_of	10	SENT_261	[p13l11t3474r170b3536],
13	rs3025000	CD	NUMBER	rs3025000	num	12	SENT_261	[p13l210t3474r585b3536],
14	in	IN	O	in	_	0	SENT_261	[p13l627t3474r694b3535],
15	the	DT	O	the	det	17	SENT_261	[p13l735t3474r841b3536],
16	VEGFA	NN	O	vegfa	nn	17	SENT_261	[p13l888t3475r1160b3536],
17	gene	NN	O	gene	prep_in	8	SENT_261	[p13l1206t3493r1370b3554],
18	and	CC	O	and	_	0	SENT_261	[p13l1414t3474r1539b3536],
19	the	DT	O	the	det	20	SENT_261	[p13l1580t3474r1686b3536],
20	outcome	NN	O	outcome	prep_in	8	SENT_261	[p13l1729t3483r2032b3536],
21	of	IN	O	of	prep	8	SENT_261	[p13l2075t3474r2152b3536],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_262	[p14l559t53r851b97],
2	Volume	NN	O	volume	dep	1	SENT_262	[p14l897t53r1030b88],
3	120	CD	NUMBER	120	num	2	SENT_262	[p14l1052t55r1126b94],
4	,	,	O	,	_	0	SENT_262	[p14l1052t55r1126b94],
5	Number	NNP	O	Number	appos	2	SENT_262	[p14l1146t53r1291b88],
6	1	CD	NUMBER	1	num	5	SENT_262	[p14l1311t55r1340b94],
7	,	,	O	,	_	0	SENT_262	[p14l1311t55r1340b94],
8	January	NNP	DATE	January	tmod	2	SENT_262	[p14l1357t55r1495b97],
9	2013	CD	DATE	2013	num	8	SENT_262	[p14l1514t55r1601b88],

1	anti-VEGF	JJ	O	anti-vegf	amod	2	SENT_263	[p14l10t228r403b291],
2	treatment	NN	O	treatment	_	0	SENT_263	[p14l443t237r779b290],
3	in	IN	O	in	_	0	SENT_263	[p14l818t228r885b290],
4	AMD	NNP	ORGANIZATION	AMD	prep_in	2	SENT_263	[p14l925t229r1149b290],
5	.	.	O	.	_	0	SENT_263	[p14l925t229r1149b290],

1	The	DT	O	the	det	3	SENT_264	[p14l1194t228r1330b290],
2	tSNP	NN	O	tsnp	nn	3	SENT_264	[p14l1371t229r1557b291],
3	rs3025000	NN	O	rs3025000	nsubj	7	SENT_264	[p14l1596t228r1970b291],
4	is	VBZ	O	be	cop	7	SENT_264	[p14l2012t228r2067b290],
5	a	DT	O	a	det	7	SENT_264	[p14l2111t248r2148b290],
6	boundary	NN	O	boundary	nn	7	SENT_264	[p14l7t326r342b406],
7	SNP	NN	ORGANIZATION	snp	_	0	SENT_264	[p14l371t326r548b400],
8	,	,	O	,	_	0	SENT_264	[p14l371t326r548b400],
9	located	JJ	O	located	amod	38	SENT_264	[p14l577t326r832b388],
10	at	IN	O	at	_	0	SENT_264	[p14l859t335r920b388],
11	position	NN	O	position	prep_at	9	SENT_264	[p14l943t326r1229b406],
12	43,746,169	CD	NUMBER	43,746,169	num	11	SENT_264	[p14l1254t326r1651b399],
13	in	IN	O	in	_	0	SENT_264	[p14l1678t326r1746b387],
14	intron	NN	O	intron	prep_in	11	SENT_264	[p14l1771t326r1981b388],
15	3	CD	NUMBER	3	num	14	SENT_264	[p14l2009t326r2044b388],
16	of	IN	O	of	_	0	SENT_264	[p14l2075t326r2151b388],
17	the	DT	O	the	det	19	SENT_264	[p14l8t423r114b485],
18	VEGFA	NN	O	vegfa	nn	19	SENT_264	[p14l156t424r428b485],
19	gene	NN	O	gene	prep_of	14	SENT_264	[p14l468t442r651b503],
20	,	,	O	,	_	0	SENT_264	[p14l468t442r651b503],
21	28	CD	NUMBER	28	num	23	SENT_264	[p14l692t423r774b485],
22	base	NN	O	base	nn	23	SENT_264	[p14l812t423r969b485],
23	pairs	NNS	O	pair	appos	19	SENT_264	[p14l1004t423r1173b503],
24	upstream	RB	O	upstream	advmod	11	SENT_264	[p14l1211t432r1537b503],
25	from	IN	O	from	_	0	SENT_264	[p14l1572t423r1743b485],
26	the	DT	O	the	det	27	SENT_264	[p14l1778t423r1884b485],
27	beginning	NN	O	beginning	prep_from	24	SENT_264	[p14l1919t423r2143b503, p14l9t519r163b600],
28	of	IN	O	of	_	0	SENT_264	[p14l190t519r266b581],
29	exon	NN	O	exon	prep_of	27	SENT_264	[p14l284t539r455b581],
30	4	CD	NUMBER	4	number	31	SENT_264	[p14l478t520r519b581],
31	(	CD	NUMBER	(	num	32	SENT_264	[p14l546t519r2142b600],
32	http://www.ncbi.nlm.nih.gov/sites/nuccore/;	NN	O	http://www.ncbi.nlm.nih.gov/sites/nuccore/;	dep	11	SENT_264	[p14l546t519r2142b600],
33	accessed	VBN	O	access	partmod	32	SENT_264	[p14l10t617r319b679],
34	April	NNP	DATE	April	tmod	33	SENT_264	[p14l350t617r536b697],
35	25	CD	DATE	25	num	34	SENT_264	[p14l569t617r674b691],
36	,	,	DATE	,	_	0	SENT_264	[p14l569t617r674b691],
37	2011	CD	DATE	2011	num	34	SENT_264	[p14l710t617r932b694],
38	)	NN	O	)	appos	7	SENT_264	[p14l710t617r932b694],
39	.	.	O	.	_	0	SENT_264	[p14l710t617r932b694],

1	Because	IN	O	because	_	0	SENT_265	[p14l116t715r410b776],
2	anti-VEGF	JJ	O	anti-vegf	prep_because	4	SENT_265	[p14l437t714r830b776],
3	medications	NNS	O	medication	nsubj	4	SENT_265	[p14l853t714r1280b776],
4	induce	VBP	O	induce	_	0	SENT_265	[p14l1307t714r1541b776],
5	their	PRP$	O	they	poss	7	SENT_265	[p14l1566t714r1729b776],
6	therapeutic	JJ	O	therapeutic	amod	7	SENT_265	[p14l1752t714r2145b794],
7	action	NN	O	action	dobj	4	SENT_265	[p14l10t810r224b872],
8	by	IN	O	by	_	0	SENT_265	[p14l257t810r345b891],
9	blocking	VBG	O	block	prepc_by	4	SENT_265	[p14l379t810r689b891],
10	all	DT	O	all	det	11	SENT_265	[p14l727t810r811b872],
11	VEGF	NN	O	vegf	dobj	9	SENT_265	[p14l846t811r1170b873],
12	.	.	O	.	_	0	SENT_265	[p14l846t811r1170b873],

1	—	NN	O	—	_	0	SENT_266	[p14l846t811r1170b873],
2	.	.	O	.	_	0	SENT_266	[p14l846t811r1170b873],

1	A	DT	O	a	det	2	SENT_267	[p14l846t811r1170b873],
2	isoforms	NNS	O	isoform	nsubj	5	SENT_267	[p14l1205t810r1512b872],
3	and	CC	O	and	_	0	SENT_267	[p14l1551t810r1676b872],
4	VEGF	NN	O	vegf	conj_and	2	SENT_267	[p14l1710t811r1941b873],
5	initiates	VBZ	O	initiate	ccomp	35	SENT_267	[p14l1975t810r2144b872, p14l10t918r143b970],
6	and	CC	O	and	_	0	SENT_267	[p14l186t908r311b970],
7	promotes	VBZ	O	promote	conj_and	5	SENT_267	[p14l349t917r677b988],
8	pathologic	JJ	O	pathologic	amod	9	SENT_267	[p14l717t908r1091b988],
9	CNV	NN	ORGANIZATION	cnv	dobj	5	SENT_267	[p14l1133t908r1337b982],
10	,	,	O	,	_	0	SENT_267	[p14l1133t908r1337b982],
11	the	DT	O	the	nsubj	35	SENT_267	[p14l1379t908r1485b970],
12	ﬁnding	VBG	O	ﬁnding	amod	11	SENT_267	[p14l1526t908r1774b988],
13	that	IN	O	that	complm	21	SENT_267	[p14l1815t908r1947b970],
14	SNP	NN	O	snp	nsubjpass	21	SENT_267	[p14l1988t909r2147b970],
15	rs3025000	CD	NUMBER	rs3025000	num	14	SENT_267	[p14l8t1005r382b1067],
16	in	IN	O	in	_	0	SENT_267	[p14l416t1005r483b1066],
17	the	DT	O	the	det	19	SENT_267	[p14l516t1005r622b1067],
18	VEGFA	NN	O	vegfa	nn	19	SENT_267	[p14l661t1006r933b1067],
19	gene	NN	O	gene	prep_in	14	SENT_267	[p14l970t1024r1134b1085],
20	is	VBZ	O	be	auxpass	21	SENT_267	[p14l1168t1005r1223b1067],
21	associated	VBN	O	associate	dep	11	SENT_267	[p14l1261t1005r1623b1067],
22	with	IN	O	with	_	0	SENT_267	[p14l1656t1005r1812b1067],
23	a	DT	O	a	det	26	SENT_267	[p14l1847t1024r1884b1067],
24	significantly	RB	O	significantly	advmod	25	SENT_267	[p14l1919t1005r2143b1085, p14l9t1101r248b1182],
25	better	JJR	O	better	amod	26	SENT_267	[p14l279t1101r482b1163],
26	outcome	NN	O	outcome	prep_with	21	SENT_267	[p14l513t1111r817b1163],
27	for	IN	O	for	_	0	SENT_267	[p14l849t1101r952b1163],
28	anti-VEGF	JJ	O	anti-vegf	amod	29	SENT_267	[p14l983t1101r1376b1164],
29	treatment	NN	O	treatment	prep_for	26	SENT_267	[p14l1406t1110r1742b1163],
30	in	IN	O	in	_	0	SENT_267	[p14l1772t1101r1840b1163],
31	patients	NNS	O	patient	prep_in	21	SENT_267	[p14l1870t1101r2144b1182],
32	with	IN	O	with	_	0	SENT_267	[p14l9t1199r165b1261],
33	neovascular	JJ	O	neovascular	amod	34	SENT_267	[p14l205t1199r630b1261],
34	AMD	NNP	ORGANIZATION	AMD	prep_with	31	SENT_267	[p14l669t1200r873b1260],
35	suggests	VBZ	O	suggest	_	0	SENT_267	[p14l918t1208r1213b1279],
36	a	DT	O	a	det	39	SENT_267	[p14l1257t1219r1294b1261],
37	potential	JJ	O	potential	amod	39	SENT_267	[p14l1331t1199r1642b1279],
38	pharmacogenetic	JJ	O	pharmacogenetic	amod	39	SENT_267	[p14l1682t1199r2143b1279, p14l9t1296r178b1358],
39	relationship	NN	O	relationship	dobj	35	SENT_267	[p14l210t1296r648b1376],
40	.	.	O	.	_	0	SENT_267	[p14l210t1296r648b1376],

1	A	DT	O	a	det	3	SENT_268	[p14l115t1393r178b1454],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_268	[p14l223t1392r590b1473],
3	association	NN	O	association	nsubjpass	7	SENT_268	[p14l633t1392r1026b1454],
4	has	VBZ	O	have	aux	7	SENT_268	[p14l1067t1392r1182b1454],
5	previously	RB	DATE	previously	advmod	7	SENT_268	[p14l1225t1392r1600b1473],
6	been	VBN	O	be	auxpass	7	SENT_268	[p14l1642t1392r1809b1454],
7	reported	VBN	O	report	_	0	SENT_268	[p14l1850t1392r2147b1473],
8	between	IN	O	between	_	0	SENT_268	[p14l7t1490r304b1552],
9	a	DT	O	a	det	10	SENT_268	[p14l327t1510r364b1552],
10	haplotype	NN	O	haplotype	prep_between	7	SENT_268	[p14l384t1490r734b1570],
11	in	IN	O	in	_	0	SENT_268	[p14l756t1490r824b1551],
12	the	DT	O	the	det	14	SENT_268	[p14l846t1490r952b1552],
13	VEGFA	NN	O	vegfa	nn	14	SENT_268	[p14l979t1491r1251b1553],
14	gene	NN	O	gene	prep_in	10	SENT_268	[p14l1278t1510r1442b1570],
15	including	VBG	O	include	_	0	SENT_268	[p14l1465t1490r1798b1570],
16	the	DT	O	the	det	18	SENT_268	[p14l1821t1490r1928b1552],
17	SNPs	NNS	O	snp	nn	18	SENT_268	[p14l1953t1490r2144b1552],
18	rs1413711	NN	O	rs1413711	prep_including	14	SENT_268	[p14l8t1588r402b1662],
19	,	,	O	,	_	0	SENT_268	[p14l8t1588r402b1662],
20	rs833070	NN	O	rs833070	prep_including	14	SENT_268	[p14l444t1588r793b1661],
21	,	,	O	,	_	0	SENT_268	[p14l444t1588r793b1661],
22	and	CC	O	and	_	0	SENT_268	[p14l839t1588r964b1650],
23	rs3025000	NN	O	rs3025000	nn	27	SENT_268	[p14l1003t1588r1378b1650],
24	and	CC	O	and	_	0	SENT_268	[p14l1420t1588r1546b1650],
25	acute	JJ	O	acute	nn	27	SENT_268	[p14l1587t1597r1770b1650],
26	mountain	NN	O	mountain	nn	27	SENT_268	[p14l1811t1588r2146b1650],
27	sickness	NN	O	sickness	conj_and	18	SENT_268	[p14l12t1684r301b1746],
28	(	CD	NUMBER	(	num	29	SENT_268	[p14l340t1685r604b1761],
29	AMS	NNP	O	AMS	dep	27	SENT_268	[p14l340t1685r604b1761],
30	)	CD	NUMBER	)	num	29	SENT_268	[p14l340t1685r604b1761],
31	.	.	O	.	_	0	SENT_268	[p14l340t1685r604b1761],

1	In	IN	O	in	_	0	SENT_269	[p14l642t1686r714b1746],
2	that	DT	O	that	det	3	SENT_269	[p14l747t1684r880b1746],
3	study	NN	O	study	prep_in	9	SENT_269	[p14l915t1684r1122b1765],
4	,	,	O	,	_	0	SENT_269	[p14l915t1684r1122b1765],
5	the	DT	O	the	det	6	SENT_269	[p14l1158t1684r1264b1746],
6	patients	NNS	O	patient	nsubj	9	SENT_269	[p14l1297t1684r1571b1765],
7	with	IN	O	with	_	0	SENT_269	[p14l1607t1684r1763b1747],
8	AMS	NNP	O	AMS	prep_with	6	SENT_269	[p14l1796t1685r1982b1747],
9	had	VBD	O	have	_	0	SENT_269	[p14l2019t1684r2147b1746],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_269	[p14l12t1782r446b1862],
11	lower	JJR	O	lower	amod	15	SENT_269	[p14l491t1782r693b1844],
12	peripheral	JJ	O	peripheral	amod	15	SENT_269	[p14l734t1782r1094b1862],
13	oxygen	NN	O	oxygen	nn	15	SENT_269	[p14l1139t1802r1398b1862],
14	saturation	NN	O	saturation	nn	15	SENT_269	[p14l1445t1782r1791b1844],
15	levels	NNS	O	level	dobj	9	SENT_269	[p14l1835t1782r2038b1844],
16	at	IN	O	at	_	0	SENT_269	[p14l2086t1791r2147b1844],
17	high	JJ	O	high	amod	18	SENT_269	[p14l8t1879r165b1959],
18	altitude	NN	O	altitude	prep_at	9	SENT_269	[p14l192t1879r454b1941],
19	compared	VBN	O	compare	_	0	SENT_269	[p14l481t1879r830b1959],
20	with	IN	O	with	prepc_compared_with	9	SENT_269	[p14l855t1879r1011b1941],
21	the	DT	O	the	det	23	SENT_269	[p14l1036t1879r1142b1941],
22	control	NN	O	control	nn	23	SENT_269	[p14l1169t1879r1418b1941],
23	group	NN	O	group	pobj	9	SENT_269	[p14l1445t1867r1738b1959],
24	.	.	O	.	_	0	SENT_269	[p14l1445t1867r1738b1959],

1	”	NN	O	”	nn	3	SENT_270	[p14l1445t1867r1738b1959],
2	The	DT	O	the	det	3	SENT_270	[p14l1764t1878r1900b1941],
3	mechanism	NN	O	mechanism	nsubjpass	11	SENT_270	[p14l1925t1879r2143b1941, p14l10t1975r220b2037],
4	of	IN	O	of	_	0	SENT_270	[p14l268t1975r344b2037],
5	development	NN	O	development	prep_of	3	SENT_270	[p14l387t1975r846b2056],
6	of	IN	O	of	_	0	SENT_270	[p14l893t1975r970b2037],
7	AMS	NNP	O	AMS	prep_of	5	SENT_270	[p14l1011t1976r1198b2038],
8	is	VBZ	O	be	auxpass	11	SENT_270	[p14l1250t1975r1305b2037],
9	not	RB	O	not	neg	11	SENT_270	[p14l1355t1985r1467b2037],
10	fully	RB	O	fully	advmod	11	SENT_270	[p14l1514t1975r1679b2056],
11	understood	VBN	O	understand	_	0	SENT_270	[p14l1727t1975r2142b2049],
12	;	:	O	;	_	0	SENT_270	[p14l1727t1975r2142b2049],
13	however	RB	O	however	advmod	30	SENT_270	[p14l8t2073r332b2146],
14	,	,	O	,	_	0	SENT_270	[p14l8t2073r332b2146],
15	hypoxemia	NN	O	hypoxemia	nsubj	30	SENT_270	[p14l365t2073r761b2153],
16	secondary	JJ	O	secondary	amod	15	SENT_270	[p14l794t2073r1150b2153],
17	to	TO	O	to	_	0	SENT_270	[p14l1181t2082r1247b2135],
18	hypoxia	NN	O	hypoxium	prep_to	16	SENT_270	[p14l1278t2073r1565b2153],
19	and	CC	O	and	_	0	SENT_270	[p14l1597t2073r1722b2135],
20	subsequent	JJ	O	subsequent	amod	22	SENT_270	[p14l1755t2073r2147b2153],
21	vascular	JJ	O	vascular	amod	22	SENT_270	[p14l9t2170r305b2232],
22	changes	NNS	O	change	prep_to	16	SENT_270	[p14l334t2170r616b2250],
23	in	IN	O	in	_	0	SENT_270	[p14l649t2170r716b2231],
24	the	DT	O	the	det	25	SENT_270	[p14l746t2170r852b2232],
25	body	NN	O	body	prep_in	22	SENT_270	[p14l882t2170r1058b2250],
26	are	VBP	O	be	cop	30	SENT_270	[p14l1091t2189r1195b2232],
27	the	DT	O	the	det	30	SENT_270	[p14l1225t2170r1332b2232],
28	main	JJ	O	main	amod	30	SENT_270	[p14l1362t2170r1539b2232],
29	pathophysiological	JJ	O	pathophysiological	amod	30	SENT_270	[p14l1568t2170r2143b2250, p14l9t2266r135b2328],
30	changes	NNS	O	change	parataxis	11	SENT_270	[p14l178t2266r460b2347],
31	seen	VBN	O	see	partmod	30	SENT_270	[p14l508t2286r662b2328],
32	in	IN	O	in	_	0	SENT_270	[p14l704t2266r771b2328],
33	AMS	NNP	O	AMS	prep_in	31	SENT_270	[p14l813t2254r1087b2329],
34	.	.	O	.	_	0	SENT_270	[p14l813t2254r1087b2329],

1	“	NN	O	“	nsubj	4	SENT_271	[p14l813t2254r1087b2329],
2	Another	DT	O	another	det	3	SENT_271	[p14l1136t2266r1428b2328],
3	study	NN	O	study	dep	1	SENT_271	[p14l1471t2266r1659b2347],
4	showed	VBD	O	show	_	0	SENT_271	[p14l1705t2266r1972b2329],
5	that	IN	O	that	complm	9	SENT_271	[p14l2015t2266r2147b2328],
6	patients	NNS	O	patient	nsubj	9	SENT_271	[p14l8t2364r281b2444],
7	with	IN	O	with	_	0	SENT_271	[p14l332t2364r489b2426],
8	AMS	NNP	O	AMS	prep_with	6	SENT_271	[p14l536t2364r723b2426],
9	had	VBD	O	have	ccomp	4	SENT_271	[p14l775t2364r903b2426],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_271	[p14l954t2364r1388b2444],
11	higher	JJR	O	higher	amod	15	SENT_271	[p14l1436t2364r1664b2444],
12	free	JJ	O	free	amod	15	SENT_271	[p14l1711t2364r1847b2426],
13	plasma	NN	O	plasma	nn	15	SENT_271	[p14l1894t2364r2147b2444],
14	VEGF-A	NN	O	vegf-a	nn	15	SENT_271	[p14l8t2461r333b2523],
15	levels	NNS	O	level	dobj	9	SENT_271	[p14l385t2461r588b2523],
16	at	IN	O	at	_	0	SENT_271	[p14l643t2470r704b2523],
17	high	JJ	O	high	amod	18	SENT_271	[p14l754t2461r911b2541],
18	altitude	NN	O	altitude	prep_at	9	SENT_271	[p14l964t2461r1226b2523],
19	compared	VBN	O	compare	_	0	SENT_271	[p14l1279t2461r1628b2541],
20	with	IN	O	with	prepc_compared_with	9	SENT_271	[p14l1679t2461r1835b2523],
21	healthy	JJ	O	healthy	amod	22	SENT_271	[p14l1885t2461r2145b2541],
22	individuals	NNS	O	individual	pobj	9	SENT_271	[p14l9t2557r421b2631],
23	,	,	O	,	_	0	SENT_271	[p14l9t2557r421b2631],
24	suggesting	VBG	O	suggest	xcomp	4	SENT_271	[p14l478t2557r852b2638],
25	a	DT	O	a	det	26	SENT_271	[p14l905t2577r941b2619],
26	role	NN	O	role	dobj	24	SENT_271	[p14l989t2557r1125b2619],
27	for	IN	O	for	_	0	SENT_271	[p14l1176t2557r1279b2619],
28	increased	VBN	O	increase	amod	32	SENT_271	[p14l1327t2557r1661b2619],
29	free	JJ	O	free	amod	32	SENT_271	[p14l1711t2557r1846b2619],
30	plasma	NN	O	plasma	nn	32	SENT_271	[p14l1895t2557r2148b2638],
31	VEGF-A	NN	O	vegf-a	nn	32	SENT_271	[p14l8t2655r333b2717],
32	levels	NNS	O	level	prep_for	26	SENT_271	[p14l360t2655r563b2717],
33	in	IN	O	in	_	0	SENT_271	[p14l592t2655r659b2716],
34	the	DT	O	the	det	35	SENT_271	[p14l685t2655r791b2717],
35	pathophysiology	NN	O	pathophysiology	prep_in	32	SENT_271	[p14l818t2655r1410b2735],
36	of	IN	O	of	_	0	SENT_271	[p14l1438t2655r1515b2717],
37	AMS	NNP	O	AMS	prep_of	35	SENT_271	[p14l1536t2643r1815b2717],
38	.	.	O	.	_	0	SENT_271	[p14l1536t2643r1815b2717],

1	”	RB	O	”	advmod	5	SENT_272	[p14l1536t2643r1815b2717],
2	It	PRP	O	it	nsubjpass	5	SENT_272	[p14l1843t2657r1896b2717],
3	is	VBZ	O	be	auxpass	5	SENT_272	[p14l1921t2655r1976b2717],
4	also	RB	O	also	advmod	5	SENT_272	[p14l2007t2655r2145b2717],
5	known	VBN	O	know	_	0	SENT_272	[p14l8t2752r249b2814],
6	that	IN	O	that	complm	11	SENT_272	[p14l293t2752r426b2814],
7	hypoxia	NN	O	hypoxium	nsubj	11	SENT_272	[p14l468t2752r755b2832],
8	is	VBZ	O	be	cop	11	SENT_272	[p14l798t2752r853b2814],
9	a	DT	O	a	det	11	SENT_272	[p14l901t2771r938b2814],
10	major	JJ	O	major	amod	11	SENT_272	[p14l981t2752r1188b2832],
11	inducer	NN	O	inducer	ccomp	5	SENT_272	[p14l1231t2752r1497b2814],
12	of	IN	O	of	_	0	SENT_272	[p14l1541t2752r1617b2814],
13	VEGFA	NN	O	vegfa	nn	15	SENT_272	[p14l1661t2753r1933b2814],
14	gene	NN	O	gene	nn	15	SENT_272	[p14l1981t2771r2145b2832],
15	transcription	NN	O	transcription	prep_of	11	SENT_272	[p14l9t2836r543b2929],
16	.	.	O	.	_	0	SENT_272	[p14l9t2836r543b2929],

1	”	NN	O	”	nn	3	SENT_273	[p14l9t2836r543b2929],
2	The	DT	O	the	det	3	SENT_273	[p14l611t2848r747b2910],
3	association	NN	O	association	nsubj	22	SENT_273	[p14l815t2848r1207b2910],
4	of	IN	O	of	_	0	SENT_273	[p14l1273t2848r1350b2910],
5	the	DT	O	the	det	8	SENT_273	[p14l1409t2848r1515b2910],
6	genetic	JJ	O	genetic	amod	8	SENT_273	[p14l1582t2848r1834b2929],
7	variant	JJ	O	variant	amod	8	SENT_273	[p14l1901t2848r2148b2911],
8	rs3025000	NN	O	rs3025000	prep_of	3	SENT_273	[p14l8t2946r382b3008],
9	with	IN	O	with	_	0	SENT_273	[p14l415t2946r571b3008],
10	both	CC	O	both	preconj	11	SENT_273	[p14l602t2946r759b3008],
11	AMS	NNP	O	AMS	prep_with	8	SENT_273	[p14l791t2946r978b3008],
12	and	CC	O	and	_	0	SENT_273	[p14l1016t2946r1141b3008],
13	the	DT	O	the	det	14	SENT_273	[p14l1173t2946r1279b3008],
14	response	NN	O	response	conj_and	11	SENT_273	[p14l1310t2966r1621b3026],
15	to	TO	O	to	_	0	SENT_273	[p14l1653t2955r1719b3008],
16	anti-VEGF	JJ	O	anti-vegf	amod	17	SENT_273	[p14l1754t2946r2147b3008],
17	treatment	NN	O	treatment	prep_to	8	SENT_273	[p14l8t3052r344b3105],
18	in	IN	O	in	_	0	SENT_273	[p14l374t3043r441b3104],
19	neovascular	JJ	O	neovascular	amod	20	SENT_273	[p14l472t3043r897b3105],
20	AMD	NNP	ORGANIZATION	AMD	prep_in	17	SENT_273	[p14l926t3043r1130b3104],
21	is	VBZ	O	be	cop	22	SENT_273	[p14l1163t3043r1218b3105],
22	interesting	JJ	O	interesting	_	0	SENT_273	[p14l1251t3043r1643b3123],
23	.	.	O	.	_	0	SENT_273	[p14l1251t3043r1643b3123],

1	One	CD	NUMBER	one	num	3	SENT_274	[p14l1680t3043r1824b3105],
2	possible	JJ	O	possible	amod	3	SENT_274	[p14l1855t3043r2145b3123],
3	mechanism	NN	O	mechanism	nsubj	17	SENT_274	[p14l9t3139r414b3201],
4	of	IN	O	of	_	0	SENT_274	[p14l438t3139r515b3201],
5	how	WRB	O	how	advmod	9	SENT_274	[p14l533t3139r684b3202],
6	SNP	NN	O	snp	nn	7	SENT_274	[p14l713t3140r872b3202],
7	rs3025000	NN	O	rs3025000	nsubj	9	SENT_274	[p14l896t3139r1270b3202],
8	may	MD	O	may	aux	9	SENT_274	[p14l1296t3159r1446b3220],
9	increase	VB	O	increase	prepc_of	3	SENT_274	[p14l1472t3139r1761b3201],
10	the	DT	O	the	det	11	SENT_274	[p14l1786t3139r1892b3201],
11	risk	NN	O	risk	dobj	9	SENT_274	[p14l1917t3139r2052b3201],
12	of	IN	O	of	_	0	SENT_274	[p14l2076t3139r2152b3201],
13	AMS	NNP	O	AMS	prep_of	11	SENT_274	[p14l8t3237r195b3299],
14	is	VBZ	O	be	cop	17	SENT_274	[p14l225t3237r281b3299],
15	a	DT	O	a	det	17	SENT_274	[p14l311t3257r347b3299],
16	hypoxia-related	JJ	O	hypoxia-related	amod	17	SENT_274	[p14l372t3237r930b3317],
17	pathway	NN	O	pathway	_	0	SENT_274	[p14l955t3237r1275b3317],
18	,	,	O	,	_	0	SENT_274	[p14l955t3237r1275b3317],
19	which	WDT	O	which	nsubj	21	SENT_274	[p14l1305t3237r1520b3299],
20	could	MD	O	could	aux	21	SENT_274	[p14l1547t3237r1742b3299],
21	have	VB	O	have	rcmod	17	SENT_274	[p14l1767t3237r1933b3299],
22	some	DT	O	some	det	23	SENT_274	[p14l1963t3257r2146b3299],
23	bearing	NN	O	bearing	dobj	21	SENT_274	[p14l7t3334r272b3414],
24	on	IN	O	on	_	0	SENT_274	[p14l317t3353r402b3396],
25	VEGF-A	NN	O	vegf-a	nn	26	SENT_274	[p14l444t3334r769b3396],
26	levels	NNS	O	level	prep_on	23	SENT_274	[p14l811t3334r1014b3396],
27	or	CC	O	or	_	0	SENT_274	[p14l1060t3353r1132b3396],
28	function	NN	O	function	conj_or	26	SENT_274	[p14l1173t3334r1467b3396],
29	and	CC	O	and	_	0	SENT_274	[p14l1511t3334r1636b3396],
30	therefore	RB	O	therefore	advmod	17	SENT_274	[p14l1678t3334r1997b3396],
31	the	DT	O	the	det	32	SENT_274	[p14l2039t3334r2145b3396],
32	efﬁcacy	NN	O	efﬁcacy	conj_and	17	SENT_274	[p14l9t3430r287b3511],
33	of	IN	O	of	_	0	SENT_274	[p14l327t3430r404b3492],
34	its	PRP$	O	its	poss	35	SENT_274	[p14l436t3430r515b3492],
35	antagonists	NNS	O	antagonist	prep_of	32	SENT_274	[p14l557t3430r952b3511],
36	in	IN	O	in	_	0	SENT_274	[p14l992t3430r1059b3492],
37	the	DT	O	the	det	38	SENT_274	[p14l1097t3430r1203b3492],
38	treatment	NN	O	treatment	prep_in	35	SENT_274	[p14l1241t3439r1577b3492],
39	of	IN	O	of	_	0	SENT_274	[p14l1614t3430r1691b3492],
40	neovascular	JJ	O	neovascular	amod	41	SENT_274	[p14l1723t3430r2148b3493],
41	AMD	NNP	O	AMD	prep_of	38	SENT_274	[p14l8t3529r232b3590],
42	.	.	O	.	_	0	SENT_274	[p14l8t3529r232b3590],

1	The	DT	O	the	det	2	SENT_275	[p15l116t24r251b86],
2	strengths	NNS	O	strength	nsubj	6	SENT_275	[p15l293t24r607b104],
3	of	IN	O	of	_	0	SENT_275	[p15l649t24r726b86],
4	our	PRP$	O	we	poss	5	SENT_275	[p15l759t43r876b86],
5	study	NN	O	study	prep_of	2	SENT_275	[p15l916t24r1103b104],
6	include	VBP	O	include	_	0	SENT_275	[p15l1142t24r1401b86],
7	the	DT	O	the	dobj	6	SENT_275	[p15l1440t24r1547b86],
8	following	VBG	O	follow	amod	7	SENT_275	[p15l1586t24r1947b104],
9	.	.	O	.	_	0	SENT_275	[p15l1586t24r1947b104],

1	This	DT	O	this	nsubj	7	SENT_276	[p15l1990t24r2144b86],
2	was	VBD	O	be	cop	7	SENT_276	[p15l9t140r143b182],
3	a	DT	O	a	det	7	SENT_276	[p15l182t140r219b182],
4	single	JJ	O	single	amod	7	SENT_276	[p15l256t120r712b201],
5	—	NN	O	—	nn	7	SENT_276	[p15l256t120r712b201],
6	center	NN	O	center	nn	7	SENT_276	[p15l256t120r712b201],
7	study	NN	O	study	_	0	SENT_276	[p15l749t120r958b201],
8	;	:	O	;	_	0	SENT_276	[p15l749t120r958b201],
9	all	DT	O	all	det	11	SENT_276	[p15l999t120r1083b182],
10	eligible	JJ	O	eligible	amod	11	SENT_276	[p15l1120t120r1384b201],
11	patients	NNS	O	patient	dep	7	SENT_276	[p15l1418t120r1692b201],
12	who	WP	O	who	nsubj	13	SENT_276	[p15l1730t120r1879b183],
13	underwent	VBD	O	undergo	rcmod	11	SENT_276	[p15l1915t120r2144b182, p15l9t227r181b280],
14	anti	JJ	O	anti	acomp	13	SENT_276	[p15l211t218r604b280],
15	.	.	O	.	_	0	SENT_276	[p15l211t218r604b280],

1	—	NN	O	—	_	0	SENT_277	[p15l211t218r604b280],
2	.	.	O	.	_	0	SENT_277	[p15l211t218r604b280],

1	VEGF	NN	O	vegf	nn	2	SENT_278	[p15l211t218r604b280],
2	treatment	NN	O	treatment	nsubjpass	20	SENT_278	[p15l633t227r968b280],
3	for	IN	O	for	_	0	SENT_278	[p15l997t218r1100b280],
4	untreated	JJ	O	untreated	amod	5	SENT_278	[p15l1128t218r1458b280],
5	neovascular	JJ	O	neovascular	amod	6	SENT_278	[p15l1487t218r1912b280],
6	AMD	NNP	ORGANIZATION	AMD	prep_for	2	SENT_278	[p15l1940t219r2144b279],
7	at	IN	O	at	_	0	SENT_278	[p15l10t324r72b377],
8	the	DT	O	the	det	11	SENT_278	[p15l111t315r217b377],
9	medical	JJ	O	medical	amod	11	SENT_278	[p15l258t315r538b377],
10	retina	NN	O	retina	nn	11	SENT_278	[p15l577t315r781b377],
11	clinic	NN	O	clinic	prep_at	6	SENT_278	[p15l821t315r1014b377],
12	of	IN	O	of	_	0	SENT_278	[p15l1057t315r1134b377],
13	the	DT	O	the	det	14	SENT_278	[p15l1169t315r1275b377],
14	RVEEH	NN	O	rveeh	prep_of	11	SENT_278	[p15l1315t316r1610b377],
15	from	IN	O	from	_	0	SENT_278	[p15l1651t315r1823b377],
16	2006	CD	DATE	2006	num	18	SENT_278	[p15l1864t315r2037b377],
17	to	TO	DATE	to	dep	18	SENT_278	[p15l2079t324r2145b377],
18	2010	CD	DATE	2010	prep_from	14	SENT_278	[p15l10t412r184b474],
19	were	VBD	O	be	auxpass	20	SENT_278	[p15l208t431r378b474],
20	included	VBN	O	include	_	0	SENT_278	[p15l401t411r724b473],
21	.	.	O	.	_	0	SENT_278	[p15l401t411r724b473],

1	The	DT	O	the	dep	127	SENT_279	[p15l751t411r887b473],
2	mean	JJ	O	mean	dep	127	SENT_279	[p15l911t431r1101b473],
3	change	NN	O	change	dep	127	SENT_279	[p15l1125t411r1374b492],
4	in	IN	O	in	dep	127	SENT_279	[p15l1397t411r1464b473],
5	VA	NNP	O	VA	dep	127	SENT_279	[p15l1487t412r1614b473],
6	of	IN	O	of	dep	127	SENT_279	[p15l1637t411r1714b473],
7	our	PRP$	O	we	dep	127	SENT_279	[p15l1733t431r1849b473],
8	patients	NNS	O	patient	dep	127	SENT_279	[p15l1869t411r2144b492],
9	was	VBD	O	be	dep	127	SENT_279	[p15l9t530r143b572],
10	+6.5:12	CD	TIME	+6.5:12	dep	127	SENT_279	[p15l185t510r541b584],
11	,	,	O	,	_	0	SENT_279	[p15l185t510r541b584],
12	+4.41	CD	NUMBER	+4.41	dep	127	SENT_279	[p15l585t510r1008b584],
13	-13.4	CD	NUMBER	-13.4	dep	127	SENT_279	[p15l585t510r1008b584],
14	,	,	O	,	_	0	SENT_279	[p15l585t510r1008b584],
15	and	CC	O	and	dep	127	SENT_279	[p15l1044t510r1169b572],
16	-	:	O	-	_	0	SENT_279	[p15l1208t510r1611b573],
17	I-23	NN	TIME	i-23	dep	127	SENT_279	[p15l1208t510r1611b573],
18	:14.6	CD	TIME	:14.6	dep	127	SENT_279	[p15l1208t510r1611b573],
19	letters	NNS	O	letter	dep	127	SENT_279	[p15l1644t510r1857b572],
20	after	IN	O	after	dep	127	SENT_279	[p15l1892t510r2052b572],
21	3	CD	NUMBER	3	dep	127	SENT_279	[p15l2084t510r2142b584],
22	,	,	O	,	_	0	SENT_279	[p15l2084t510r2142b584],
23	6	CD	NUMBER	6	dep	127	SENT_279	[p15l10t607r69b680],
24	,	,	O	,	_	0	SENT_279	[p15l10t607r69b680],
25	and	CC	DURATION	and	dep	127	SENT_279	[p15l101t607r226b669],
26	12	CD	DURATION	12	dep	127	SENT_279	[p15l261t607r338b668],
27	months	NNS	NUMBER	month	dep	127	SENT_279	[p15l365t607r644b680],
28	,	,	O	,	_	0	SENT_279	[p15l365t607r644b680],
29	respectively	RB	O	respectively	dep	127	SENT_279	[p15l673t607r1121b687],
30	,	,	O	,	_	0	SENT_279	[p15l673t607r1121b687],
31	and	CC	O	and	dep	127	SENT_279	[p15l1153t607r1278b669],
32	compared	VBN	O	compare	dep	127	SENT_279	[p15l1305t607r1654b687],
33	well	RB	O	well	dep	127	SENT_279	[p15l1680t607r1830b669],
34	with	IN	O	with	dep	127	SENT_279	[p15l1857t607r2013b669],
35	the	DT	O	the	dep	127	SENT_279	[p15l2039t607r2145b669],
36	VA	NNP	O	VA	dep	127	SENT_279	[p15l8t704r135b765],
37	outcomes	NNS	O	outcome	dep	127	SENT_279	[p15l159t713r495b765],
38	in	IN	O	in	dep	127	SENT_279	[p15l520t703r587b765],
39	the	DT	O	the	dep	127	SENT_279	[p15l609t703r716b765],
40	RCTs	NNS	MISC	rct	dep	127	SENT_279	[p15l739t704r942b766],
41	with	IN	O	with	dep	127	SENT_279	[p15l968t703r1124b766],
42	similar	JJ	O	similar	dep	127	SENT_279	[p15l1149t703r1393b765],
43	number	NN	O	number	dep	127	SENT_279	[p15l1415t703r1686b765],
44	of	IN	O	of	dep	127	SENT_279	[p15l1708t703r1785b765],
45	injections	NNS	O	injection	dep	127	SENT_279	[p15l1802t703r2144b784],
46	over	IN	O	over	dep	127	SENT_279	[p15l9t821r166b863],
47	12	CD	NUMBER	12	dep	127	SENT_279	[p15l200t801r278b862],
48	months5	NN	O	months5	dep	127	SENT_279	[p15l306t789r671b874],
49	’	CD	NUMBER	’	dep	127	SENT_279	[p15l306t789r671b874],
50	6	CD	NUMBER	6	dep	127	SENT_279	[p15l306t789r671b874],
51	;	:	O	;	_	0	SENT_279	[p15l306t789r671b874],
52	the	DT	O	the	dep	127	SENT_279	[p15l701t801r808b863],
53	distribution	NN	O	distribution	dep	127	SENT_279	[p15l836t801r1245b863],
54	of	IN	O	of	dep	127	SENT_279	[p15l1273t801r1350b863],
55	the	DT	O	the	dep	127	SENT_279	[p15l1371t801r1477b863],
56	lesion	NN	O	lesion	dep	127	SENT_279	[p15l1505t801r1716b863],
57	types	NNS	O	type	dep	127	SENT_279	[p15l1742t810r1926b881],
58	(	VBP	O	(	dep	127	SENT_279	[p15l1958t801r2142b878],
59	24	CD	PERCENT	24	dep	127	SENT_279	[p15l1958t801r2142b878],
60	%	NN	PERCENT	%	dep	127	SENT_279	[p15l1958t801r2142b878],
61	predominantly	RB	O	predominantly	dep	127	SENT_279	[p15l8t898r525b978],
62	classic	JJ	O	classic	dep	127	SENT_279	[p15l557t898r790b960],
63	versus	CC	O	versus	dep	127	SENT_279	[p15l822t917r1045b960],
64	76	CD	PERCENT	76	dep	127	SENT_279	[p15l1078t898r1234b960],
65	%	NN	PERCENT	%	dep	127	SENT_279	[p15l1078t898r1234b960],
66	non	JJ	O	non	dep	127	SENT_279	[p15l1269t898r1949b978],
67	—	NN	O	—	dep	127	SENT_279	[p15l1269t898r1949b978],
68	predominantly	RB	O	predominantly	dep	127	SENT_279	[p15l1269t898r1949b978],
69	classic	JJ	O	classic	dep	127	SENT_279	[p15l1981t898r2143b960, p15l12t994r154b1071],
70	)	NN	O	)	dep	127	SENT_279	[p15l1981t898r2143b960, p15l12t994r154b1071],
71	,	,	O	,	_	0	SENT_279	[p15l1981t898r2143b960, p15l12t994r154b1071],
72	mean	VB	O	mean	dep	127	SENT_279	[p15l190t1014r381b1056],
73	age	NN	O	age	dep	127	SENT_279	[p15l415t1014r534b1075],
74	of	IN	O	of	dep	127	SENT_279	[p15l569t994r645b1056],
75	patients	NNS	O	patient	dep	127	SENT_279	[p15l671t994r966b1075],
76	,	,	O	,	_	0	SENT_279	[p15l671t994r966b1075],
77	and	CC	O	and	dep	127	SENT_279	[p15l1004t994r1129b1056],
78	VA	NN	ORGANIZATION	va	dep	127	SENT_279	[p15l1161t995r1288b1056],
79	response	NN	O	response	dep	127	SENT_279	[p15l1319t1014r1629b1075],
80	patterns	NNS	O	pattern	dep	127	SENT_279	[p15l1661t1003r1940b1075],
81	were	VBD	O	be	dep	127	SENT_279	[p15l1975t1014r2145b1057],
82	similar	JJ	O	similar	dep	127	SENT_279	[p15l12t1093r255b1155],
83	to	TO	O	to	dep	127	SENT_279	[p15l294t1102r360b1155],
84	those	DT	O	those	dep	127	SENT_279	[p15l402t1093r587b1155],
85	of	IN	O	of	dep	127	SENT_279	[p15l629t1093r706b1155],
86	the	DT	O	the	dep	127	SENT_279	[p15l740t1093r846b1155],
87	RCTs	NNS	O	rct	dep	127	SENT_279	[p15l887t1081r1198b1155],
88	.5	CD	NUMBER	.5	dep	127	SENT_279	[p15l887t1081r1198b1155],
89	’	CD	NUMBER	’	dep	127	SENT_279	[p15l887t1081r1198b1155],
90	6	CD	NUMBER	6	dep	127	SENT_279	[p15l887t1081r1198b1155],
91	In	IN	O	in	dep	127	SENT_279	[p15l1239t1095r1311b1154],
92	addition	NN	O	addition	dep	127	SENT_279	[p15l1354t1093r1660b1167],
93	,	,	O	,	_	0	SENT_279	[p15l1354t1093r1660b1167],
94	minor	JJ	O	minor	dep	127	SENT_279	[p15l1704t1093r1917b1155],
95	allele	NN	O	allele	dep	127	SENT_279	[p15l1957t1093r2146b1155],
96	frequencies	NNS	O	frequency	dep	127	SENT_279	[p15l9t1190r415b1270],
97	for	IN	O	for	dep	127	SENT_279	[p15l445t1190r548b1252],
98	the	DT	O	the	dep	127	SENT_279	[p15l574t1190r680b1252],
99	7	CD	NUMBER	7	dep	127	SENT_279	[p15l709t1191r747b1252],
100	tSNPs	NNS	O	tsnp	dep	127	SENT_279	[p15l778t1190r997b1252],
101	in	IN	O	in	dep	127	SENT_279	[p15l1026t1190r1094b1251],
102	our	PRP$	O	we	dep	127	SENT_279	[p15l1123t1209r1240b1252],
103	cohort	NN	O	cohort	dep	127	SENT_279	[p15l1266t1190r1492b1252],
104	were	VBD	O	be	dep	127	SENT_279	[p15l1519t1209r1689b1252],
105	very	RB	O	very	dep	127	SENT_279	[p15l1717t1209r1872b1270],
106	similar	JJ	O	similar	dep	127	SENT_279	[p15l1904t1190r2148b1252],
107	to	TO	O	to	dep	127	SENT_279	[p15l9t1295r75b1348],
108	those	DT	O	those	dep	127	SENT_279	[p15l128t1286r313b1348],
109	in	IN	O	in	dep	127	SENT_279	[p15l365t1286r433b1348],
110	a	DT	O	a	dep	127	SENT_279	[p15l486t1306r523b1348],
111	CEU	NNP	O	CEU	dep	127	SENT_279	[p15l574t1287r749b1349],
112	(	CD	NUMBER	(	dep	127	SENT_279	[p15l804t1286r1002b1363],
113	Utah	NNP	LOCATION	Utah	dep	127	SENT_279	[p15l804t1286r1002b1363],
114	residents	NNS	O	resident	dep	127	SENT_279	[p15l1053t1286r1366b1348],
115	with	IN	O	with	dep	127	SENT_279	[p15l1421t1286r1577b1349],
116	ancestry	NN	O	ancestry	dep	127	SENT_279	[p15l1630t1296r1922b1367],
117	from	IN	O	from	dep	127	SENT_279	[p15l1975t1286r2147b1348],
118	northern	JJ	O	northern	dep	127	SENT_279	[p15l9t1384r309b1446],
119	and	CC	O	and	dep	127	SENT_279	[p15l342t1384r467b1446],
120	western	JJ	O	western	dep	127	SENT_279	[p15l499t1393r774b1446],
121	Europe	NNP	LOCATION	Europe	dep	127	SENT_279	[p15l805t1385r1088b1464],
122	)	CD	NUMBER	)	dep	127	SENT_279	[p15l805t1385r1088b1464],
123	population	NN	O	population	dep	127	SENT_279	[p15l1121t1384r1502b1464],
124	(	CD	NUMBER	(	dep	127	SENT_279	[p15l1536t1384r1763b1460],
125	Table	NNP	O	Table	dep	127	SENT_279	[p15l1536t1384r1763b1460],
126	4	CD	NUMBER	4	dep	127	SENT_279	[p15l1796t1385r1886b1461],
127	)	CD	NUMBER	)	_	0	SENT_279	[p15l1796t1385r1886b1461],
128	.	.	O	.	_	0	SENT_279	[p15l1796t1385r1886b1461],

1	The	DT	O	the	det	2	SENT_280	[p15l116t1481r251b1543],
2	weakness	NN	O	weakness	nsubj	6	SENT_280	[p15l291t1481r628b1543],
3	of	IN	O	of	_	0	SENT_280	[p15l669t1481r745b1543],
4	this	DT	O	this	det	5	SENT_280	[p15l778t1481r903b1543],
5	study	NN	O	study	prep_of	2	SENT_280	[p15l946t1481r1133b1561],
6	was	VBD	O	be	_	0	SENT_280	[p15l1173t1500r1306b1543],
7	that	IN	O	that	complm	11	SENT_280	[p15l1346t1481r1479b1543],
8	the	DT	O	the	det	9	SENT_280	[p15l1516t1481r1623b1543],
9	patients	NNS	O	patient	nsubjpass	11	SENT_280	[p15l1661t1481r1934b1561],
10	were	VBD	O	be	auxpass	11	SENT_280	[p15l1975t1500r2145b1543],
11	treated	VBN	O	treat	ccomp	6	SENT_280	[p15l9t1577r249b1639],
12	with	IN	O	with	_	0	SENT_280	[p15l275t1577r431b1640],
13	a	DT	O	a	det	16	SENT_280	[p15l459t1597r496b1639],
14	pro	JJ	O	pro	amod	16	SENT_280	[p15l519t1597r636b1658],
15	re	NN	O	re	nn	16	SENT_280	[p15l662t1597r729b1639],
16	nata	NN	O	na	prep_with	11	SENT_280	[p15l756t1587r904b1639],
17	(	CD	NUMBER	(	dobj	11	SENT_280	[p15l931t1577r1306b1658],
18	according	VBG	O	accord	_	0	SENT_280	[p15l931t1577r1306b1658],
19	to	TO	O	to	aux	20	SENT_280	[p15l1333t1587r1399b1639],
20	need	VB	O	need	prepc_according	17	SENT_280	[p15l1426t1577r1619b1654],
21	)	JJ	O	)	amod	22	SENT_280	[p15l1426t1577r1619b1654],
22	regimen	NNS	O	regimen	dobj	20	SENT_280	[p15l1647t1577r1955b1658],
23	.	.	O	.	_	0	SENT_280	[p15l1647t1577r1955b1658],

1	As	IN	O	as	_	0	SENT_281	[p15l1986t1578r2081b1639],
2	a	DT	O	a	det	3	SENT_281	[p15l2111t1597r2148b1639],
3	result	NN	O	result	prep_as	9	SENT_281	[p15l8t1675r223b1748],
4	,	,	O	,	_	0	SENT_281	[p15l8t1675r223b1748],
5	the	DT	O	the	det	6	SENT_281	[p15l254t1675r360b1737],
6	patients	NNS	O	patient	nsubj	9	SENT_281	[p15l387t1675r661b1755],
7	did	VBD	O	do	aux	9	SENT_281	[p15l691t1675r803b1737],
8	not	RB	O	not	neg	9	SENT_281	[p15l830t1684r942b1737],
9	receive	VB	O	receive	_	0	SENT_281	[p15l967t1675r1223b1737],
10	exactly	RB	O	exactly	advmod	13	SENT_281	[p15l1252t1675r1505b1755],
11	the	DT	O	the	det	13	SENT_281	[p15l1533t1675r1640b1737],
12	same	JJ	O	same	amod	13	SENT_281	[p15l1670t1695r1848b1737],
13	number	NN	O	number	dobj	9	SENT_281	[p15l1876t1675r2147b1737],
14	of	IN	O	of	_	0	SENT_281	[p15l10t1772r86b1834],
15	injections	NNS	O	injection	prep_of	13	SENT_281	[p15l113t1772r455b1852],
16	over	IN	O	over	_	0	SENT_281	[p15l491t1791r647b1834],
17	the	DT	O	the	det	19	SENT_281	[p15l678t1772r784b1834],
18	12-month	JJ	DURATION	12-month	amod	19	SENT_281	[p15l826t1772r1162b1834],
19	course	NN	O	course	prep_over	15	SENT_281	[p15l1194t1791r1424b1834],
20	of	IN	O	of	_	0	SENT_281	[p15l1458t1772r1535b1834],
21	the	DT	O	the	det	22	SENT_281	[p15l1561t1772r1667b1834],
22	study	NN	O	study	prep_of	19	SENT_281	[p15l1703t1772r1908b1852],
23	.	.	O	.	_	0	SENT_281	[p15l1703t1772r1908b1852],

1	However	RB	O	however	advmod	6	SENT_282	[p15l1945t1773r2143b1834, p15l9t1888r178b1942],
2	,	,	O	,	_	0	SENT_282	[p15l1945t1773r2143b1834, p15l9t1888r178b1942],
3	all	DT	O	all	det	4	SENT_282	[p15l209t1868r293b1930],
4	patients	NNS	O	patient	nsubj	6	SENT_282	[p15l317t1868r591b1949],
5	did	VBD	O	do	aux	6	SENT_282	[p15l619t1868r730b1930],
6	receive	VB	O	receive	_	0	SENT_282	[p15l753t1868r1009b1930],
7	3	CD	NUMBER	3	num	10	SENT_282	[p15l1036t1869r1072b1931],
8	initial	JJ	O	initial	amod	10	SENT_282	[p15l1101t1868r1306b1930],
9	monthly	JJ	SET	monthly	amod	10	SENT_282	[p15l1331t1868r1626b1949],
10	injections	NNS	O	injection	dobj	6	SENT_282	[p15l1651t1868r1993b1949],
11	and	CC	O	and	_	0	SENT_282	[p15l2022t1868r2147b1930],
12	the	DT	O	the	det	13	SENT_282	[p15l9t1966r115b2028],
13	treatment	NN	O	treatment	nsubj	21	SENT_282	[p15l148t1975r483b2028],
14	in	IN	O	in	_	0	SENT_282	[p15l515t1966r582b2027],
15	the	DT	O	the	det	16	SENT_282	[p15l614t1966r721b2028],
16	ﬁrst	NN	O	ﬁrst	prep_in	13	SENT_282	[p15l755t1966r891b2028],
17	6	CD	DURATION	6	num	18	SENT_282	[p15l924t1966r963b2028],
18	months	NNS	NUMBER	month	tmod	16	SENT_282	[p15l997t1966r1255b2028],
19	was	VBD	O	be	cop	21	SENT_282	[p15l1291t1986r1424b2028],
20	very	RB	O	very	advmod	21	SENT_282	[p15l1459t1986r1614b2046],
21	similar	JJ	O	similar	conj_and	6	SENT_282	[p15l1650t1966r1894b2028],
22	for	IN	O	for	_	0	SENT_282	[p15l1925t1966r2028b2028],
23	all	DT	O	all	det	24	SENT_282	[p15l2061t1966r2146b2028],
24	patients	NNS	O	patient	prep_for	21	SENT_282	[p15l8t2063r281b2143],
25	(	IN	O	(	_	0	SENT_282	[p15l324t2063r503b2139],
26	4-6	CD	NUMBER	4-6	num	27	SENT_282	[p15l324t2063r503b2139],
27	injections	NNS	O	injection	prep_(	21	SENT_282	[p15l542t2063r884b2143],
28	for	IN	O	for	_	0	SENT_282	[p15l925t2063r1027b2125],
29	most	JJS	O	most	amod	30	SENT_282	[p15l1064t2072r1236b2125],
30	patients	NNS	O	patient	prep_for	27	SENT_282	[p15l1271t2063r1595b2143],
31	)	CD	NUMBER	)	tmod	21	SENT_282	[p15l1271t2063r1595b2143],
32	.	.	O	.	_	0	SENT_282	[p15l1271t2063r1595b2143],

1	This	DT	O	this	nsubj	2	SENT_283	[p15l1637t2063r1792b2125],
2	indicates	VBZ	O	indicate	_	0	SENT_283	[p15l1832t2063r2144b2125],
3	that	IN	O	that	complm	7	SENT_283	[p15l9t2159r141b2221],
4	the	DT	O	the	det	6	SENT_283	[p15l200t2159r306b2221],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_283	[p15l370t2159r737b2240],
6	association	NN	O	association	nsubj	17	SENT_283	[p15l798t2159r1190b2221],
7	observed	VBN	O	observe	ccomp	2	SENT_283	[p15l1252t2159r1570b2222],
8	between	IN	O	between	_	0	SENT_283	[p15l1629t2159r1925b2222],
9	SNP	NN	O	snp	nn	10	SENT_283	[p15l1987t2160r2146b2222],
10	rs3025000	NN	O	rs3025000	prep_between	7	SENT_283	[p15l8t2257r382b2319],
11	and	CC	O	and	_	0	SENT_283	[p15l417t2257r542b2319],
12	VA	NN	ORGANIZATION	va	nn	13	SENT_283	[p15l574t2258r701b2319],
13	outcome	NN	O	outcome	dep	17	SENT_283	[p15l735t2266r1038b2319],
14	at	IN	O	at	_	0	SENT_283	[p15l1073t2266r1135b2319],
15	6	CD	DURATION	6	num	16	SENT_283	[p15l1168t2257r1207b2319],
16	months	NNS	NUMBER	month	prep_at	13	SENT_283	[p15l1240t2257r1499b2319],
17	anti	JJ	O	anti	conj_and	7	SENT_283	[p15l1536t2257r1928b2319],
18	.	.	O	.	_	0	SENT_283	[p15l1536t2257r1928b2319],

1	—	NN	O	—	_	0	SENT_284	[p15l1536t2257r1928b2319],
2	.	.	O	.	_	0	SENT_284	[p15l1536t2257r1928b2319],

1	VEGF	NN	O	vegf	nn	2	SENT_285	[p15l1536t2257r1928b2319],
2	treatment	NN	O	treatment	nsubjpass	10	SENT_285	[p15l1960t2266r2143b2319, p15l9t2363r186b2416],
3	was	VBD	O	be	auxpass	10	SENT_285	[p15l237t2373r371b2416],
4	minimally	RB	O	minimally	advmod	10	SENT_285	[p15l425t2354r809b2434],
5	,	,	O	,	_	0	SENT_285	[p15l425t2354r809b2434],
6	if	IN	O	if	mark	7	SENT_285	[p15l865t2354r923b2415],
7	at	IN	O	at	dep	4	SENT_285	[p15l971t2363r1032b2416],
8	all	DT	O	all	pobj	7	SENT_285	[p15l1085t2354r1189b2427],
9	,	,	O	,	_	0	SENT_285	[p15l1085t2354r1189b2427],
10	affected	VBN	O	affect	_	0	SENT_285	[p15l1247t2354r1531b2416],
11	by	IN	O	by	_	0	SENT_285	[p15l1581t2354r1668b2434],
12	the	DT	O	the	det	16	SENT_285	[p15l1722t2354r1828b2416],
13	ﬂexible	JJ	O	ﬂexible	amod	16	SENT_285	[p15l1882t2354r2145b2416],
14	l2O	NN	O	l2o	nn	16	SENT_285	[p15l17t2585r152b2656],
15	treatment	NN	O	treatment	nn	16	SENT_285	[p15l7t2701r344b2754],
16	regimen	NN	O	regimen	agent	10	SENT_285	[p15l387t2691r679b2773],
17	and	CC	O	and	_	0	SENT_285	[p15l725t2691r851b2754],
18	actual	JJ	O	actual	amod	19	SENT_285	[p15l897t2691r1105b2754],
19	number	NN	O	number	agent	10	SENT_285	[p15l1150t2691r1423b2754],
20	of	IN	O	of	_	0	SENT_285	[p15l1467t2691r1544b2754],
21	injections	NNS	O	injection	prep_of	19	SENT_285	[p15l1583t2691r1946b2773],
22	.	.	O	.	_	0	SENT_285	[p15l1583t2691r1946b2773],

1	This	DT	O	this	det	2	SENT_286	[p15l1996t2691r2150b2754],
2	further	JJ	O	further	nsubj	3	SENT_286	[p15l8t2791r250b2853],
3	strengthens	VBZ	O	strengthen	_	0	SENT_286	[p15l275t2791r676b2872],
4	the	DT	O	the	det	5	SENT_286	[p15l701t2791r808b2853],
5	idea	NN	O	idea	dobj	3	SENT_286	[p15l832t2791r981b2853],
6	that	IN	O	that	complm	13	SENT_286	[p15l1003t2791r1136b2853],
7	the	DT	O	the	det	10	SENT_286	[p15l1159t2791r1265b2853],
8	6-month	JJ	DURATION	6-month	amod	10	SENT_286	[p15l1291t2790r1591b2854],
9	VA	NN	O	va	nn	10	SENT_286	[p15l1614t2791r1741b2854],
10	outcome	NN	O	outcome	nsubjpass	13	SENT_286	[p15l1766t2800r2070b2853],
11	is	VBZ	O	be	auxpass	13	SENT_286	[p15l2095t2791r2150b2853],
12	less	RBR	O	less	advmod	13	SENT_286	[p15l8t2891r137b2954],
13	affected	VBN	O	affect	ccomp	3	SENT_286	[p15l165t2891r449b2954],
14	by	IN	O	by	_	0	SENT_286	[p15l471t2891r558b2972],
15	individual	JJ	O	individual	amod	17	SENT_286	[p15l583t2891r943b2954],
16	treatment	NN	O	treatment	nn	17	SENT_286	[p15l967t2900r1304b2954],
17	regimens	NNS	O	regimen	agent	13	SENT_286	[p15l1325t2891r1649b2972],
18	and	CC	O	and	_	0	SENT_286	[p15l1677t2891r1802b2954],
19	would	MD	O	would	aux	24	SENT_286	[p15l1826t2891r2048b2954],
20	be	VB	O	be	cop	24	SENT_286	[p15l2069t2891r2152b2954],
21	a	DT	O	a	det	24	SENT_286	[p15l9t3010r46b3053],
22	good	JJ	O	good	amod	24	SENT_286	[p15l96t2990r272b3072],
23	time	NN	O	time	nn	24	SENT_286	[p15l322t2990r479b3053],
24	point	NN	O	point	ccomp	3	SENT_286	[p15l529t2990r713b3071],
25	to	TO	O	to	aux	26	SENT_286	[p15l762t3000r828b3053],
26	look	VB	O	look	xcomp	24	SENT_286	[p15l880t2990r1038b3053],
27	for	IN	O	for	_	0	SENT_286	[p15l1088t2990r1190b3053],
28	the	DT	O	the	det	29	SENT_286	[p15l1239t2990r1346b3053],
29	inﬂuence	NN	O	inﬂuence	prep_for	26	SENT_286	[p15l1397t2990r1722b3053],
30	of	IN	O	of	_	0	SENT_286	[p15l1774t2990r1851b3053],
31	genetic	JJ	O	genetic	amod	32	SENT_286	[p15l1897t2990r2150b3072],
32	variation	NN	O	variation	prep_of	29	SENT_286	[p15l8t3087r324b3150],
33	on	IN	O	on	_	0	SENT_286	[p15l353t3107r439b3149],
34	the	DT	O	the	det	35	SENT_286	[p15l466t3087r573b3149],
35	outcome	NN	O	outcome	prep_on	26	SENT_286	[p15l603t3097r925b3149],
36	.	.	O	.	_	0	SENT_286	[p15l603t3097r925b3149],

1	The	DT	O	the	det	2	SENT_287	[p15l957t3087r1094b3149],
2	outcome	NN	O	outcome	nsubjpass	37	SENT_287	[p15l1123t3097r1428b3149],
3	at	IN	O	at	_	0	SENT_287	[p15l1458t3097r1520b3149],
4	around	IN	O	around	quantmod	5	SENT_287	[p15l1548t3087r1793b3149],
5	6	CD	DURATION	6	num	6	SENT_287	[p15l1822t3087r1861b3150],
6	months	NNS	NUMBER	month	prep_at	2	SENT_287	[p15l1891t3087r2150b3149],
7	after	IN	O	after	mark	11	SENT_287	[p15l9t3186r170b3248],
8	the	DT	O	the	det	10	SENT_287	[p15l191t3186r298b3248],
9	treatment	NN	O	treatment	nn	10	SENT_287	[p15l320t3195r657b3248],
10	commencement	NN	O	commencement	nsubj	11	SENT_287	[p15l679t3195r1244b3248],
11	is	VBZ	O	be	dep	6	SENT_287	[p15l1265t3186r1320b3248],
12	in	IN	O	in	_	0	SENT_287	[p15l1344t3186r1412b3247],
13	the	DT	O	the	det	17	SENT_287	[p15l1434t3186r1540b3248],
14	so-called	JJ	O	so-called	amod	17	SENT_287	[p15l1567t3186r1885b3248],
15	critical	JJ	O	critical	amod	17	SENT_287	[p15l1907t3186r2152b3248],
16	predictive	JJ	O	predictive	amod	17	SENT_287	[p16l7t25r362b106],
17	window	NN	O	window	prep_in	11	SENT_287	[p16l394t25r678b88],
18	whereby	IN	O	whereby	_	0	SENT_287	[p16l710t25r1014b106],
19	the	DT	O	the	det	20	SENT_287	[p16l1045t25r1152b88],
20	course	NN	O	course	prep_whereby	17	SENT_287	[p16l1183t45r1413b88],
21	a	DT	O	a	det	22	SENT_287	[p16l1446t45r1483b88],
22	patient	NN	O	patient	poss	24	SENT_287	[p16l1511t25r1816b106],
23	’s	POS	O	’s	_	0	SENT_287	[p16l1511t25r1816b106],
24	vision	NN	O	vision	nsubj	26	SENT_287	[p16l1849t25r2065b88],
25	is	VBZ	O	be	aux	26	SENT_287	[p16l2095t25r2150b88],
26	going	VBG	O	go	rcmod	20	SENT_287	[p16l9t124r208b206],
27	to	TO	O	to	aux	28	SENT_287	[p16l239t134r305b187],
28	take	VB	O	take	xcomp	26	SENT_287	[p16l336t124r483b187],
29	over	RP	O	over	prt	28	SENT_287	[p16l515t144r672b187],
30	the	DT	DURATION	the	det	35	SENT_287	[p16l700t124r807b187],
31	next	JJ	DATE	next	amod	35	SENT_287	[p16l837t134r991b187],
32	12	CD	DATE	12	number	34	SENT_287	[p16l1028t125r1105b186],
33	to	TO	DURATION	to	dep	34	SENT_287	[p16l1136t134r1203b187],
34	24	CD	DURATION	24	num	35	SENT_287	[p16l1235t125r1320b186],
35	months	NNS	NUMBER	month	tmod	28	SENT_287	[p16l1351t124r1610b187],
36	is	VBZ	O	be	auxpass	37	SENT_287	[p16l1643t124r1698b187],
37	determined	VBN	O	determine	_	0	SENT_287	[p16l1731t124r2148b187],
38	.	.	O	.	_	0	SENT_287	[p16l1731t124r2148b187],

1	Over	IN	O	over	_	0	SENT_288	[p16l9t222r186b285],
2	the	DT	O	the	det	3	SENT_288	[p16l234t221r340b284],
3	ﬁrst	NN	O	ﬁrst	prep_over	27	SENT_288	[p16l392t221r529b284],
4	6	CD	DURATION	6	num	5	SENT_288	[p16l580t221r619b285],
5	months	NNS	NUMBER	month	tmod	3	SENT_288	[p16l671t221r930b284],
6	of	IN	O	of	_	0	SENT_288	[p16l983t221r1060b284],
7	treatment	NN	O	treatment	prep_of	3	SENT_288	[p16l1104t231r1459b296],
8	,	,	O	,	_	0	SENT_288	[p16l1104t231r1459b296],
9	patients	NNS	O	patient	nsubj	27	SENT_288	[p16l1511t221r1786b303],
10	with	IN	O	with	_	0	SENT_288	[p16l1839t221r1995b284],
11	the	DT	O	the	det	12	SENT_288	[p16l2045t221r2151b284],
12	presence	NN	O	presence	prep_with	9	SENT_288	[p16l7t340r317b402],
13	of	IN	O	of	_	0	SENT_288	[p16l343t321r420b383],
14	the	DT	O	the	det	17	SENT_288	[p16l438t321r545b383],
15	minor	JJ	O	minor	amod	17	SENT_288	[p16l569t320r782b383],
16	T	NN	O	t	nn	17	SENT_288	[p16l805t322r857b383],
17	allele	NN	O	allele	prep_of	12	SENT_288	[p16l883t321r1072b383],
18	(	CD	NUMBER	(	num	19	SENT_288	[p16l1100t321r1233b398],
19	TT	NN	O	tt	nsubj	23	SENT_288	[p16l1100t321r1233b398],
20	or	CC	O	or	_	0	SENT_288	[p16l1259t340r1332b383],
21	TC	NN	O	tc	nn	22	SENT_288	[p16l1354t321r1464b384],
22	genotypes	NNS	O	genotype	conj_or	19	SENT_288	[p16l1491t321r1877b402],
23	)	VBP	O	)	rcmod	17	SENT_288	[p16l1491t321r1877b402],
24	at	IN	O	at	_	0	SENT_288	[p16l1906t330r1968b383],
25	SNP	NN	O	snp	prep_at	23	SENT_288	[p16l1993t321r2153b384],
26	rs3025000	CD	NUMBER	rs3025000	num	25	SENT_288	[p16l7t421r382b484],
27	received	VBD	O	receive	_	0	SENT_288	[p16l425t421r727b484],
28	a	DT	O	a	det	29	SENT_288	[p16l771t441r808b484],
29	mean	NN	O	mean	dobj	27	SENT_288	[p16l849t441r1041b484],
30	:	:	O	:	_	0	SENT_288	[p16l1093t426r1146b481],
31	SD	NN	O	sd	dep	29	SENT_288	[p16l1201t421r1308b484],
32	of	IN	O	of	_	0	SENT_288	[p16l1354t421r1431b484],
33	4.1:1.1	CD	NUMBER	4.1:1.1	num	34	SENT_288	[p16l1468t421r1756b484],
34	injections	NNS	O	injection	prep_of	31	SENT_288	[p16l1807t421r2150b502],
35	compared	VBN	O	compare	_	0	SENT_288	[p16l8t520r358b601],
36	with	IN	O	with	prepc_compared_with	34	SENT_288	[p16l398t520r554b583],
37	4.1	CD	NUMBER	4.1	pobj	34	SENT_288	[p16l593t521r888b583],
38	:	:	O	:	_	0	SENT_288	[p16l593t521r888b583],
39	l.	NN	O	l.	dep	31	SENT_288	[p16l593t521r888b583],
40	2	CD	NUMBER	2	num	41	SENT_288	[p16l593t521r888b583],
41	injections	NNS	O	injection	dep	39	SENT_288	[p16l928t520r1272b602],
42	in	IN	O	in	_	0	SENT_288	[p16l1313t520r1380b582],
43	patients	NNS	O	patient	prep_in	27	SENT_288	[p16l1418t520r1694b601],
44	without	IN	O	without	_	0	SENT_288	[p16l1735t520r2007b583],
45	the	DT	O	the	det	52	SENT_288	[p16l2045t520r2152b583],
46	minor	JJ	O	minor	amod	52	SENT_288	[p16l8t617r221b680],
47	T	NN	O	t	nn	52	SENT_288	[p16l257t619r309b679],
48	allele	NN	O	allele	nn	52	SENT_288	[p16l349t617r538b680],
49	(	CD	NUMBER	(	num	52	SENT_288	[p16l579t618r722b695],
50	CC	NN	O	cc	nn	52	SENT_288	[p16l579t618r722b695],
51	genotype	NN	O	genotype	nn	52	SENT_288	[p16l763t618r1114b699],
52	)	NN	O	)	prep_without	27	SENT_288	[p16l763t618r1114b699],
53	at	IN	O	at	_	0	SENT_288	[p16l1157t627r1218b680],
54	this	DT	O	this	det	55	SENT_288	[p16l1255t617r1380b680],
55	SNP	NN	O	snp	prep_at	52	SENT_288	[p16l1423t618r1599b681],
56	.	.	O	.	_	0	SENT_288	[p16l1423t618r1599b681],

1	This	DT	O	this	nsubj	2	SENT_289	[p16l1642t617r1797b680],
2	indicates	VBZ	O	indicate	_	0	SENT_289	[p16l1837t617r2151b680],
3	that	IN	O	that	complm	9	SENT_289	[p16l7t717r141b779],
4	the	DT	O	the	det	5	SENT_289	[p16l163t717r269b779],
5	number	NN	O	number	nsubj	9	SENT_289	[p16l294t717r566b779],
6	of	IN	O	of	_	0	SENT_289	[p16l590t717r666b779],
7	injections	NNS	O	injection	prep_of	5	SENT_289	[p16l684t716r1028b798],
8	was	VBD	O	be	cop	9	SENT_289	[p16l1054t736r1188b780],
9	unlikely	JJ	O	unlikely	ccomp	2	SENT_289	[p16l1214t717r1504b798],
10	to	TO	O	to	aux	14	SENT_289	[p16l1529t726r1595b779],
11	be	VB	O	be	cop	14	SENT_289	[p16l1618t717r1701b779],
12	a	DT	O	a	det	14	SENT_289	[p16l1728t736r1764b779],
13	confounding	JJ	O	confounding	amod	14	SENT_289	[p16l1788t716r2149b779, p16l8t817r118b898],
14	factor	NN	O	factor	xcomp	9	SENT_289	[p16l150t817r358b880],
15	for	IN	O	for	_	0	SENT_289	[p16l387t817r490b880],
16	the	DT	O	the	det	18	SENT_289	[p16l519t817r625b880],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_289	[p16l659t817r1028b898],
18	association	NN	O	association	prep_for	14	SENT_289	[p16l1059t817r1452b880],
19	of	IN	O	of	_	0	SENT_289	[p16l1483t817r1561b880],
20	genetic	JJ	O	genetic	amod	21	SENT_289	[p16l1586t817r1839b898],
21	variants	NNS	O	variant	prep_of	18	SENT_289	[p16l1872t817r2150b880],
22	at	IN	O	at	_	0	SENT_289	[p16l9t924r71b977],
23	SNP	NN	O	snp	nn	24	SENT_289	[p16l127t916r286b978],
24	rs3025000	NN	O	rs3025000	prep_at	21	SENT_289	[p16l340t915r716b978],
25	and	CC	O	and	_	0	SENT_289	[p16l773t915r899b977],
26	the	DT	O	the	det	27	SENT_289	[p16l953t915r1059b977],
27	outcome	NN	O	outcome	conj_and	21	SENT_289	[p16l1116t924r1420b977],
28	of	IN	O	of	_	0	SENT_289	[p16l1477t915r1554b977],
29	treatment	NN	O	treatment	prep_of	27	SENT_289	[p16l1602t924r1939b977],
30	at	IN	O	at	_	0	SENT_289	[p16l1995t925r2056b977],
31	6	CD	NUMBER	6	prep_at	29	SENT_289	[p16l2112t915r2151b978],

1	months	NNS	DURATION	month	_	0	SENT_290	[p16l7t1012r286b1074],
2	.	.	O	.	_	0	SENT_290	[p16l7t1012r286b1074],

1	The	DT	O	the	det	2	SENT_291	[p16l115t1111r251b1173],
2	decision	NN	O	decision	nsubj	11	SENT_291	[p16l275t1111r571b1173],
3	to	TO	O	to	aux	4	SENT_291	[p16l593t1120r660b1173],
4	re	VB	O	re	infmod	2	SENT_291	[p16l683t1120r941b1173],
5	—	RB	O	—	advmod	4	SENT_291	[p16l683t1120r941b1173],
6	treat	VB	O	treat	ccomp	4	SENT_291	[p16l683t1120r941b1173],
7	in	IN	O	in	_	0	SENT_291	[p16l963t1111r1030b1173],
8	the	DT	O	the	det	10	SENT_291	[p16l1053t1111r1159b1173],
9	ﬂexible	JJ	O	ﬂexible	amod	10	SENT_291	[p16l1184t1110r1448b1173],
10	phase	NN	O	phase	prep_in	6	SENT_291	[p16l1471t1111r1672b1192],
11	was	VBD	O	be	_	0	SENT_291	[p16l1697t1130r1831b1174],
12	solely	RB	O	solely	advmod	11	SENT_291	[p16l1859t1111r2067b1192],
13	at	IN	O	at	_	0	SENT_291	[p16l2093t1120r2154b1173],
14	the	DT	O	the	det	15	SENT_291	[p16l7t1211r114b1274],
15	discretion	NN	O	discretion	prep_at	11	SENT_291	[p16l152t1211r502b1274],
16	of	IN	O	of	_	0	SENT_291	[p16l539t1211r617b1274],
17	the	DT	O	the	det	19	SENT_291	[p16l647t1211r754b1274],
18	retinal	JJ	O	retinal	amod	19	SENT_291	[p16l790t1211r1016b1274],
19	specialists	NNS	O	specialist	prep_of	15	SENT_291	[p16l1057t1211r1417b1292],
20	on	IN	O	on	_	0	SENT_291	[p16l1457t1231r1543b1274],
21	the	DT	O	the	det	22	SENT_291	[p16l1580t1211r1686b1274],
22	basis	NN	O	basis	prep_on	11	SENT_291	[p16l1722t1211r1898b1274],
23	of	IN	O	of	_	0	SENT_291	[p16l1938t1211r2015b1274],
24	the	DT	O	the	det	28	SENT_291	[p16l2045t1211r2152b1274],
25	re	NN	O	re	nn	28	SENT_291	[p16l7t1320r444b1373],
26	—	NN	O	—	nn	28	SENT_291	[p16l7t1320r444b1373],
27	treatment	NN	O	treatment	nn	28	SENT_291	[p16l7t1320r444b1373],
28	criteria	NNS	O	criterion	prep_of	22	SENT_291	[p16l470t1310r721b1373],
29	at	IN	O	at	_	0	SENT_291	[p16l748t1320r809b1373],
30	each	DT	O	each	det	31	SENT_291	[p16l835t1310r996b1373],
31	visit	NN	O	visit	prep_at	28	SENT_291	[p16l1023t1310r1192b1373],
32	.	.	O	.	_	0	SENT_291	[p16l1023t1310r1192b1373],

1	They	PRP	O	they	nsubjpass	4	SENT_292	[p16l1223t1310r1404b1392],
2	were	VBD	O	be	auxpass	4	SENT_292	[p16l1431t1330r1601b1373],
3	totally	RB	O	totally	advmod	4	SENT_292	[p16l1628t1310r1854b1392],
4	masked	VBN	O	mask	_	0	SENT_292	[p16l1881t1310r2153b1373],
5	to	TO	O	to	_	0	SENT_292	[p16l7t1417r74b1470],
6	the	DT	O	the	det	7	SENT_292	[p16l113t1407r220b1470],
7	genotype	NN	O	genotype	prep_to	4	SENT_292	[p16l260t1417r585b1489],
8	of	IN	O	of	_	0	SENT_292	[p16l625t1407r702b1470],
9	the	DT	O	the	det	10	SENT_292	[p16l735t1407r841b1470],
10	patient	NN	O	patient	prep_of	7	SENT_292	[p16l880t1407r1123b1489],
11	so	IN	O	so	mark	18	SENT_292	[p16l1164t1427r1236b1470],
12	that	IN	O	that	dep	18	SENT_292	[p16l1277t1407r1410b1470],
13	treatment	NN	O	treatment	nn	14	SENT_292	[p16l1447t1417r1784b1470],
14	decisions	NNS	O	decision	nsubj	18	SENT_292	[p16l1823t1407r2150b1470],
15	should	MD	O	should	aux	18	SENT_292	[p16l11t1507r245b1569],
16	have	VB	O	have	aux	18	SENT_292	[p16l267t1507r434b1570],
17	been	VBN	O	be	cop	18	SENT_292	[p16l457t1507r625b1569],
18	random	JJ	O	random	advcl	4	SENT_292	[p16l648t1507r921b1569],
19	in	IN	O	in	_	0	SENT_292	[p16l944t1507r1011b1569],
20	relation	NN	O	relation	prep_in	18	SENT_292	[p16l1034t1507r1306b1569],
21	to	TO	O	to	_	0	SENT_292	[p16l1330t1516r1396b1569],
22	the	DT	O	the	det	24	SENT_292	[p16l1421t1507r1527b1569],
23	SNP	NN	O	snp	nn	24	SENT_292	[p16l1555t1507r1714b1570],
24	proﬁle	NN	O	proﬁle	prep_to	18	SENT_292	[p16l1737t1507r1987b1588],
25	.	.	O	.	_	0	SENT_292	[p16l1737t1507r1987b1588],

1	The	DT	O	the	det	2	SENT_293	[p16l2015t1507r2152b1569],
2	drop	NN	O	drop	nsubj	12	SENT_293	[p16l8t1607r168b1688],
3	in	IN	O	in	_	0	SENT_293	[p16l218t1607r285b1669],
4	mean	JJ	O	mean	amod	5	SENT_293	[p16l334t1627r525b1670],
5	improvement	NN	O	improvement	prep_in	2	SENT_293	[p16l574t1607r1050b1688],
6	in	IN	O	in	_	0	SENT_293	[p16l1098t1607r1165b1669],
7	VA	NNP	O	VA	prep_in	5	SENT_293	[p16l1214t1608r1341b1670],
8	after	IN	O	after	_	0	SENT_293	[p16l1391t1607r1552b1670],
9	6	CD	DATE	6	num	10	SENT_293	[p16l1601t1607r1641b1670],
10	months	NNS	DATE	month	prep_after	7	SENT_293	[p16l1691t1607r1950b1670],
11	may	MD	DATE	may	aux	12	SENT_293	[p16l2000t1627r2151b1688],
12	indicate	VB	O	indicate	_	0	SENT_293	[p16l8t1706r288b1769],
13	the	DT	O	the	det	15	SENT_293	[p16l311t1706r418b1769],
14	injection	NN	O	injection	nn	15	SENT_293	[p16l441t1706r752b1788],
15	frequency	NN	O	frequency	dobj	12	SENT_293	[p16l775t1706r1129b1788],
16	after	IN	O	after	mark	22	SENT_293	[p16l1155t1706r1316b1769],
17	6	CD	DURATION	6	num	18	SENT_293	[p16l1339t1706r1378b1769],
18	months	NNS	NUMBER	month	nsubj	22	SENT_293	[p16l1402t1706r1661b1769],
19	was	VBD	O	be	cop	22	SENT_293	[p16l1687t1726r1821b1769],
20	less	JJR	O	less	dep	21	SENT_293	[p16l1846t1706r1975b1769],
21	than	IN	O	than	advmod	22	SENT_293	[p16l2000t1706r2152b1769],
22	optimal	JJ	O	optimal	advcl	12	SENT_293	[p16l9t1803r296b1885],
23	.	.	O	.	_	0	SENT_293	[p16l9t1803r296b1885],

1	Patients	NNS	O	patient	nsubj	17	SENT_294	[p16l115t1902r394b1965],
2	with	IN	O	with	_	0	SENT_294	[p16l427t1902r584b1966],
3	the	DT	O	the	det	4	SENT_294	[p16l614t1903r720b1965],
4	presence	NN	O	presence	prep_with	1	SENT_294	[p16l750t1922r1061b1984],
5	of	IN	O	of	_	0	SENT_294	[p16l1094t1902r1171b1965],
6	1	CD	NUMBER	1	num	9	SENT_294	[p16l1204t1903r1230b1965],
7	or	CC	O	or	_	0	SENT_294	[p16l1269t1922r1342b1965],
8	2	CD	NUMBER	2	num	9	SENT_294	[p16l1372t1903r1412b1965],
9	copies	NNS	O	copy	prep_of	4	SENT_294	[p16l1445t1902r1668b1984],
10	of	IN	O	of	_	0	SENT_294	[p16l1702t1903r1779b1965],
11	the	DT	O	the	det	13	SENT_294	[p16l1804t1903r1910b1965],
12	minor	JJ	O	minor	amod	13	SENT_294	[p16l1941t1903r2154b1965],
13	allele	NN	O	allele	prep_of	9	SENT_294	[p16l9t2002r198b2064],
14	at	IN	O	at	_	0	SENT_294	[p16l228t2011r290b2064],
15	SNP	NN	O	snp	nn	16	SENT_294	[p16l318t2002r477b2064],
16	rs3025000	NN	O	rs3025000	prep_at	13	SENT_294	[p16l504t2002r879b2064],
17	showed	VBD	O	show	_	0	SENT_294	[p16l910t2002r1178b2064],
18	similar	JJ	O	similar	amod	20	SENT_294	[p16l1208t2002r1453b2064],
19	visual	JJ	O	visual	amod	20	SENT_294	[p16l1479t2002r1690b2064],
20	outcomes	NNS	O	outcome	dobj	17	SENT_294	[p16l1718t2011r2055b2064],
21	to	TO	O	to	_	0	SENT_294	[p16l2085t2011r2151b2064],
22	those	DT	O	those	prep_to	17	SENT_294	[p16l8t2100r194b2162],
23	of	IN	O	of	_	0	SENT_294	[p16l244t2100r322b2162],
24	the	DT	O	the	det	28	SENT_294	[p16l365t2100r471b2162],
25	ANCHOR	NN	O	anchor	nn	28	SENT_294	[p16l521t2101r897b2163],
26	and	CC	O	and	_	0	SENT_294	[p16l947t2100r1073b2162],
27	MARINA	NN	MISC	marina	nn	28	SENT_294	[p16l1121t2101r1482b2162],
28	RCTs	NNS	MISC	rct	prep_of	22	SENT_294	[p16l1531t2101r1756b2163],
29	.	.	O	.	_	0	SENT_294	[p16l1531t2101r1756b2163],

1	This	DT	O	this	nsubjpass	3	SENT_295	[p16l1810t2100r1964b2162],
2	was	VBD	O	be	auxpass	3	SENT_295	[p16l2016t2120r2150b2162],
3	achieved	VBN	O	achieve	_	0	SENT_295	[p16l9t2197r324b2260],
4	with	IN	O	with	_	0	SENT_295	[p16l349t2197r505b2260],
5	63:21	CD	NUMBER	63:21	num	6	SENT_295	[p16l532t2197r818b2261],
6	injections	NNS	O	injection	prep_with	3	SENT_295	[p16l851t2197r1194b2279],
7	over	IN	O	over	_	0	SENT_295	[p16l1223t2217r1380b2261],
8	12	CD	DURATION	12	num	9	SENT_295	[p16l1412t2198r1490b2259],
9	months	NNS	NUMBER	month	prep_over	6	SENT_295	[p16l1516t2197r1775b2260],
10	compared	VBN	O	compare	_	0	SENT_295	[p16l1803t2197r2153b2279],
11	with	IN	O	with	prepc_compared_with	3	SENT_295	[p16l8t2297r164b2360],
12	monthly	JJ	SET	monthly	amod	13	SENT_295	[p16l195t2297r490b2378],
13	injections	NNS	O	injection	pobj	3	SENT_295	[p16l521t2296r865b2378],
14	in	IN	O	in	_	0	SENT_295	[p16l897t2297r965b2359],
15	those	DT	O	those	det	16	SENT_295	[p16l995t2297r1181b2359],
16	RCTs	NNS	O	rct	prep_in	13	SENT_295	[p16l1212t2297r1436b2360],
17	.	.	O	.	_	0	SENT_295	[p16l1212t2297r1436b2360],

1	On	IN	O	on	_	0	SENT_296	[p16l1473t2297r1579b2360],
2	the	DT	O	the	det	4	SENT_296	[p16l1609t2297r1715b2359],
3	other	JJ	O	other	amod	4	SENT_296	[p16l1747t2297r1930b2359],
4	hand	NN	O	hand	prep_on	26	SENT_296	[p16l1958t2297r2149b2371],
5	,	,	O	,	_	0	SENT_296	[p16l1958t2297r2149b2371],
6	the	DT	O	the	det	8	SENT_296	[p16l7t2397r114b2460],
7	visual	JJ	O	visual	amod	8	SENT_296	[p16l145t2397r355b2460],
8	outcome	NN	O	outcome	nsubj	26	SENT_296	[p16l386t2407r690b2460],
9	of	IN	O	of	_	0	SENT_296	[p16l722t2397r799b2460],
10	the	DT	O	the	det	11	SENT_296	[p16l823t2397r929b2460],
11	patients	NNS	O	patient	prep_of	8	SENT_296	[p16l958t2397r1233b2478],
12	with	IN	O	with	_	0	SENT_296	[p16l1265t2397r1422b2460],
13	the	DT	O	the	det	15	SENT_296	[p16l1451t2397r1558b2460],
14	CC	NN	O	cc	nn	15	SENT_296	[p16l1589t2397r1703b2460],
15	genotype	NN	O	genotype	prep_with	11	SENT_296	[p16l1736t2406r2060b2478],
16	at	IN	O	at	_	0	SENT_296	[p16l2092t2406r2154b2460],
17	this	DT	O	this	det	18	SENT_296	[p16l7t2496r132b2559],
18	SNP	NN	O	snp	prep_at	15	SENT_296	[p16l172t2497r351b2571],
19	,	,	O	,	_	0	SENT_296	[p16l172t2497r351b2571],
20	despite	IN	O	despite	_	0	SENT_296	[p16l391t2496r640b2577],
21	a	DT	O	a	det	23	SENT_296	[p16l678t2516r716b2559],
22	similar	JJ	O	similar	amod	23	SENT_296	[p16l753t2496r997b2559],
23	number	NN	O	number	prep_despite	11	SENT_296	[p16l1031t2496r1304b2559],
24	of	IN	O	of	_	0	SENT_296	[p16l1339t2496r1416b2559],
25	injections	NNS	O	injection	prep_of	23	SENT_296	[p16l1446t2496r1789b2578],
26	(	VBP	O	(	ccomp	35	SENT_296	[p16l1830t2496r2148b2574],
27	6.2:2.5	CD	NUMBER	6.2:2.5	num	28	SENT_296	[p16l1830t2496r2148b2574],
28	injections	NNS	O	injection	dobj	26	SENT_296	[p16l8t2593r351b2675],
29	over	IN	O	over	_	0	SENT_296	[p16l378t2613r535b2657],
30	12	CD	DURATION	12	num	31	SENT_296	[p16l566t2594r644b2655],
31	months	NNS	NUMBER	month	prep_over	28	SENT_296	[p16l669t2593r979b2671],
32	)	RB	O	)	advmod	26	SENT_296	[p16l669t2593r979b2671],
33	,	,	O	,	_	0	SENT_296	[p16l669t2593r979b2671],
34	never	RB	O	never	neg	35	SENT_296	[p16l1006t2613r1204b2656],
35	rose	VBD	O	rise	_	0	SENT_296	[p16l1225t2613r1373b2656],
36	to	TO	O	to	_	0	SENT_296	[p16l1397t2603r1463b2656],
37	the	DT	O	the	det	38	SENT_296	[p16l1488t2593r1595b2656],
38	level	NN	O	level	prep_to	35	SENT_296	[p16l1619t2593r1790b2656],
39	seen	VBN	O	see	partmod	38	SENT_296	[p16l1818t2613r1972b2656],
40	with	IN	O	with	_	0	SENT_296	[p16l1996t2593r2152b2657],
41	the	DT	O	the	det	45	SENT_296	[p16l7t2693r114b2755],
42	TT	NN	O	tt	nn	45	SENT_296	[p16l149t2694r255b2755],
43	or	CC	O	or	_	0	SENT_296	[p16l290t2712r364b2755],
44	TC	NN	O	tc	nn	45	SENT_296	[p16l396t2693r506b2756],
45	genotypes	NNS	O	genotype	prep_with	39	SENT_296	[p16l543t2702r900b2774],
46	and	CC	O	and	_	0	SENT_296	[p16l938t2693r1064b2755],
47	was	VBD	O	be	cop	48	SENT_296	[p16l1097t2712r1232b2756],
48	poorer	JJR	O	poorer	conj_and	35	SENT_296	[p16l1267t2712r1500b2774],
49	than	IN	O	than	_	0	SENT_296	[p16l1533t2693r1685b2755],
50	those	DT	O	those	prep_than	48	SENT_296	[p16l1718t2693r1904b2755],
51	of	IN	O	of	_	0	SENT_296	[p16l1940t2692r2017b2755],
52	the	DT	O	the	det	54	SENT_296	[p16l2045t2693r2152b2755],
53	weighted	JJ	O	weighted	amod	54	SENT_296	[p16l8t2793r334b2874],
54	ANCHORfMARINA	NN	O	anchorfmarina	prep_of	50	SENT_296	[p16l367t2793r1130b2856],
55	over	IN	O	over	_	0	SENT_296	[p16l1165t2813r1321b2856],
56	the	DT	O	the	det	60	SENT_296	[p16l1353t2793r1460b2856],
57	pro	JJ	O	pro	amod	60	SENT_296	[p16l1493t2813r1610b2874],
58	re	NN	O	re	nn	60	SENT_296	[p16l1644t2813r1711b2856],
59	nata	NN	O	na	nn	60	SENT_296	[p16l1746t2803r1894b2856],
60	period	NN	O	period	prep_over	54	SENT_296	[p16l1925t2793r2153b2874],
61	(	CD	NUMBER	(	num	64	SENT_296	[p16l10t2892r268b2973],
62	Figure	NN	O	figure	nn	64	SENT_296	[p16l10t2892r268b2973],
63	1	CD	NUMBER	1	num	64	SENT_296	[p16l326t2893r407b2970],
64	)	NN	O	)	nsubj	48	SENT_296	[p16l326t2893r407b2970],
65	.	.	O	.	_	0	SENT_296	[p16l326t2893r407b2970],

1	This	DT	O	this	nsubj	2	SENT_297	[p16l460t2892r615b2955],
2	suggests	VBZ	O	suggest	_	0	SENT_297	[p16l668t2902r964b2974],
3	that	IN	O	that	complm	14	SENT_297	[p16l1015t2892r1148b2955],
4	the	DT	O	the	det	5	SENT_297	[p16l1195t2892r1301b2955],
5	patients	NNS	O	patient	nsubj	14	SENT_297	[p16l1350t2892r1624b2974],
6	with	IN	O	with	_	0	SENT_297	[p16l1675t2892r1832b2955],
7	the	DT	O	the	det	9	SENT_297	[p16l1880t2892r1987b2955],
8	CC	NN	O	cc	nn	9	SENT_297	[p16l2037t2893r2151b2955],
9	genotype	NN	O	genotype	prep_with	5	SENT_297	[p16l9t2999r333b3071],
10	at	IN	O	at	_	0	SENT_297	[p16l384t2999r445b3052],
11	SNP	NN	ORGANIZATION	snp	nn	12	SENT_297	[p16l495t2990r654b3053],
12	rs3025000	NN	O	rs3025000	prep_at	9	SENT_297	[p16l702t2989r1077b3053],
13	may	MD	O	may	aux	14	SENT_297	[p16l1127t3009r1277b3071],
14	require	VB	O	require	ccomp	2	SENT_297	[p16l1326t2989r1577b3071],
15	more	JJR	O	more	amod	17	SENT_297	[p16l1626t3009r1807b3052],
16	frequent	JJ	O	frequent	amod	17	SENT_297	[p16l1856t2989r2153b3071],
17	injections	NNS	O	injection	dobj	14	SENT_297	[p16l8t3089r351b3170],
18	to	TO	O	to	aux	19	SENT_297	[p16l396t3098r462b3151],
19	achieve	VB	O	achieve	xcomp	14	SENT_297	[p16l508t3089r776b3152],
20	the	DT	O	the	det	23	SENT_297	[p16l820t3089r926b3151],
21	optimal	JJ	O	optimal	amod	23	SENT_297	[p16l970t3089r1240b3170],
22	early	JJ	O	early	amod	23	SENT_297	[p16l1284t3089r1459b3170],
23	outcomes	NNS	O	outcome	dobj	19	SENT_297	[p16l1503t3098r1841b3151],
24	or	CC	O	or	_	0	SENT_297	[p16l1887t3108r1960b3151],
25	may	MD	O	may	aux	26	SENT_297	[p16l2001t3108r2152b3170],
26	lack	VB	O	lack	conj_or	2	SENT_297	[p16l8t3189r156b3252],
27	the	DT	O	the	det	28	SENT_297	[p16l192t3189r298b3252],
28	ability	NN	O	ability	dobj	26	SENT_297	[p16l339t3189r562b3270],
29	to	TO	O	to	aux	30	SENT_297	[p16l602t3199r668b3252],
30	respond	VB	O	respond	infmod	28	SENT_297	[p16l706t3189r988b3270],
31	as	RB	O	as	_	0	SENT_297	[p16l1028t3209r1096b3252],
32	well	RB	O	well	_	0	SENT_297	[p16l1136t3189r1287b3252],
33	as	IN	O	as	_	0	SENT_297	[p16l1327t3209r1396b3252],
34	the	DT	O	the	det	35	SENT_297	[p16l1436t3189r1542b3252],
35	others	NNS	O	other	conj_and	28	SENT_297	[p16l1582t3189r1795b3252],
36	from	IN	O	from	_	0	SENT_297	[p16l1836t3189r2008b3252],
37	the	DT	O	the	det	39	SENT_297	[p16l2044t3189r2151b3252],
38	treatment	NN	O	treatment	nn	39	SENT_297	[p16l7t3297r344b3351],
39	onset	NN	O	onset	prep_from	35	SENT_297	[p16l375t3298r578b3351],
40	.	.	O	.	_	0	SENT_297	[p16l375t3298r578b3351],

1	The	DT	O	the	det	2	SENT_298	[p16l613t3288r749b3351],
2	proportion	NN	O	proportion	nsubj	15	SENT_298	[p16l780t3288r1156b3369],
3	of	IN	O	of	_	0	SENT_298	[p16l1188t3288r1265b3351],
4	different	JJ	O	different	amod	6	SENT_298	[p16l1291t3288r1597b3351],
5	lesion	NN	O	lesion	nn	6	SENT_298	[p16l1627t3288r1837b3351],
6	types	NNS	O	type	prep_of	2	SENT_298	[p16l1868t3298r2052b3370],
7	in	IN	O	in	_	0	SENT_298	[p16l2085t3288r2153b3350],
8	patients	NNS	O	patient	prep_in	6	SENT_298	[p16l7t3385r281b3467],
9	with	IN	O	with	_	0	SENT_298	[p16l325t3385r482b3449],
10	TT	NN	O	tt	nn	13	SENT_298	[p16l522t3387r629b3447],
11	or	CC	O	or	_	0	SENT_298	[p16l671t3405r744b3448],
12	TC	NN	O	tc	conj_or	10	SENT_298	[p16l784t3386r894b3449],
13	genotypes	NNS	O	genotype	prep_with	8	SENT_298	[p16l938t3395r1295b3467],
14	was	VBD	O	be	cop	15	SENT_298	[p16l1339t3405r1473b3449],
15	similar	JJ	O	similar	_	0	SENT_298	[p16l1519t3385r1764b3448],
16	to	TO	O	to	_	0	SENT_298	[p16l1803t3395r1870b3448],
17	that	DT	O	that	prep_to	15	SENT_298	[p16l1911t3385r2045b3448],
18	in	IN	O	in	_	0	SENT_298	[p16l2085t3385r2152b3447],
19	patients	NNS	O	patient	prep_in	17	SENT_298	[p16l7t3485r281b3566],
20	with	IN	O	with	_	0	SENT_298	[p16l317t3485r473b3548],
21	CC	NN	O	cc	nn	22	SENT_298	[p16l507t3485r621b3548],
22	genotype	NN	O	genotype	prep_with	19	SENT_298	[p16l657t3494r981b3566],
23	at	IN	O	at	_	0	SENT_298	[p16l1016t3494r1078b3547],
24	SNP	NN	O	snp	prep_at	15	SENT_298	[p16l1112t3485r1271b3548],
25	rs3025000	CD	NUMBER	rs3025000	num	24	SENT_298	[p16l1303t3484r1697b3548],
26	.	.	O	.	_	0	SENT_298	[p16l1303t3484r1697b3548],

1	In	IN	O	in	_	0	SENT_299	[p16l1734t3486r1807b3547],
2	addition	NN	O	addition	prep_in	18	SENT_299	[p16l1841t3485r2149b3559],
3	,	,	O	,	_	0	SENT_299	[p16l1841t3485r2149b3559],
4	in	IN	O	in	_	0	SENT_299	[p16l8t3585r75b3647],
5	a	DT	O	a	det	7	SENT_299	[p16l124t3605r161b3648],
6	preliminary	JJ	O	preliminary	amod	7	SENT_299	[p16l205t3585r620b3666],
7	analysis	NN	O	analysis	prep_in	18	SENT_299	[p16l670t3585r952b3666],
8	of	IN	O	of	_	0	SENT_299	[p16l1003t3585r1080b3648],
9	OCT	NN	DATE	oct	nn	10	SENT_299	[p16l1123t3585r1298b3648],
10	characteristics	NNS	O	characteristic	prep_of	7	SENT_299	[p16l1346t3585r1852b3648],
11	after	IN	O	after	_	0	SENT_299	[p16l1903t3585r2064b3648],
12	3	CD	NUMBER	3	num	13	SENT_299	[p16l2112t3585r2148b3648],
13	injections	NNS	O	injection	prep_after	10	SENT_299	[p16l8t3684r372b3765],
14	,	,	O	,	_	0	SENT_299	[p16l8t3684r372b3765],
15	we	PRP	O	we	nsubj	18	SENT_299	[p16l398t3704r499b3747],
16	could	MD	O	could	aux	18	SENT_299	[p16l522t3684r719b3747],
17	not	RB	O	not	neg	18	SENT_299	[p16l740t3693r853b3747],
18	link	VB	O	link	_	0	SENT_299	[p16l874t3684r1013b3746],
19	the	DT	O	the	det	21	SENT_299	[p16l1032t3684r1139b3747],
20	VA	NNP	O	VA	nn	21	SENT_299	[p16l1162t3685r1289b3747],
21	outcomes	NNS	O	outcome	dobj	18	SENT_299	[p16l1312t3694r1649b3747],
22	in	IN	O	in	_	0	SENT_299	[p16l1673t3684r1741b3746],
23	the	DT	O	the	det	26	SENT_299	[p16l1762t3684r1869b3747],
24	various	JJ	O	various	amod	26	SENT_299	[p16l1892t3684r2150b3747],
25	genotypic	JJ	O	genotypic	amod	26	SENT_299	[p17l9t16r356b97],
26	groups	NNS	O	group	prep_in	21	SENT_299	[p17l393t36r631b97],
27	with	IN	O	with	_	0	SENT_299	[p17l668t16r824b79],
28	the	DT	O	the	det	29	SENT_299	[p17l857t16r964b79],
29	presence	NN	O	presence	prep_with	18	SENT_299	[p17l998t36r1308b97],
30	or	CC	O	or	_	0	SENT_299	[p17l1344t36r1417b79],
31	absence	NN	O	absence	conj_or	29	SENT_299	[p17l1451t16r1729b79],
32	of	IN	O	of	_	0	SENT_299	[p17l1765t16r1842b79],
33	ﬂuid	NN	O	ﬂuid	prep_of	29	SENT_299	[p17l1871t16r2032b79],
34	on	IN	O	on	_	0	SENT_299	[p17l2067t36r2153b79],
35	OCT	NN	DATE	oct	nn	37	SENT_299	[p17l9t116r184b178],
36	image	NN	O	image	nn	37	SENT_299	[p17l216t115r432b197],
37	analysis	NN	O	analysis	prep_on	18	SENT_299	[p17l466t115r748b197],
38	(	CD	NUMBER	(	num	40	SENT_299	[p17l785t115r1248b196],
39	unpublished	JJ	O	unpublished	amod	40	SENT_299	[p17l785t115r1248b196],
40	data	NNS	O	datum	dep	37	SENT_299	[p17l1281t115r1474b193],
41	)	NN	O	)	dep	40	SENT_299	[p17l1281t115r1474b193],
42	.	.	O	.	_	0	SENT_299	[p17l1281t115r1474b193],

1	The	DT	O	the	det	2	SENT_300	[p17l115t212r251b275],
2	evidence	NN	O	evidence	nsubj	3	SENT_300	[p17l286t212r600b275],
3	provided	VBD	O	provide	_	0	SENT_300	[p17l634t212r951b294],
4	suggests	VBZ	O	suggest	ccomp	3	SENT_300	[p17l987t222r1283b294],
5	that	IN	O	that	complm	7	SENT_300	[p17l1319t212r1452b275],
6	there	EX	O	there	expl	7	SENT_300	[p17l1484t212r1660b275],
7	is	VBZ	O	be	ccomp	4	SENT_300	[p17l1694t212r1750b275],
8	a	DT	O	a	det	10	SENT_300	[p17l1788t232r1825b275],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_300	[p17l1855t212r2150b294, p17l8t312r346b393],
10	interaction	NN	O	interaction	nsubj	7	SENT_300	[p17l375t312r756b374],
11	between	IN	O	between	_	0	SENT_300	[p17l782t312r1079b375],
12	the	DT	O	the	det	14	SENT_300	[p17l1106t312r1212b374],
13	anti-VEGF	JJ	O	anti-vegf	amod	14	SENT_300	[p17l1242t312r1636b375],
14	treatment	NN	O	treatment	prep_between	10	SENT_300	[p17l1662t321r2000b374],
15	and	CC	O	and	_	0	SENT_300	[p17l2027t312r2153b374],
16	VA	NN	O	va	nn	17	SENT_300	[p17l7t412r135b475],
17	outcomes	NNS	O	outcome	prep_between	10	SENT_300	[p17l181t421r538b475],
18	.	.	O	.	_	0	SENT_300	[p17l181t421r538b475],

1	Genetic	JJ	O	genetic	amod	2	SENT_301	[p17l590t412r862b475],
2	variants	NNS	O	variant	nsubj	7	SENT_301	[p17l910t412r1188b475],
3	within	IN	O	within	_	0	SENT_301	[p17l1236t412r1462b475],
4	the	DT	O	the	det	6	SENT_301	[p17l1507t412r1613b475],
5	VEGFA	NN	O	vegfa	nn	6	SENT_301	[p17l1665t413r1937b475],
6	gene	NN	O	gene	prep_within	2	SENT_301	[p17l1987t431r2152b493],
7	seem	VBP	O	seem	_	0	SENT_301	[p17l11t532r190b575],
8	to	TO	O	to	aux	9	SENT_301	[p17l223t521r290b575],
9	play	VB	O	play	xcomp	7	SENT_301	[p17l324t512r476b593],
10	an	DT	O	a	det	12	SENT_301	[p17l513t532r593b575],
11	important	JJ	O	important	amod	12	SENT_301	[p17l628t512r974b593],
12	role	NN	O	role	dobj	9	SENT_301	[p17l1006t512r1144b575],
13	in	IN	O	in	_	0	SENT_301	[p17l1178t512r1246b574],
14	treatment	NN	O	treatment	nn	15	SENT_301	[p17l1280t521r1617b575],
15	outcome	NN	O	outcome	prep_in	12	SENT_301	[p17l1651t522r1955b575],
16	after	IN	O	after	_	0	SENT_301	[p17l1992t512r2153b575],
17	anti-VEGF	JJ	O	anti-vegf	amod	18	SENT_301	[p17l9t611r403b674],
18	treatment	NN	O	treatment	prep_after	9	SENT_301	[p17l441t620r794b674],
19	.	.	O	.	_	0	SENT_301	[p17l441t620r794b674],

1	More	RBR	O	more	advmod	2	SENT_302	[p17l836t613r1027b674],
2	individualized	JJ	O	individualized	amod	4	SENT_302	[p17l1065t611r1576b674],
3	treatment	NN	O	treatment	nn	4	SENT_302	[p17l1613t620r1949b674],
4	regimens	NNS	O	regimen	nsubj	14	SENT_302	[p17l1985t611r2150b692, p17l8t730r213b784],
5	,	,	O	,	_	0	SENT_302	[p17l1985t611r2150b692, p17l8t730r213b784],
6	based	VBN	O	base	partmod	4	SENT_302	[p17l254t710r457b773],
7	on	IN	O	on	_	0	SENT_302	[p17l496t730r582b773],
8	the	DT	O	the	det	11	SENT_302	[p17l620t710r726b773],
9	VEGFA	NNP	O	VEGFA	nn	11	SENT_302	[p17l771t711r1044b774],
10	genotype	NN	O	genotype	nn	11	SENT_302	[p17l1086t720r1410b792],
11	variants	NNS	O	variant	prep_on	6	SENT_302	[p17l1449t710r1749b784],
12	,	,	O	,	_	0	SENT_302	[p17l1449t710r1749b784],
13	may	MD	O	may	aux	14	SENT_302	[p17l1791t730r1942b792],
14	offer	VB	O	offer	_	0	SENT_302	[p17l1982t710r2154b773],
15	optimal	JJ	O	optimal	amod	17	SENT_302	[p17l9t807r278b889],
16	visual	JJ	O	visual	amod	17	SENT_302	[p17l321t807r532b871],
17	outcomes	NNS	O	outcome	dobj	14	SENT_302	[p17l576t817r913b870],
18	in	IN	O	in	_	0	SENT_302	[p17l957t807r1024b869],
19	patients	NNS	O	patient	prep_in	14	SENT_302	[p17l1065t807r1340b889],
20	receiving	VBG	O	receive	partmod	19	SENT_302	[p17l1384t807r1714b889],
21	anti-VEGF	JJ	O	anti-vegf	amod	22	SENT_302	[p17l1759t807r2153b871],
22	treatment	NN	O	treatment	dobj	20	SENT_302	[p17l8t916r344b969],
23	for	IN	O	for	_	0	SENT_302	[p17l368t907r471b969],
24	neovascular	JJ	O	neovascular	amod	25	SENT_302	[p17l493t907r920b969],
25	AMD	NNP	O	AMD	prep_for	20	SENT_302	[p17l943t907r1167b969],
26	.	.	O	.	_	0	SENT_302	[p17l943t907r1167b969],

1	Patients	NNS	O	patient	nsubj	12	SENT_303	[p17l1195t907r1475b969],
2	with	IN	O	with	_	0	SENT_303	[p17l1501t907r1658b969],
3	the	DT	O	the	det	7	SENT_303	[p17l1682t907r1788b969],
4	TC	NN	O	tc	nn	7	SENT_303	[p17l1813t907r1923b969],
5	or	CC	O	or	_	0	SENT_303	[p17l1951t926r2023b969],
6	TT	NN	O	tt	nn	7	SENT_303	[p17l2046t908r2153b968],
7	genotypes	NNS	O	genotype	prep_with	1	SENT_303	[p17l9t1014r366b1086],
8	at	IN	O	at	_	0	SENT_303	[p17l407t1014r469b1068],
9	SNP	NN	O	snp	nn	10	SENT_303	[p17l507t1005r666b1068],
10	rs3025000	NN	O	rs3025000	prep_at	7	SENT_303	[p17l702t1004r1078b1068],
11	may	MD	O	may	aux	12	SENT_303	[p17l1116t1025r1267b1086],
12	achieve	VB	O	achieve	_	0	SENT_303	[p17l1307t1005r1575b1068],
13	promising	JJ	O	promising	amod	14	SENT_303	[p17l1612t1005r1972b1086],
14	outcomes	NNS	O	outcome	dobj	12	SENT_303	[p17l2011t1014r2149b1068, p17l8t1125r232b1168],
15	with	IN	O	with	_	0	SENT_303	[p17l279t1105r435b1168],
16	fewer	JJR	O	fewer	amod	17	SENT_303	[p17l479t1105r681b1168],
17	injections	NNS	O	injection	prep_with	12	SENT_303	[p17l724t1105r1088b1186],
18	,	,	O	,	_	0	SENT_303	[p17l724t1105r1088b1186],
19	which	WDT	O	which	nsubj	20	SENT_303	[p17l1136t1105r1352b1168],
20	makes	VBZ	O	make	rcmod	17	SENT_303	[p17l1396t1105r1620b1168],
21	the	DT	O	the	det	22	SENT_303	[p17l1666t1105r1772b1168],
22	treatment	NN	O	treatment	nsubj	25	SENT_303	[p17l1817t1114r2154b1168],
23	more	RBR	O	more	advmod	24	SENT_303	[p17l7t1223r189b1265],
24	cost	NN	O	cost	amod	22	SENT_303	[p17l216t1212r358b1265],
25	effective	JJ	O	effective	xcomp	20	SENT_303	[p17l385t1203r712b1265],
26	.	.	O	.	_	0	SENT_303	[p17l385t1203r712b1265],

1	Further	JJ	O	further	amod	3	SENT_304	[p17l742t1203r1006b1265],
2	validation	NN	O	validation	nn	3	SENT_304	[p17l1031t1203r1386b1265],
3	studies	NNS	O	study	nsubj	5	SENT_304	[p17l1415t1203r1656b1265],
4	will	MD	O	will	aux	5	SENT_304	[p17l1686t1203r1821b1265],
5	lead	VB	O	lead	_	0	SENT_304	[p17l1848t1203r1995b1265],
6	to	TO	O	to	_	0	SENT_304	[p17l2021t1212r2087b1265],
7	a	DT	O	a	det	9	SENT_304	[p17l2117t1223r2154b1265],
8	better	JJR	O	better	amod	9	SENT_304	[p17l6t1302r210b1365],
9	understanding	NN	O	understanding	prep_to	5	SENT_304	[p17l244t1302r748b1384],
10	of	IN	O	of	_	0	SENT_304	[p17l785t1302r862b1365],
11	determinants	NNS	O	determinant	prep_of	9	SENT_304	[p17l892t1302r1349b1365],
12	of	IN	O	of	_	0	SENT_304	[p17l1387t1302r1464b1365],
13	VA	NNP	ORGANIZATION	VA	nn	14	SENT_304	[p17l1493t1303r1620b1365],
14	outcome	NN	O	outcome	prep_of	11	SENT_304	[p17l1656t1312r1960b1365],
15	with	IN	O	with	_	0	SENT_304	[p17l1996t1302r2153b1365],
16	this	DT	O	this	det	18	SENT_304	[p17l8t1399r132b1461],
17	common	JJ	O	common	amod	18	SENT_304	[p17l168t1419r477b1461],
18	treatment	NN	O	treatment	prep_with	5	SENT_304	[p17l509t1409r846b1461],
19	for	IN	O	for	_	0	SENT_304	[p17l878t1399r981b1461],
20	neovascular	JJ	O	neovascular	amod	21	SENT_304	[p17l1011t1399r1438b1462],
21	AMD	NNP	O	AMD	prep_for	18	SENT_304	[p17l1468t1400r1692b1461],
22	.	.	O	.	_	0	SENT_304	[p17l1468t1400r1692b1461],

1	Abedi	NNP	PERSON	Abedi	nn	3	SENT_305	[p17l433t1537r535b1572],
2	et	NNP	O	et	nn	3	SENT_305	[p17l551t1548r581b1572],
3	al	NNP	O	al	_	0	SENT_305	[p17l597t1537r627b1572],
4	-	:	O	-	_	0	SENT_305	[p17l654t1552r661b1559],
5	VEGFA	NNP	O	VEGFA	nn	7	SENT_305	[p17l687t1538r840b1572],
6	Gene	NNP	O	Gene	nn	7	SENT_305	[p17l856t1538r956b1572],
7	Variants	NNS	O	variant	dep	3	SENT_305	[p17l973t1539r1129b1572],
8	and	CC	O	and	_	0	SENT_305	[p17l1147t1537r1214b1572],
9	Anti-VEGF	NN	O	anti-vegf	dep	3	SENT_305	[p17l1230t1538r1451b1572],
10	in	IN	O	in	_	0	SENT_305	[p17l1469t1542r1505b1572],
11	Wet	NNP	O	Wet	nn	12	SENT_305	[p17l1520t1539r1601b1572],
12	AMD	NNP	O	AMD	prep_in	7	SENT_305	[p17l1617t1538r1726b1572],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_306	[p17l115t1715r753b1791],
2	.	.	O	.	_	0	SENT_306	[p17l115t1715r753b1791],

1	The	DT	O	the	det	2	SENT_307	[p17l785t1720r907b1776],
2	authors	NNS	O	author	nsubj	4	SENT_307	[p17l938t1720r1168b1776],
3	are	VBP	O	be	cop	4	SENT_307	[p17l1200t1738r1294b1776],
4	grateful	JJ	O	grateful	_	0	SENT_307	[p17l1324t1720r1571b1793],
5	to	TO	O	to	_	0	SENT_307	[p17l1599t1728r1658b1776],
6	Professor	NNP	O	Professor	nn	7	SENT_307	[p17l1688t1720r1991b1776],
7	Bob	NNP	PERSON	Bob	prep_to	4	SENT_307	[p17l2018t1720r2149b1776],

1	Augusteyn	NNP	O	Augusteyn	_	0	SENT_308	[p17l8t1810r354b1882],
2	for	IN	O	for	_	0	SENT_308	[p17l384t1809r476b1865],
3	helpful	JJ	O	helpful	amod	4	SENT_308	[p17l503t1809r729b1882],
4	discussions	NNS	O	discussion	prep_for	1	SENT_308	[p17l759t1809r1138b1865],
5	.	.	O	.	_	0	SENT_308	[p17l759t1809r1138b1865],

1	References	NNS	O	reference	_	0	SENT_309	[p17l9t2022r534b2104],

1	1	LS	NUMBER	1	_	0	SENT_310	[p17l56t2255r103b2311],
2	.	.	O	.	_	0	SENT_310	[p17l56t2255r103b2311],

1	Meyer	NNP	PERSON	Meyer	nn	2	SENT_311	[p17l148t2256r358b2328],
2	CH	NN	O	ch	_	0	SENT_311	[p17l382t2255r507b2321],
3	,	,	O	,	_	0	SENT_311	[p17l382t2255r507b2321],
4	Holz	NNP	PERSON	Holz	nn	5	SENT_311	[p17l535t2255r688b2311],
5	FG	NNP	O	FG	appos	2	SENT_311	[p17l713t2255r830b2311],
6	.	.	O	.	_	0	SENT_311	[p17l713t2255r830b2311],

1	Preclinical	JJ	O	preclinical	amod	2	SENT_312	[p17l858t2255r1200b2311],
2	aspects	NNS	O	aspect	_	0	SENT_312	[p17l1226t2263r1452b2328],
3	of	IN	O	of	_	0	SENT_312	[p17l1479t2255r1549b2311],
4	anti-VEGF	JJ	O	anti-vegf	amod	5	SENT_312	[p17l1569t2255r1923b2311],
5	agents	NNS	O	agent	prep_of	2	SENT_312	[p17l1948t2263r2148b2328],
6	for	IN	O	for	_	0	SENT_312	[p17l149t2342r242b2398],
7	the	DT	O	the	det	8	SENT_312	[p17l262t2342r357b2398],
8	treatment	NN	O	treatment	prep_for	5	SENT_312	[p17l379t2351r682b2398],
9	of	IN	O	of	_	0	SENT_312	[p17l703t2342r772b2398],
10	wet	JJ	O	wet	amod	11	SENT_312	[p17l788t2350r903b2399],
11	AMD	NNP	O	AMD	prep_of	8	SENT_312	[p17l923t2343r1125b2398],
12	:	:	O	:	_	0	SENT_312	[p17l923t2343r1125b2398],
13	ranibizumab	NN	O	ranibizumab	dep	2	SENT_312	[p17l1151t2342r1550b2398],
14	and	CC	O	and	_	0	SENT_312	[p17l1574t2342r1687b2398],
15	bevacizumab	NN	O	bevacizumab	conj_and	13	SENT_312	[p17l1707t2342r2146b2399],
16	.	.	O	.	_	0	SENT_312	[p17l1707t2342r2146b2399],

1	Eye	NNP	O	Eye	nn	3	SENT_313	[p17l149t2432r272b2503],
2	(	NNP	O	(	nn	3	SENT_313	[p17l303t2430r519b2500],
3	Lond	NNP	O	Lond	_	0	SENT_313	[p17l303t2430r519b2500],
4	)	CD	NUMBER	)	num	5	SENT_313	[p17l303t2430r519b2500],
5	20ll	NN	O	20ll	dep	3	SENT_313	[p17l552t2430r1091b2497],
6	;	:	O	;	_	0	SENT_313	[p17l552t2430r1091b2497],
7	25:66	CD	NUMBER	25:66	num	8	SENT_313	[p17l552t2430r1091b2497],
8	l	NN	O	l	dep	3	SENT_313	[p17l552t2430r1091b2497],
9	—	CD	NUMBER	—	number	10	SENT_313	[p17l552t2430r1091b2497],
10	72	CD	NUMBER	72	dep	8	SENT_313	[p17l552t2430r1091b2497],
11	.	.	O	.	_	0	SENT_313	[p17l552t2430r1091b2497],

1	2	LS	NUMBER	2	_	0	SENT_314	[p17l50t2519r103b2575],
2	.	.	O	.	_	0	SENT_314	[p17l50t2519r103b2575],

1	Rosenfeld	NNP	PERSON	Rosenfeld	nn	2	SENT_315	[p17l149t2519r473b2575],
2	PJ	NNP	PERSON	PJ	_	0	SENT_315	[p17l507t2520r598b2585],
3	,	,	O	,	_	0	SENT_315	[p17l507t2520r598b2585],
4	Brown	NNP	PERSON	Brown	nn	5	SENT_315	[p17l635t2520r852b2575],
5	DM	NN	O	dm	appos	2	SENT_315	[p17l886t2520r1030b2585],
6	,	,	O	,	_	0	SENT_315	[p17l886t2520r1030b2585],
7	Heier	NNP	PERSON	Heier	nn	9	SENT_315	[p17l1068t2519r1245b2575],
8	J	NNP	PERSON	J	nn	9	SENT_315	[p17l1278t2520r1307b2575],
9	S	NN	PERSON	s	appos	2	SENT_315	[p17l1312t2519r1369b2585],
10	,	,	O	,	_	0	SENT_315	[p17l1312t2519r1369b2585],
11	et	FW	O	et	nn	12	SENT_315	[p17l1407t2527r1463b2575],
12	al	FW	O	al	appos	2	SENT_315	[p17l1498t2519r1569b2585],
13	,	,	O	,	_	0	SENT_315	[p17l1498t2519r1569b2585],
14	MARINA	NNP	O	MARINA	nn	16	SENT_315	[p17l1606t2519r1930b2575],
15	Study	NNP	O	Study	nn	16	SENT_315	[p17l1966t2519r2149b2591],
16	Group	NNP	O	Group	appos	2	SENT_315	[p17l150t2606r368b2679],
17	.	.	O	.	_	0	SENT_315	[p17l150t2606r368b2679],

1	Ranibizumab	NNP	O	Ranibizumab	_	0	SENT_316	[p17l400t2606r825b2662],
2	for	IN	O	for	_	0	SENT_316	[p17l854t2606r947b2662],
3	neovascular	JJ	O	neovascular	amod	6	SENT_316	[p17l973t2606r1356b2662],
4	age-related	JJ	O	age-related	amod	6	SENT_316	[p17l1384t2606r1738b2679],
5	macular	JJ	O	macular	amod	6	SENT_316	[p17l1765t2606r2023b2662],
6	degeneration	NN	O	degeneration	prep_for	1	SENT_316	[p17l2050t2606r2147b2662, p17l150t2694r502b2767],
7	.	.	O	.	_	0	SENT_316	[p17l2050t2606r2147b2662, p17l150t2694r502b2767],

1	N	NN	O	n	nn	3	SENT_317	[p17l535t2696r591b2751],
2	Engl	NNP	O	Engl	nn	3	SENT_317	[p17l620t2694r769b2767],
3	J	NNP	O	J	nsubj	4	SENT_317	[p17l798t2696r828b2751],
4	Med	VBD	O	med	_	0	SENT_317	[p17l856t2694r1002b2751],
5	2006	CD	DATE	2006	num	7	SENT_317	[p17l1032t2694r1661b2761],
6	;	:	O	;	_	0	SENT_317	[p17l1032t2694r1661b2761],
7	355	CD	NUMBER	355	dobj	4	SENT_317	[p17l1032t2694r1661b2761],
8	:	:	O	:	_	0	SENT_317	[p17l1032t2694r1661b2761],
9	l4l9	CD	NUMBER	l4l9	num	11	SENT_317	[p17l1032t2694r1661b2761],
10	—	CD	NUMBER	—	num	11	SENT_317	[p17l1032t2694r1661b2761],
11	3l	NN	O	3l	dep	7	SENT_317	[p17l1032t2694r1661b2761],
12	.	.	O	.	_	0	SENT_317	[p17l1032t2694r1661b2761],

1	3	LS	NUMBER	3	_	0	SENT_318	[p17l51t2783r103b2839],
2	.	.	O	.	_	0	SENT_318	[p17l51t2783r103b2839],

1	Brown	JJ	PERSON	brown	amod	2	SENT_319	[p17l149t2784r372b2839],
2	DM	NN	O	dm	_	0	SENT_319	[p17l400t2784r548b2849],
3	,	,	O	,	_	0	SENT_319	[p17l400t2784r548b2849],
4	Michels	NNP	PERSON	Michels	nn	5	SENT_319	[p17l579t2783r844b2839],
5	M	NNP	O	M	appos	2	SENT_319	[p17l874t2784r962b2849],
6	,	,	O	,	_	0	SENT_319	[p17l874t2784r962b2849],
7	Kaiser	NNP	ORGANIZATION	Kaiser	nn	8	SENT_319	[p17l995t2783r1211b2839],
8	PK	NNP	ORGANIZATION	PK	appos	2	SENT_319	[p17l1238t2784r1359b2849],
9	,	,	O	,	_	0	SENT_319	[p17l1238t2784r1359b2849],
10	et	FW	O	et	nn	11	SENT_319	[p17l1391t2791r1449b2839],
11	al	FW	O	al	appos	2	SENT_319	[p17l1478t2783r1552b2849],
12	,	,	O	,	_	0	SENT_319	[p17l1478t2783r1552b2849],
13	ANCHOR	NNP	O	ANCHOR	nn	15	SENT_319	[p17l1584t2783r1930b2839],
14	Study	NNP	O	Study	nn	15	SENT_319	[p17l1960t2783r2149b2855],
15	Group	NNP	O	Group	appos	2	SENT_319	[p17l150t2870r376b2943],
16	.	.	O	.	_	0	SENT_319	[p17l150t2870r376b2943],

1	Ranibizumab	NNP	O	Ranibizumab	_	0	SENT_320	[p17l404t2870r845b2926],
2	versus	CC	O	versus	prep	1	SENT_320	[p17l871t2888r1080b2926],
3	verteporﬁn	JJ	O	verteporﬁn	amod	5	SENT_320	[p17l1106t2870r1471b2943],
4	photodynamic	JJ	O	photodynamic	amod	5	SENT_320	[p17l1493t2870r1969b2943],
5	therapy	NN	O	therapy	dep	2	SENT_320	[p17l1993t2870r2147b2926, p17l151t2976r265b3031],
6	for	IN	O	for	_	0	SENT_320	[p17l292t2958r387b3014],
7	neovascular	JJ	O	neovascular	amod	10	SENT_320	[p17l411t2958r810b3015],
8	age-related	JJ	O	age-related	amod	10	SENT_320	[p17l835t2958r1205b3031],
9	macular	JJ	O	macular	amod	10	SENT_320	[p17l1229t2958r1497b3015],
10	degeneration	NN	O	degeneration	prep_for	5	SENT_320	[p17l1521t2958r1969b3031],
11	:	:	O	:	_	0	SENT_320	[p17l1521t2958r1969b3031],
12	twoyear	JJ	O	twoyear	amod	13	SENT_320	[p17l2000t2967r2148b3015, p17l149t3064r291b3120],
13	results	NNS	O	result	dep	1	SENT_320	[p17l321t3047r537b3103],
14	of	IN	O	of	_	0	SENT_320	[p17l572t3047r643b3103],
15	the	DT	O	the	det	17	SENT_320	[p17l669t3047r768b3103],
16	ANCHOR	NN	O	anchor	nn	17	SENT_320	[p17l800t3047r1146b3103],
17	study	NN	O	study	prep_of	13	SENT_320	[p17l1180t3047r1373b3120],
18	.	.	O	.	_	0	SENT_320	[p17l1180t3047r1373b3120],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_321	[p17l1410t3047r1930b3120],
2	2009	CD	DATE	2009	num	1	SENT_321	[p17l1963t3047r2146b3113],
3	;	:	O	;	_	0	SENT_321	[p17l1963t3047r2146b3113],
4	1	CD	NUMBER	1	num	5	SENT_321	[p17l157t3134r180b3190],
5	l6	NN	O	l6	dep	1	SENT_321	[p17l199t3134r422b3191],
6	:57	CD	NUMBER	:57	number	7	SENT_321	[p17l199t3134r422b3191],
7	—	CD	NUMBER	—	num	8	SENT_321	[p17l199t3134r422b3191],
8	65	CD	NUMBER	65	dep	5	SENT_321	[p17l435t3134r531b3191],
9	.	.	O	.	_	0	SENT_321	[p17l435t3134r531b3191],

1	4	LS	NUMBER	4	_	0	SENT_322	[p18l48t23r103b79],
2	.	.	O	.	_	0	SENT_322	[p18l48t23r103b79],

1	CATT	NNP	ORGANIZATION	CATT	nn	3	SENT_323	[p18l150t23r357b79],
2	Research	NNP	ORGANIZATION	Research	nn	3	SENT_323	[p18l377t22r670b79],
3	Group	NNP	ORGANIZATION	Group	_	0	SENT_323	[p18l692t23r911b95],
4	,	,	O	,	_	0	SENT_323	[p18l692t23r911b95],
5	Martin	NNP	PERSON	Martin	nn	6	SENT_323	[p18l935t22r1151b79],
6	DF	NNP	PERSON	DF	appos	3	SENT_323	[p18l1172t24r1290b89],
7	,	,	O	,	_	0	SENT_323	[p18l1172t24r1290b89],
8	Maguire	NNP	ORGANIZATION	Maguire	nn	9	SENT_323	[p18l1313t22r1583b95],
9	MG	NN	ORGANIZATION	mg	appos	3	SENT_323	[p18l1604t23r1749b89],
10	,	,	O	,	_	0	SENT_323	[p18l1604t23r1749b89],
11	Ying	NNP	O	Ying	nn	12	SENT_323	[p18l1773t22r1930b95],
12	GS	NN	O	g	appos	3	SENT_323	[p18l1953t23r2070b89],
13	,	,	O	,	_	0	SENT_323	[p18l1953t23r2070b89],
14	et	FW	O	et	nn	15	SENT_323	[p18l2094t31r2150b79],
15	al.	FW	O	al.	appos	3	SENT_323	[p18l151t111r221b167],
16	.	.	O	.	_	0	SENT_323	[p18l151t111r221b167],

1	Ranibizumab	NNP	O	Ranibizumab	_	0	SENT_324	[p18l247t111r673b167],
2	and	CC	O	and	_	0	SENT_324	[p18l698t111r811b167],
3	bevacizumab	NNP	O	bevacizumab	conj_and	1	SENT_324	[p18l832t111r1253b167],
4	for	IN	O	for	_	0	SENT_324	[p18l1277t111r1370b167],
5	neovascular	JJ	O	neovascular	amod	8	SENT_324	[p18l1391t111r1774b167],
6	age-related	JJ	O	age-related	amod	8	SENT_324	[p18l1796t111r2150b184],
7	macular	JJ	O	macular	amod	8	SENT_324	[p18l149t199r407b255],
8	degeneration	NN	O	degeneration	prep_for	1	SENT_324	[p18l435t199r863b272],
9	.	.	O	.	_	0	SENT_324	[p18l435t199r863b272],

1	N	NN	O	n	nn	3	SENT_325	[p18l896t200r953b255],
2	Engl	NNP	O	Engl	nn	3	SENT_325	[p18l981t199r1131b272],
3	J	NNP	O	J	nsubj	4	SENT_325	[p18l1160t200r1189b255],
4	Med	VBD	O	med	_	0	SENT_325	[p18l1218t199r1364b255],
5	20l1	CD	NUMBER	20l1	dobj	4	SENT_325	[p18l1393t199r2053b265],
6	;	:	O	;	_	0	SENT_325	[p18l1393t199r2053b265],
7	364:1897	CD	NUMBER	364:1897	num	8	SENT_325	[p18l1393t199r2053b265],
8	—	NN	O	—	dep	5	SENT_325	[p18l1393t199r2053b265],
9	908	CD	NUMBER	908	dep	8	SENT_325	[p18l1393t199r2053b265],
10	.	.	O	.	_	0	SENT_325	[p18l1393t199r2053b265],

1	5	CD	NUMBER	5	_	0	SENT_326	[p18l50t286r103b343],
2	.	.	O	.	_	0	SENT_326	[p18l50t286r103b343],

1	Holz	NNP	ORGANIZATION	Holz	nn	2	SENT_327	[p18l149t286r303b342],
2	FG	NNP	ORGANIZATION	FG	nsubj	7	SENT_327	[p18l323t287r441b353],
3	,	,	O	,	_	0	SENT_327	[p18l323t287r441b353],
4	Amoaku	NNP	O	Amoaku	nn	5	SENT_327	[p18l464t286r738b343],
5	W	NNP	O	W	appos	2	SENT_327	[p18l758t288r849b353],
6	,	,	O	,	_	0	SENT_327	[p18l758t288r849b353],
7	Donate	VB	O	donate	_	0	SENT_327	[p18l872t288r1102b343],
8	J	NN	O	j	dobj	7	SENT_327	[p18l1122t288r1169b353],
9	,	,	O	,	_	0	SENT_327	[p18l1122t288r1169b353],
10	et	FW	O	et	nn	11	SENT_327	[p18l1193t295r1249b343],
11	al	FW	O	al	appos	8	SENT_327	[p18l1269t286r1341b353],
12	,	,	O	,	_	0	SENT_327	[p18l1269t286r1341b353],
13	SUSTAIN	NNP	O	SUSTAIN	nn	15	SENT_327	[p18l1366t287r1701b343],
14	Study	NNP	O	Study	nn	15	SENT_327	[p18l1723t286r1906b359],
15	Group	NNP	O	Group	appos	11	SENT_327	[p18l1928t287r2146b359],
16	.	.	O	.	_	0	SENT_327	[p18l1928t287r2146b359],

1	Safety	NN	O	safety	_	0	SENT_328	[p18l151t375r352b448],
2	and	CC	O	and	_	0	SENT_328	[p18l392t375r505b431],
3	efﬁcacy	NN	O	efﬁcacy	conj_and	1	SENT_328	[p18l543t375r794b447],
4	of	IN	O	of	_	0	SENT_328	[p18l834t375r903b431],
5	a	DT	O	a	det	8	SENT_328	[p18l937t392r970b431],
6	ﬂexible	JJ	O	ﬂexible	amod	8	SENT_328	[p18l1009t375r1246b431],
7	dosing	NN	O	dosing	nn	8	SENT_328	[p18l1285t375r1495b448],
8	regimen	NN	O	regimen	prep_of	1	SENT_328	[p18l1534t375r1796b448],
9	of	IN	O	of	_	0	SENT_328	[p18l1835t375r1904b431],
10	ranibizumab	NN	O	ranibizumab	prep_of	8	SENT_328	[p18l1936t375r2147b431, p18l150t463r360b519],
11	in	IN	O	in	_	0	SENT_328	[p18l395t463r456b518],
12	neovascular	JJ	O	neovascular	amod	15	SENT_328	[p18l489t463r873b519],
13	age-related	JJ	O	age-related	amod	15	SENT_328	[p18l907t463r1261b536],
14	macular	JJ	O	macular	amod	15	SENT_328	[p18l1294t463r1552b519],
15	degeneration	NN	O	degeneration	prep_in	10	SENT_328	[p18l1585t463r2014b536],
16	:	:	O	:	_	0	SENT_328	[p18l1585t463r2014b536],
17	the	DT	O	the	det	19	SENT_328	[p18l2054t463r2149b519],
18	SUSTAIN	NNP	O	SUSTAIN	nn	19	SENT_328	[p18l151t551r486b607],
19	study	NN	O	study	dep	1	SENT_328	[p18l518t550r703b623],
20	.	.	O	.	_	0	SENT_328	[p18l518t550r703b623],

1	Ophthalmology	NNP	O	Ophthalmology	nn	2	SENT_329	[p18l738t550r1238b623],
2	20ll	NN	O	20ll	_	0	SENT_329	[p18l1269t550r1848b617],
3	;	:	O	;	_	0	SENT_329	[p18l1269t550r1848b617],
4	118:663	CD	NUMBER	118:663	number	5	SENT_329	[p18l1269t550r1848b617],
5	—	CD	NUMBER	—	dep	2	SENT_329	[p18l1269t550r1848b617],
6	71	CD	NUMBER	71	dep	5	SENT_329	[p18l1269t550r1848b617],
7	.	.	O	.	_	0	SENT_329	[p18l1269t550r1848b617],

1	6	CD	NUMBER	6	_	0	SENT_330	[p18l50t639r103b695],
2	.	.	O	.	_	0	SENT_330	[p18l50t639r103b695],

1	Schmidt-Erfurth	JJ	O	schmidt-erfurth	amod	2	SENT_331	[p18l151t639r674b695],
2	U	NNP	O	U	_	0	SENT_331	[p18l694t640r767b705],
3	,	,	O	,	_	0	SENT_331	[p18l694t640r767b705],
4	Eldem	NNP	ORGANIZATION	Eldem	nn	5	SENT_331	[p18l791t639r1000b695],
5	B	NNP	ORGANIZATION	B	appos	2	SENT_331	[p18l1020t640r1088b705],
6	,	,	O	,	_	0	SENT_331	[p18l1020t640r1088b705],
7	Guymer	NNP	PERSON	Guymer	nn	8	SENT_331	[p18l1113t639r1375b711],
8	R	NNP	PERSON	R	appos	2	SENT_331	[p18l1394t640r1462b705],
9	,	,	O	,	_	0	SENT_331	[p18l1394t640r1462b705],
10	et	FW	O	et	nn	11	SENT_331	[p18l1487t647r1543b695],
11	al	FW	O	al	appos	2	SENT_331	[p18l1565t639r1636b705],
12	,	,	O	,	_	0	SENT_331	[p18l1565t639r1636b705],
13	EXCITE	NNP	O	EXCITE	nn	15	SENT_331	[p18l1659t639r1943b695],
14	Study	NNP	O	Study	nn	15	SENT_331	[p18l1966t639r2149b711],
15	Group	NNP	O	Group	appos	2	SENT_331	[p18l150t727r368b800],
16	.	.	O	.	_	0	SENT_331	[p18l150t727r368b800],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_332	[p18l394t727r659b800],
2	and	CC	O	and	_	0	SENT_332	[p18l683t727r796b783],
3	safety	NN	O	safety	conj_and	1	SENT_332	[p18l820t727r1006b800],
4	of	IN	O	of	_	0	SENT_332	[p18l1030t727r1099b783],
5	monthly	JJ	SET	monthly	prep_of	1	SENT_332	[p18l1115t727r1380b800],
6	versus	CC	O	versus	prep	5	SENT_332	[p18l1403t745r1604b783],
7	quarterly	JJ	SET	quarterly	amod	9	SENT_332	[p18l1628t727r1915b800],
8	ranibizumab	NN	O	ranibizumab	nn	9	SENT_332	[p18l1936t727r2147b783, p18l150t814r360b871],
9	treatment	NN	O	treatment	dep	6	SENT_332	[p18l448t823r751b871],
10	in	IN	O	in	_	0	SENT_332	[p18l836t814r896b870],
11	neovascular	JJ	O	neovascular	amod	14	SENT_332	[p18l983t814r1366b871],
12	age-related	JJ	O	age-related	amod	14	SENT_332	[p18l1453t814r1807b887],
13	macular	JJ	O	macular	amod	14	SENT_332	[p18l1893t814r2151b870],
14	degeneration	NN	O	degeneration	prep_in	9	SENT_332	[p18l150t902r579b975],
15	:	:	O	:	_	0	SENT_332	[p18l150t902r579b975],
16	the	DT	O	the	det	18	SENT_332	[p18l615t902r711b959],
17	EXCITE	NNP	O	EXCITE	nn	18	SENT_332	[p18l742t903r1026b959],
18	Study	NNP	O	Study	dep	1	SENT_332	[p18l1058t903r1258b975],
19	.	.	O	.	_	0	SENT_332	[p18l1058t903r1258b975],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_333	[p18l1294t902r1794b975],
2	2011	CD	DATE	2011	num	1	SENT_333	[p18l1827t903r2144b969],
3	;	:	O	;	_	0	SENT_333	[p18l1827t903r2144b969],
4	l18	CD	NUMBER	l18	num	6	SENT_333	[p18l1827t903r2144b969],
5	:	:	O	:	_	0	SENT_333	[p18l1827t903r2144b969],
6	831-9	CD	NUMBER	831-9	dep	1	SENT_333	[p18l152t991r364b1048],
7	.	.	O	.	_	0	SENT_333	[p18l152t991r364b1048],

1	7	CD	NUMBER	7	_	0	SENT_334	[p18l49t1080r103b1134],
2	.	.	O	.	_	0	SENT_334	[p18l49t1080r103b1134],

1	McKibbin	NN	PERSON	mckibbin	nn	2	SENT_335	[p18l149t1078r477b1134],
2	M	NN	O	m	_	0	SENT_335	[p18l500t1080r586b1144],
3	,	,	O	,	_	0	SENT_335	[p18l500t1080r586b1144],
4	Ali	NNP	PERSON	Ali	nn	5	SENT_335	[p18l611t1078r711b1133],
5	M	NNP	O	M	appos	2	SENT_335	[p18l734t1080r821b1144],
6	,	,	O	,	_	0	SENT_335	[p18l734t1080r821b1144],
7	Bansal	NNP	PERSON	Bansal	nn	8	SENT_335	[p18l847t1078r1062b1134],
8	S	NNP	O	S	appos	2	SENT_335	[p18l1088t1079r1145b1144],
9	,	,	O	,	_	0	SENT_335	[p18l1088t1079r1145b1144],
10	et	FW	O	et	nn	11	SENT_335	[p18l1171t1087r1228b1134],
11	al.	FW	O	al.	appos	2	SENT_335	[p18l1251t1078r1321b1134],
12	.	.	O	.	_	0	SENT_335	[p18l1251t1078r1321b1134],

1	CFH	NNP	O	CFH	nsubj	9	SENT_336	[p18l1351t1079r1518b1143],
2	,	,	O	,	_	0	SENT_336	[p18l1351t1079r1518b1143],
3	VEGF	NNP	O	VEGF	nsubj	9	SENT_336	[p18l1553t1079r1756b1135],
4	and	CC	O	and	_	0	SENT_336	[p18l1776t1078r1889b1134],
5	HTRA1	NN	O	htra1	nn	7	SENT_336	[p18l1909t1079r2144b1133],
6	promoter	NN	O	promoter	nn	7	SENT_336	[p18l148t1174r443b1238],
7	genotype	NN	O	genotype	conj_and	1	SENT_336	[p18l471t1174r762b1238],
8	may	MD	O	may	aux	9	SENT_336	[p18l791t1183r927b1238],
9	inﬂuence	VB	O	inﬂuence	_	0	SENT_336	[p18l956t1165r1249b1222],
10	the	DT	O	the	det	11	SENT_336	[p18l1278t1166r1373b1222],
11	response	NN	O	response	dobj	9	SENT_336	[p18l1402t1183r1681b1238],
12	to	TO	O	to	_	0	SENT_336	[p18l1710t1174r1770b1222],
13	intravitreal	JJ	O	intravitreal	amod	15	SENT_336	[p18l1799t1165r2150b1222],
14	ranibizumab	NN	O	ranibizumab	nn	15	SENT_336	[p18l148t1254r547b1310],
15	therapy	NN	O	therapy	prep_to	9	SENT_336	[p18l578t1254r816b1327],
16	for	IN	O	for	_	0	SENT_336	[p18l847t1254r940b1310],
17	neovascular	JJ	O	neovascular	amod	20	SENT_336	[p18l968t1254r1351b1310],
18	age-related	JJ	O	age-related	amod	20	SENT_336	[p18l1380t1254r1734b1327],
19	macular	JJ	O	macular	amod	20	SENT_336	[p18l1763t1254r2021b1310],
20	degeneration	NN	O	degeneration	prep_for	15	SENT_336	[p18l2050t1254r2148b1310, p18l150t1341r502b1414],
21	.	.	O	.	_	0	SENT_336	[p18l2050t1254r2148b1310, p18l150t1341r502b1414],

1	Br	NN	O	br	nn	3	SENT_337	[p18l535t1343r615b1397],
2	J	NN	O	j	nn	3	SENT_337	[p18l642t1343r671b1398],
3	Ophthalmol	NN	O	ophthalmol	_	0	SENT_337	[p18l701t1341r1082b1414],
4	2012	CD	DATE	2012	dep	3	SENT_337	[p18l1112t1341r1661b1408],
5	;	:	O	;	_	0	SENT_337	[p18l1112t1341r1661b1408],
6	96:208	CD	NUMBER	96:208	number	7	SENT_337	[p18l1112t1341r1661b1408],
7	—	CD	NUMBER	—	dep	3	SENT_337	[p18l1112t1341r1661b1408],
8	l2	NN	O	l2	dep	7	SENT_337	[p18l1112t1341r1661b1408],
9	.	.	O	.	_	0	SENT_337	[p18l1112t1341r1661b1408],

1	8	CD	NUMBER	8	_	0	SENT_338	[p18l52t1430r103b1486],
2	.	.	O	.	_	0	SENT_338	[p18l52t1430r103b1486],

1	Teper	NNP	PERSON	Teper	nn	2	SENT_339	[p18l149t1431r336b1502],
2	SJ	NNP	O	SJ	_	0	SENT_339	[p18l366t1430r455b1496],
3	,	,	O	,	_	0	SENT_339	[p18l366t1430r455b1496],
4	Nowinska	NNP	O	Nowinska	nn	5	SENT_339	[p18l487t1429r813b1486],
5	A	NNP	O	A	appos	2	SENT_339	[p18l841t1430r914b1496],
6	,	,	O	,	_	0	SENT_339	[p18l841t1430r914b1496],
7	Pilat	NNP	PERSON	Pilat	nn	8	SENT_339	[p18l946t1429r1093b1486],
8	J	NNP	O	J	appos	2	SENT_339	[p18l1121t1431r1167b1496],
9	,	,	O	,	_	0	SENT_339	[p18l1121t1431r1167b1496],
10	et	FW	O	et	nn	11	SENT_339	[p18l1201t1438r1257b1486],
11	al.	FW	O	al.	appos	2	SENT_339	[p18l1287t1430r1357b1486],
12	.	.	O	.	_	0	SENT_339	[p18l1287t1430r1357b1486],

1	Involvement	NN	O	involvement	_	0	SENT_340	[p18l1391t1429r1796b1486],
2	of	IN	O	of	_	0	SENT_340	[p18l1826t1429r1895b1486],
3	genetic	JJ	O	genetic	amod	4	SENT_340	[p18l1920t1429r2148b1502],
4	factors	NNS	O	factor	prep_of	1	SENT_340	[p18l149t1518r364b1574],
5	in	IN	O	in	_	0	SENT_340	[p18l389t1518r450b1573],
6	the	DT	O	the	det	7	SENT_340	[p18l473t1518r569b1574],
7	response	NN	O	response	prep_in	1	SENT_340	[p18l592t1536r872b1591],
8	to	TO	O	to	_	0	SENT_340	[p18l896t1526r955b1574],
9	a	DT	O	a	det	13	SENT_340	[p18l982t1536r1015b1574],
10	variable-dosing	JJ	O	variable-dosing	amod	13	SENT_340	[p18l1038t1518r1534b1591],
11	ranibizumab	NN	O	ranibizumab	nn	13	SENT_340	[p18l1558t1518r1957b1574],
12	treatment	NN	O	treatment	nn	13	SENT_340	[p18l1982t1526r2147b1574, p18l149t1614r309b1661],
13	regimen	NN	O	regimen	prep_to	7	SENT_340	[p18l336t1605r598b1678],
14	for	IN	O	for	_	0	SENT_340	[p18l627t1605r720b1661],
15	age-related	JJ	O	age-related	amod	17	SENT_340	[p18l749t1605r1103b1678],
16	macular	JJ	O	macular	amod	17	SENT_340	[p18l1132t1605r1390b1661],
17	degeneration	NN	O	degeneration	prep_for	1	SENT_340	[p18l1418t1605r1846b1678],
18	.	.	O	.	_	0	SENT_340	[p18l1418t1605r1846b1678],

1	Mol	NNP	O	Mol	nn	2	SENT_341	[p18l1879t1605r2011b1661],
2	Vis	NNP	O	Vis	_	0	SENT_341	[p18l2040t1605r2148b1661],
3	[	CD	NUMBER	[	dep	2	SENT_341	[p18l155t1693r348b1762],
4	serial	JJ	O	serial	amod	2	SENT_341	[p18l155t1693r348b1762],
5	online	NN	O	online	prep	2	SENT_341	[p18l381t1693r600b1762],
6	]	CD	NUMBER	]	num	7	SENT_341	[p18l381t1693r600b1762],
7	2010	CD	DATE	2010	dep	5	SENT_341	[p18l638t1693r1277b1760],
8	;	:	O	;	_	0	SENT_341	[p18l638t1693r1277b1760],
9	16:2598	CD	NUMBER	16:2598	num	10	SENT_341	[p18l638t1693r1277b1760],
10	—	NN	O	—	dep	2	SENT_341	[p18l638t1693r1277b1760],
11	604	CD	NUMBER	604	dep	10	SENT_341	[p18l638t1693r1277b1760],
12	.	.	O	.	_	0	SENT_341	[p18l638t1693r1277b1760],

1	Available	JJ	O	available	_	0	SENT_342	[p18l1313t1693r1623b1750],
2	at	IN	O	at	advmod	1	SENT_342	[p18l1657t1702r1728b1750],
3	:	:	O	:	_	0	SENT_342	[p18l1657t1702r1728b1750],
4	http://WWW	NN	O	http://www	dep	1	SENT_342	[p18l1765t1693r2145b1766],
5	.	.	O	.	_	0	SENT_342	[p18l1765t1693r2145b1766],

1	molvis.org/molvis/v16/a278/	NN	O	molvis.org/molvis/v16/a278/	_	0	SENT_343	[p18l149t1782r1094b1855],
2	.	.	O	.	_	0	SENT_343	[p18l149t1782r1094b1855],

1	Accessed	VBN	O	access	_	0	SENT_344	[p18l1127t1782r1429b1838],
2	August	NNP	DATE	August	tmod	1	SENT_344	[p18l1457t1782r1688b1855],
3	8	CD	DATE	8	num	2	SENT_344	[p18l1719t1782r1771b1848],
4	,	,	DATE	,	_	0	SENT_344	[p18l1719t1782r1771b1848],
5	2012	CD	DATE	2012	num	2	SENT_344	[p18l1804t1782r1977b1838],
6	.	.	O	.	_	0	SENT_344	[p18l1804t1782r1977b1838],

1	9	CD	NUMBER	9	_	0	SENT_345	[p18l50t1869r103b1926],
2	.	.	O	.	_	0	SENT_345	[p18l50t1869r103b1926],

1	Nischler	NN	MISC	nischler	nn	2	SENT_346	[p18l148t1869r421b1925],
2	C	NN	O	c	_	0	SENT_346	[p18l445t1869r513b1936],
3	,	,	O	,	_	0	SENT_346	[p18l445t1869r513b1936],
4	Oberkoﬂer	NN	O	oberkoﬂer	nn	5	SENT_346	[p18l543t1869r889b1926],
5	H	NN	O	h	appos	2	SENT_346	[p18l912t1871r985b1936],
6	,	,	O	,	_	0	SENT_346	[p18l912t1871r985b1936],
7	Ortner	NNP	PERSON	Ortner	nn	8	SENT_346	[p18l1015t1870r1223b1926],
8	C	NNP	O	C	appos	2	SENT_346	[p18l1248t1870r1315b1936],
9	,	,	O	,	_	0	SENT_346	[p18l1248t1870r1315b1936],
10	et	FW	O	et	nn	11	SENT_346	[p18l1344t1878r1401b1925],
11	al.	FW	O	al.	appos	2	SENT_346	[p18l1426t1869r1496b1925],
12	.	.	O	.	_	0	SENT_346	[p18l1426t1869r1496b1925],

1	Complement	NN	O	complement	nn	6	SENT_347	[p18l1527t1869r1940b1942],
2	factor	NN	O	factor	nn	6	SENT_347	[p18l1964t1869r2151b1925],
3	H	NN	O	h	nn	6	SENT_347	[p18l149t1959r205b2013],
4	Y402H	NN	O	y402h	nn	6	SENT_347	[p18l247t1958r481b2014],
5	gene	NN	O	gene	nn	6	SENT_347	[p18l523t1975r672b2030],
6	polymorphism	NN	O	polymorphism	_	0	SENT_347	[p18l712t1957r1181b2030],
7	and	CC	O	and	_	0	SENT_347	[p18l1223t1957r1336b2014],
8	response	NN	O	response	conj_and	6	SENT_347	[p18l1376t1975r1655b2030],
9	to	TO	O	to	_	0	SENT_347	[p18l1697t1966r1757b2014],
10	intravitreal	JJ	O	intravitreal	amod	11	SENT_347	[p18l1799t1957r2149b2014],
11	bevacizumab	NN	O	bevacizumab	prep_to	6	SENT_347	[p18l148t2046r570b2102],
12	in	IN	O	in	_	0	SENT_347	[p18l608t2046r668b2101],
13	exudative	JJ	O	exudative	amod	18	SENT_347	[p18l705t2046r1014b2102],
14	age-related	JJ	O	age-related	amod	18	SENT_347	[p18l1053t2046r1407b2119],
15	macular	JJ	O	macular	amod	18	SENT_347	[p18l1443t2046r1701b2102],
16	degeneration	NN	O	degeneration	nn	18	SENT_347	[p18l1737t2046r2150b2119],
17	[	NN	O	[	nn	18	SENT_347	[p18l155t2134r367b2206],
18	report	NN	O	report	prep_in	6	SENT_347	[p18l155t2134r367b2206],
19	online	NN	O	online	prep	6	SENT_347	[p18l396t2133r636b2201],
20	]	NN	O	]	dep	19	SENT_347	[p18l396t2133r636b2201],
21	.	.	O	.	_	0	SENT_347	[p18l396t2133r636b2201],

1	Acta	NNP	O	Acta	nn	2	SENT_348	[p18l669t2134r820b2189],
2	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_348	[p18l849t2133r1229b2206],
3	201	CD	NUMBER	201	num	4	SENT_348	[p18l1259t2134r1369b2190],
4	l	NN	O	l	tmod	2	SENT_348	[p18l1386t2133r1697b2200],
5	;	:	O	;	_	0	SENT_348	[p18l1386t2133r1697b2200],
6	89	CD	NUMBER	89	dep	2	SENT_348	[p18l1386t2133r1697b2200],
7	:	:	O	:	_	0	SENT_348	[p18l1386t2133r1697b2200],
8	e344	CD	NUMBER	e344	num	9	SENT_348	[p18l1386t2133r1697b2200],
9	-9	CD	NUMBER	-9	dep	6	SENT_348	[p18l1708t2134r1804b2190],
10	.	.	O	.	_	0	SENT_348	[p18l1708t2134r1804b2190],

1	10	CD	NUMBER	10	_	0	SENT_349	[p18l16t2222r103b2278],
2	.	.	O	.	_	0	SENT_349	[p18l16t2222r103b2278],

1	Wickremasinghe	NNP	O	Wickremasinghe	nn	2	SENT_350	[p18l148t2221r691b2294],
2	SS	NNP	O	SS	_	0	SENT_350	[p18l716t2222r818b2288],
3	,	,	O	,	_	0	SENT_350	[p18l716t2222r818b2288],
4	Xie	NNP	PERSON	Xie	nn	5	SENT_350	[p18l843t2221r957b2278],
5	J	NNP	PERSON	J	appos	2	SENT_350	[p18l979t2223r1026b2288],
6	,	,	O	,	_	0	SENT_350	[p18l979t2223r1026b2288],
7	Lim	NNP	PERSON	Lim	nn	8	SENT_350	[p18l1051t2221r1184b2277],
8	J	NNP	PERSON	J	appos	2	SENT_350	[p18l1205t2223r1251b2288],
9	,	,	O	,	_	0	SENT_350	[p18l1205t2223r1251b2288],
10	et	FW	O	et	nn	11	SENT_350	[p18l1278t2230r1334b2278],
11	al.	FW	O	al.	appos	2	SENT_350	[p18l1357t2221r1427b2278],
12	.	.	O	.	_	0	SENT_350	[p18l1357t2221r1427b2278],

1	Variants	NNS	O	variant	nsubjpass	7	SENT_351	[p18l1453t2221r1721b2278],
2	in	IN	O	in	_	0	SENT_351	[p18l1746t2221r1806b2277],
3	the	DT	O	the	det	5	SENT_351	[p18l1828t2222r1924b2278],
4	APOE	NN	ORGANIZATION	apoe	nn	5	SENT_351	[p18l1941t2223r2152b2278],
5	gene	NN	O	gene	prep_in	1	SENT_351	[p18l150t2327r299b2383],
6	are	VBP	O	be	auxpass	7	SENT_351	[p18l329t2327r424b2366],
7	associated	VBN	O	associate	_	0	SENT_351	[p18l455t2310r782b2366],
8	with	IN	O	with	_	0	SENT_351	[p18l811t2310r952b2366],
9	improved	VBN	O	improve	amod	10	SENT_351	[p18l981t2310r1287b2383],
10	outcome	NN	O	outcome	prep_with	7	SENT_351	[p18l1317t2318r1591b2366],
11	after	IN	O	after	_	0	SENT_351	[p18l1622t2310r1767b2366],
12	anti-VEGF	NN	O	anti-vegf	prep_after	10	SENT_351	[p18l1796t2310r2150b2366],

1	Footnotes	NNS	O	footnote	_	0	SENT_352	[p18l8t2522r474b2599],
2	and	CC	O	and	_	0	SENT_352	[p18l516t2516r690b2599],
3	Financial	JJ	O	financial	amod	4	SENT_352	[p18l729t2516r1169b2599],
4	Disclosures	NNS	O	disclosure	conj_and	1	SENT_352	[p18l1205t2517r1743b2599],
5	treatment	NN	O	treatment	dep	1	SENT_352	[p18l146t2768r449b2816],
6	for	IN	O	for	_	0	SENT_352	[p18l481t2759r574b2816],
7	neovascular	JJ	O	neovascular	amod	8	SENT_352	[p18l606t2760r989b2816],
8	AMD	NNP	O	AMD	prep_for	5	SENT_352	[p18l1021t2760r1222b2816],
9	.	.	O	.	_	0	SENT_352	[p18l1021t2760r1222b2816],

1	Invest	VB	O	invest	_	0	SENT_353	[p18l1260t2761r1455b2816],
2	Ophthalmol	NNP	O	Ophthalmol	nn	4	SENT_353	[p18l1489t2759r1869b2832],
3	Vis	NNP	O	Vis	nn	4	SENT_353	[p18l1903t2759r2010b2816],
4	Sci	NNP	O	Sci	dobj	1	SENT_353	[p18l2048t2759r2146b2816],
5	2011	CD	DATE	2011	num	4	SENT_353	[p18l147t2851r686b2917],
6	;	:	O	;	_	0	SENT_353	[p18l147t2851r686b2917],
7	52:4072	CD	NUMBER	52:4072	number	8	SENT_353	[p18l147t2851r686b2917],
8	—	CD	NUMBER	—	dep	4	SENT_353	[p18l147t2851r686b2917],
9	9	CD	NUMBER	9	dep	8	SENT_353	[p18l147t2851r686b2917],
10	.	.	O	.	_	0	SENT_353	[p18l147t2851r686b2917],

1	ll	NN	O	ll	_	0	SENT_354	[p18l13t2941r99b2996],
2	.	.	O	.	_	0	SENT_354	[p18l13t2941r99b2996],

1	Leung	NNP	PERSON	Leung	nn	2	SENT_355	[p18l145t2942r348b3013],
2	DW	NNP	O	DW	_	0	SENT_355	[p18l383t2942r532b3007],
3	,	,	O	,	_	0	SENT_355	[p18l383t2942r532b3007],
4	Cachianes	NNP	PERSON	Cachianes	nn	5	SENT_355	[p18l570t2940r895b2997],
5	G	NNP	PERSON	G	appos	2	SENT_355	[p18l933t2940r1005b3007],
6	,	,	O	,	_	0	SENT_355	[p18l933t2940r1005b3007],
7	Kuang	NNP	PERSON	Kuang	nn	9	SENT_355	[p18l1043t2942r1253b3013],
8	W	NNP	O	W	nn	9	SENT_355	[p18l1287t2942r1410b3007],
9	]	NN	O	]	appos	2	SENT_355	[p18l1287t2942r1410b3007],
10	,	,	O	,	_	0	SENT_355	[p18l1287t2942r1410b3007],
11	et	FW	O	et	nn	12	SENT_355	[p18l1448t2948r1504b2996],
12	al.	FW	O	al.	appos	2	SENT_355	[p18l1539t2940r1609b2996],
13	.	.	O	.	_	0	SENT_355	[p18l1539t2940r1609b2996],

1	Vascular	JJ	O	vascular	amod	4	SENT_356	[p18l1647t2940r1933b2996],
2	endothelial	JJ	O	endothelial	amod	4	SENT_356	[p18l1966t2940r2144b2996, p18l146t3030r345b3087],
3	growth	NN	O	growth	nn	4	SENT_356	[p18l367t3030r591b3103],
4	factor	NN	O	factor	nsubj	6	SENT_356	[p18l612t3030r798b3087],
5	is	VBZ	O	be	cop	6	SENT_356	[p18l818t3030r867b3087],
6	a	DT	O	a	_	0	SENT_356	[p18l891t3048r924b3087],
7	secreted	VBN	O	secrete	partmod	6	SENT_356	[p18l947t3031r1206b3087],
8	angiogenic	JJ	O	angiogenic	amod	9	SENT_356	[p18l1227t3030r1575b3103],
9	mitogen	NN	O	mitogen	dobj	7	SENT_356	[p18l1597t3030r1874b3103],
10	.	.	O	.	_	0	SENT_356	[p18l1597t3030r1874b3103],

1	Science	NN	O	science	_	0	SENT_357	[p18l1901t3030r2147b3087],
2	1989	CD	DATE	1989	num	1	SENT_357	[p18l154t3121r464b3187],
3	;	:	O	;	_	0	SENT_357	[p18l154t3121r464b3187],
4	246	CD	NUMBER	246	num	6	SENT_357	[p18l154t3121r464b3187],
5	:	:	O	:	_	0	SENT_357	[p18l154t3121r464b3187],
6	1306-9	CD	NUMBER	1306-9	dep	1	SENT_357	[p18l479t3121r736b3178],
7	.	.	O	.	_	0	SENT_357	[p18l479t3121r736b3178],

1	Nagineni	NNP	O	Nagineni	nn	2	SENT_358	[p19l145t18r438b91],
2	CN	NN	O	cn	_	0	SENT_358	[p19l459t18r585b85],
3	,	,	O	,	_	0	SENT_358	[p19l459t18r585b85],
4	Kommineni	NNP	PERSON	Kommineni	nn	5	SENT_358	[p19l609t18r989b74],
5	VK	NNP	O	VK	appos	2	SENT_358	[p19l1009t20r1140b85],
6	,	,	O	,	_	0	SENT_358	[p19l1009t20r1140b85],
7	William	NNP	PERSON	William	nn	8	SENT_358	[p19l1162t18r1425b74],
8	A	NNP	PERSON	A	appos	2	SENT_358	[p19l1444t19r1517b85],
9	,	,	O	,	_	0	SENT_358	[p19l1444t19r1517b85],
10	et	FW	O	et	nn	11	SENT_358	[p19l1541t27r1597b74],
11	al.	FW	O	al.	appos	2	SENT_358	[p19l1617t18r1687b74],
12	.	.	O	.	_	0	SENT_358	[p19l1617t18r1687b74],

1	Regulation	NN	O	regulation	_	0	SENT_359	[p19l1711t18r2062b91],
2	of	IN	O	of	_	0	SENT_359	[p19l2083t18r2152b74],
3	VEGF	NN	O	vegf	nn	4	SENT_359	[p19l146t109r354b165],
4	expression	NN	O	expression	prep_of	1	SENT_359	[p19l383t108r723b181],
5	in	IN	O	in	_	0	SENT_359	[p19l751t108r812b164],
6	human	JJ	O	human	amod	8	SENT_359	[p19l839t109r1057b165],
7	retinal	JJ	O	retinal	amod	8	SENT_359	[p19l1084t108r1288b165],
8	cells	NNS	O	cell	prep_in	4	SENT_359	[p19l1317t108r1459b165],
9	by	IN	O	by	_	0	SENT_359	[p19l1488t109r1567b181],
10	cytokines	NNS	O	cytokine	prep_by	8	SENT_359	[p19l1597t108r1919b181],
11	:	:	O	:	_	0	SENT_359	[p19l1597t108r1919b181],
12	implications	NNS	O	implication	dep	1	SENT_359	[p19l1952t108r2144b181, p19l146t199r369b255],
13	for	IN	O	for	_	0	SENT_359	[p19l410t199r502b255],
14	the	DT	O	the	det	15	SENT_359	[p19l538t199r634b255],
15	role	NN	O	role	prep_for	12	SENT_359	[p19l671t199r795b255],
16	of	IN	O	of	_	0	SENT_359	[p19l833t199r903b255],
17	inﬂammation	NN	O	inﬂammation	prep_of	15	SENT_359	[p19l935t199r1361b255],
18	in	IN	O	in	_	0	SENT_359	[p19l1399t199r1460b254],
19	age	NN	O	age	npadvmod	21	SENT_359	[p19l1499t199r1852b272],
20	—	CD	NUMBER	—	num	19	SENT_359	[p19l1499t199r1852b272],
21	related	JJ	O	related	amod	23	SENT_359	[p19l1499t199r1852b272],
22	macular	JJ	O	macular	amod	23	SENT_359	[p19l1889t199r2148b255],
23	degeneration	NN	O	degeneration	prep_in	17	SENT_359	[p19l147t288r575b361],
24	.	.	O	.	_	0	SENT_359	[p19l147t288r575b361],

1	J	NN	O	j	nn	2	SENT_360	[p19l607t290r637b345],
2	Cell	NN	O	cell	_	0	SENT_360	[p19l667t288r797b345],
3	Physiol	NNP	O	Physiol	dep	2	SENT_360	[p19l826t288r1065b361],
4	2012	CD	DATE	2012	num	3	SENT_360	[p19l1096t288r1685b355],
5	;	:	O	;	_	0	SENT_360	[p19l1096t288r1685b355],
6	227:116	CD	NUMBER	227:116	num	7	SENT_360	[p19l1096t288r1685b355],
7	-26	CD	NUMBER	-26	dep	2	SENT_360	[p19l1096t288r1685b355],
8	.	.	O	.	_	0	SENT_360	[p19l1096t288r1685b355],

1	Ferrara	NNP	PERSON	Ferrara	nn	6	SENT_361	[p19l145t380r377b435],
2	N.	NNP	O	N.	nn	6	SENT_361	[p19l408t380r480b435],
3	Vascular	JJ	O	vascular	amod	6	SENT_361	[p19l516t379r801b435],
4	endothelial	JJ	O	endothelial	amod	6	SENT_361	[p19l833t378r1187b435],
5	growth	NN	O	growth	nn	6	SENT_361	[p19l1220t378r1445b451],
6	factor	NN	O	factor	_	0	SENT_361	[p19l1477t378r1679b435],
7	:	:	O	:	_	0	SENT_361	[p19l1477t378r1679b435],
8	basic	JJ	O	basic	amod	9	SENT_361	[p19l1716t378r1879b435],
9	science	NN	O	science	dep	6	SENT_361	[p19l1915t378r2146b435],
10	and	CC	O	and	_	0	SENT_361	[p19l147t469r260b525],
11	clinical	JJ	O	clinical	amod	12	SENT_361	[p19l290t469r523b525],
12	progress	NN	O	progress	dep	6	SENT_361	[p19l551t487r838b542],
13	.	.	O	.	_	0	SENT_361	[p19l551t487r838b542],

1	Endocr	NNP	O	Endocr	nn	2	SENT_362	[p19l871t469r1102b525],
2	Rev	NN	O	rev	_	0	SENT_362	[p19l1130t470r1257b525],
3	2004	CD	DATE	2004	num	2	SENT_362	[p19l1287t469r1877b535],
4	;	:	O	;	_	0	SENT_362	[p19l1287t469r1877b535],
5	25:581	CD	NUMBER	25:581	number	6	SENT_362	[p19l1287t469r1877b535],
6	-611	CD	NUMBER	-611	dep	2	SENT_362	[p19l1287t469r1877b535],
7	.	.	O	.	_	0	SENT_362	[p19l1287t469r1877b535],

1	Lantry	NNP	O	Lantry	nn	2	SENT_363	[p19l146t560r350b631],
2	LE	NNP	O	LE	_	0	SENT_363	[p19l371t560r480b615],
3	.	.	O	.	_	0	SENT_363	[p19l371t560r480b615],

1	Ranibizumab	NNP	O	Ranibizumab	nsubj	14	SENT_364	[p19l505t558r931b625],
2	,	,	O	,	_	0	SENT_364	[p19l505t558r931b625],
3	a	DT	O	a	det	4	SENT_364	[p19l956t576r990b615],
4	mAb	NN	O	mab	appos	1	SENT_364	[p19l1009t558r1163b614],
5	against	IN	O	against	_	0	SENT_364	[p19l1187t558r1402b631],
6	VEGF-A	NN	O	vegf-a	prep_against	4	SENT_364	[p19l1422t559r1707b615],
7	for	IN	O	for	_	0	SENT_364	[p19l1728t558r1818b614],
8	the	DT	O	the	det	10	SENT_364	[p19l1837t558r1929b614],
9	potential	JJ	O	potential	amod	10	SENT_364	[p19l1949t567r2144b631, p19l146t649r242b705],
10	treatment	NN	O	treatment	prep_for	6	SENT_364	[p19l267t657r557b705],
11	of	IN	O	of	_	0	SENT_364	[p19l583t649r651b705],
12	age	NN	O	age	prep_of	10	SENT_364	[p19l673t649r1011b722],
13	—	CD	NUMBER	—	num	12	SENT_364	[p19l673t649r1011b722],
14	related	JJ	O	related	_	0	SENT_364	[p19l673t649r1011b722],
15	macular	JJ	O	macular	amod	16	SENT_364	[p19l1036t649r1285b705],
16	degeneration	NN	O	degeneration	dobj	14	SENT_364	[p19l1310t649r1705b722],
17	and	CC	O	and	_	0	SENT_364	[p19l1732t649r1842b705],
18	other	JJ	O	other	amod	20	SENT_364	[p19l1868t649r2025b705],
19	ocular	JJ	O	ocular	amod	20	SENT_364	[p19l2050t666r2145b705, p19l145t739r265b795],
20	complications	NNS	O	complication	dobj	14	SENT_364	[p19l290t739r734b812],
21	.	.	O	.	_	0	SENT_364	[p19l290t739r734b812],

1	Curr	NNP	O	Curr	nn	4	SENT_365	[p19l765t739r906b795],
2	Opin	NNP	O	Opin	nn	4	SENT_365	[p19l931t739r1084b812],
3	Mol	NNP	O	Mol	nn	4	SENT_365	[p19l1109t739r1238b795],
4	Ther	NNP	DATE	Ther	_	0	SENT_365	[p19l1264t739r1410b795],
5	2007	CD	DATE	2007	num	4	SENT_365	[p19l1436t739r1824b806],
6	;	:	O	;	_	0	SENT_365	[p19l1436t739r1824b806],
7	9:592	CD	NUMBER	9:592	num	9	SENT_365	[p19l1436t739r1824b806],
8	-	:	O	-	_	0	SENT_365	[p19l1436t739r1824b806],
9	602	CD	NUMBER	602	dep	4	SENT_365	[p19l1835t739r1963b795],
10	.	.	O	.	_	0	SENT_365	[p19l1835t739r1963b795],

1	Kloeckener-Gruissem	NNP	O	Kloeckener-Gruissem	nn	2	SENT_366	[p19l147t828r850b884],
2	B	NNP	O	B	_	0	SENT_366	[p19l873t830r941b894],
3	,	,	O	,	_	0	SENT_366	[p19l873t830r941b894],
4	Barthelmes	NNP	ORGANIZATION	Barthelmes	nn	5	SENT_366	[p19l968t828r1330b884],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_366	[p19l1356t830r1428b894],
6	,	,	O	,	_	0	SENT_366	[p19l1356t830r1428b894],
7	Labs	NNPS	O	Labs	appos	2	SENT_366	[p19l1455t828r1608b884],
8	S	NN	O	s	dep	7	SENT_366	[p19l1635t829r1693b894],
9	,	,	O	,	_	0	SENT_366	[p19l1635t829r1693b894],
10	et	FW	O	et	nn	11	SENT_366	[p19l1720t837r1777b884],
11	al.	FW	O	al.	appos	2	SENT_366	[p19l1801t828r1871b884],
12	.	.	O	.	_	0	SENT_366	[p19l1801t828r1871b884],

1	Genetic	JJ	O	genetic	amod	2	SENT_367	[p19l1900t828r2145b884],
2	association	NN	O	association	_	0	SENT_367	[p19l147t918r501b974],
3	with	IN	O	with	_	0	SENT_367	[p19l538t918r678b974],
4	response	NN	O	response	prep_with	2	SENT_367	[p19l713t935r993b991],
5	to	TO	O	to	_	0	SENT_367	[p19l1030t926r1089b974],
6	intravitreal	JJ	O	intravitreal	amod	7	SENT_367	[p19l1126t918r1477b974],
7	ranibizumab	NN	O	ranibizumab	prep_to	2	SENT_367	[p19l1512t918r1912b974],
8	in	IN	O	in	_	0	SENT_367	[p19l1949t918r2010b973],
9	patients	NNS	O	patient	prep_in	2	SENT_367	[p19l2045t935r2144b991, p19l146t1007r316b1063],
10	with	IN	O	with	_	0	SENT_367	[p19l363t1007r504b1063],
11	neovascular	JJ	O	neovascular	amod	12	SENT_367	[p19l549t1007r932b1063],
12	AMD	NNP	O	AMD	prep_with	9	SENT_367	[p19l975t1008r1176b1063],
13	.	.	O	.	_	0	SENT_367	[p19l975t1008r1176b1063],

1	Invest	VB	O	invest	_	0	SENT_368	[p19l1226t1009r1421b1063],
2	Ophthalmol	NNP	O	Ophthalmol	nn	4	SENT_368	[p19l1466t1007r1846b1080],
3	Vis	NNP	O	Vis	nn	4	SENT_368	[p19l1891t1007r1999b1063],
4	Sci	NNP	O	Sci	dobj	1	SENT_368	[p19l2048t1007r2146b1064],
5	201	CD	NUMBER	201	number	6	SENT_368	[p19l147t1098r257b1153],
6	1	CD	NUMBER	1	dep	4	SENT_368	[p19l274t1098r297b1152],
7	;	:	O	;	_	0	SENT_368	[p19l312t1097r589b1163],
8	52:4694	CD	NUMBER	52:4694	num	9	SENT_368	[p19l312t1097r589b1163],
9	-702	CD	NUMBER	-702	dep	4	SENT_368	[p19l601t1098r776b1153],
10	.	.	O	.	_	0	SENT_368	[p19l601t1098r776b1153],

1	Nakata	NNP	PERSON	Nakata	nn	2	SENT_369	[p19l145t1187r373b1243],
2	I	NNP	O	I	_	0	SENT_369	[p19l418t1188r459b1253],
3	,	,	O	,	_	0	SENT_369	[p19l418t1188r459b1253],
4	Yamashiro	NNP	PERSON	Yamashiro	nn	5	SENT_369	[p19l510t1187r859b1243],
5	K	NNP	O	K	appos	2	SENT_369	[p19l908t1188r979b1253],
6	,	,	O	,	_	0	SENT_369	[p19l908t1188r979b1253],
7	Nakanishi	NNP	PERSON	Nakanishi	nn	8	SENT_369	[p19l1029t1187r1352b1243],
8	H	NNP	O	H	appos	2	SENT_369	[p19l1400t1188r1472b1253],
9	,	,	O	,	_	0	SENT_369	[p19l1400t1188r1472b1253],
10	et	FW	O	et	nn	11	SENT_369	[p19l1523t1195r1579b1243],
11	al.	FW	O	al.	appos	2	SENT_369	[p19l1626t1187r1697b1243],
12	.	.	O	.	_	0	SENT_369	[p19l1626t1187r1697b1243],

1	VEGF	NN	ORGANIZATION	vegf	nn	3	SENT_370	[p19l1752t1188r1954b1244],
2	gene	NN	O	gene	nn	3	SENT_370	[p19l1998t1204r2146b1260],
3	polymorphism	NN	O	polymorphism	nsubj	15	SENT_370	[p19l145t1276r614b1349],
4	and	CC	O	and	_	0	SENT_370	[p19l647t1276r759b1332],
5	response	NN	O	response	conj_and	3	SENT_370	[p19l790t1294r1070b1349],
6	to	TO	O	to	_	0	SENT_370	[p19l1103t1285r1162b1332],
7	intravitreal	JJ	O	intravitreal	amod	8	SENT_370	[p19l1195t1276r1546b1332],
8	bevacizumab	NN	O	bevacizumab	prep_to	5	SENT_370	[p19l1578t1276r1999b1333],
9	and	CC	O	and	_	0	SENT_370	[p19l2034t1276r2147b1332],
10	triple	JJ	O	triple	amod	11	SENT_370	[p19l146t1366r313b1439],
11	therapy	NN	O	therapy	conj_and	5	SENT_370	[p19l337t1367r575b1439],
12	in	IN	O	in	_	0	SENT_370	[p19l599t1366r660b1422],
13	age	NN	O	age	prep_in	11	SENT_370	[p19l685t1366r1038b1439],
14	—	CD	NUMBER	—	num	13	SENT_370	[p19l685t1366r1038b1439],
15	related	JJ	O	related	_	0	SENT_370	[p19l685t1366r1038b1439],
16	macular	JJ	O	macular	amod	17	SENT_370	[p19l1061t1366r1320b1423],
17	degeneration	NN	O	degeneration	dobj	15	SENT_370	[p19l1342t1366r1770b1439],
18	.	.	O	.	_	0	SENT_370	[p19l1342t1366r1770b1439],

1	Jpn	NN	O	jpn	nn	3	SENT_371	[p19l1797t1368r1908b1439],
2	J	NN	O	j	nn	3	SENT_371	[p19l1930t1368r1960b1423],
3	Ophthalmol	NN	O	ophthalmol	_	0	SENT_371	[p19l1985t1366r2144b1439, p19l146t1458r390b1514],
4	2011	CD	DATE	2011	dep	3	SENT_371	[p19l419t1457r968b1524],
5	;	:	O	;	_	0	SENT_371	[p19l419t1457r968b1524],
6	55:435	CD	NUMBER	55:435	num	7	SENT_371	[p19l419t1457r968b1524],
7	-43	CD	NUMBER	-43	dep	3	SENT_371	[p19l419t1457r968b1524],
8	.	.	O	.	_	0	SENT_371	[p19l419t1457r968b1524],

1	Kaiser	NNP	PERSON	Kaiser	nn	2	SENT_372	[p19l147t1547r355b1603],
2	PK	NNP	O	PK	_	0	SENT_372	[p19l396t1549r514b1614],
3	,	,	O	,	_	0	SENT_372	[p19l396t1549r514b1614],
4	Brown	NNP	PERSON	Brown	nn	5	SENT_372	[p19l559t1549r775b1603],
5	DM	NN	O	dm	appos	2	SENT_372	[p19l817t1549r962b1614],
6	,	,	O	,	_	0	SENT_372	[p19l817t1549r962b1614],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_372	[p19l1006t1547r1209b1620],
8	K	NNP	PERSON	K	appos	2	SENT_372	[p19l1254t1549r1325b1614],
9	,	,	O	,	_	0	SENT_372	[p19l1254t1549r1325b1614],
10	et	FW	O	et	nn	11	SENT_372	[p19l1371t1555r1428b1603],
11	al.	FW	O	al.	appos	2	SENT_372	[p19l1470t1547r1540b1603],
12	.	.	O	.	_	0	SENT_372	[p19l1470t1547r1540b1603],

1	Ranibizumab	NNP	O	Ranibizumab	_	0	SENT_373	[p19l1586t1547r2012b1603],
2	for	IN	O	for	_	0	SENT_373	[p19l2055t1547r2148b1603],
3	predominantly	RB	O	predominantly	advmod	4	SENT_373	[p19l145t1637r612b1710],
4	classic	JJ	O	classic	amod	7	SENT_373	[p19l696t1637r905b1694],
5	neovascular	JJ	O	neovascular	amod	7	SENT_373	[p19l989t1638r1372b1694],
6	age	NN	O	age	nn	7	SENT_373	[p19l1454t1637r1808b1710],
7	—	NN	O	—	prep_for	1	SENT_373	[p19l1454t1637r1808b1710],
8	related	JJ	O	related	amod	10	SENT_373	[p19l1454t1637r1808b1710],
9	macular	JJ	O	macular	amod	10	SENT_373	[p19l1890t1638r2148b1694],
10	degeneration	NN	O	degeneration	dep	1	SENT_373	[p19l147t1728r576b1801],
11	:	:	O	:	_	0	SENT_373	[p19l147t1728r576b1801],
12	subgroup	NN	O	subgroup	nn	13	SENT_373	[p19l623t1728r916b1801],
13	analysis	NN	O	analysis	dep	1	SENT_373	[p19l958t1728r1211b1801],
14	of	IN	O	of	_	0	SENT_373	[p19l1253t1728r1323b1784],
15	ﬁrst-year	JJ	O	ﬁrst-year	amod	17	SENT_373	[p19l1357t1728r1645b1801],
16	ANCHOR	NN	O	anchor	nn	17	SENT_373	[p19l1683t1728r2021b1784],
17	results	NNS	O	result	prep_of	13	SENT_373	[p19l2059t1746r2144b1784, p19l149t1817r307b1873],
18	.	.	O	.	_	0	SENT_373	[p19l2059t1746r2144b1784, p19l149t1817r307b1873],

1	Am	NNP	O	Am	nn	3	SENT_374	[p19l340t1818r460b1873],
2	J	NNP	O	J	nn	3	SENT_374	[p19l487t1819r517b1874],
3	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_374	[p19l547t1817r927b1890],
4	2007	CD	DATE	2007	num	3	SENT_374	[p19l957t1817r1506b1884],
5	;	:	O	;	_	0	SENT_374	[p19l957t1817r1506b1884],
6	144:850	CD	NUMBER	144:850	number	7	SENT_374	[p19l957t1817r1506b1884],
7	-7	CD	NUMBER	-7	dep	3	SENT_374	[p19l957t1817r1506b1884],
8	.	.	O	.	_	0	SENT_374	[p19l957t1817r1506b1884],

1	Boyer	NNP	PERSON	Boyer	nn	2	SENT_375	[p19l146t1909r342b1980],
2	DS	NN	O	d	_	0	SENT_375	[p19l376t1908r494b1974],
3	,	,	O	,	_	0	SENT_375	[p19l376t1908r494b1974],
4	Antoszyk	NNP	PERSON	Antoszyk	appos	2	SENT_375	[p19l533t1908r841b1980],
5	AN	DT	O	a	dep	4	SENT_375	[p19l875t1908r1006b1974],
6	,	,	O	,	_	0	SENT_375	[p19l875t1908r1006b1974],
7	Awh	NNP	O	Awh	nn	8	SENT_375	[p19l1045t1907r1200b1964],
8	CC	NN	O	cc	appos	2	SENT_375	[p19l1236t1908r1357b1974],
9	,	,	O	,	_	0	SENT_375	[p19l1236t1908r1357b1974],
10	et	FW	O	et	nn	11	SENT_375	[p19l1398t1916r1454b1964],
11	al	FW	O	al	appos	2	SENT_375	[p19l1491t1907r1562b1974],
12	,	,	O	,	_	0	SENT_375	[p19l1491t1907r1562b1974],
13	MARINA	NNP	O	MARINA	nn	15	SENT_375	[p19l1600t1908r1925b1964],
14	Study	NNP	O	Study	nn	15	SENT_375	[p19l1963t1908r2146b1980],
15	Group	NNP	O	Group	appos	2	SENT_375	[p19l147t1998r365b2071],
16	.	.	O	.	_	0	SENT_375	[p19l147t1998r365b2071],

1	Subgroup	NN	O	subgroup	nn	2	SENT_376	[p19l404t1998r711b2071],
2	analysis	NN	O	analysis	nsubj	13	SENT_376	[p19l747t1998r1000b2071],
3	of	IN	O	of	_	0	SENT_376	[p19l1036t1998r1105b2054],
4	the	DT	O	the	det	6	SENT_376	[p19l1133t1998r1229b2054],
5	MARINA	NNP	O	MARINA	nn	6	SENT_376	[p19l1261t1998r1586b2054],
6	Study	NNP	O	Study	prep_of	2	SENT_376	[p19l1620t1998r1803b2071],
7	of	IN	O	of	_	0	SENT_376	[p19l1838t1998r1907b2054],
8	ranibizumab	NN	O	ranibizumab	prep_of	6	SENT_376	[p19l1933t1998r2144b2054, p19l147t2087r357b2143],
9	in	IN	O	in	_	0	SENT_376	[p19l382t2087r442b2143],
10	neovascular	JJ	O	neovascular	amod	12	SENT_376	[p19l465t2087r848b2144],
11	age	NN	O	age	nn	12	SENT_376	[p19l871t2087r1225b2160],
12	—	NN	O	—	prep_in	8	SENT_376	[p19l871t2087r1225b2160],
13	related	JJ	O	related	_	0	SENT_376	[p19l871t2087r1225b2160],
14	macular	JJ	O	macular	amod	15	SENT_376	[p19l1248t2087r1506b2143],
15	degeneration	NN	O	degeneration	dobj	13	SENT_376	[p19l1528t2087r1956b2160],
16	.	.	O	.	_	0	SENT_376	[p19l1528t2087r1956b2160],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_377	[p19l1985t2087r2145b2160, p19l146t2177r509b2250],
2	2007	CD	DATE	2007	num	1	SENT_377	[p19l540t2178r753b2244],
3	;	:	O	;	_	0	SENT_377	[p19l540t2178r753b2244],
4	1	CD	NUMBER	1	number	5	SENT_377	[p19l540t2178r753b2244],
5	142246	CD	NUMBER	142246	dep	1	SENT_377	[p19l770t2177r982b2234],
6	-52	CD	NUMBER	-52	dep	5	SENT_377	[p19l994t2177r1129b2234],
7	.	.	O	.	_	0	SENT_377	[p19l994t2177r1129b2234],

1	Gerding	VBG	O	gerd	_	0	SENT_378	[p19l147t2268r406b2341],
2	H	NN	O	h	dobj	1	SENT_378	[p19l434t2269r507b2334],
3	,	,	O	,	_	0	SENT_378	[p19l434t2269r507b2334],
4	Loukopoulos	NNP	O	Loukopoulos	nn	5	SENT_378	[p19l537t2268r957b2341],
5	V	NNP	O	V	appos	2	SENT_378	[p19l986t2269r1059b2334],
6	,	,	O	,	_	0	SENT_378	[p19l986t2269r1059b2334],
7	Riese	NNP	PERSON	Riese	nn	8	SENT_378	[p19l1089t2268r1265b2324],
8	J	NNP	PERSON	J	appos	2	SENT_378	[p19l1292t2269r1339b2335],
9	,	,	O	,	_	0	SENT_378	[p19l1292t2269r1339b2335],
10	et	FW	O	et	nn	11	SENT_378	[p19l1369t2276r1426b2324],
11	al.	FW	O	al.	appos	2	SENT_378	[p19l1453t2268r1523b2324],
12	.	.	O	.	_	0	SENT_378	[p19l1453t2268r1523b2324],

1	Results	NNS	O	result	nsubj	9	SENT_379	[p19l1554t2268r1787b2324],
2	of	IN	O	of	_	0	SENT_379	[p19l1817t2268r1886b2324],
3	ﬂexible	JJ	O	ﬂexible	amod	5	SENT_379	[p19l1909t2268r2146b2324],
4	ranibizumab	NN	O	ranibizumab	nn	5	SENT_379	[p19l145t2357r544b2414],
5	treatment	NN	O	treatment	prep_of	1	SENT_379	[p19l589t2366r891b2413],
6	in	IN	O	in	_	0	SENT_379	[p19l933t2357r993b2413],
7	age	NN	O	age	prep_in	5	SENT_379	[p19l1038t2357r1391b2430],
8	—	CD	NUMBER	—	num	7	SENT_379	[p19l1038t2357r1391b2430],
9	related	JJ	O	related	_	0	SENT_379	[p19l1038t2357r1391b2430],
10	macular	JJ	O	macular	amod	11	SENT_379	[p19l1434t2357r1692b2414],
11	degeneration	NN	O	degeneration	dobj	9	SENT_379	[p19l1734t2357r2147b2430],
12	and	CC	O	and	_	0	SENT_379	[p19l148t2448r261b2504],
13	search	NN	O	search	dobj	9	SENT_379	[p19l296t2448r496b2504],
14	for	IN	O	for	_	0	SENT_379	[p19l529t2448r622b2504],
15	parameters	NNS	O	parameter	prep_for	11	SENT_379	[p19l652t2456r1002b2521],
16	with	IN	O	with	_	0	SENT_379	[p19l1037t2448r1178b2504],
17	impact	NN	O	impact	prep_with	15	SENT_379	[p19l1210t2448r1428b2521],
18	on	IN	O	on	_	0	SENT_379	[p19l1461t2465r1538b2504],
19	outcome	NN	O	outcome	prep_on	9	SENT_379	[p19l1572t2456r1862b2504],
20	.	.	O	.	_	0	SENT_379	[p19l1572t2456r1862b2504],

1	Graefes	NNP	O	Graefes	nn	5	SENT_380	[p19l1900t2448r2144b2504],
2	Arch	NNP	O	Arch	nn	5	SENT_380	[p19l146t2538r305b2594],
3	Clin	NNP	O	Clin	nn	5	SENT_380	[p19l334t2538r470b2594],
4	Exp	NNP	O	Exp	nn	5	SENT_380	[p19l498t2539r625b2611],
5	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_380	[p19l656t2538r1037b2611],
6	201	CD	NUMBER	201	number	7	SENT_380	[p19l1067t2538r1177b2594],
7	1	CD	NUMBER	1	dep	5	SENT_380	[p19l1194t2538r1551b2604],
8	;	:	O	;	_	0	SENT_380	[p19l1194t2538r1551b2604],
9	249:653	CD	NUMBER	249:653	num	11	SENT_380	[p19l1194t2538r1551b2604],
10	-	:	O	-	_	0	SENT_380	[p19l1194t2538r1551b2604],
11	62	CD	DATE	62	dep	5	SENT_380	[p19l1563t2538r1656b2594],
12	.	.	O	.	_	0	SENT_380	[p19l1563t2538r1656b2594],

1	Ding	VBG	PERSON	ding	_	0	SENT_381	[p19l146t2627r304b2700],
2	H	NN	PERSON	h	dobj	1	SENT_381	[p19l342t2629r415b2694],
3	,	,	O	,	_	0	SENT_381	[p19l342t2629r415b2694],
4	Liu	NNP	PERSON	Liu	nn	5	SENT_381	[p19l456t2627r565b2683],
5	Q	NNP	O	Q	appos	2	SENT_381	[p19l604t2628r676b2697],
6	,	,	O	,	_	0	SENT_381	[p19l604t2628r676b2697],
7	Hua	NNP	PERSON	Hua	nn	8	SENT_381	[p19l717t2629r849b2683],
8	M	NNP	O	M	appos	2	SENT_381	[p19l885t2629r972b2694],
9	,	,	O	,	_	0	SENT_381	[p19l885t2629r972b2694],
10	et	FW	O	et	nn	11	SENT_381	[p19l1014t2636r1070b2683],
11	al.	FW	O	al.	appos	2	SENT_381	[p19l1108t2627r1178b2684],
12	.	.	O	.	_	0	SENT_381	[p19l1108t2627r1178b2684],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_382	[p19l1220t2627r1721b2700],
2	of	IN	O	of	_	0	SENT_382	[p19l1761t2627r1831b2683],
3	hypoxiarelated	JJ	O	hypoxiarelated	amod	4	SENT_382	[p19l1862t2627r2144b2700, p19l145t2718r363b2774],
4	genes	NNS	O	gene	prep_of	1	SENT_382	[p19l395t2735r573b2791],
5	in	IN	O	in	_	0	SENT_382	[p19l605t2718r666b2773],
6	subjects	NNS	O	subject	nn	11	SENT_382	[p19l699t2718r951b2791],
7	susceptible	JJ	O	susceptible	amod	9	SENT_382	[p19l987t2718r1339b2791],
8	to	TO	O	to	dep	9	SENT_382	[p19l1371t2726r1430b2774],
9	acute	JJ	O	acute	amod	11	SENT_382	[p19l1463t2726r1629b2774],
10	mountain	NN	O	mountain	nn	11	SENT_382	[p19l1660t2718r1962b2774],
11	sickness	NN	O	sickness	prep_in	1	SENT_382	[p19l1995t2718r2144b2774, p19l146t2825r298b2863],
12	.	.	O	.	_	0	SENT_382	[p19l1995t2718r2144b2774, p19l146t2825r298b2863],

1	Respiration	NN	MISC	respiration	nn	2	SENT_383	[p19l331t2807r700b2880],
2	20ll	NN	O	20ll	_	0	SENT_383	[p19l730t2807r1289b2874],
3	;	:	O	;	_	0	SENT_383	[p19l730t2807r1289b2874],
4	8l	NN	O	8l	nn	9	SENT_383	[p19l730t2807r1289b2874],
5	:236	CD	NUMBER	:236	num	9	SENT_383	[p19l730t2807r1289b2874],
6	-4	CD	NUMBER	-4	num	9	SENT_383	[p19l730t2807r1289b2874],
7	l.	NNP	O	l.	nn	9	SENT_383	[p19l730t2807r1289b2874],
8	Dumont	NNP	ORGANIZATION	Dumont	nn	9	SENT_383	[p19l146t2899r408b2954],
9	L	NNP	ORGANIZATION	L	dep	2	SENT_383	[p19l432t2899r497b2964],
10	,	,	O	,	_	0	SENT_383	[p19l432t2899r497b2964],
11	Mardirosoff	NNP	O	Mardirosoff	nn	12	SENT_383	[p19l525t2897r917b2954],
12	C	NNP	O	C	dep	2	SENT_383	[p19l938t2898r1006b2964],
13	,	,	O	,	_	0	SENT_383	[p19l938t2898r1006b2964],
14	Tramer	NNP	O	Tramer	nn	16	SENT_383	[p19l1034t2899r1270b2953],
15	MR.	NNP	O	MR.	nn	16	SENT_383	[p19l1294t2899r1433b2954],
16	Efﬁcacy	NNP	O	Efﬁcacy	dep	2	SENT_383	[p19l1462t2897r1728b2970],
17	and	CC	O	and	_	0	SENT_383	[p19l1755t2897r1868b2953],
18	harm	NN	O	harm	dep	2	SENT_383	[p19l1893t2897r2057b2954],
19	of	IN	O	of	_	0	SENT_383	[p19l2082t2897r2152b2953],
20	pharmacological	JJ	O	pharmacological	amod	21	SENT_383	[p19l145t2989r679b3062],
21	prevention	NN	O	prevention	prep_of	18	SENT_383	[p19l699t2989r1042b3062],
22	of	IN	O	of	_	0	SENT_383	[p19l1063t2989r1132b3045],
23	acute	JJ	O	acute	amod	25	SENT_383	[p19l1149t2997r1314b3045],
24	mountain	NN	O	mountain	nn	25	SENT_383	[p19l1335t2989r1637b3045],
25	sickness	NN	O	sickness	prep_of	21	SENT_383	[p19l1660t2989r1940b3045],
26	:	:	O	:	_	0	SENT_383	[p19l1660t2989r1940b3045],
27	quantitative	JJ	O	quantitative	amod	21	SENT_383	[p19l1966t3006r2144b3062, p19l146t3078r367b3134],
28	systematic	JJ	O	systematic	amod	29	SENT_383	[p19l399t3078r732b3151],
29	review	NN	O	review	dep	21	SENT_383	[p19l761t3078r994b3134],
30	.	.	O	.	_	0	SENT_383	[p19l761t3078r994b3134],

1	BMJ	NNP	O	BMJ	_	0	SENT_384	[p19l1028t3080r1182b3135],
2	2000	CD	DATE	2000	num	1	SENT_384	[p19l1212t3078r1791b3145],
3	;	:	O	;	_	0	SENT_384	[p19l1212t3078r1791b3145],
4	321:267	CD	NUMBER	321:267	number	5	SENT_384	[p19l1212t3078r1791b3145],
5	-72	CD	NUMBER	-72	dep	1	SENT_384	[p19l1212t3078r1791b3145],
6	.	.	O	.	_	0	SENT_384	[p19l1212t3078r1791b3145],

1	Tissot	NNP	PERSON	Tissot	nn	4	SENT_385	[p19l146t3168r341b3225],
2	van	NNP	O	van	nn	4	SENT_385	[p19l369t3186r483b3225],
3	Patot	NNP	O	Patot	nn	4	SENT_385	[p19l511t3170r675b3225],
4	MC	NNP	O	MC	_	0	SENT_385	[p19l702t3169r842b3235],
5	,	,	O	,	_	0	SENT_385	[p19l702t3169r842b3235],
6	Leadbetter	NNP	PERSON	Leadbetter	nn	7	SENT_385	[p19l873t3168r1217b3225],
7	G	NNP	PERSON	G	appos	4	SENT_385	[p19l1244t3169r1316b3235],
8	,	,	O	,	_	0	SENT_385	[p19l1244t3169r1316b3235],
9	Keyes	NNP	PERSON	Keyes	nn	10	SENT_385	[p19l1349t3170r1545b3241],
10	LE	NNP	PERSON	LE	appos	4	SENT_385	[p19l1574t3170r1688b3235],
11	,	,	O	,	_	0	SENT_385	[p19l1574t3170r1688b3235],
12	et	FW	O	et	nn	13	SENT_385	[p19l1720t3177r1776b3225],
13	al.	FW	O	al.	appos	4	SENT_385	[p19l1805t3169r1875b3225],
14	.	.	O	.	_	0	SENT_385	[p19l1805t3169r1875b3225],

1	Greater	NNP	O	Greater	nsubj	2	SENT_386	[p19l1909t3169r2148b3225],
2	free	JJ	O	free	_	0	SENT_386	[p19l146t3259r269b3315],
3	plasma	NN	O	plasma	nn	4	SENT_386	[p19l308t3259r536b3332],
4	VEGF	NN	O	vegf	dobj	2	SENT_386	[p19l575t3259r783b3315],
5	and	CC	O	and	_	0	SENT_386	[p19l825t3259r938b3315],
6	lower	JJR	O	lower	amod	9	SENT_386	[p19l978t3259r1160b3315],
7	soluble	JJ	O	soluble	amod	9	SENT_386	[p19l1202t3259r1429b3315],
8	VEGF	NN	O	vegf	nn	9	SENT_386	[p19l1469t3259r1678b3315],
9	receptor-1	NN	O	receptor-1	dobj	2	SENT_386	[p19l1717t3259r2039b3332],
10	in	IN	O	in	_	0	SENT_386	[p19l2086t3259r2147b3314],
11	acute	JJ	O	acute	amod	13	SENT_386	[p19l148t3358r313b3405],
12	mountain	NN	O	mountain	nn	13	SENT_386	[p19l342t3349r644b3405],
13	sickness	NN	O	sickness	prep_in	2	SENT_386	[p19l675t3349r954b3405],
14	.	.	O	.	_	0	SENT_386	[p19l675t3349r954b3405],

1	J	NNP	O	J	nn	3	SENT_387	[p19l987t3350r1016b3405],
2	Appl	NNP	O	Appl	nn	3	SENT_387	[p19l1045t3349r1204b3422],
3	Physiol	NNP	O	Physiol	_	0	SENT_387	[p19l1233t3349r1472b3422],
4	2005	CD	DATE	2005	num	3	SENT_387	[p19l1502t3349r1656b3405],
5	;	:	O	;	_	0	SENT_387	[p19l1667t3349r1944b3416],
6	98	CD	NUMBER	98	dep	3	SENT_387	[p19l1667t3349r1944b3416],
7	:	:	O	:	_	0	SENT_387	[p19l1667t3349r1944b3416],
8	l626	CD	NUMBER	l626	num	9	SENT_387	[p19l1667t3349r1944b3416],
9	-9	CD	NUMBER	-9	dep	6	SENT_387	[p19l1956t3349r2051b3406],
10	.	.	O	.	_	0	SENT_387	[p19l1956t3349r2051b3406],

1	Originally	RB	O	originally	_	0	SENT_388	[p19l7t3559r299b3625],
2	received	VBN	O	receive	partmod	1	SENT_388	[p19l324t3559r580b3610],
3	:	:	O	:	_	0	SENT_388	[p19l324t3559r580b3610],
4	April	NNP	DATE	April	dep	1	SENT_388	[p19l611t3559r761b3625],
5	7	CD	DATE	7	num	4	SENT_388	[p19l787t3560r836b3619],
6	,	,	DATE	,	_	0	SENT_388	[p19l787t3560r836b3619],
7	2012	CD	DATE	2012	appos	4	SENT_388	[p19l865t3560r1020b3610],
8	.	.	O	.	_	0	SENT_388	[p19l865t3560r1020b3610],

1	Final	JJ	O	final	amod	2	SENT_389	[p19l6t3648r151b3698],
2	revision	NN	O	revision	_	0	SENT_389	[p19l177t3648r421b3698],
3	:	:	O	:	_	0	SENT_389	[p19l177t3648r421b3698],
4	October	NNP	DATE	October	dep	2	SENT_389	[p19l453t3648r682b3698],
5	2	CD	DATE	2	num	4	SENT_389	[p19l708t3648r756b3707],
6	,	,	DATE	,	_	0	SENT_389	[p19l708t3648r756b3707],
7	2012	CD	DATE	2012	num	4	SENT_389	[p19l786t3648r940b3698],
8	.	.	O	.	_	0	SENT_389	[p19l786t3648r940b3698],

1	Accepted	JJ	O	accepted	_	0	SENT_390	[p19l6t3736r290b3801],
2	:	:	O	:	_	0	SENT_390	[p19l6t3736r290b3801],
3	October	NNP	DATE	October	dep	1	SENT_390	[p19l322t3736r551b3787],
4	2	CD	DATE	2	num	3	SENT_390	[p19l577t3737r624b3796],
5	,	,	DATE	,	_	0	SENT_390	[p19l577t3737r624b3796],
6	2012	CD	DATE	2012	num	3	SENT_390	[p19l654t3737r809b3787],
7	.	.	O	.	_	0	SENT_390	[p19l654t3737r809b3787],

1	Available	JJ	O	available	amod	2	SENT_391	[p20l6t19r283b69],
2	online	NN	O	online	_	0	SENT_391	[p20l310t19r501b69],
3	:	:	O	:	_	0	SENT_391	[p20l310t19r501b69],
4	November	NNP	DATE	November	dep	2	SENT_391	[p20l531t19r834b69],
5	11	CD	DATE	11	num	4	SENT_391	[p20l865t19r943b78],
6	,	,	DATE	,	_	0	SENT_391	[p20l865t19r943b78],
7	2012	CD	DATE	2012	num	4	SENT_391	[p20l972t19r1127b69],
8	.	.	O	.	_	0	SENT_391	[p20l972t19r1127b69],

1	Manuscript	NN	O	manuscript	nsubj	3	SENT_392	[p20l1400t19r1726b84],
2	no.	SYM	O	no.	dep	3	SENT_392	[p20l1751t34r1835b69],
3	2012-505	CD	NUMBER	2012-505	_	0	SENT_392	[p20l1865t18r2151b69],
4	.	.	O	.	_	0	SENT_392	[p20l1865t18r2151b69],

1	1	CD	NUMBER	1	_	0	SENT_393	[p20l11t97r27b127],
2	Centre	NNP	O	Centre	dep	1	SENT_393	[p20l52t107r240b157],
3	for	IN	O	for	_	0	SENT_393	[p20l281t107r364b157],
4	Eye	NNP	ORGANIZATION	Eye	nn	6	SENT_393	[p20l403t108r512b172],
5	Research	NNP	ORGANIZATION	Research	nn	6	SENT_393	[p20l553t107r815b157],
6	Australia	NNP	ORGANIZATION	Australia	prep_for	2	SENT_393	[p20l855t107r1131b166],
7	,	,	ORGANIZATION	,	_	0	SENT_393	[p20l855t107r1131b166],
8	University	NNP	ORGANIZATION	University	appos	6	SENT_393	[p20l1174t107r1475b172],
9	of	IN	ORGANIZATION	of	_	0	SENT_393	[p20l1516t107r1578b157],
10	Melbourne	NNP	ORGANIZATION	Melbourne	prep_of	8	SENT_393	[p20l1614t107r1942b166],
11	,	,	O	,	_	0	SENT_393	[p20l1614t107r1942b166],
12	Royal	NNP	ORGANIZATION	Royal	prep_for	2	SENT_393	[p20l1985t107r2154b172],
13	Victorian	JJ	ORGANIZATION	victorian	amod	14	SENT_393	[p20l6t195r275b246],
14	Eye	NNP	ORGANIZATION	Eye	dep	12	SENT_393	[p20l300t196r410b260],
15	and	CC	O	and	_	0	SENT_393	[p20l438t195r538b245],
16	Ear	NN	LOCATION	ear	nn	17	SENT_393	[p20l563t196r662b245],
17	Hospital	NN	LOCATION	hospital	conj_and	6	SENT_393	[p20l687t195r943b260],
18	,	,	O	,	_	0	SENT_393	[p20l687t195r943b260],
19	Victoria	NNP	LOCATION	Victoria	nn	23	SENT_393	[p20l971t195r1220b255],
20	,	,	O	,	_	0	SENT_393	[p20l971t195r1220b255],
21	Australia	NNP	LOCATION	Australia	appos	23	SENT_393	[p20l1248t195r1510b245],
22	2	CD	NUMBER	2	num	23	SENT_393	[p20l7t274r31b304],
23	Centre	NNP	O	Centre	appos	17	SENT_393	[p20l52t285r240b334],
24	for	IN	O	for	_	0	SENT_393	[p20l278t284r361b334],
25	MEGA	NNP	ORGANIZATION	MEGA	nn	26	SENT_393	[p20l396t285r606b334],
26	Epidemiology	NNP	ORGANIZATION	Epidemiology	prep_for	23	SENT_393	[p20l642t284r1063b349],
27	,	,	O	,	_	0	SENT_393	[p20l642t284r1063b349],
28	University	NNP	ORGANIZATION	University	appos	26	SENT_393	[p20l1102t284r1403b349],
29	of	IN	ORGANIZATION	of	_	0	SENT_393	[p20l1442t284r1504b334],
30	Melbourne	NNP	ORGANIZATION	Melbourne	prep_of	28	SENT_393	[p20l1536t284r1864b343],
31	,	,	O	,	_	0	SENT_393	[p20l1536t284r1864b343],
32	Victoria	NNP	LOCATION	Victoria	nn	34	SENT_393	[p20l1903t284r2152b343],
33	,	,	O	,	_	0	SENT_393	[p20l1903t284r2152b343],
34	Australia	NNP	LOCATION	Australia	dep	1	SENT_393	[p20l6t372r268b423],

1	*	NN	O	*	nn	4	SENT_394	[p20l10t502r167b552],
2	Paul	NNP	PERSON	Paul	nn	4	SENT_394	[p20l10t502r167b552],
3	N.	NNP	PERSON	N.	nn	4	SENT_394	[p20l193t503r258b553],
4	Baird	NNP	PERSON	Baird	nsubj	9	SENT_394	[p20l287t502r445b552],
5	and	CC	O	and	_	0	SENT_394	[p20l471t502r572b552],
6	Robyn	NNP	PERSON	Robyn	nn	8	SENT_394	[p20l597t502r787b567],
7	H.	NNP	PERSON	H.	nn	8	SENT_394	[p20l812t503r876b552],
8	Guymer	NNP	PERSON	Guymer	nsubj	9	SENT_394	[p20l907t502r1140b567],
9	contributed	VBD	O	contribute	_	0	SENT_394	[p20l1166t502r1490b552],
10	equally	RB	O	equally	advmod	9	SENT_394	[p20l1515t502r1724b567],
11	to	TO	O	to	_	0	SENT_394	[p20l1750t510r1803b552],
12	this	DT	O	this	det	13	SENT_394	[p20l1829t502r1930b552],
13	work	NN	O	work	prep_to	9	SENT_394	[p20l1957t502r2116b552],
14	.	.	O	.	_	0	SENT_394	[p20l1957t502r2116b552],

1	Presented	VBN	O	present	_	0	SENT_395	[p20l6t655r283b705],
2	at	IN	O	at	_	0	SENT_395	[p20l312t662r375b705],
3	:	:	O	:	_	0	SENT_395	[p20l312t662r375b705],
4	the	DT	O	the	det	5	SENT_395	[p20l407t655r492b705],
5	Association	NNP	ORGANIZATION	Association	prep_at	1	SENT_395	[p20l520t655r857b705],
6	for	IN	ORGANIZATION	for	_	0	SENT_395	[p20l884t654r967b705],
7	Research	NNP	ORGANIZATION	Research	prep_for	5	SENT_395	[p20l993t655r1254b705],
8	in	IN	O	in	_	0	SENT_395	[p20l1281t655r1335b704],
9	Vision	NNP	O	Vision	prep_in	7	SENT_395	[p20l1362t655r1551b705],
10	and	CC	O	and	_	0	SENT_395	[p20l1580t655r1680b705],
11	Ophthalmology	NNP	O	Ophthalmology	conj_and	5	SENT_395	[p20l1708t655r2154b720],
12	(	CD	NUMBER	(	num	11	SENT_395	[p20l8t744r253b806],
13	ARVO	NNP	O	ARVO	dep	15	SENT_395	[p20l8t744r253b806],
14	)	CD	NUMBER	)	num	13	SENT_395	[p20l8t744r253b806],
15	Annual	JJ	SET	annual	amod	11	SENT_395	[p20l281t744r490b794],
16	Meeting	VBG	O	meet	partmod	11	SENT_395	[p20l515t744r768b809],
17	,	,	O	,	_	0	SENT_395	[p20l515t744r768b809],
18	Fort	NNP	LOCATION	Fort	nn	19	SENT_395	[p20l796t745r915b794],
19	Lauderdale	NNP	LOCATION	Lauderdale	prep_at	1	SENT_395	[p20l939t744r1276b804],
20	,	,	O	,	_	0	SENT_395	[p20l939t744r1276b804],
21	Florida	NNP	LOCATION	Florida	appos	19	SENT_395	[p20l1303t744r1524b804],
22	,	,	O	,	_	0	SENT_395	[p20l1303t744r1524b804],
23	May	NNP	DATE	May	appos	19	SENT_395	[p20l1553t745r1697b809],
24	,	,	DATE	,	_	0	SENT_395	[p20l1553t745r1697b809],
25	2011	CD	DATE	2011	appos	19	SENT_395	[p20l1727t744r1882b795],
26	.	.	O	.	_	0	SENT_395	[p20l1727t744r1882b795],

1	Financial	JJ	O	financial	amod	3	SENT_396	[p20l6t833r270b883],
2	Disc1osure	NN	O	disc1osure	nn	3	SENT_396	[p20l297t833r691b894],
3	(	NN	O	(	nsubj	5	SENT_396	[p20l297t833r691b894],
4	s	VBZ	O	s	cop	5	SENT_396	[p20l297t833r691b894],
5	)	CD	NUMBER	)	_	0	SENT_396	[p20l297t833r691b894],
6	:	:	O	:	_	0	SENT_396	[p20l297t833r691b894],
7	The	DT	O	the	det	8	SENT_396	[p20l6t921r115b970],
8	authors	NNS	O	author	nsubj	9	SENT_396	[p20l154t921r360b970],
9	have	VBP	O	have	parataxis	5	SENT_396	[p20l398t921r531b970],
10	no	DT	O	no	det	14	SENT_396	[p20l569t936r637b970],
11	proprietary	NN	O	proprietary	nn	14	SENT_396	[p20l675t921r991b985],
12	or	CC	O	or	_	0	SENT_396	[p20l1030t936r1087b970],
13	commercial	JJ	O	commercial	conj_or	11	SENT_396	[p20l1124t921r1459b970],
14	interest	NN	O	interest	dobj	9	SENT_396	[p20l1496t921r1706b970],
15	in	IN	O	in	_	0	SENT_396	[p20l1742t921r1796b969],
16	any	DT	O	any	prep_in	14	SENT_396	[p20l1834t936r1934b985],
17	of	IN	O	of	_	0	SENT_396	[p20l1972t920r2034b970],
18	the	DT	O	the	det	19	SENT_396	[p20l2066t921r2151b970],
19	materials	NNS	O	material	prep_of	16	SENT_396	[p20l6t1007r265b1056],
20	discussed	VBN	O	discuss	partmod	19	SENT_396	[p20l293t1007r565b1056],
21	in	IN	O	in	_	0	SENT_396	[p20l591t1007r645b1056],
22	this	DT	O	this	det	23	SENT_396	[p20l670t1007r770b1056],
23	article	NN	O	article	prep_in	20	SENT_396	[p20l799t1007r988b1056],
24	.	.	O	.	_	0	SENT_396	[p20l799t1007r988b1056],

1	This	DT	O	this	det	2	SENT_397	[p20l6t1095r126b1144],
2	project	NN	O	project	nsubjpass	5	SENT_397	[p20l149t1095r339b1159],
3	was	VBD	O	be	auxpass	5	SENT_397	[p20l360t1110r464b1144],
4	partly	RB	O	partly	advmod	5	SENT_397	[p20l487t1095r646b1159],
5	funded	VBN	O	fund	_	0	SENT_397	[p20l668t1094r858b1144],
6	by	IN	O	by	_	0	SENT_397	[p20l879t1095r948b1159],
7	the	DT	O	the	det	9	SENT_397	[p20l970t1095r1052b1144],
8	National	NNP	ORGANIZATION	National	nn	9	SENT_397	[p20l1074t1095r1309b1144],
9	Health	NNP	ORGANIZATION	Health	agent	5	SENT_397	[p20l1331t1094r1513b1144],
10	and	CC	ORGANIZATION	and	_	0	SENT_397	[p20l1536t1095r1634b1144],
11	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_397	[p20l1655t1095r1879b1144],
12	Research	NNP	ORGANIZATION	Research	nn	18	SENT_397	[p20l1901t1095r2152b1144],
13	Council	NNP	ORGANIZATION	Council	nn	18	SENT_397	[p20l7t1182r222b1232],
14	(	CD	NUMBER	(	num	18	SENT_397	[p20l241t1182r536b1243],
15	NHMRC	NNP	ORGANIZATION	NHMRC	nn	18	SENT_397	[p20l241t1182r536b1243],
16	)	CD	NUMBER	)	num	18	SENT_397	[p20l241t1182r536b1243],
17	project	NN	O	project	nn	18	SENT_397	[p20l553t1182r744b1246],
18	grants	NNS	O	grant	agent	5	SENT_397	[p20l760t1190r924b1246],
19	590205	CD	NUMBER	590205	dep	9	SENT_397	[p20l942t1182r1144b1232],
20	and	CC	O	and	_	0	SENT_397	[p20l1165t1182r1263b1231],
21	1008979	CD	NUMBER	1008979	conj_and	19	SENT_397	[p20l1285t1182r1532b1241],
22	,	,	O	,	_	0	SENT_397	[p20l1285t1182r1532b1241],
23	an	DT	O	a	det	28	SENT_397	[p20l1552t1198r1615b1231],
24	NHMRC	NNP	ORGANIZATION	NHMRC	nn	28	SENT_397	[p20l1631t1182r1922b1232],
25	—	CD	NUMBER	—	num	28	SENT_397	[p20l1631t1182r1922b1232],
26	Clinical	JJ	O	clinical	amod	28	SENT_397	[p20l1937t1182r2151b1232],
27	Research	NN	O	research	nn	28	SENT_397	[p20l6t1269r257b1319],
28	Excellence	NN	O	excellence	conj_and	9	SENT_397	[p20l274t1269r573b1319],
29	grant	NN	O	grant	dep	28	SENT_397	[p20l592t1277r732b1334],
30	529923	CD	NUMBER	529923	num	29	SENT_397	[p20l749t1269r968b1328],
31	,	,	O	,	_	0	SENT_397	[p20l749t1269r968b1328],
32	NHMRC	NNP	ORGANIZATION	NHMRC	nn	34	SENT_397	[p20l987t1270r1241b1319],
33	practitioner	NN	O	practitioner	nn	34	SENT_397	[p20l1259t1269r1573b1334],
34	fellowship	NN	O	fellowship	conj_and	9	SENT_397	[p20l1589t1269r1876b1334],
35	(	CD	NUMBER	(	num	36	SENT_397	[p20l1896t1270r2149b1331],
36	R.H.G.	NNP	O	R.H.G.	dep	34	SENT_397	[p20l1896t1270r2149b1331],
37	)	CD	NUMBER	)	num	36	SENT_397	[p20l1896t1270r2149b1331],
38	,	,	O	,	_	0	SENT_397	[p20l1896t1270r2149b1331],
39	NHMRC	NNP	ORGANIZATION	NHMRC	nn	41	SENT_397	[p20l6t1357r260b1406],
40	Research	NNP	ORGANIZATION	Research	nn	41	SENT_397	[p20l278t1357r529b1406],
41	Fellowship	NNP	ORGANIZATION	Fellowship	conj_and	9	SENT_397	[p20l546t1357r849b1421],
42	(	CD	NUMBER	(	num	43	SENT_397	[p20l869t1357r1110b1418],
43	P.N.B.	NNP	O	P.N.B.	dep	41	SENT_397	[p20l869t1357r1110b1418],
44	)	CD	NUMBER	)	num	43	SENT_397	[p20l869t1357r1110b1418],
45	,	,	O	,	_	0	SENT_397	[p20l869t1357r1110b1418],
46	and	CC	O	and	_	0	SENT_397	[p20l1131t1357r1229b1406],
47	the	DT	O	the	det	52	SENT_397	[p20l1245t1357r1327b1406],
48	Macular	NNP	ORGANIZATION	Macular	nn	52	SENT_397	[p20l1344t1357r1575b1406],
49	Vision	NNP	ORGANIZATION	Vision	nn	52	SENT_397	[p20l1590t1357r1772b1406],
50	Loss	NN	ORGANIZATION	loss	nn	52	SENT_397	[p20l1789t1358r1917b1406],
51	Support	NN	ORGANIZATION	support	nn	52	SENT_397	[p20l1937t1357r2153b1421],
52	Society	NN	ORGANIZATION	society	conj_and	9	SENT_397	[p20l8t1444r210b1508],
53	of	IN	O	of	_	0	SENT_397	[p20l231t1444r291b1493],
54	Australia	NNP	LOCATION	Australia	prep_of	52	SENT_397	[p20l305t1444r568b1494],
55	.	.	O	.	_	0	SENT_397	[p20l305t1444r568b1494],

1	The	DT	O	the	det	2	SENT_398	[p20l591t1444r697b1493],
2	Centre	NNP	O	Centre	nsubj	10	SENT_398	[p20l717t1444r898b1494],
3	for	IN	O	for	_	0	SENT_398	[p20l918t1444r998b1493],
4	Eye	NNP	ORGANIZATION	Eye	nn	6	SENT_398	[p20l1015t1445r1122b1508],
5	Research	NNP	ORGANIZATION	Research	nn	6	SENT_398	[p20l1142t1444r1392b1493],
6	Australia	NNP	ORGANIZATION	Australia	prep_for	2	SENT_398	[p20l1411t1444r1662b1493],
7	(	CD	NUMBER	(	num	8	SENT_398	[p20l1682t1444r1907b1505],
8	CERA	NNP	ORGANIZATION	CERA	dep	6	SENT_398	[p20l1682t1444r1907b1505],
9	)	CD	NUMBER	)	num	8	SENT_398	[p20l1682t1444r1907b1505],
10	receives	VBZ	O	receive	_	0	SENT_398	[p20l1928t1444r2150b1494],
11	Operational	NNP	O	Operational	nn	13	SENT_398	[p20l7t1531r313b1596],
12	Infrastructure	NNP	O	Infrastructure	nn	13	SENT_398	[p20l327t1531r677b1581],
13	Support	NN	O	support	dobj	10	SENT_398	[p20l692t1532r899b1596],
14	from	IN	O	from	_	0	SENT_398	[p20l911t1531r1041b1581],
15	the	DT	O	the	det	17	SENT_398	[p20l1053t1531r1132b1581],
16	Victorian	JJ	MISC	victorian	amod	17	SENT_398	[p20l1146t1531r1392b1581],
17	Govemment	NN	MISC	govemment	prep_from	13	SENT_398	[p20l1406t1532r1746b1581],
18	.	.	O	.	_	0	SENT_398	[p20l1406t1532r1746b1581],

1	The	DT	O	the	det	5	SENT_399	[p20l1763t1531r1866b1581],
2	sponsor	NN	O	sponsor	nn	5	SENT_399	[p20l1882t1547r2085b1596],
3	or	CC	O	or	_	0	SENT_399	[p20l2097t1547r2153b1581],
4	funding	NN	O	funding	conj_or	2	SENT_399	[p20l6t1618r209b1683],
5	organizations	NNS	O	organization	nsubj	6	SENT_399	[p20l231t1619r578b1683],
6	had	VBD	O	have	_	0	SENT_399	[p20l599t1619r696b1668],
7	no	DT	O	no	det	8	SENT_399	[p20l715t1634r781b1668],
8	role	NN	O	role	dobj	6	SENT_399	[p20l801t1618r902b1668],
9	in	IN	O	in	_	0	SENT_399	[p20l923t1619r974b1667],
10	the	DT	O	the	det	11	SENT_399	[p20l994t1619r1073b1668],
11	design	NN	O	design	prep_in	8	SENT_399	[p20l1094t1619r1265b1683],
12	or	CC	O	or	_	0	SENT_399	[p20l1285t1634r1341b1668],
13	conduct	NN	O	conduct	prep_in	8	SENT_399	[p20l1360t1619r1568b1668],
14	of	IN	O	of	_	0	SENT_399	[p20l1588t1618r1647b1668],
15	this	DT	O	this	det	16	SENT_399	[p20l1662t1619r1753b1668],
16	research	NN	O	research	prep_of	11	SENT_399	[p20l1774t1619r2003b1668],
17	.	.	O	.	_	0	SENT_399	[p20l1774t1619r2003b1668],

1	Correspondence	NN	O	correspondence	_	0	SENT_400	[p20l7t1775r484b1839],
2	:	:	O	:	_	0	SENT_400	[p20l7t1775r484b1839],
3	Farshad	NNP	PERSON	Farshad	nn	4	SENT_400	[p20l6t1863r223b1912],
4	Abedi	NNP	PERSON	Abedi	dep	1	SENT_400	[p20l246t1863r428b1922],
5	,	,	O	,	_	0	SENT_400	[p20l246t1863r428b1922],
6	MD	NNP	O	MD	appos	1	SENT_400	[p20l454t1864r580b1922],
7	,	,	O	,	_	0	SENT_400	[p20l454t1864r580b1922],
8	Centre	NNP	O	Centre	appos	1	SENT_400	[p20l608t1863r789b1913],
9	for	IN	O	for	_	0	SENT_400	[p20l813t1863r893b1912],
10	Eye	NNP	ORGANIZATION	Eye	nn	12	SENT_400	[p20l915t1864r1022b1927],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_400	[p20l1046t1863r1297b1913],
12	Australia	NNP	ORGANIZATION	Australia	prep_for	8	SENT_400	[p20l1321t1863r1584b1922],
13	,	,	O	,	_	0	SENT_400	[p20l1321t1863r1584b1922],
14	32	CD	NUMBER	32	num	16	SENT_400	[p20l1613t1863r1678b1913],
15	Gisborne	NNP	LOCATION	Gisborne	nn	16	SENT_400	[p20l1704t1863r1953b1913],
16	Street	NNP	LOCATION	Street	appos	1	SENT_400	[p20l1979t1863r2149b1922],
17	,	,	O	,	_	0	SENT_400	[p20l1979t1863r2149b1922],
18	East	NNP	O	East	nn	19	SENT_400	[p20l6t1952r120b2001],
19	Melboume	NNP	O	Melboume	appos	1	SENT_400	[p20l139t1951r441b2010],
20	,	,	O	,	_	0	SENT_400	[p20l139t1951r441b2010],
21	Victoria	NNP	LOCATION	Victoria	appos	1	SENT_400	[p20l464t1951r678b2001],
22	3002	CD	NUMBER	3002	num	21	SENT_400	[p20l699t1952r842b2010],
23	,	,	O	,	_	0	SENT_400	[p20l699t1952r842b2010],
24	Australia	NNP	LOCATION	Australia	appos	1	SENT_400	[p20l866t1951r1115b2001],
25	.	.	O	.	_	0	SENT_400	[p20l866t1951r1115b2001],

1	E	NN	O	e	nn	3	SENT_401	[p20l1138t1951r1347b2001],
2	—	CD	NUMBER	—	num	3	SENT_401	[p20l1138t1951r1347b2001],
3	mail	NN	O	mail	_	0	SENT_401	[p20l1138t1951r1347b2001],
4	:	:	O	:	_	0	SENT_401	[p20l1138t1951r1347b2001],
5	abedifarshad@yahoo.com	NNP	O	abedifarshad@yahoo.com	dep	3	SENT_401	[p20l1377t1951r2135b2015],
6	.	.	O	.	_	0	SENT_401	[p20l1377t1951r2135b2015],

1	l2l	NN	O	l2l	_	0	SENT_402	[p20l2015t2176r2136b2246],

